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ABSTRACT 
 
The marine environment is a tremendous source of biologically active 
metabolites, representing a valuable source with great potential for the 
development of pharmaceuticals. Marine-derived fungi are known to produce 
structurally unique secondary metabolites, and since the beginning of the 1990s, a 
sharp and exponential increase in the number of reported relevant biologically 
active metabolites occurred.  
 
The aim of this study was to isolate and evaluate the biological activity of 
secondary metabolites produced by marine derived-fungi collected from the Gulf of 
Thailand. To achieve this aim, three marine sponge-associated fungi, Emericella 
variecolor KUFC 7092, Eurotium cristatum KUFC 7356 and Neosartorya 
paulistensis KUFC 7897, and the diseased coral-derived fungus Neosartorya 
laciniosa KUFC 7896, were investigated. 
  
Chemical investigation of the ethyl acetate extract of the culture of E. 
variecolor KUFC 7092, isolated from the marine sponge Clathria reinwardti, 
resulted in the isolation of five known compounds, ergosterol, ergosterol peroxide, 
orcinol, 1H-indole-3-carboxylic acid and cyclo-(L-tryptophyl-L-phenylalanyl). 
  
A new diketopiperazine dimer, eurocristatine, was isolated in addition to 
nine known metabolites including the anthraquinones erythroglaucin, physcion, 
catenarin, emodin and questin, and the diketopiperazine alkaloids echinulin, 
neoechinulin, neoechinulin A and neoechinulin E, from the ethyl acetate extract of 
the culture of the sponge-associated fungus E. cristatum KUFC 7356. The 
diketopiperazine derivatives, including the new diketopiperazine dimer, were 
evaluated for their in vitro growth inhibitory activity against MCF-7 (breast 
adenocarcinoma), NCI-H-460 (non-small lung cancer) and A375-C5 (melanoma) 
cell lines, and the results showed that they were inactive against the three cell 
lines. Both anthraquinones and diketopiperazine alkaloids were also evaluated for 
their antifungal activity against the human pathogenic fungi Candida albicans, 
Aspergillus fumigatus and Trichophyton rubrum, as well as for their antibacterial 
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activity against the human pathogenic bacteria Staphylococcus aureus, 
Escherichia coli and Pseudomonas aeruginosa, but no antimicrobial activity was 
registered. 
 
The ethyl acetate extract of the culture of the diseased coral-derived fungus 
N. laciniosa KUFC 7896 furnished a new tryptoquivaline analogue, tryptoquivaline 
T, in addition to the previously described tryptoquivaline L, 3’-(4-oxoquinazolin-3-
yl)spiro[1H-indole-3,5’-oxolane]-2,2’-dione, and the meroditerpenes chevalone B, 
and aszonapyrones A and B. Aszonapyrones A and B were also evaluated for 
their in vitro growth inhibitory activity against MCF-7, NCI-H-460 and A375-C5 cell 
lines. Aszonapyrone A displayed strong growth inhibitory activity against the three 
cell lines with GI50 values of 13.6 ± 0.9 µM, 11.6 ± 1.5 µM and 10.2 ± 1.2 µM, for 
MCF-7, NCI-H-460 and A375-C5, respectively, while aszonapyrone B was inactive 
at the highest concentration tested (150 µM) 
 
Chemical investigation of the ethyl acetate extract of the culture of the 
marine sponge-associated fungus N. paulistensis KUFC 7897, resulted in isolation 
of a new aszonapyrone analogue which we have named sartorypyrone C, in 
addition to five known metabolites including tryptoquivalines L, H, F, 3′-(4-
oxoquinazolin-3-yl)spiro[1H-indole-3,5′-oxolane]-2,2′-dione and 4(3H)-
quinazolinone.  
 
In addition to the metabolites isolated from N. paulistensis KUFC 7897, 
tryptoquivaline T and aszonapyrones A and B isolated from N. laciniosa KUFC 
7896, were also tested for their antibacterial activity against four reference strains 
(Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Pseudomonas 
aeruginosa), as well as the environmental multidrug-resistant isolates.  Only 
aszonapyrone A exhibited significant antibacterial activity as well as synergism 
with antibiotics against the Gram-positive multidrug-resistant strains. Additionally, 
aszonapyrone A was also found to inhibit the biofilm formation in both reference 
strains and multi-drug resistant isolates.  
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 O ambiente marinho é um importante reservatório de metabolitos 
bioactivos, representando uma fonte valiosa e com enorme potencial para a 
descoberta e desenvolvimento de novos fármacos. Os fungos marinhos são 
conhecidos por produzirem metabolitos secundários com estruturas químicas 
únicas e, desde o início dos anos 90 houve um aumento acentuado e exponencial 
no número de metabolitos com atividade biológica relevante.  
 
 Os objetivos deste estudo foram o isolamento e avaliação da atividade 
biológica de metabolitos secundários produzidos por fungos marinhos coletados 
no Golfo da Tailândia. Para esse efeito foram investigados três fungos associados 
com esponjas marinhas, Emericella variecolor KUFC 7092, Eurotium cristatum 
KUFC 7356 e Neosartorya paulistensis KUFC 7897, bem como um fungo 
associado com um coral infetado, Neosartorya laciniosa KUFC 7896. 
 
 O estudo químico do extrato de acetato de etilo da cultura de E. variecolor 
KUFC 7092, isolado da esponja marinha Clathria reinwardti, resultou no 
isolamento de cinco compostos conhecidos, ergosterol, peróxido de ergosterol, 
orcinol, ácido 1H-indole-3-carboxílico e ciclo-(L-triptofil-L-fenilalanil). 
 
 Um novo dímero de dicetopiperazina, eurocristatine, foi isolado além de 
nove metabolitos conhecidos incluindo as antraquinonas eritroglaucina, fisciona, 
catenarina, emodina e questina, e os alcaloides dicetopiperazínicos equinulina, 
neoequinulina, neoequinulina A e neoequinulina E, do extrato de acetato de etilo 
da cultura de E. cristatum KUFC 7356 isolado de uma esponja marinha. Foi 
efetuada a avaliação in vitro da atividade citotóxica dos derivados 
dicetopiperazínicos, incluindo o novo dímero dicetopiperazínico, sobre as linhas 
celulares MCF-7 (adenocarcinoma da mama), NCI-H-460 (cancro de pulmão de 
não-pequenas células) e A375-C5 (melanoma), tendo-se verificado que todos os 
compostos testados foram inativos nas três linhas celulares. Foi também avaliada 
a atividade antifúngica das antraquinonas e dos alcaloides dicetopiperazínicos 
contra os fungos patogénicos para o humano, Candida albicans, Aspergillus 
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fumigatus e Trichophyton rubrum, assim como a sua atividade antibacteriana 
contra as bactérias patogénicas para o humano, Staphylococcus aureus, 
Escherichia coli e Pseudomonas aeruginosa, mas não se verificou qualquer 
atividade antimicrobiana. 
 
 Do extrato de acetato de etilo da cultura de N. laciniosa KUFC 7896, 
isolado de um coral infetado, foi isolado um novo análogo da triptoquivalina, 
triptoquivalina T, além de triptoquivalina L, 3’-(4-oxoquinazolin-3-il)espiro[1H-
indole-3,5’-oxolano]-2,2’-diona, e os meroditerpenos chevalona B, e as 
aszonapironas A e B. Efetuou-se a avaliação da atividade citotóxica in vitro das 
aszonapironas A e B contra as linhas celulares MCF-7, NCI-H-460 e A375-C5. A 
aszonapirona A exibiu forte atividade nas três linhas celulares com valores de IC50 
de 13.6 ± 0.9 µM, 11.6 ± 1.5 µM and 10.2 ± 1.2 µM, para MCF-7, NCI-H-460 and 
A375-C5 respetivamente, enquanto a aszonapirona B foi inativa na maior 
concentração testada (150 µM). 
 
 O estudo químico do extrato de acetato de etilo da cultura de N. 
paulistensis KUFC 7897 isolado de uma esponja marinha, resultou no isolamento 
da sartorypirona C, um novo análogo das aszonapironas, além de cinco 
compostos conhecidos incluindo as triptoquivalinas L, H e F, 3’-(4-oxoquinazolin-
3-il)espiro[1H-indole-3,5’-oxolano]-2,2’-diona e 4(3H)-quinazolinona. 
 
 Além dos metabolitos isolados da cultura N. paulistensis KUFC 7897, os 
compostos triptoquivalina L e aszonapironas A e B, isolados da cultura N. 
laciniosa KUFC 7896, foram também avaliados pela sua atividade antibacteriana 
em quatro estirpes-referência (Staphylococcus aureus, Bacillus subtilis, 
Escherichia coli e Pseudomonas aeruginosa), assim como em estirpes multi-
resistentes contra fármacos isoladas do meio ambiente. Apenas a aszonapirona A 
apresentou atividade antibacteriana significativa assim como sinergismo com 
antibióticos contra as estirpes Gram-positivas multi-resistentes a fármacos. 
Adicionalmente, verificou-se que a aszonapirona A também causou inibição na 
formação de biofilme nas estirpes-referência, assim como nas estirpes multi-
resistentes a fármacos.  
 
 xxix 
 
LIST OF ABBREVIATIONS 
 
LIST OF ABBREVIATIONS 
 
[3H]EBOB [3H]Ethynylbicycloorthobenzoate 
[M+H+] Pseudo-molecular ion (Positive ion mode) 
[α]20D Specific optical rotation at 20 ºC for D (sodium) line 
[α]25D Specific optical rotation at 25 ºC for D (sodium) line 
® Register or Trademark 
Å Angstrom 
Ac Acetyl 
Ac2O Acetic anhydride 
ADC Antibody Drug Conjugate 
Akt Protein kinase B 
AMP Ampicillin 
amu Atomic mass unit 
Ara-A Arabino furanosyladenine 
Ara-C Arabinosyl cytosine 
ASK-1 Apoptosis Signal-regulating Kinase 1 
ATCC American Type Culture Collection 
Bcl-2 B-cell lymphoma 2 
BIC Biofilm Inhibitory Concentration 
brd Broad doublet 
brs Broad singlet 
C/EBPβ CCAAT-Enhancer-binding protein β 
Calcd. Calculated 
cAMP Cyclic adenosine monophosphate 
CCDC Cambrige Crystallographic Data Centre 
CCR5 C-C Chemokine Receptor type 5 
CDCl3 Deuterated chloroform 
CDP Cyclodipeptide Synthase 
CFU Colony-Forming Unit 
CH2Cl2 Dichloromethane 
CHCl3 Chloroform 
CIP Ciprofloxacin 
 xxx 
 
LIST OF ABBREVIATIONS 
 
CLSI Clinical Laboratory Standards Institute  
CO2 Carbon dioxide 
CoA Coenzyme A 
ConA Concanavalin A 
COSY Correlated Spectroscopy 
COX-2 Cyclooxygenase 2 
CREB cAMP Response Element-Binding protein 
CTX Cefotaxime 
CXCR4 Chemokine (C-X-C) receptor 
CYA Czapek Yeast Autolysate Agar 
CZA Czapek’s Agar 
dd Double doublet 
ddd Double double doublet 
DEPT Distortionless Enhancement by Polarization Transfer 
DHA Docosahexaenoic Acid 
DMSO Dimethylsulfoxide 
DMSO-d6 Deuterated dimethylsulfoxide 
DNA Deoxyribonucleic Acid 
DPPH 2,2-Diphenylpicrylhydrazyl 
dt Double triplet 
E Erythromycin 
EMA European Medicines Agency 
EPA Eicosapentaenoic Acid 
ERCC1 Excision Repair Cross-Complementation group 1 
ERα Estrogen Receptor α 
ESI Electrospray Ionization 
EtOAc Ethyl acetate 
EU European Union 
FBS Fetal Bovine Serum 
FDA Food and Drug Administration 
FGFR2 Fibroblast Growth Factor Receptor 2 
FIC Fractional Inhibitory Concentration 
g Gram 
 xxxi 
 
LIST OF ABBREVIATIONS 
 
GABA Gamma-aminobutyric acid 
GC Gas Chromatography 
GI50 Half maximal growth inhibitory concentration 
H2O Water 
hACAT Cultured Human Keratinocyte 
HeLa Henrietta Lacks 
HMBC Heteronuclear Multiple Bond Correlation 
HRMS High Resolution Mass Spectrometry 
HSQC Heteronuclear Single Quantum Coherence 
HSV Herpes simplex Virus 
HUVEC Human Umbilical Vein Endothelial Cells 
Hz Hertz 
IC50 Half maximal inhibitory concentration 
ICAM-1 Intercellular Adhesion Molecule 1 
ICTF International Commission on the Taxonomy of Fungi 
IgG Immunoglobulin G 
IL-1β Interleukin 1β 
IL-6 Interleukin 6 
iNOS Inducible Nitric Oxide Synthase 
IR Infrared 
J Coupling constant in Hz 
JNK Jun N-terminal Kinase 
KDR/Flk-1 Fetal Liver Kinase 1 
KUFC Kasetsart University Fungal Culture 
LC Liquid Chromatography 
Lp-PLA2 Lipoprotein-associated phospholipase A2 
LPS Lipopolysaccharide 
m Multiplet 
m/z Mass per charge 
MAO Monoamine Oxidase 
MAPK Mitogen-Activated Protein Kinase 
MBC Minimum Bactericidal Concentration 
Me Methyl 
 xxxii 
 
LIST OF ABBREVIATIONS 
 
Me2CO Acetone 
MEA Malt Extract Agar 
MeOH Methanol 
MetAP2 Methionine aminopeptidase-2 
MH Mueller-Hinton Agar 
MHB Mueller-Hinton Broth 
MHz Mega hertz 
MIC Minimum Inhibitory Concentration 
MIP Macrophage Inflammatory Protein 
MKK6 Mitogen-activated protein kinase kinase 6 
MKK7 Mitogen-activated protein kinase kinase 7 
mm Millimeter 
MMAE Monomethyl Auristatin E 
MMAF Monomethyl Auristatin F 
MMP-2 Matrix Metalloproteinase 2 
MMP-9 Matrix Metalloproteinase 9 
MOPS 3-(N-morpholino)propanesulfonic acid 
mp Melting point in ºC 
MPP+ 1-Methyl-4-phenylpyridinium 
MRSA Methicillin-resistant Staphylococcus aureus 
MS Mass Spectrometry 
NA Not Available 
Na2SO4 Sodium sulfate 
NAD(P)H Nicotinamide Adenine Dinucleotide Phosphate 
NaHCO3 Sodium bicarbonate 
NCE  New Chemical Entities 
NCI National Cancer Institute 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells 
NK-1 Human Neurokinin Receptor 1 
nm Nanometer 
NMR Nuclear Magnetic Resonance 
NO Nitric oxide 
NOESY Nuclear Overhauser Effect Spectroscopy 
 xxxiii 
 
LIST OF ABBREVIATIONS 
 
NRPS Nonribossomal Peptide Synthetase 
NSCLC Non-Small Cell Lung Cancer 
ºC Celsius degrees 
OD595 Optical Density at 595 nm 
ORTEP Oak Ridge Thermal Ellipsoid Plot 
OX Oxacillin 
PBS Phosphate Buffered Saline 
pcPTase Polycyclic polyketide prenyltransferase 
PEPCK Phosphoenolpyruvate carboxykinase 
PGE2 Prostaglandin E2 
P-gp P-glycoprotein 1 
PKCα Protein Kinase C α 
PTLC Preparative Thin Layer Chromatography 
PTP1B Protein-Tyrosine Phosphatase 1B 
Py Pyridine 
q Quartet 
QToF Quantum Time of Flight 
RAPD Random Amplified Polymorphic DNA 
ROS Reactive Oxygen Species 
RPMI Roswell Park Memorial Institute  
s Singlet 
S Streptomycin 
SAR Structure-Activity Relationship 
SEM Scanning Electron Microscope 
SEM Standard error of the mean 
Si gel Silica gel 
SP Substance P 
sp. Species (singular)  
spp. Species (plural) 
SRB Sulforhodamine B 
SSF Solid State Fermentation 
t Triplet 
TGF-β1 Transforming Growth Factor β1 
 xxxiv 
 
LIST OF ABBREVIATIONS 
 
TLC Thin Layer Chromatography 
TNF-α Tumor Necrosis Factor α  
TSB Tryptic Soy Broth 
UPLC Ultra Performance Liquid Chromatography 
US United States 
UV Ultraviolet 
VA Vancomycin 
VEGF Vascular Endothelial Growth Factor 
VRE Vancomycin-resistant Enterococcus 
δ Chemical shift value in ppm 
ε Molar absorptivity (molar extinction coefficient) 
ΣFIC FIC index 
 
 
 
 xxxv 
 
STATEMENT OF THE OBJECTIVES 
 
STATEMENT OF THE OBJECTIVES 
 
 The main objective of the present study is to investigate the secondary 
metabolites produced by cultures of the marine sponge and coral-associated fungi 
for evaluation of their anticancer, antibacterial and antifungal activities. As our 
group has been focusing mainly on the constituents of the genus Neosartorya, 
investigation of the secondary metabolites of the marine-derived Neosartorya 
species will allow us to compare the chemical profiles of the marine strains with 
their terrestrial counterparts. Besides, this comparative study will provide an 
additional tool, useful for a taxonomic characterization of the genus, through a 
chemotaxonomic analysis (Frisvad et al., 2008).  
 To achieve these objectives, the work was divided according to Scheme 1: 
 
  
 
Scheme 1. Schematic diagram of the research process. 
 
I. Collection, Isolation, Identification and Culture of the Marine 
Fungi 
 
The marine sponges and coral were collected by scuba diving in the Gulf of 
Thailand and the Andaman Sea. 
Identification of the fungi was based on macro- and microscopic 
characteristics observed under light and scanning electron microscopes (SEM) as 
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well as with molecular data such as DNA GC content and RAPD (random 
amplified polymorphic DNA) fingerprint (Glass and Donaldson, 1995). 
 
II. Isolation and Identification of the Secondary Metabolites 
 
The crude ethyl extracts of the culture of the marine fungi were fractionated 
by column chromatography, and the purification of the metabolites from the 
column fractions was carried out by PTLC, and/or crystallization. The structures of 
the pure compounds were established by 1D and 2D NMR spectral analysis (1H, 
13C, DEPT 90º and 135º, COSY, HSQC, HMBC, NOESY), HRMS, IR, UV, and X-
ray crystallography when the compounds exist in crystalline form. 
 
III. Biological Activity Evaluation 
 
 a) Screening of antitumor activity: The effects of the compounds on the 
growth of human tumor cell lines were evaluated according to the procedure 
adopted by the National Cancer Institute (NCI, US) in the “In vitro Anticancer Drug 
Discovery Screen” using the protein-binding dye sulforhodamine B to assess cell 
growth (Skehan et al., 1990). 
 
b) Screening of antifungal activity: The compounds were evaluated for 
their growth inhibitory effects against yeasts, filamentous fungi and filamentous 
dermatophytes by a dilution method (Wayne, 2002a; 2002b). 
 
c) Screening of antibacterial activity: The compounds were tested for 
their antibacterial activity against human pathogenic bacteria (including multidrug-
resistant isolates) (Johnson et al., 2002; Odds, 2003; Wayne, 2011). 
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1.1. General Introduction 
 
Since ancient times, Nature played a major role as the main source of 
medicinal extracts used, as well as the source of several natural products that led 
to the development of various drugs currently used for the treatment of a wide 
spectrum of diseases. Based on empirical knowledge, natural product extracts, 
mainly plant-derived, have formed the basis of traditional medicine systems. 
However, it was only in the 20th century that research focused on the identification 
and characterization of the compounds responsible for the medicinal properties. 
The urgent need of new therapeutic alternatives, mainly for the treatment of 
cancer and infectious diseases, as well as the new chemical entities (NCE) decline 
in drug development pipelines, led to the rekindling of interest in “rediscovering 
natural products” focusing in alternative sources such as the oceans. It is clear 
that Nature will continue to be a major source of new structural leads (Cragg and 
Newman, 2013).  
Berkowitz’s comment in Rouhi’s report clearly states the potential and 
essential role of natural products in therapeutics:  “We would not have the top-
selling drug class today, the statins; the whole field of angiotensin antagonists and 
angiotensin converting-enzyme inhibitors; the whole area of immuno-
suppressives; nor most of the anticancer and antibacterial drugs. Imagine all of 
those drugs not being available to physicians or patients today.” (Rouhi, 2003).  
 
1.1.1. Natural Products: An Established and Continuing 
Source of Novel Drug Leads 
 
Despite the millenary use of natural medicinal products, research 
concerning the isolation and use of pure substances in therapeutics dates from the 
post-Industrial Revolution period in the 19th century. The emergence of natural 
products clearly reached its climax in the last century, with the discovery of several 
drugs covering a wide range of diseases (Cragg and Newman, 2013).  
The discovery of penicillin G (1) (Figure 1) from the filamentous fungus 
Penicillium notatum by Fleming in the late 1920s, and the observation of the broad 
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therapeutic use of this agent in the 1940s, was a landmark discovery that ushered 
in a new Era in medicine, “The Golden Age of Antibiotics”, and promoted the 
intensive investigation of Nature as a source of novel bioactive agents (Walsh, 
2004). The opium poppy (Papaver somniferum) is another classic and valuable 
example being the source of papaverine (2) (Figure 1), which formed the basis for 
the antihypertensive agent verapamil. However this plant is better known as a 
source of the opiate analgesic alkaloid morphine (3) (Figure 1).  
Most of the cholesterol lowering agents (statins) are synthetic analogues 
derived from the fungal metabolites mevastatin (4) (Figure 1), isolated from 
Penicillium citrinum (Endo et al., 1976), as well as lovastatin (5) (Figure 1) isolated 
from Monascus ruber and Aspergillus terreus (Buckland et al., 1989; Negishi et al., 
1986). Two lipid-regulating drugs of this class, atorvastatin and simvastatin, 
feature prominently in the top ten drugs by cost, led by Lipitor® (atorvastatin) with 
an annual sale reaching 7.2 billion US dollars in 2010, only in the US (Kleinrock, 
2011).  
 
1 2
3
4 R = H
5 R = Me 6
 
 
Figure 1. Some examples of natural drug leads approved for use in Medicine. 
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Paclitaxel (6) (Taxol®) (Figure 1), the exciting plant-derived chemotherapy 
drug was originally isolated from the Pacific yew tree Taxus brevifolia. The 
discovery in 1979 of its mode of action, through promotion of the assembly of 
tubulin into microtubules by Schiff and Horwitz and its report in 1980 (Schiff and 
Horwitz, 1980), was a key milestone in the lengthy development process, being 
approved for clinical use against ovarian cancer in 1992 and against breast cancer 
in 1994. Recently, a new semi-synthetic derivative, cabazitaxel (Jevtana®) 
developed by Sanofi-Aventis, was approved by the FDA for the treatment of 
hormone-refractory prostate cancer 
(http://www.cancer.gov/cancertopics/druginfo/fda-cabazitaxel, accessed on 24th 
November 2013). 
During the last century, natural products research led to the development of 
several drugs currently used in Medicine against a wide range of diseases. In fact, 
the most recent survey by Newman and Cragg (2012) analyzing the sources of 
new drugs over the period 01/1981 – 12/2010, indicates that while 66% of the 
1073 small molecule NCEs are formally synthetic, only 36% can be classified as 
truly synthetic or devoid of natural inspiration.  Furthermore, when considering 
disease categories, for the 1073 small molecules, 69% of anti-infectives and 75% 
of anticancer drugs introduced into the market can be traced back as naturally 
derived or inspired. 
The role of natural sources in the finding of novel drug leads is 
unquestionable and since there are still many unexplored resources from Nature, 
an enormous chance for finding new or less investigated organisms, and thereby 
new lead structures still exists (Aly et al., 2011; Hill, 2013). 
 
1.2. Ocean as an Unlimited Source for Novel Drugs  
 
Comprising almost three quarters of the Earth’s surface, oceans represent a 
rich source of both biological and chemical diversity, containing nearby 200 000 
catalogued species, representing only ~9% from the estimated value of 2.2 million 
of species dwelling in ocean depths (Mora et al., 2011). Some marine habitats are 
known to be particularly numerous in species, especially tropical marine reefs, 
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which represent one of the most diverse ecosystems encountered on Earth, 
comparable in diversity to tropical rain forests. 
Marine organisms growing in a unique and stressful habitat can develop the 
ability to produce unusual and structurally complex secondary metabolites. In the 
marine environment, where a different environment results in a different 
transcriptome, proteosome, and finally a different metabolome which allows an 
organism to survive, one can speculate that different secondary metabolites might 
be the result of special requirements to adapt to such an extreme environment 
(Firn and Jones, 2000). Almost all forms of life in the marine environment have 
been investigated for their natural products content, representing a valuable 
source of novel compounds with great potential as pharmaceuticals, nutritional 
supplements, cosmetics, agrochemicals and enzymes, many of them with a strong 
potential market value (Blunt et al., 2013; Kijjoa and Sawangwong, 2004).  
Bioactive marine natural products can be defined as biologically active 
products, including primary and secondary metabolites, from marine sources and 
despite the increasing interest in marine primary metabolites such as lipids, 
enzymes and complex heteropolysaccharides, the main focus and potential rely on 
the secondary metabolites. Over 22 000 structurally diverse marine metabolites 
have been isolated and characterized over the last fifty years. (Blunt et al., 2013; 
Hu et al., 2011). Main areas of research on marine natural products are devoted to 
the discovery of new anticancer and antimicrobial drugs, somehow related to the 
severe mortality and morbidity related to cancer, as well as the increasing drug 
resistant bacterial pathogens (Blunt et al., 2013; Hill, 2013; Mayer et al., 2013). 
However, the study of marine natural products so far has not only allowed the 
development of new drug leads, but also the identification of new molecular 
targets for therapeutic intervention (Amador et al., 2003). 
Drug discovery from marine sources seems to have benefited from a 
renaissance in the past ten years, which was made possible by new developments 
in analytical technology, spectroscopy and high-throughput screening (Molinski, 
2010). Additionally, the recognized potential from marine environment led to 
significant efforts to isolate and identify new marine-derived natural products over 
the last decade by collaboration of both pharmaceutical companies and academic 
institutions, accompanied by funding supports from governmental agencies 
(Bórrensen et al., 2010).  
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In 2010, the global market for marine biotechnology products and 
processes was estimated in €2.8 billion with a cumulative annual growth rate of 4-
5 %. Less conservative estimates predicted an annual growth in the sector of even 
up to 10-12 % in the following years, considering the huge potential and high 
expectations for further development of this sector at a global scale (Bórrensen et 
al., 2010). 
The annual reviews on marine natural products by Blunt et al. (2013 and 
previous reviews) as well as the MarinLit database 
(http://www.rsc.org/Publishing/CurrentAwareness/MarinLit.asp), established in 
1970’s by Blunt and Munro and recently acquired by the Royal Society of 
Chemistry, clearly states the unequivocal potential of marine organisms as 
sources of novel drug leads, and an overview of the impressive variety of marine-
derived compounds.  
 
1.2.1. Clinical Pipeline of Marine Pharmaceuticals 
  
The first described marine natural product to enter clinical trials as an 
antineoplastic agent was didemnin B (7) (Figure 2), a cyclic depsipeptide isolated 
from the tunicate Trididemnum solidum (Rinehart Jr. et al., 1981).  
 
7  
 
Figure 2. Structure of didemnin B (7). 
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The compound displayed good antitumor activity against B16 melanoma, 
and moderate activity against M5076 sarcoma and P388 leukemia cell lines, as 
well as good antiviral and potent immunosuppressive activities (Chun et al., 1986). 
Although the Phase II clinical trials against kidney adenocarcinoma, advanced 
epithelial ovarian cancer, and metastatic breast cancer have been concluded, 
didemnin B (7) exhibited high toxicity and no further trials were held (Nuijen et al., 
2000).  
Marine clinical pharmaceutical pipeline (Table 1) currently consists of seven 
FDA approved drugs (Figures 3a and 3b) and ten compounds in Phase I, II and III 
of clinical development (http://marinepharmacology.midwestern.edu/ accessed on 
18th October 2013).  
Cytarabine (Ara-C, arabinosyl cytosine) (8) (Figure 3a) is a synthetic 
pyrimidine nucleoside which was developed from spongothymidine (9) (Figure 3a), 
originally isolated from the Caribbean sponge Tethya crypta (Bergmann and 
Feeney, 1951). The compound is a cytotoxic agent which, when converted 
intracellularly to cytosine arabinoside triphosphate, competes with the physiologic 
substrate deoxycytidine triphosphate, resulting in both inhibition of DNA 
polymerase and DNA synthesis.  Cytarabine (8) became the first marine-derived 
drug that received a FDA approval in 1969, and is currently available as either 
conventional cytarabine (Cytosar-U®) or liposomal formulations (Depocyt®). 
Conventional cytarabine (Cytosar-U®) is for treatment of acute lymphocytic 
leukemia, acute myelocytic leukemia and blast crisis phase of chronic 
myelogenous leukemia and meningeal leukemia, while liposomal cytarabone 
(Depocyt®) is indicated for intrathecal treatment of lymphomatous meningitis 
(Absalon and Smith, 2009; Thomas, 2009; 
http://www.cancer.gov/cancertopics/druginfo/cytarabine accessed on 3rd 2013).  
Vidarabine (Ara-A, arabino furanosyladenine) (10) (Figure 3a) is a synthetic purine 
nucleoside, developed from the nucleoside spongouridine (11) (Figure 3a), also 
isolated from the same sponge (Bergmann and Feeney, 1951). Although its 
antiviral mechanism of action has not been established, vidarabine (10) appears to 
interfere with the early steps of viral DNA synthesis.  
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Table 1. Marine pharmaceuticals: Current pipeline 
(http://marinepharmacology.midwestern.edu/ accessed on 18th October 2013) 
Clinical 
status 
Compound name 
(Trademark) 
Marine 
organism
a
 
Chemical 
class 
Disease area C / I
b
 
FDA 
EMA 
Approved 
Cytarabine 
(Cytosar-U
®
) 
Sponge Nucleoside Cancer 1 
Vidarabine (Vira-A
®
) Sponge Nucleoside Antiviral NA 
Ziconotide (Prialt
®
) Cone snail Peptide Pain 2 
Eribulin mesylate 
(Halaven
®
) 
Sponge Macrolide Cancer 3 
Omega-3-acid ethyl 
esters (Lovaza
®
) 
Fish ω-3 fatty 
acids 
Hyper- 
-triglyceridemia 
4 
Trabectedin (ET-743) 
(Yondelis
®
) 
Tunicate Alkaloid Cancer 5 
Brentuximab vedotin 
(Adcentris
®
) 
Mollusk  
cyanobacterium 
ADC 
(MMAE) 
Cancer 6 
Phase III Plitidepsin (Aplidin
®
) Tunicate Depsipeptide Cancer 5 
Phase II 
DMXBA Worm Alkaloid Schizophrenia 7 
PM00104 (Zalypsis
®
) Mollusk Alkaloid Cancer 5 
PM01183 Tunicate Alkaloid Cancer 5 
CDX-011 Mollusc  
cyanobacterium 
ADC 
(MMAE) 
Cancer 8 
Phase I 
Marizomib 
(Salinosporamide A) 
Bacterium β-lactone-γ-
lactam 
Cancer 9 
PM060184 Sponge Polyketide Cancer 5 
Bryostatin Bryozoan Macrolide 
lactone 
Cancer 10 
SGN-75 Mollusk  
cyanobacterium 
ADC (MMAF) Cancer 6 
ASG-5ME Mollusk  
cyanobacterium 
ADC 
(MMAE) 
Cancer 6 
 
a
The marine pharmaceuticals pipeline consists of natural products, analogs or derivatives of compounds produced by this 
marine organism. 
b
C / I (Company or Institution): 1 Bedford Laboratories; 2 Azurpharma; 3 Eisai Inc; 4 GlaxoSmithKline; 5 Pharmamar; 6 
Seattle Genetics; 7 University of Colorado Health Sciences Center; 8 Celldex Therapeutics; 9 Phase I Clinical Trial 
sponsored by Triphase Research and Development Corporation; 10 National Cancer Institute. 
Abbreviations: FDA: Food and Drug Administration; EMA: European Medicines Agency; NA: Not available; ADC: 
Antibody drug conjugate; MMAE: Monomethyl auristatin E; MMAF: Monomethyl auristatin F. 
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Vidarabine (Vira-A®) received the FDA approval in 1976 and is currently 
used as a 3% opththalmic ointment for the treatment of acute keratoconjunctivitis, 
recurrent epithelial keratitis caused by herpes simplex virus type 1 and 2, and 
superficial keratitis caused by herpes simplex virus that has not responded to 
topical idoxuridine (Herplex®) (Martindale, 2012). 
Ziconotide (12) (Figure 3a) (Prialt®) is the synthetic equivalent of a naturally 
occurring 25-amino acid peptide, ω-conotoxin MVIIA (13) (Figure 3a), originally 
isolated from the venom of the fish-hunting marine snail Conus magus (Olivera, 
2000). Ziconotide (12) is a potent analgesic with a completely novel mechanism of 
action (Bingham et al., 2010), reversibly blocking N-type calcium channels located 
on primary nociceptive afferent nerves in the superficial layers of the dorsal horn of 
the spinal cord. Binding of ziconotide (12) to presynaptic N-type calcium channels 
reduces the release of excitatory neurotransmitter from the primary afferent nerve 
terminals (McGivern, 2006). Ziconotide (12) received the FDA approval in 2004, 
and is currently used for the management of severe chronic pain in patients with 
cancer or AIDS for whom intrathecal therapy is warranted and who are intolerant 
or refractory to other treatments such as systemic analgesics, adjunctive therapies 
or morphine (Pope and Deer, 2013; Rauck et al., 2009; Staats et al., 2004).   
In 2001, trabectedin (14) (Figure 3a) (Yondelis®), also known as 
ecteinascidin-743 (ET-743), a tetrahydroisoquinolone alkaloid originally extracted 
from the tunicate Ecteinascidia turbinata, was developed by PharmaMar (Rinehart 
et al., 1990, 1991; Wright et al., 1990). Although the mechanism of action is not 
fully understood, it is well known that trabectedin (14) binds by a covalent 
reversible bond to the DNA minor groove (Zewail-Foote and Hurley, 2001). 
Yondelis® was approved in EU for the treatment of soft tissue sarcoma (Verweij, 
2009), and later for the treatment of relapsed platinum-sensitive ovarian cancer 
(Yap et al., 2009). 
Halichondrin B (15) (Figure 3a), a polyether macrolide originally isolated 
from the marine sponge Halichondria okadai in the late 1980s, displayed potent 
anticancer activity in preclinical animal models (Fodstad et al., 1996; Hirata and 
Uemura 1986). Eribulin mesylate (16) (Figure 3a), a synthetic analog of 
halichondrin B (15), developed by Esai Pharmaceuticals, is a non-taxane 
microtubule inhibitor currently used in US, EU and Asia, under the trade name 
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Halaven® for the treatment of metastatic breast cancer after two or more 
chemotherapy regimens for metastatic disease (Martindale, 2012). 
 
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys-NH2
13
15
16
14
12
8 9   R = Me
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10
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys-NH2
 
 
Figure 3a. Marine natural products or derivatives thereof approved for use by FDA 
or EMA. 
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 Lovaza®, a highly purified and concentrated ω-3 polyunsaturated fatty acids 
preparation obtained from fish oils mainly comprised of EPA (20:5(n-3)) (17) and 
DHA (22:6(n-3)) (18) (Figure 3b), was approved in 2004 by FDA as an adjunct to 
diet in adults with high triglyceride levels (≥500 mg/dL) (Koski, 2008). It was 
commercialized in EU under the tradename Omacor®, and is also used in coronary 
arteriosclerosis, familial combined hyperlipidemia as well as for secondary 
prevention after myocardial infarction (Martindale, 2012). 
 
20
19
17
18
 
 
Figure 3b. Marine natural products or derivatives thereof approved for use by FDA 
or EMA. 
 
Brentuximab vedotin is a CD30-directed antibody-drug conjugate (ADC) 
consisting of three components: the chimeric IgG1 antibody cAC10 which is 
specific for human CD30, the microtubule disrupting agent monomethyl auristatin 
E (19) (Figure 3b) (MMAE), and a protease-cleavable linker that covalently 
attaches MMAE (19) to cAC10. The microtubule disrupting agent MMAE (19) 
binds to tubulin, disrupting the microtubule network which leads to cell cycle arrest 
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and apoptotic death of the cells (Watanabe et al., 2007). Brentuximab vedotin 
(Adcentris®) was approved by FDA for the treatment of anaplastic large T-cell 
systemic malignant lymphoma and Hodgkin’s disease (Martindale, 2012).  MMAE 
(19) is a synthetic analog of dolastatin 10 (20) (Figure 3b) originally isolated from 
the sea hare Dolabella auricularia, and recently from a marine cyanobacterium 
Symploca sp. (Luesch et al., 2001). 
It is expected that the number of candidates to enter clinical trials in a near 
future is vast. Only referring to the period from 2009 to 2011, the preclinical 
pharmaceutical pipeline consists of over 250 marine compounds that will enrich 
the marine clinical pharmaceutical pipeline with novel lead compounds (Mayer et 
al., 2013). Despite some limitations, the current success rate of discovery from the 
marine world, namely seven clinically approved drugs from 22 000, is significantly 
better than the industry average (Gerwick and Moore, 2012).  
 
1.2.2. Statistical Perspective on Marine Natural Products 
Research 
 
Over 22 000 structurally diverse marine metabolites have been isolated and 
characterized over the last five decades, with 1152 new compounds only for the 
year 2011 (Blunt et al., 2013).  
 
 
Figure 4. Temporal trend in the number of novel products obtained from marine 
organisms (Hu et al., 2011). 
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Before the 1980s, marine natural products discovered annually were less 
than 100, however there was an outstanding development since the mid-1980s 
(Figure 4), coincident with the development and progress of structure elucidation 
techniques (Hu et al., 2011). 
Regarding to its source, majority of novel compounds from marine 
organisms, approximately 75% were isolated from invertebrates mainly from the 
phyla Porifera (mostly sponges) but also from Coelenterate phyla (mostly coral) 
(Figure 5). Additionally, algae and microorganisms are also major sources of novel 
metabolites, with a special focus on microorganisms due to the increasing focus 
from marine natural product chemists (Hu et al., 2011). In contrast to 
macroorganisms, microorganisms represent promising natural product sources 
due to the feasible and sustainable production of large quantities of secondary 
metabolites with reasonable cost, by large-scale cultivation and fermentation of the 
source organisms (Waites et al., 2001; Xiong et al., 2013). 
 
 
Figure 5. Temporal trends in the number of novel compounds isolated from 
different marine organisms between 1985 and 2008. ▲ Marine invertebrate; ■ 
Marine algae;   Marine microorganisms (including phytoplankton) (Hu et al., 2011) 
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1.2.3. Marine Microbial Consortia as the True Metabolic 
Source of Bioactive Metabolites 
 
 
The symbiotic microbial consortia also prove to be a source of bioactive 
compounds with pharmaceutical potential, and there is a growing recognition that 
marine invertebrates and marine plants surface are usually populated with 
enormous quantities of associated or symbiotic microorganisms (Gerwick and 
Fenner, 2013). 
According to Gerwick and Fenner (2013), at the end of the year 2012, there 
were twenty-one marine derived or marine-inspired agents in the clinic or clinical 
trials (outdated data). Pie chart A (Figure 6) summarizes the collected sources of 
organisms that have yielded these agents, and reveals that marine invertebrates 
are the richest collected source (18 of 21, 86%).   
 
 
 
Figure 6. Pie charts showing A: the collected sources of the twenty-one marine-
derived or marine-inspired agents in the clinic or clinical trial, and B: the same 
agents with their demonstrated or predicted metabolic sources (Gerwick and 
Fenner, 2013). 
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However, there are strong evidences that some promising marine natural 
compounds in clinical trials, as well as some approved marine-derived agents 
supposedly produced by invertebrates, are in fact metabolic products of their 
associated microorganisms or derived from a diet of prokaryotic microorganisms 
(Gerwick and Fenner, 2013; Gerwick and Moore, 2012; Haefner, 2003; Simmons 
et al., 2008). For example, dolastatin 10 (20) (Figure 3b) which was first reported 
as a metabolite of the Indian Ocean sea hare Dolabella auricularia (Pettit et al., 
1987), was later found to be produced by the gastropod’s diet cyanobacteria of the 
genera Simploca and Lyngbya (Luesch et al., 2001; Williamson et al., 2000).  
Another example refers to a recent report by Rath and co-workers on 
metagenomic sequencing of total DNA from Ecteinascidia turbinata and 
associated microorganisms, suggesting that the individual genes responsible for 
trabectedin (14) (Figure 3a) production has microbial origin from the associated-γ-
proteobacterium Candidatus Endoecteinascidia frumentensis (Rath et al., 2011). 
As noted above, the collected source has oftentimes been shown or is strongly 
suspected of harboring or feeding upon microorganisms that are the actual 
producers of the bioactive agent. Analysis of pie chart B (Figure 6), displaying the 
actual or suspected metabolic source of the twenty-one marine derived or marine-
inspired agents in the clinic or clinical trials by the time of the end of 2012, reveals 
that marine microbes are the real metabolic jewels of the world’s oceans, 
accounting for 90% of the twenty-one marine derived agents in clinical trials and 
approved pharmaceutical agents by the end of 2012 (Gerwick and Fenner, 2013). 
The realization that microbes are the true metabolic sources of several 
relevant bioactive compounds raised hope of obtaining a sustainable and less 
limited supply of compounds for testing and drug development. 
   
1.2.4. Marine Natural Products Research and the “Supply 
Problem” 
 
 The fact that virtually no marine natural product can so far be found on the 
shelves of pharmacies is certainly not due to a limited chemical diversity of marine 
organisms. The last fifty years of research on marine natural products led to the 
development of seven agents that have entered the clinic as approved drugs, plus 
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a substantial number of candidates progressing through the development process. 
However, despite the success stories, several factors contribute to the lack of the 
development in the area of marine pharmaceuticals. Biologically active natural 
products are often produced in relatively small amounts, and often by rare animals 
whose natural populations cannot sustain the extensive collections required for 
clinical trials. Insufficient quantities of material to allow for study completion, 
difficulties of retrieving a sustained and reliable harvest of a marine organism, 
limited amounts of compounds for pre-clinical development, and difficulties in 
culturing marine organisms, are limiting factors that need to be overcome 
(Bhadury et al., 2006). To overcome such limitations, several approaches can be 
used like the chemical synthesis, mass cultivation of the producer organisms, or 
through genomic engineering, but the large scale production of metabolites with 
potential clinical relevance to meet the demand for clinical trials and drug 
development, continues to be a major challenge.  
 Despite the vast number of examples of successfully synthesized natural 
products with medicinal relevance (Nicolaou et al., 2012), not always chemical 
synthesis may be a solution due to the economically non viable approach.  
Trabectedin (ecteinascidin-743) (14) and halichondrin B (15) (Figure 3a) examples 
demonstrate that some marine natural products have such complex structures 
leading to high costs associated with their chemical synthesis (Cuevas et al., 
2000). A notable exception is ziconotide (12) (Figure 3a), which due to its peptide 
nature can be obtained in virtually unlimited amount through synthesis (Olivera, 
2000). 
 Mariculture of macroorganims is another alternative mean for the production 
of large amounts of metabolites, but rarely can be considered to be cost-effective. 
The first example of mass cultivation of sponge species for pharmaceutical 
purposes was the large-scale culture of Lissodendoryx sp. to obtain sufficient 
amount of halichondrin B (15) (Figure 3a) for clinical trials. From one metric ton of 
the sponge, only ca. 300 mg of a mixture of two halichondrin analogues could be 
obtained (Hart et al., 2000). Even with a more favorable ratio of compound 
production vs. biomass, to obtain approximately 1 g of trabectedin (14) (Figure 
3a), close to one metric ton (wet weight) of Ecteinascidia turbinata has to be 
collected and extracted, which is economically unfeasible (Mendola, 2000).  
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Organisms that could easily be cultured in large amounts would thus be ideal. 
Such organisms might well be marine microorganisms. 
 
1.3. The Potential of Marine Microbial Diversity 
 
Whereas in the last decades the focus in marine natural product research 
was mainly on macroorganisms such as sponges, sea weeds and others, 
nowadays it is clearly evident that microorganisms from the marine habitat are 
equally rich sources of novel constituents, and often the true metabolic producers 
of bioactive metabolites whose production was originally attributed to a 
macroorganism (Gerwick and Fenner, 2013; Gerwick and Moore, 2012; Haefner, 
2003; Simmons et al., 2008). Additionally, microorganisms are far more accessible 
through sustainable production by fermentation than many marine 
macroorganisms that usually have to be collected from limited wild stocks 
(Proksch et al., 2010). These two main factors reveal that microbes are truly the 
treasure troves of new marine pharmaceuticals. 
As microorganisms occupy almost every niche on Earth, scientists 
speculate that each drop of water taken from the ocean will contain microbial 
species unknown to humans in a ratio 9:1 (Colwell, 2002). To maximize the 
chemical diversity available from marine microbes, other sources like the deep-
ocean and geothermal vents are becoming the focus of considerable interest from 
natural product research chemists (Bhatnagar and Kim, 2010; Pettit, 2011). In fact, 
diverse bioactive secondary metabolites have been reported from cultured 
extreme-tolerant microorganisms, extremophiles, and deep-sea microbes. Due to 
the extreme physical and chemical conditions at deep-sea, hydrothermal vents 
sites conditions are constantly fluctuating, representing a nearly inexhaustible 
source of genomic innovation (Pettit, 2011). 
Although numerous natural products have been identified from marine 
microorganisms during the last decades, it is obvious that a plethora of 
compounds still await discovery. This assumption results not only from the fact 
that only a small number of microorganisms have been cultivated and discovered 
yet but also from recent genome sequencing projects (Brakhage and Schroeckh, 
2011).  
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1.3.1. Marine Microorganims as a Source of Novel Drug 
Candidates 
 
Microorganisms are a prolific source of structurally diverse bioactive 
metabolites and have yielded some of the most important products of the 
pharmaceutical industry, including antibiotics and blockbuster medicines with 
tremendous economic importance. These include antibacterial agents such as the 
penicillins and cephalosporins, aminoglycosides and tetracyclines, 
immunosuppressive agents, cholesterol lowering agents such as mevastatin and 
lovastatin, and antihelmintic and antiparasitic drugs such as ivermectins. These 
tremendous successful stories of drug discovery from microorganisms, 
revolutionized the therapy concepts, pushing the academia and pharmaceutical 
industry to develop programs on natural product discovery, emphasized on marine 
microbial fermentation based technologies (Debbab et al., 2010). 
 Current marine clinical pharmaceutical pipeline includes one microbial 
metabolite in phase I of clinical trials, but several drug leads from marine 
microbiota in pre-clinical development are expected to advance clinical 
development to be pharmaceutically relevant drugs (Bhatnagar and Kim, 2010; 
Gerwick and Fenner, 2013; Newman and Hill, 2006).     
Salinosporamide A (NPI-0052) (21) (Figure 7), a β-lactone produced by 
fermentation cultures of Salinispora tropica, is a powerful 20S proteasome inhibitor 
and one of the most promising candidates in chemotherapy (Feling et al., 2003). 
Nereus Pharmaceuticals has licensed this compound under the name Marizomib®, 
which is now in Phase I clinical trials as a single agent in patients with advanced 
solid tumors, and also in combination with vorinostat, a histone deacetylase 
inhibitor, for the treatment of advanced pancreatic carcinoma, non-small cell lung 
carcinoma and melanoma (Hamlin et al., 2009; Potts et al., 2011). Interestingly, S. 
tropica belongs to the recently described and exclusively marine genus of 
Streptomycete bacteria known as Salinispora, of which three species are 
recognized and all inhabit marine sediments. From over 100 cultivated Salinispora 
spp. strains, more than 80% inhibited human tumor cell growth, and 35% showed 
antibacterial properties toward a wide range of drug-resistant human pathogens, 
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representing one of the most recent and promising sources for novel drug leads 
(Fenical and Jensen, 2006). 
Plinabulin (NPI-2358) (22) (Figure 7) is a potent and selective tumor 
vascular disrupting agent, and one of over 200 synthetic analogues in the series 
that were prepared following the discovery of the parent compound phenylahistidin 
(also known as halimide) (23) (Figure 7). Phenylahistidin (23) was isolated from 
cultures of the marine alga-derived fungus Aspergillus ustus, and displayed potent 
cytotoxic activity toward human cancer cell lines and tubulin polymerization 
inhibition (Kanoh et al., 1997; 1999). Two phase I trials have been reported, as a 
single agent in patients with advanced solid tumors or lymphomas (Mita et al., 
2010), or in combination with docetaxel in patients with non-smal cell lung cancer 
(NSCLS) (Millward et al., 2012). The favorable results led to a phase II ADVANCE 
clinical trial of plinabulin (22) in combination with docetaxel in patients with 
NSCLS, that was recently completed, but no further information was provided 
(http://clinicaltrials.gov/show/NCT00630110 accessed on 18th October 2013).  
 
21
23
22
 
 
Figure 7. Chemical structures of novel drug candidates produced by marine 
microorganisms. 
 
Finally, the most recent and exciting discovery is seriniquinone, produced 
by a unique marine bacterium of the genus Serinicoccus, recovered from shallow 
marine sediments. In vitro screening in the NCI 60 cell line panel showed 
pronounced selectivity toward all melanoma cell lines tested, particularly hostile to 
a dangerous form of metastatic melanoma. Seriniquinone has a unique way of 
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inducing apoptosis, targeting the recently discovered protein dermcidin, 
overexpressed in melanoma, activating apoptosis and the induction of 
autophagocytosis leading to efficient cell death (Fenical et al., 2013). 
 
1.3.2. Marine Microorganisms: Cultivating the Uncultured 
and Activating Silent Clusters 
  
Until recently, the inability to cultivate most naturally occurring 
microorganisms has severely limited the exploration of the potential of both 
terrestrial and marine microbes. In fact, it has been estimated that much less than 
1% of microorganisms seen microscopically have been cultured. However, marine 
microorganisms low culturability may reflect the artificial conditions inherent in 
most culture media, e.g., the lack of specific nutrient required for growth. Energy 
sources, nutrients and proper physicochemical conditions are necessary for 
microbial growth, and culture mimicking the natural environment is critical to 
recover the uncultivated microorganisms (Kjer et al., 2010; Zengler et al., 2002).  
 
24 14  
 
Figure 8. Structures of cyanosafracin B (24) and the hemisynthesis product 
trabectedin (14). 
 
Alternatively, these compounds could be produced in bulk, by total or 
semisynthetic pathways, through fermentation technologies. A widely known 
example is the production of trabectedin (14) (Figure 8). Due to the supply 
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problem and high costs associated with chemical synthesis, this drug is produced 
by hemisynthesis starting from cyanosafracin B (24) (Figure 8), a fermentation 
product of the terrestrially-derived bacterium Pseudomonas fluorescens (Cuevas 
et al., 2000). Fermentation processes have gained considerable relevance for 
commercial production of relevant metabolites like trabectedin (Demain, 2000).  
On the other hand, Solid State Fermentation (SSF) became quite popular 
and is widely used for the production of bioactive secondary metabolites from fungi 
(Hölker et al., 2004). 
Recent advances in molecular biology of fungal secondary metabolism may 
offer a better insight into how biogenetic gene clusters are regulated and whether 
their expression is affected by culture conditions and environmental changes, 
allowing the optimization of secondary metabolites production under laboratory 
conditions (Fox and Howlett, 2008; Yu and Keller, 2005). Additionally, 
combinatorial biosynthesis involving introduction of biosynthetic gene clusters into 
microorganisms, is a powerful and recent tool allowing the synthesis of novel 
metabolites, due to the effect of new enzymes on the metabolic pathways. 
Genomic technologies provide a unique opportunity not only to produce 
pharmacologically relevant compounds, thus overcoming the supplying issue, but 
also to explore further the potential of marine microorganisms to generate new and 
potentially useful chemicals (Firn and Jones, 2000).  Currently, the main challenge 
is not the cultivation of potentially relevant microorganisms in the laboratory, but 
the perception that the majority of the secondary metabolite biosynthesis gene 
clusters are silent under standard laboratory conditions, thus not allowing the 
expression of silent gene clusters and the consecutive production of new 
potentially natural products (Hertweck, 2009).   
 
1.4. Fungi from Marine Habitats as Producers of 
Relevant Bioactive Secondary Metabolites 
  
 Besides blockbuster drugs from fungal origin such as the cholesterol 
biosynthesis inhibitors (statins) and β-lactam antibiotics, there are several further 
examples of drugs approved for clinical use such as the immunosuppressant 
drugs mycophenolate mofetil (25) (CellCept®) and cyclosporine A (26) (Restasis® / 
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Sandimmune®), the alkaloid ergotamine (27) (Migranal® / Ergomar®) still used for 
migraine treatment, and the widely used antibiotics terpenoid fusidic acid (28) 
(Fucidin® / Fucithalmic®) and griseofulvin (29) (Grivulfin® / Fulvicin-U/F®) (Figure 9) 
(Aly et al., 2011).   
In the meantime, world’s bestselling anticancer drug paclitaxel (Taxol®) (6) 
(Figure 1), initially isolated from the plant Taxus brevifolia, was found to be a 
biosynthetic product of several endophytic fungi like Taxomyces andreanae 
(Stierle et al., 1993) and Pestalotiopsis microspora (Li et al., 1998). More recently 
other endophytic fungi were shown to also produce camptothecin (Puri et al., 
2005) and anticancer drugs precursor podophyllotoxin (Amna et al., 2006; 
Eyberger et al., 2006). This reason contributed to the increasing recognition of 
fungal secondary metabolites as an auspicious resource for new drug leads, 
especially in the cancer area (Greve et al., 2010).  
 
25
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Figure 9. Examples of fungal-derived drugs currently used in therapeutics. 
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The early years of drug discovery from microfungi revolutionized medicine, 
with metabolites mainly isolated from soil samples, however the reduced hit-rate of 
novel compounds led to the study of alternative sources, mainly from marine 
habitats (Bugni and Ireland, 2004; Rateb and Ebel., 2011; Saleem et al., 2007)  
 
1.4.1. Definition of Marine Fungi and Taxonomy 
 
 The origin of marine fungal strains has been the subject of controversy, 
limiting the definition of “marine fungi”. According to Kohlmeyer “classic” definition, 
fungi growing in the sea can be grouped into obligate and facultative marine fungi. 
“Obligate marine fungi” are those “that grow and sporulate exclusively in a marine 
or estuarine habitat” while “facultative marine fungi” are defined as “fungi from 
freshwater or terrestrial areas also able to grow in the natural marine 
environment”. Additionally, based on the germination ability, it has been suggested 
that indigenous marine species should be separated from non-indigenous species, 
often referred to as “contaminants” or “transients”, i.e. terrestrial or freshwater 
species that are dormant in marine habitats  (Kohlmeyer and Kohlmeyer, 1979).  
 Oceans are the source of an amazing biological diversity, regarding to 
marine fungi, with various estimates being proposed for the number of species, 
depending on whether the taxa are obligate or facultative. The final estimated 
number points to 10 000 species of marine fungi, 537 already described as 
obligate marine fungi (Jones, 2011).  
Literature surveys showed that the most deeply studied marine fungal 
strains belong to genera that are ubiquitous in the terrestrial environment such as 
Aspergillus, Penicillium, Cladosporium, Phoma and Fusarium, being Aspergillus 
genus the main contributor as source of bioactive secondary metabolites from 
marine fungi (Lee et al., 2013). Although most metabolites from marine fungi are 
closely related to metabolites from their terrestrial counterparts, there are some 
unique examples indicating that marine strains may possess biosynthetic 
capabilities which differ in some aspects from those of terrestrial fungi (Bianabi 
and Laatsch, 1998). Lack of reports and the fact that many obligate marine fungi 
species are slow-growing and therefore, not convenient for standard chemical and 
biological screening methods, leads to a limited contribution to the overall number 
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of metabolites reported (Bugni and Ireland, 2004; Rateb and Ebel, 2011; Saleem 
et al., 2007). 
 
1.4.2. Distribution of Marine-Derived Fungi and Chemical 
Studies 
 
Marine fungi are known to produce structurally unique secondary 
metabolites due to the adaptation to a very distinct set of environmental pressures 
from marine environment (Bhadury et al., 2006,). Mechanisms of fungal 
antagonism and defense often include the production of biologically active 
metabolites by one species that exert effects on potential competitors and/or 
predators, being often hypothesized that some of their metabolic capabilities may 
be influenced by selection pressures exerted by other organisms (Gloer, 1995).  
However, only recently marine-derived fungi have received attention from 
Natural Products chemists, and until the 1990s studies reporting chemistry from 
marine fungi were rare, with only fifteen metabolites being discovered until 1992 
(Fenical and Jensen, 1993). First report of a bioactive marine fungal metabolite 
dates back to the 1940s with the identification of cephalosporin C (30) (Figure 10) 
from Acremonium chrysogenum, and siccayne (31) (Figure 10) was most likely the 
first antibiotic reported from an obligate marine fungus Halocyphina villosa in 1981 
(Kupka et al., 1981), although it was known to be produced by the terrestrial 
mitosporic fungus Helminthosporium siccans (Ishibashi et al., 1968). 
 Since the beginning of the 1990s, a sharp and exponential increase in the 
number of reported structures from marine-derived fungi occurred, and this trend 
continues nowadays, supposedly far from reaching its climax. 
 
30
31  
 
Figure 10. The structures of cephalosporin C (30) and siccayne (31). 
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Three main review papers covering the reports since the beginning until 
mid-2010 allow a general overview on the potential of marine fungi as a source of 
new bioactive compounds (Bugni and Ireland, 2004; Rateb and Ebel, 2011; 
Saleem et al., 2007). The general overview from Saleem et al. (2007) covering the 
period 2000-2005, clearly lacks a large number of reported metabolites, thus not 
being considered for statistical purposes. According to Bugni and Ireland (2004), 
from the beginning until 2002, only 272 new structures have been reported, while 
in 2009 alone more than two thirds of this figure was reached, being predicted that 
the total number of new natural products from marine fungi was superior to 1000 
by the mid-2010 (Figure 11) (Rateb and Ebel, 2011). Algae and sponges are the 
top-ranking sources of marine fungal diversity, expressed in the number of new 
structures reported, while corals account for only 3% of the total compounds in 
literature (Figure 12).  
Despite the notable increase in isolates from sediments, especially from the 
deep sea, almost two thirds of all new compounds derived from isolates from living 
matter, stating the enormous potential of symbiotic fungal consortia as an exciting 
target for drug discovery (Rateb and Ebel, 2011).  
 
 
Figure 11. New compounds from marine-derived fungi, according to year of 
publication (Rateb and Ebel, 2011). 
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Figure 12. New compounds from marine-derived fungi until mid-2010, divided by 
sources of the fungal strains (Rateb and Ebel, 2011). 
 
1.4.3. Marine Sponge-Associated Fungi – A Promising 
Source of Bioactive Secondary Metabolites 
 
 Over the past years, marine invertebrates mainly sponges, became the 
dominant source of novel bioactive metabolites (Hu et al., 2011). When compared 
to other marine invertebrates, the phylum Porifera seems to possess a wide range 
of biosynthetic capabilities, being the focus of much recent interest due to the 
formation of close associations with a wide variety of microorganisms, often 
correlated with the richness of biologically active secondary metabolites (Taylor et 
al., 2007; Wang et al., 2013).   
Marine sponges are hosts for a large community of microorganisms, 
including bacteria and fungi, which can comprise as much as 40% of the sponge 
tissue volume, allowing nutrient acquisition, stabilization of sponge skeleton, 
processing of metabolic waste and, secondary metabolite production (Taylor et al., 
2007; Thomas et al., 2010). Soft-bodied organisms like sponges, lack obvious 
structural defense mechanisms, and thus rely on chemical defense by production 
of secondary metabolites, often from associated microflora (Debbab et al., 2012; 
Taylor et al., 2007; Wang et al., 2013). As an example, Oscillatoria spongeliae, a 
cyanobacterial symbiont of Dysidea herbacea, is proven to be the producer of 
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antimicrobial polybrominated biphenyl ethers which might keep the sponge free of 
other bacteria (Unson et al., 1994). 
Marine sponges have been demonstrated to represent one of the richest 
sources of fungal diversity. Several cultivation-based studies with marine sponges 
have shown a vast biological diversity, yielding the greatest taxonomic diversity in 
comparison with other marine sources (Figure 13) (Bugni and Ireland, 2004).  
 
 
 
 
Figure 13. The number of distinct fungal genera based on the marine source 
(Bugni and Ireland, 2004). 
 
For some given species of sponges, analogously to sponge-associated 
bacteria, some of the marine-derived strains appear to be unique and at least 
partially sponge specific and fairly stable in both space and time (Hentschel et al., 
2002; Taylor et al., 2007). However, opposite to bacteria, it seems that many of 
the isolated fungi from sponges are of suspected terrestrial origin, due to the 
similarity to typical terrestrial strains. Interestingly of 681 fungal strains isolated 
from sixteen sponges worldwide, most belonged to Aspergillus and Penicillium 
genera, ubiquitous in terrestrial habitats (Höller et al., 2000).  
The isolation of several metabolites from terrestrial microorganisms 
originally reported from marine sponges, also supports and provides experimental 
evidence to this hypothesis, however unlike bacteria, so far there is no report on 
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fungi as source of any natural product previously ascribed to a marine sponge 
(König et al., 2006; Thomas et al., 2010).  
 A plausible and widely accepted explanation for the fact that many of the 
fungi isolated from sponges belong to genera ubiquitous from terrestrial habitats, 
is that fungal spores may be washed into the sea and sequestered by sponges 
through filter feeding and retained in the inhalant canals. Furthermore, so far there 
is no evidence indicating that fungi actively grow inside sponges suggesting that 
their presence is in fact limited to spores. However, many of the compounds 
reported from marine isolates of the genera Aspergillus or Penicilium are often 
remarkably different from those of terrestrial counterparts suggesting that at least, 
on a biosynthetic level, many sponge-associated fungi are distinguished from their 
terrestrial analogues (Proksch et al., 2010). 
  
1.4.4. Biologically Active Metabolites from Marine 
Sponge-Associated Fungi in Preclinical Development 
 
Despite the absence of marine fungal metabolites in the current marine 
clinical pharmaceutical pipeline, marine sponge-associated fungi are known for 
being an excellent reservoir of bioactive metabolites with potent activities covering 
a wide range of biological functions (Bugni and Ireland, 2004; Rateb and Ebel, 
2011; Saleem et al., 2007).  The previously referred phenylahistidin (23) (Figure 
7), the lead structure of plinabulin (22) (Figure 7) whose phase II clinical trials have 
been recently completed, is the most important representative of marine fungal-
derived natural products so far.  
The first metabolite reported from a sponge-associated fungus is the 
polyketide trichoharzin (32) (Figure 14), which was isolated from an imperfect 
fungus Trichoderma harzianum Rifai isolated from a marine sponge Mycale cecilia 
(Kobayashi et al., 1993). Interestingly, the trichoharzin analog, 
deoxynortrichoharzin (33) (Figure14) was also obtained from the sponge derived-
fungus Paecilomyces cf. javanica (Rahbaek et al., 1998). 
Sorbicillactone A (34) (Figure 14), an alkaloid possessing a unique bicyclic 
lactone structure isolated from the sponge Ircinia fasciculata-associated fungus 
Penicillium chrysogenum, is known to have antiviral and neuroprotective 
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properties (Bringmann et al., 2005; 2007). Owing to its highly selective cytostatic 
activity against murine leukemic lymphoblasts, this compound has been recently 
qualified for human trials. The heterodimer asperazine (35), isolated from the 
saltwater culture of the Caribbean Hyrtios sponge-associated Aspergillus niger, 
also displayed significant differential cytotoxicity against a mouse leukemia cell 
line (L1210) (Varoglu et al., 1997). 
 
38 R = MeOH
39 R = Me
32 R = EtOH
33 R = Me
34
35
36 R = Et
37 R = H
 
 
Figure 14. Examples of marine sponge-derived fungi compounds with potential for 
preclinical development. 
 
Moreover, scopularides A (36) and B (37) (Figure 14), natural 
cyclodepsipeptides isolated from the marine sponge-derived fungus 
Scopulariopsis brevicaulis were recently patented due to their potent inhibitory 
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activity against several tumor cell lines, including pancreatic and colon tumor cell 
lines (Yu et al., 2008). The fungus Paraconiothyrium cf sporulosum, isolated from 
the Caribbean marine sponge Ectyplasia perox, was found to produce a new class 
of sesquiterpene epoxycyclohexenones with an unprecedented distinctive 
substitution and oxidation patters (Mohamed et al., 2009). Strikingly, 
epoxyphomalin A (38) (Figure 14) displayed not only remarkable cytotoxicity at 
nanomolar concentrations, but also an intriguing activity profile in COMPARE 
analyses that did not correlate with those of reference anticancer agents, 
suggesting a different mode of action from that of the reference compounds. 
Furthermore, it was also found that incubation of purified human 20S proteasome 
with epoxyphomalins A (38) and B (39) (Figure 14) led to a dose-dependent 
inhibition of chymotrypsin-, caspase-, and trypsin-like proteasome activities, 
indicating a potent inhibition of 20S proteasome. Consequently, epoxyphomalins 
could be considered as new promising chemotherapeutic alternatives for the 
treatment of several tumors, due to their capacity to inhibit the proteasome 
(Mohamed et al., 2010).  
There is a vast number of bioactive marine sponge-derived fungal 
metabolites with a wide set of bioactivities, and many of them are potential 
candidates for preclinical development (Blunt et al., 2013; Proksch et al., 2010; 
Rateb and Ebel, 2011; Thomas et al., 2010; Xiong et al., 2013).  
Thus, sponge-fungal association is a potential chemical and ecological 
phenomenon which provides sustainable resource for developing novel 
pharmaceutical leads for a promising and rational target in drug discovery. 
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Four marine-derived fungi selected for chemical investigation in this thesis 
belong to three distinct genera, namely Emericella (Emericella variecolor KUFC 
7092), Eurotium (Eurotium cristatum KUFC 7356) and Neosartorya (Neosartorya 
paulistensis KUFC 7897 and N. laciniosa KUFC 7896).  
The four fungal species are the sexual counterparts of the genus 
Aspergillus, a relevant and efficient saprophytic genus widely found in diverse 
environments, including Oceans. Aspergillus genus consists of several hundred 
highly aerobic mold species and has been the target of several studies mainly due 
to several human pathogenic species responsible for infections leading to a high 
rate of morbidity and mortality, but also due to the relevant economic impact, 
mainly in developing countries, associated with the destructive effect in agriculture. 
On the other hand, this genus includes several species widely used in the food 
and beverage industry, being classified as a biotechnological “cell factory” 
(Gibbons and Rokas, 2013). Additionally, the genus Aspergillus was the source of 
several drugs currently used in therapeutics as referred previously, having 
revolutionized Medicine, yielding several blockbuster drugs and drug leads of 
enormous potential (Aly et al., 2011). 
The biotechnological potential of Aspergillus relies not only on economic 
relevance of microbial fermentations, but also on the genomic diversity leading to 
the production of several bioactive metabolites, classifying the genus as an 
attractive and valuable source for drug discovery, which is the main focus of the 
present study (Lee et al., 2013). Also the fact that ascomycetous fungi can be 
grown easily in culture and their teleomorphic states induced in the laboratory, led 
to the selection of these genera as a target for chemical and biological studies. 
 
2.1. An Overview of Secondary Metabolites 
 
 Contrary to Aspergillus genus, only a few species of teleomorphs have 
been investigated for their secondary metabolites and associated biological 
activities. However, the number of bioactive compounds reported so far is 
exponentially increasing, both the previously reported from other species and 
novel chemical structures. Due to the highly specific profiles of secondary 
metabolites, especially from Aspergillus and Penicillium teleomorphs, it is not 
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surprising the isolation of several common extrolites produced by a limited number 
of fungal species from the same genus.  
 The distinct morphological features from fungal sexual stages allowed a 
dual nomenclature permitting separate names for anamorphs of fungi with a 
pleomorphic life-cycle, causing several equivoques regarding the correct and 
unequivocal taxonomic classification of several species. The increased number of 
mycologists recognizing the urgent need of a transition to a single-name 
nomenclatural system for fungi, resulted in the preparation of “Amsterdam 
Declaration on Fungal Nomenclature”, agreed under the auspices of the 
International Commission on the Taxonomy of Fungi (ICTF) during the symposium 
“One Fungus = One Name” held in Amsterdam in April 2011 (Hawksworth et al., 
2011a; 2011b). The discontinuance of the dual nomenclature system was later 
approved and adopted in the 18th International Botanical Congress in Melbourne in 
July 2011, and the Vienna edition of the “International Code of Botanical 
Nomenclature” has been replaced by the “The International Code of Nomenclature 
for algae, fungi, and plants (The Melbourne Code)” published in December 2012. 
According to the “Melbourne Code”, after 1 January 2013 one fungus can only 
have one name (Hawksworth, 2011a; 2011b; McNeill et al., 2011).   
The following literature review will focus strictly on the teleomorphs from the 
genera Emericella, Eurotium and Neosartorya, following the taxonomic 
classification of the species adopted by the authors by the date of the publication, 
not necessarily adopting “Melbourne Code” recent recommendations.  Despite the 
chemotaxonomic importance of secondary metabolites, the aim of this review is 
not to give an extensive and exhaustive report of all the secondary metabolites 
isolated from the referred genera. Instead, an overview on novel secondary 
metabolites and their associated bioactivities will be presented as an insight on the 
potential of the selected species for the isolation of novel bioactive secondary 
metabolites.   
 
2.2. The Genus Emericella 
  
 The genus Emericella was described by Berkeley (1857) based on E. 
variecolor Berk. & Broome, and comprises thirty-four species, corresponding to the 
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sexual state of Aspergillus species, notably the A. nidulans group among others. 
The genus Emericella comprises a well-studied group of secondary metabolite-rich 
fungi that are of concern in food and feed processing and storage, because of 
many sterigmatocystin producing species. Additionally, the genus was proved to 
be a prolific source of relevant bioactive metabolites with E. nidulans being the 
source of echinocandin B (40) (Figure 15), the starting molecule for the semi-
synthetic antifungal anidulafungin (Eraxistm®) (41) (Figure 15) approved for the 
treatment of candidiasis of the esophagus and disseminated candidiasis, intra-
abdominal and peritonitis (Hof and Dietz, 2009; Martindale, 2012). 
 
 
40
41
 
 
Figure 15. Structures of echinocandin B (40) and semi-synthetic derivative 
anidulafungin (41). 
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2.2.1. Emericella aurantio-brunnea 
 
 Bioassay guided fractionation of the bioactive extract of the. E. aurantio-
brunnea strain yielded four new variecolin analogues, emericolins A-D (42-45) 
(Figure 16). Despite the extract activity competing with macrophage inflammatory 
protein (MIP)-1α for binding to human CCR5, none of the variecolin analogues 
displayed activity in the CCR5 assay (Yoganathan et al., 2004). Two additional 
sesterterpenes related to variecolin, variecoacetals A and B (46, 47) were reported 
by Fujimoto et al. (2000) as well as the new sesquiterpenetriol diester 
emeremophiline (48) (Figure 16), from the EtOAc extract of E. aurantio-brunnea 
IFM42008. Both variecoacetals A and B (46, 47), as well as emeromophiline (48) 
displayed moderate immunosuppressive activity. 
 
42 R = CHO
43 R = MeOH
44 R = Me
45 46 R = Me
47 R = Et
48  
 
Figure 16. New constituents of E. aurantio-brunnea. 
 
2.2.2. Emericella desertorum 
 
 Three new bicoumarins, desertorins A-C (49-51) (Figure 17) were isolated 
from the chloroform extract of the mycelia of E. desertorum strain CBS 653.73, 
collected from desert soils in Egypt (Nozawa et al., 1987a). Later, the two new 
indoloditerpenes emindoles DA (52) and DB (53) (Figure 17) were also isolated 
from the same strain (Nozawa et al., 1988). 
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49 R1 = R2 = H
50 R1 = H, R2 = Me
51 R1 = R2 = Me
52
53  
 
Figure 17. New constituents of E. desertorum strain CBS 653.73. 
 
2.2.3. Emericella falconensis 
 
 Azaphilone derivatives falconensins A-N (54-67) and a new azaphilone, 
monomethyldihydromitorubrin (68) (Figure 18), were reported from E. falconensis 
strain NHL 2999 isolated from Venezuelan soil (Itabashi et al., 1992; 1993; 1996; 
Ogasawara and Kawai, 1998). Despite the lack of antibacterial activity, 
falconensins A-C (54-56) displayed an inhibitory effect on 12-O-
tetradecanoylphorbol 13-acetate-induced inflammatory ear edema in mice 
(Yasuhara et al., 1994). 
From the same strain, the two new cyclopentenone pigments 
falconensones A (69) and B (70) (Figure 18) were later isolated (Ogasawara et al., 
1997). Falconensone A (69) and its synthetic derivatives caused inhibition of cell 
growth and induction of differentiation in human promyelocytic leukemia cell line 
HL60, suggesting eventual clinical potential as an antiproliferative agent for 
leukemia treatment (Takahashi et al., 1998). Additionally, falconensone A (69) and 
its derivatives also appear to be effective antioxidants (Takahashi et al., 2000). 
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54 R1 = H, R2 = R3 = Cl, R4 = Me
56 R1 = Ac, R2 = R3 = Cl, R4 = Me
58 R1 = R3 = R2 = Cl, R4 = Me
59 R1 = R2 = R3 = H, R4 = Me
60 R1 = Ac, R2 = R3 = H, R4 = Me
62 R1 = R2 = R3 = R4 = H
64 R1 = R2 = R4 = H, R2 = Cl
66 R1 = R4 = H, R2 = R3 = Cl
61 68
69 R = CH3
70 R = H
55 R1 = H, R2 = R3 = Cl, R4 = Me
57 R1 = Ac, R2 = R3 = Cl, R4 = Me
63 R1 = R2 = R3 = R4 = H
65 R1 = R3 = R4 = H, R2 = Cl
67 R1 = R4 = H, R2 = R3 = Cl
 
 
Figure 18. New constituents of E. falconensis strain NHL 2999. 
 
2.2.4. Emericella foveolata 
 
 A new member of the epitetrathiodiketopiperazine family, secoemestrin C 
(71) (Figure 19), related to the macrocyclic antifungal dithiodiketopiperazine 
emestrin (97) (Figure 25) previously isolated from other Emericella species, was 
isolated from E. foveolata strain IFO 30559 (Ooike et al., 1997). 
 
71  
Figure 19. Structure of secoemestrin C (71). 
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2.2.5. Emericella heterothallica 
 
 From the chloroform extract of the mycelia of the fungus E. heterothallica 
strain ATCC 16824, the pyrazinone emeheterone (72) along with a new 
thiodiketopiperazine emethacin A (73) (Figure 20) were isolated (Kawahara et al., 
1988a; 1989a). Later, four novel epipolythiodiketopiperazines, emethallicins A-D 
(74-77) (Figure 20), were reported from the same strain as well as from the 
additional ATCC 16847 strain. Emethallicins A-D (74-77) displayed potent 
inhibitory activities upon compound 48/80-induced histamine release from mast 
cells, and were also shown to be potent 5-lipoxygenase inhibitors (Kawahara et 
al., 1989b; 1990).  
 
72 73
74 x = 2
75 x = 4
77 x = 3
76  
 
Figure 20. New constituents of E. heterothallica. 
 
2.2.6. Emericella nidulans 
 
 The marine-derived fungus E. nidulans var. acristata which was isolated as 
an endophyte from a green alga collected around Sardinia, was found to produce 
two new arugosins G (78) and H (79) (Figure 21). Contrary to additional arugosins, 
also isolated from the same extract, arugosins G (78) and H (79) did not exhibit 
antitumor activity in a wide panel of 36 human tumor cell lines (Kralj et ai., 2006). 
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78
79
 
 
Figure 21. Structures of arugosins G (78) and H (79). 
 
 2.2.7. Emericella purpurea 
 
 Two new sesterterpenes variecolol (80) and variecolactone (81) (Figure 22) 
were identified as metabolites of the fungus E. purpurea strain IFO 30849 
(Takahashi et al., 1999). The same extract yielded three new yellow pigments 
epurpurins A-C (82-84) and three new indoloditerpenes emindole PA, PB and PC 
(85-87) (Figure 22) (Hosoe et al., 2006; Takahashi et al., 1996). 
 
2.2.8. Emericella quadrilineata 
 
 In a screening study of immunomodulatory fungal constituents, Fujimoto et 
al. (2006) reported the isolation of the new xanthone (4S,4aR,9aR)-4a-
carbomethoxy-1,4,4a,9a-tetrahydro-4,8-dihydroxy-6-methylxanthone (88) and the 
new furanone 9-hydroxymicroperfuranone (89) (Figure 23), from the EtOAc extract 
of E. quadrilineata IFM42027. Despite the immunosuppressive activity of the 
extract, none of the new compounds were showed to be active (Fujimoto et al., 
2006). 
 Recently, a new echinocandin analog, echinocandin E (90) (Figure 23) was 
identified from a strain of E. quadrilineata. Echinocandin E (90) was determined to 
be less potent (IC50 = 1.5 µm) against Candida albicans than echinocandin B (40) 
(Figure 15) (IC50 = 0.27 µm) (Cruz et al., 2012). 
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80 R = H2
81 R = O
82 R1 = H, R2 = R3 =
83 R1 = R2 = H, R3 =
84 R1 = R2 = R3 = H
85 R1 =                           , R2 = H 86 R1 = H, R2 = 
87
 
 
Figure 22. New constituents of E. purpurea strain IFO 30849. 
 
 
 
90
88
89
 
 
Figure 23. New constituents of E. quadrilineata. 
 
 
 
 44 
 
CHAPTER II.CHEMISTRY OF THE GENERA EMERICELLA, EUROTIUM AND NEOSARTORYA 
 
2.2.9. Emericella rugulosa 
 
New prenylated xanthones, reguloxanthones A-C (91-93), 14-
methoxytajixanthone (94), and tajixanthone ethanoate (95) (Figure 24) were 
isolated from the fungus E. rugulosa, along with several known xanthones. 
Additionally, regulosone (96) (Figure 24) was also isolated from E. rugulosa and 
exhibited the in vitro antimalarial activity against Plasmodium falciparum, 
antimycobacterial activity, as well as strong cytotoxic activity against BC1, KB, and 
NCI-H187 cancer cell lines (Moosophon et al., 2009). 
  
95
91
96
92 93
94  
 
Figure 24. New constituents of E. rugulosa. 
 
2.2.10. Emericella striata 
 
 Chemical analysis of E. striata strain 80-NE-22 resulted in the isolation of 
emestrin (97), emestrin B (98) and related dethiodiketopiperazine derivatives 
lacking polysulfide internal bond, namely aurantioemestrin (99) and 
dethiosecoemestrin (100) (Figure 25) (Kawahara et al., 1986; Nozawa et al., 
1987b; Seya et al., 1985; 1986a; 1986b).  
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97 x = 2
98 x = 3
  99 R = S
100 R = O 101  
 
Figure 25. New constituents of E. striata strain 80-NE-22. 
 
Both emestrin (97) and emestrin B (98) were found to possess antibacterial 
activity against Escherichia coli and Bacillus subtilis, while dethiosecoemestrin 
(100) was active against E.coli (Seya et al., 1986b; Nozawa et al., 1987b). 
Additionally, emestrin (97) displayed also antifungal activity, inhibiting the growth 
of Gibberella zeae and Penicillium expansum (Seya et al., 1986a). Recently, 
emestrin (97) was also isolated from E. nidulans MFW39, isolated from marine 
ascidia, and was found to exhibit relevant cytotoxicity against T47D, HepG2, C28, 
and HeLa cell lines (Nursid et al., 2011). Also from E. striata strain 80-NE-22, the 
new xanthone cycloisoemericellin (101) was later reported (Figure 25) along with 
the known arugosins (Kawahara et al., 1988b). 
 
2.2.11. Emericella unguis 
 
E. unguis strain IFM 42017 was found to produce four new depsidones, 
emeguisins A-C (102-104) and 2-chlorounguinol (105), along with the new 
phthalide 3-ethyl-5,7-dihydroxy-3,6-dimethylphthalide (106) (Figure 26). Although 
the EtOAc extract of this fungus was found to have monoamine oxidase (MAO) 
inhibitory activity, the isolated depsidones displayed only a moderate activity. 
Additionally, emeguisin A (102) was found to inhibit the growth of Bacillus subtilis 
(Kawahara et al., 1988c; 1988d).  
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102 R1 = R2 = R3 = H
103 R1 = R3 = H, R2 = Me
104 R1 = Me, R2 = H, R3 = Cl
105
107
106
108 R1 = Ph, R2 = Me
109 R1 = i-Pr, R2 = Me
110 R1 = Ph, R2 = CH2OH
 
 
Figure 26. New constituents of E. unguis. 
 
Later, the new emerguisins-related depside guisinol (107) (Figure 26) was 
reported from a marine isolate originated from the jellyfish Stomolophus meleagris 
collected in the Paria Bay, Venezuela, by Nielsen et al. (1999). Guisinol (107) 
exhibited antibacterial activity against Staphylococcus aureus. Unguisins A-C 
(108-110) (Figure 26), the first cyclic heptapeptides with GABA incorporated in the 
ring, were also isolated from the same extract. Unguisin A (108) and B (109) were 
found to exhibit moderate antibacterial activity against S. aureus and Vibrio 
parahaemolyticus (Malmström, 1999; Malmström et al., 2002a). 
 
2.2.12. E. variecolor 
 
 E. variecolor, the perfect state of Aspergillus variecolor (syn. A. stellatus) is 
one of the most studied species from the genus Emericella. It was found to 
produce a variety of secondary metabolites, including prenylated xanthones, 
sesterterpenes and meroterpenoids.  
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Emervaridione (111) and varioxiranediol (112) (Figure 27) were isolated 
from the EtOAc extract of an endophytic E. variecolor (Liangsakul et al., 2011). 
The marine E. variecolor strain M75-2, isolated from a Caribbean sponge, was 
found to produce three new terrein derivatives, varitriol (113), varioxirane (114) 
and dihydroterrein (115), along with the new xanthone varixanthone (116) (Figure 
27). Varitriol (113) was tested in the NCI 60-cell line in vitro panel, and was found 
to exhibit strong cytotoxic activity against several cancer cell lines, with remarkable 
potency toward renal cancer cell line RXF 393 (GI50 = 0.163 µM) and breast 
cancer cell line T-47D (GI50 = 0.210 µM). While varixanthone (116) displayed 
potent antimicrobial activity against Escherichia coli, Proteus sp. and Bacillus 
subtilis, with a minimal inhibitory concentration (MIC) value of 12.5 µg/mL 
(Malmström et al., 2002b).  
Another marine sponge-derived strain isolated from the marine sponge 
Haliclona valliculata collected in Elba, Italy, yielded the new prenylated xanthone 
isoemericellin (117) and a new anthraquinone evariquinone (118) (Figure 27). 
Evariquinone (118) exhibited strong antiproliferative activity towards KB and NCI-
H460 cells at a concentration of 3.16 µg/mL (Bringmann et al., 2003).  
Two new sesterterpenes, 6-epi-ophiobolin G (119) and 6-epi-ophiobolin N 
(120) (Figure 27), along with six previously reported ophiobolins, were isolated by 
Wei et al. (2004) from the EtOAc extract of E. variecolor GF10 which was isolated 
from a marine sediment collected in Gokasyo Gulf, Japan. All ophiobolins, 
including 6-epi-ophiobolin G (119) and 6-epi-ophiobolin N (120) displayed 
cytotoxic activity against neuroblastoma cell line Neuro 2A (Wei et al., 2004). 
Later, a new polyketide, shimalactone A (121) (Figure 27) was discovered from the 
same extract, and was shown to induce neuritogenesis in neuroblastoma cell line 
Neuro 2A at 10 µg/mL (Wei et al., 2005). The toxic metabolite asteltoxine (122) 
(Figure 27) was isolated from the moldy rice artificially infected with E. variecolor 
NHL 2881 (Maebaxashi et al., 1983). 
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Figure 27. New constituents of E. variecolor. 
 
2.2.13. Unspecified Emericella species 
 
 Bioassay guided-fractionation of the endophytic Emericella sp. HK-ZJ, 
isolated from the mangrove plant Aegiceras corniculatum, resulted in the discovery 
of six new isoindolone derivatives, emerimidines A (123) and B (124), and the 
meroterpenoids emeriphenolicins A-D (125-128) (Figure 28). Only emerimidines A 
(123) and B (124) showed moderate in vitro antiviral activity against H1N1, with 
IC50 values of 42.07 µg/mL and 62.05 µg/mL, respectively (Zhang et al., 2011).   
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123 R1 = H, R2 = Me
124 R1 = Me, R2 = H
125 R1 = R2 = OMe, R3 = Cl, R4 = OH
126 R1 = OMe, R2 = R4 = OH, R3 = Cl
127 R1 = R2 = OMe, R3 = R4 = OH
128  
 
Figure 28. New constituents of Emericella sp. HK-ZJ. 
 
Competing co-culture of the marine-derived fungus Emericella sp. (strain 
CNL-665) with the marine actinomycete Salinispora arenicola, yielded two new 
cyclic depsipeptides, emericellamides A (129) and B (130) (Figure 29), both of 
which displayed modest antibacterial activity against methicillin-resistant 
Staphylococcus aureus (MRSA) (Oh et al., 2007). 
 
129 130  
 
Figure 29. Structures of emericellamides A (129) and B (130). 
 
Recently, Xu et al. (2013a) reported the isolation of the new 
epitetrathiodiketopiperazine secoemestrin D (136), along with five new 
sesterterpenoids with an unprecedented carbon skeleton, emericellenes A-E (131-
135) (Figure 30), from the endophytic fungal strain Emericella sp. AST0036, 
isolated from a leaf of Astragalus lentiginosus. Secoemestrin D (136) exhibited 
strong cytotoxic activity against six cancer cell lines with apparent selectivity to 
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human glioma (SF-268) and metastatic breast adenocarcinoma (MDA-MB-231) 
cell lines. 
 
131 R = CHO
132 R = COOH
133
134 R = α - CHO
135 R = β - CHO 136
 
 
Figure 30. New constituents of Emericella sp. AST0036. 
 
The strain 25379 of Emericella sp., isolated from the surface of a coral 
collected at Marietas Islands, Mexico, produced the new xanthones 15-
chlorotajixanthone hydrate (137) and 14-methoxytajixanthone (138) (Figure 31). 
Both compounds inhibited the activation of the calmodulin-sensitive cAMP 
phosphodiesterase, with 14-methoxytajixanthone (138) displaying comparable 
effect with that of chlorpromazine (Figueroa et al., 2009).  
 
137 138
 
 
Figure 31. New xanthones of Emericella sp. 25379 strain. 
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2.3. The Genus Eurotium 
 
 Eurotium species are the sexual states of Aspergillus species, notably the 
A. glaucus group among others which is closely related to Emericella, and are also 
widely found in the environment (Geiser, 2009).  Some Eurotium species have 
been used for manufacturing the traditional Japanese fermented food “dried 
bonito” (katsuobushi) and “karebushi” (Miyake et al., 2010).  
Although only a few species of Eurotium have been investigated for their 
bioactive secondary metabolites, there are already some recent reports on the 
isolation of numerous types of compounds, such as alkaloids, phenolic 
compounds and anthraquinones. 
 
2.3.1. Eurotium chevalieri 
 
 The strain E. chevalieri EuCO1 collected from rhizosphere soil at Surathani 
Province, Thailand was found to produce five new meroditerpenoids, chevalones 
A-D (139-142) and aszonapyrone B (143), as well as the new sesquiterpene 
alkaloid eurochevalierine (144) (Figure 32). Chevalone D (142) and 
eurochevalierine (144) exhibited antimalarial activity against Plasmodium 
falciparum with IC50 values of 3.1 and 3.4 µg/mL, while chevalone C (141) 
displayed strong antibacterial activity against Mycobacterium tuberculosis, with a 
MIC value of 6.3 µg/mL. Additionally, chevalones B-D (140-142) and 
eurochevalierine (144) were found to be cytotoxic against BC1, KB and NCI-H187 
cancer cell lines, with IC50 values ranging from 2.9 to 9.8 µg/mL (Kanokmedhakul 
et al., 2011). 
 
2.3.2. Eurotium cristatum 
 
 Three new diketopiperazine indole alkaloids and a new diketopiperazine 
dimer, cristatumins A-D (145-148) (Figure 33) have been reported from the culture 
extract of the endophytic fungus E. cristatum EN-220, which was isolated from the 
marine alga Sargassum thunbergii. While cristatumin A (145) exhibited potent 
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inhibitory activity against Escherichia coli and Staphylococcus aureus, cristatumin 
B (146) displayed moderate lethal activity against brine shrimp (Artemia salina) 
(Du et al., 2012).  
 
139 R = H
140 R = Ac
141
142 143
144
 
 
Figure 32. New constituents of E. chevalieri EuCO1. 
 
2.3.3. Eurotium herbariourum 
 
A new diketopiperazine dimer, cristatumin E (149) (Figure 33), was recently 
isolated from a marine alga-associated E. herbariorum strain HT-2. Cristatumin E 
(149) was found to be moderately cytotoxic against K562 tumor cell line with an 
IC50 value of 8.3 µM, however it displayed weak antibacterial activity against 
Enterobacter aerogenes and Escherichia coli (Li et al., 2013a). 
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2.3.4. Eurotium repens 
 
 Benzyl derivatives have frequently been reported from several Eurotium 
species. Two new additional benzyl derivatives, (E)-2-(hept-1-enyl)-3-
(hydroxymethyl)-5-(3-methylbut-2-enyl)benzene-1,4-diol (150) and (E)-4-(hept-1-
enyl)-7-(3-methylbut-2-enyl)-2,3-dihydrobenzofuran-2,5-diol (151) (Figure 34) have 
been isolated from the fungus E. repens (UM-031509), along with several known 
benzyl derivatives. 
 
145
147 149
146 148
 
 
Figure 33. Structures of cristatumins A-E (145-149). 
 
Compound 150 showed good binding affinity for human opioid or 
cannabinoid receptors (Gao et al., 2011a). It also exhibited antimicrobial activity 
against Staphylococcus aureus and Candida glabrata, and moderate antimalarial 
activity against chloroquine-sensitive and –resistant Plasmodium falciparum (Gao 
et al., 2012). 
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150 151
 
 
Figure 34. New benzyl derivatives of E. repens (UM-031509). 
 
2.3.5. Eurotium rubrum 
 
 Chemical analysis of the endophytic fungus E. rubrum, isolated from the 
inner tissue of stems of the mangrove plant Hibiscus tiliaceus collected from 
Hainan Island (China), resulted in isolation of four new benzaldehyde derivatives, 
eurotirumin (152), 2-(2’,3-epoxy-1’-heptenyl)-6-hydroxy-5-(3’’-methyl-2’’-
butenyl)benzaldehyde (153), (E)-6-hydroxy-7-(3-methyl-2-butenyl)-2-(3-oxobut-1-
enyl)chroman-5-carbaldehyde (154) and 2-(1’,5’-heptadienyl)-3,6-dihydroxy-5-(3’’-
methyl-2’’-butenyl)benzaldehyde (155) (Figure 35) (Li et al., 2008a). From the 
same extract, eurorubrin (156) and four new anthraquinone derivatives, 2-O-
methyl-9-dehydroxyeurotinone (157), 2-O-methyl-4-O-(α-ᴅ-ribofuranosyl)-9-
dehydroxyeurotinone (158), 9-dehydroxyeurotinone, (160) and the anthraquinone 
glycoside 3-O-(α-ᴅ-ribofuranosyl)-questin (159) were also isolated (Figure 35). All 
compounds were evaluated for their radical scavenging properties by using DPPH 
radical scavenging assay, and only eurorubrin (156) showed strong activity with 
IC50 value of 44.0 µM (Li et al., 2009a). Additionally, 9-dehydroxyeurotinone (160) 
exhibited moderate cytotoxic activity against SW1990 cancer cell line, and weak 
antibacterial activity against Escherichia coli (Yan et al., 2012). This extract was 
also shown to be the source of new diketopiperazine alkaloids, namely 12-
demethyl-12-oxo-eurotechinulin (161), dehydroechinulin (162), and 
dehydrovariecolorin L (163) (Figure 35). Among the three new alkaloids, only 12-
demethyl-12-oxo-eurotechinulin (161) exhibited moderate cytotoxic activity against 
a single cancer cell line (SMMC-7721) (Li et al., 2008b; Yan et al., 2012).   
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161
159
152
163
156
162
157 R1 = R2 = H, R3 = Me
158 R1 = α-D-ribofuranosyl, R2 = H, R3 = Me
160 R1 = R2 = R3 = H 
153
155
154
 
Figure 35. New constituents of E. rubrum. 
 
2.4. The Genus Neosartorya 
  
 Neosartorya species are the teleomorphic state of Aspergillus section 
Fumigati. While the Aspergillus species only produce conidiospores, Neosartorya 
species produce both a sexual state, with ascospores, and an asexual state with 
conidiospores (Frisvad et al., 2009). Neosartorya includes several species which 
are important because they can be pathogenic or allergic to man, causing food 
spoilage and production of mycotoxins. However, Neosartorya species became 
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also an attractive source for the purpose of drug discovery due to the production of 
several interesting bioactive secondary metabolites (Hong et al., 2008).   
 
2.4.1. Neosartorya fischeri 
 
 A culture of N. fischeri (SC4) isolated from a plant rhizosphere collected 
near We Fung Chi Cascade, Taiwan, was found to produce three new quinazolone 
indole alkaloids, fiscalins A-C (164-166) (Figure 36), all causing inhibition of 
radiolabeled substance P (SP) ligand to the human neurokinin (NK-1) receptor 
with Ki values of 57, 174 and 68 µM, respectively (Wong et al., 1992).  
From the strain IFO9857 of N. fischeri var. glabra, researchers from Nippon 
Kayaku Co. Ltd., reported the isolation of three potent antifungal metabolites, 
NK372135 A-C (167-169) (Figure 36). These compounds, especially NK372135 C 
(169), exhibited potent antifungal activity against Candida albicans with an IC50 
value of 0.27 µg/mL (Morino et al., 1994).  
The strain IFM52672 produced two new cyclopentanone derivatives, 
isoterrein (170) and terrein (171) (Wakana et al., 2006), while fischeacid (172) and 
fischexanthone (173) (Figure 36) were reported from a marine-derived N. fischeri 
strain 1008F1 (Tan et al., 2012). 
 The activation of the polycyclic polyketide prenyltransferase (pcPTase) in 
transformant T2 N. fischeri culture induced the production of the new metabolite 
neosartoricin (174) (Figure 36) which exhibited in vitro antiproliferative activity on 
anti-CD3/CD28-activated murine spleenic T-cells with an IC50 value of 2.99 µM. 
Interestingly, the LC/MS analysis of the transformant T2 extract indicated the 
production of multiple new metabolites that are not found in wild strains of N. 
fischeri (Chooi et al., 2013).     
 Chemical investigation of a N. fischeri strain isolated from the river Vah 
sediments in Slovakia, led to the isolation of a new yellow pigment named 
neosartorin (175) (Proksa et al., 1998). Recently, Eamvijarn et al., (2013) reported 
the isolation of the 5-hydroxyl analogue of aszonalenin (176), as well as a new 
meroditerpene named sartorypyrone A (177) (Figure 36) from the culture of the 
soil fungus N. fischeri KUFC 6344. While sartorypyrone A (177) displayed strong 
growth inhibitory activity against MCF-7 (breast adenocarcinoma), NCI-H460 (non-
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small cell lung cancer) and A375-C5 (melanoma) cell lines, with GI50 values 
ranging from 17.8 ± 7.4 to 25.0 ± 2.4 µM , 1-formyl-5-hydroxyaszonalenin (176) 
exhibited only weak inhibitory activity (Eamvijarn et al., 2013). 
 
164 R1 = Me, R2 = H
166 R1 = R2 = Me
165
167 R = H
168 R = OMe
169 R = OH
170 R1 = H, R2 = OH
171 R1 = OH, R2 = H
172
173
174
175
176
177
 
 
Figure 36. New constituents of N. fischeri. 
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2.4.2. Neosartorya glabra 
 
 Three new bicyclic lactones, glabramycins A-C (178-180) (Figure 37) were 
obtained from the soil N. glabra strain MF7030, F-155,700, using an antisense 
strategy. When tested against a panel of pathogenic bacteria, the three 
glabramycins exhibited antibacterial activity however, glabramycin C (180) showed 
pronounced activity against Streptococcus pneumoniae, and modest antibacterial 
activity against Staphylococcus aureus with MIC values of 2 and 16 µg/mL, 
respectively (Jayasuriya et al., 2009).  
 Three new reverse prenylated indole alkaloids, sartoryglabrins A-C (181-
183) (Figure 37) have been reported by Kijjoa et al. (2011) from an unidentified 
strain of N. glabra obtained from an agricultural soil at Chonburi Province, 
Thailand. All the compounds exhibited strong to moderate in vitro growth inhibitory 
activity on MCF-7 cancer cell line with GI50 values ranging from 27.0 ± 0.57 to 53.0 
± 4.7 µM. 
 
178
181 R = H
182 R = OH
183
179
180
 
 
Figure 37. New constituents of N. glabra. 
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2.4.3. Neosartorya pseudofischeri 
 
 Chemical investigation of a collection of N. pseudofischeri KUFC 6422 from 
agricultural soil collected in Thailand, led to the isolation of 3-hydroxy-5-
methylphenyl 2,4-dihydroxy-6-methylbenzoate (184),  3,8-diacetyl-4-(3-methoxy-
4,5-methylenedioxy)benzyl-7-phenyl-6-oxa-3,8-diazabicyclo[3.2.1]octane (185a 
and 185b) and a new quinazolinone-containing indole alkaloid pseudofischerine 
(186) (Figure 38) (Eamvijarn et al., 2012). Another strain of N. pseudofischeri 
(CBS 404.67) was found to produce a new cytotoxic pyrroloindole 
sesquiterpenoid, named fischerindoline (187) (Figure 38), that exhibited moderate 
in vitro growth inhibitory activity against six human and mouse cancer cell lines 
(Masi et al., 2013). 
 
184
185a
186 187
185b
 
 
Figure 38. New constituents of N. pseudofischeri. 
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2.4.4. Neosartorya quadricincta 
 
 A new prenylated dihydroisocoumarin derivative, PF1223 (188) (Figure 39), 
was reported from the culture of N. quadricincta strain PF1223.  
 
188  
 
Figure 39. Structure of PF1223 (188). 
 
PF1223 (188) inhibited [3H]ethynylbicycloorthobenzoate ([3H]EBOB) binding by 
65% at the concentration of 2.2 µM, exhibiting binding activity for the insect GABA 
receptor and proving to be a lead compound for the development of novel 
insecticides (Ozoe et al., 2004).   
 
2.4.5. Neosartorya siamensis 
 
 The EtOAc extract of the culture of the new specie N. siamensis KUFC 
6349 collected from forest soil at Samaesarn Island, Chonburi Province (Thailand), 
yielded two new quinazolinone derivatives, tryptoquivaline O (189) and 3’-(4-
oxoquinazolin-3-yl)spiro[1H-indole-3,5’-oxolane]-2,2’-dione (190), four new fiscalin 
analogues, epi-fiscalin C (191), epi-fiscalin A (192), neofiscalin A (193) and, epi-
neofiscalin A (194), as well as the new indoloazepinone derivative, sartorymensin 
(195) (Figure 40). Sartorymensin (195) exhibited moderate in vitro growth 
inhibitory activity on the human U373 and Hs683 glioblastoma, the A549 non-small 
cell lung cancer, the MCF-7 breast cancer and the SKMEL-28 melanoma cell 
lines, with IC50 values ranging from 39 to 73 µM (Buttachon et al., 2012). 
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189
191 R1 = i-Pr, R2 = H, R3 = R4 = Me
192 R1 = i-Pr, R2 = R4 = H, R3 = Me
193 R1 = R3 = H, R2 = i-Pr, R4 = Me
194 R1 = i-Pr, R2 = R3 = H, R4 = Me
195
190
 
 
Figure 40. New constituents of N. siamensis KUFC 6349. 
 
2.4.6. Neosartorya tsunodae 
 
 The only report on the chemical investigation of N. tsunodae was recently 
published by Kijjoa’s group. The marine sponge-associated fungus N. tsunodae 
KUFC 9213, yielded sartorypyrone B (196) (Figure 41), a new analogue of 
chevalone C. Sartorypyrone B (196) displayed strong growth inhibitory activity 
against MCF-7, NCI-H460 and A375-C5 cancer cell lines with GI50 values of 17.8 ± 
7.4, 20.5 ± 2.4 and 25.0 ± 4.4 µM, respectively (Eamvijarn et al., 2013).  
 
196  
 
Figure 41. Structure of sartorypyrone B (196). 
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2.4.7. Unspecified Neosartorya species 
 
 Chemical investigation of an unspecified Neosartorya sp. from soil sample 
led to the isolation of a novel angiogenesis inhibitor, azaspirene (197) (Figure 42). 
Azaspirene (197) completely inhibited VEGF (vascular endothelial growth factor) 
induced cell migration in human umbilical vein endothelial cells (HUVECs) at the 
concentration of 27.1 µM, without significant cell toxicity (Asami et al., 2002). 
Further studies showed that the anti-angiogenic activity was associated with the 
suppression of Raf-1 activation (Asami et al., 2008). Another endothelial-cell 
growth inhibitor RK-805 (6-oxo-6-deoxyfumagillol) (198) was later isolated from the 
same culture. Additionally, RK-805 (198) also selectively inhibited methionine 
aminopeptidase-2 (MetAP2), supporting the potential of the compound for the 
development of new angiogenesis inhibitors (Asami et al., 2004). 
Marine-derived Neosartorya sp. HN-M-3, collected from marine mud in the 
intertidal zone of Hainan Province (China), was found to produce four new 
tryptoquivaline analogues, tryptoquivalines P-S (199-202) (Figure 42) (Sun et al., 
2012; Xu et al., 2013b).  
 
197 198
199 R1 = H, R2 = OMe
200 R1 = H, R2 = OH
201 R1 = OH, R2 = OMe
202  
 
Figure 42. New constituents of unspecified Neosartorya species. 
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3.1. Chemical Investigation of the Marine Derived 
Fungi  
 
Chemical investigation of the marine sponge-associated fungus Emericella 
variecolor KUFC 7092, resulted in isolation of ergosterol (EV1), ergosterol 
peroxide (EV2), orcinol (EV3), 1H-indole-3-carboxylic acid (EV4) and cyclo-(L-
tryptophyl-L-phenylalanyl) (EV5) (Figure 43).  
 
EV1
EV4 EV5
EV2
EV3  
 
Figure 43. Constituents of Emericella variecolor KUFC 7092. 
 
The EtOAc extract of the marine sponge-derived fungus Eurotium cristatum 
KUFC 7356 furnished five known anthraquinones (EC1-EC5), four previously 
reported indolopolyketopiperazine alkaloids (EC6-EC9) and a new 
diketopiperazine dimer (EC10) (Figure 44).  
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EC8 EC9
EC10
EC1 R1 = OH, R2 = CH3, R3 = H
EC2 R1 = R3 = H, R2 =CH3
EC3 R1 =OH, R2 = R3=H
EC4 R1 = R2 = R3 = H 
EC5 R1 = R2 = H, R3 = CH3 
EC6
EC7
 
 
Figure 44. Constituents of Eurotium cristatum KUFC 7356. 
 
 Two marine-derived Neosartorya species were investigated namely, the 
diseased coral-derived N. laciniosa KUFC 7896 and the marine sponge associated 
N. paulistensis KUFC 7897.  
 
From the EtOAc extract of the culture of N. laciniosa KUFC 7896, a new 
tryptoquivaline analogue, tryptoquivaline T (NL6) , was isolated, in addition to five 
known metabolites including the meroditerpenes chevalone B (NL1), 
aszonapyrones A (NL2) and B (NL3), tryptoquivaline L (NL4) and 3’-(4-
oxoquinazolin-3-yl)spiro[1H-indole-3,5’-oxolane]-2, 2’-dione (NL5) (Figure 45). 
Examination of the EtOAc extract of the culture of N. paulistensis KUFC 
7897 yielded a new aszonapyrone analogue, sartorypyrone C (NP1), in addition to 
five previously reported metabolites including tryptoquivalines L (NP2), H (NP3) 
and F (NP6), 4(3H)-quinazolinone (NP4) and 3’-(4-oxoquinazolin-3-yl)spiro[1H-
indole-3,5’-oxolane]-2, 2’-dione (NP5) (Figure 46). 
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NL2 R = Ac
NL3 R = H
NL1
NL5
NL4 R = OH
NL6 R = CHO  
 
Figure 45. Constituents of Neosartorya laciniosa KUFC 7896. 
 
 
 
NP4
NP5
NP1
NP2 R1 = OH, R2 = Me
NP3 R1 = OH, R2 = H
NP6 R1 = H, R2 = H
 
 
Figure 46. Constituents of Neosartorya paulistensis KUFC 7897. 
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3.1.1. Structure Elucidation of Triterpenoid Steroids 
 
 3.1.1.1. Ergosterol (EV1) 
 EV1 was isolated as white amorphous solid. The 13C NMR, DEPT and 
HSQC spectra (Table 2) revealed the presence of two quaternary sp2 (δC 141.3, 
139.7), four methine sp2 (δC 135.5, 131.9, 119.5, 116.3), two quaternary sp
3 (δC 
42.0, 37.0), seven methine sp3 (δC 70.3, 55.7, 54.5, 46.2, 42.8, 40.4, 33.0), seven 
methylene sp3 (δC 40.7, 39.0, 38.3, 31.9, 29.5, 28.3, 23.0) and six methyl (δC 21.1, 
19.9, 19.6, 17.6, 16.2, 12.0) carbons.  
 
Table 2. 1H and 13C NMR data (CDCl3, 300.13 and 75.47 MHz) of EV1. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1α 
β 
 
38.3, CH2 
 
1.29, m 
2.01, m 
 
H-2a 
H-2b 
 
C-3 
--- 
2a 
b 
31.9, CH2 2.01, m 
1.51, m 
H-1α 
H-1β, 3 
--- 
--- 
3 70.3, CH 3.63, m H-2b, 4a, 4b --- 
4a 
b 
40.7, CH2 2.44, m 
2.28, m 
H-3, 4b, 6 
H-3, 4a, 6 
C-2, 3, 5, 6, 10 
--- 
5 139.7, C --- --- --- 
6 119.5, CH 5.57, dd (5.6, 2.3) H-4a, 4b, 7 C-4, 8, 10 
7 116.3, CH 5.38, m H-6, 14 C-5, 9, 14 
8 141.3, C --- --- --- 
9 46.2, CH 1.96, m --- C-5 
10 37.0, C --- --- --- 
11a 
b 
23.0, CH2 1.69, m 
1.33, m 
H-11b, 12a 
H-11a, 12b 
--- 
--- 
12a 
b 
39.0, CH2 2.04, m 
1.24, m 
H-11a, 12b 
H-11b, 12a 
C-14 
C-18 
13 42.0, C --- --- --- 
14 54.5, CH 2.02, m H-7 C-9, 13, 17 
15 28.3, CH2 1.74, m H-16b --- 
16a 
b 
29.5, CH2 1.76, m 
1.29, m 
--- 
H-15 
--- 
--- 
17 55.7, CH 1.26, m H-20 C-12, 13, 14, 15, 16, 20, 21 
18 12.0, CH3 0.63, s --- C-12, 13, 14, 17 
19 16.2, CH3 0.94, s --- C-1, 5, 9, 10 
20 40.4, CH 2.03, m H-17, 21, 22 C-13 
21 21.1, CH3 1.04, d (6.7) H-20 C-17, 20, 22, 23 
22 135.5, CH 5.16, dd (15.0, 7.5) H-20, 23 C-20, 22, 24 
23 131.9, CH 5.23, dd (15.0, 7.0) H-22, 24 C-20, 22, 24, 25, 28 
24 42.8, CH 1.82, m H-23, 25, 28 C-22, 23, 25, 26/27 
25 33.0, CH 1.48, m H-24, 26/27 C-22, 23, 26/27 
26/27 19.9, CH3 
19.6, CH3. 
0.84, d (6.7) 
0.82, d (6.7) 
H-25 
H-25 
C-24, 25, 26/27 
C-24, 25, 26/27 
28 17.6, CH3 0.92, d (6.7) H-24 C-23, 24, 25 
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The presence of six sp2 carbons (δC 141.3, 139.7, 135.5, 131.9, 119.5 and 
116.3), together with the four olefinic protons at δH 5.57, dd (J = 5.6, 2.3 Hz), 5.38, 
m, 5.23, dd (J = 15.0, 7.0 Hz) and 5.16, dd (J = 15.0, 7.5 Hz), suggested the 
existence of three double bonds in the molecule. The COSY spectrum (Table 2) 
showed that the proton at δH 5.16, dd (J = 15.0, 7.5 Hz; δC 135.5) was coupled to 
the proton at δH 5.23, dd (J = 15.0, 7.0 Hz; δC 131.9), suggesting that they belong 
to a trans substituted double bond. The COSY spectrum also displayed 
correlations between the olefinic proton at δH 5.23, dd (J = 15.0, 7.0 Hz) and the 
methine proton at δH 1.82, m (δC 42.8). In turn, the multiplet of the methine proton 
at δH 1.82 gave cross peaks to the signals of the methine proton at δH 1.48, m (δC 
33.0) and the doublet of the methyl protons at δH 0.92 (J = 6.7 Hz; δC 17.6), 
whereas the multiplet of the methine proton at δH 1.48 (δC 33.0) also gave cross 
peaks with the two methyl doublets at δH 0.84 (J = 6.7 Hz; δC 19.9) and δH 0.82 (J 
= 6.7 Hz; δC 19.6). These correlations suggested the presence of the coupling 
system of: 
 
5.16 dd
(15.0, 7.5)
135.5
131.9
5.23 dd
(15.0, 7.0)
0.82 d (6.7)
0.92 d (6.7)
1.82 m
0.84 d (6.7)
1.48 m
19.9
33.0
42.8
17.6
19.6
 
 
 On the other hand, the olefinic proton at δH 5.16, dd (J = 15.0, 7.5 Hz; δC 
135.5) gave cross peaks to the multiplet of the methine proton at  δH 2.03 (δC 40.4) 
which, in turn, gave cross peaks to the methyl doublet at δH 1.04 (J = 6.7 Hz; δC 
21.1) as well as the multiplet of the methine proton at δH 1.26 (δC 55.7), suggesting 
the presence of the coupling system of 2,5,6-trimethyl-3-hepten-2-yl (A).  
 
 
 70 
 
CHAPTER III. RESULTS AND DISCUSSION 
 
0.82 d (6.7)
1
A
0.92 d (6.7)
1.82 m
2
0.84 d (6.7)
2.03 m
3
1.48 m
19.9
6 7
33.0
4 42.8
17.6
5
19.6
55.7
5.16 dd
(15.0, 7.5)
21.1
1.04 d (6.7)
40.4
1.26 m
135.5
131.9
5.23 dd
(15.0, 7.0)
 
  
The HMBC correlations (Table 2) of the methyl protons at δH 0.92, d (J = 
6.7 Hz; δC 17.6) to the carbons at δC 131.9, 42.8 and 33.0; of the methyl protons at 
δH 0.84, d (J = 6.7 Hz; δC 19.9) and δH 0.82, d (J = 6.7 Hz; δC 19.6) to the carbon 
at δC 42.8; of the olefinic proton at δH 5.23, dd (J = 15.0, 7.0 Hz; δC 131.9) to the 
carbons at δC 40.4, 33.0 and 17.6, and of the methyl protons at δH 1.04, d (J = 6.7 
Hz; δC 21.1) to the olefinic carbon at δC 135.5 and the methine carbon at δC 55.7, 
confirmed this structure. 
 Another portion of the molecule comprised two methyl groups (δH 0.94, s; 
δC 16.2 and δH 0.63, s; δC 12.0) on quaternary carbons, two tetrasubstituted 
double bonds (δC 141.3, 139.7, 119.5, 116.3; δH 5.57, dd, J = 5.6, 2.3 Hz and 5.38, 
m), one oxymethine carbon (δC 70.3; δH 3.63, m), three methine carbons (δC 55.7, 
54.5 and 46.2), seven methylene carbons (δC 40.7, 39.0, 38.3, 31.9, 29.5, 28.3, 
23.0) and two quaternary carbons (δC 42.0 and 37.0). The COSY spectrum 
displayed strong cross peak between the signals of the olefinic protons at δH 5.57, 
dd (J = 5.6, 2.3 Hz; δC 119.5) and δH 5.38, m (δC 116.3) as well as weak cross 
peaks between the signal of the olefinic proton at δH 5.57, dd (J = 5.6, 2.3 Hz; δC 
119.5) and the signals of the methylene protons at δH 2.44, m and 2.28, m (δC 
40.7). In turn, these methylene protons also showed correlations with the 
oxymethine proton at δH 3.63, m (δC 70.3). The HMBC spectrum showed cross 
peaks of the multiplet of the olefinic proton at δH 5.38 (δC 116.3) to the quaternary 
sp2 carbon δC 139.7 and the methine sp
3 carbon at δC 46.2; of the signal of the 
olefinic proton at δH 5.57, dd (J = 5.6, 2.3 Hz; δC 119.5) to the quaternary carbon 
at δC 141.3 and the quaternary sp
3 carbon at δC 37.0; of the signals of the 
methylene protons at δH 2.44, m and 2.28, m (δC 40.7) to the methine sp
2 carbon 
at δC 119.5 and the methylene carbon at δC 31.9, and of the methyl singlet at δH 
0.94 (δC 16.2) to the quaternary sp
3 carbon at δC 37.0, the quaternary sp
2 carbon 
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at δC 139.7, the methine sp
3 carbon at δC 46.2 and the methylene carbon at δC 
38.3.  These correlations suggested the existence of the 6,7-substituted 4a-
methyl-1,2,3,4,4a,5-hexahydronaphthalen-2-ol moiety.  
 
40.7
2.28 m
3.63 m
0.94 s
2.44 m
5.57 dd (5.6, 2.3)
5.38 m
16.2
1.96 m
46.2
38.3
37.0
70.3
31.9
116.3
141.3
139.7
119.5
 
  
 Moreover, the HMBC spectrum also displayed cross peaks of the multiplet 
of the olefinic proton at δH 5.38 (δC 116.3) and the methyl singlet at δH 0.63 (δC 
12.0) to the methine sp3 carbon at δC 54.5. Furthermore, the methyl singlet at δH 
0.63 (δC 12.0) gave HMBC cross peaks with the quaternary carbon at δC 42.0, the 
methine sp3 carbon at δC 55.7 and the methylene carbon at δC 39.0, the signal of 
the methine proton at δH 2.02, m (δC 54.5) gave cross peaks to the methine sp
3 
carbons at δC 46.2 and δC 55.7, and to the quaternary sp
3 carbon at δC 42.0, and 
the signal of the methine proton at δH 1.26, m (δC 55.7)  gave cross peaks to the 
methylene carbons at δC 39.0, 29.5 and 28.3, the methine carbon at δC 54.5, and 
the quaternary carbon at δC 42.0. Consequently the hexahydronaphthalene moiety 
was fused with the octahydro-1H-indene moiety through the olefinic carbon at δC 
141.3 and the methine carbon at δC 46.2, forming thus a tetracyclic skeleton of 
androstane (B).     
 
39.0
B
12.0
55.7
42.0
1.96 m
28.3
0.63 s
1.26 m
116.3
141.3
46.2
5.38 m
29.5
54.5
2.02 m
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 Since the COSY spectrum exhibited correlation between the proton signal 
at δH 2.03, m (δC 40.4) of fragment A and the proton signal at δH 1.26, m (δC 55.7) 
of fragment B, it was clear that these two fragments were connected through the 
methine carbons at δC 40.4 of the former and at δC 55.7 of the latter. This was 
supported by the HMBC correlations of the methyl singlet at δH 1.04, d (J = 6.7; δC 
21.1) to the methine carbon at δC 55.7, as well as of the methine proton at δH 1.26, 
m (δC 55.7) to the methine carbon at δC 40.4, and the methyl carbon at δC 21.1. 
Therefore the complete structure of EV1 was: 
 
1.26 m
55.7
21.1
40.4
1.04 d
(6.7)
2.03 m
 
  
Literature survey revealed that the structure of EV1 corresponded to 
ergosterol (Figure 47), a fungal sterol widely reported from many fungal species 
such as Aspergillus fumigatus (Alcazar-Fuoli et al., 2008), Pleurotus ostreatus 
(Ramos-Ligonio et al., 2012), and from various strains of Emericella spp., namely 
E. striata (Kawahara et al., 1988b), E. unguis (Kawahara et al., 1998c) as well as 
from other strains of E. variecolor (Liangsakul et al., 2011; Malmström et al., 
2002b). The 1H and 13C NMR data of EV 1 were compatible with those of 
ergosterol reported by Tuckey et al. (2012).   
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1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
 
 
Figure 47. Structure of ergosterol (EV1). 
 
 3.1.1.2. Ergosterol peroxide (EV2) 
EV2 was isolated as colorless needles, and the general features of its 1H 
and 13C NMR spectra (Table 3) closely resembled those of EV1. The 13C NMR 
spectrum of EV2 also displayed twenty-eight carbon signals, which can be 
categorized through DEPT and HSQC spectra, as four methine sp2 (δC 135.6, 
135.2, 131.5, 130.2), four quaternary sp3 (δC 81.4, 78.4, 44.0, 36.5), seven 
methine sp3 (δC 64.6, 55.4, 51.2, 50.8, 42.0, 39.9, 32.5), seven methylene sp
3 (δC 
38.7, 36.9, 34.5, 29.9, 28.3, 22.8, 20.2) and six methyl (δC 20.7, 19.8, 19.5, 17.9, 
17.3, 12.6) carbons.  
Like EV1, EV2 also contained the 2,5,6-trimethyl-3-hepten-2-yl moiety 
which was confirmed by the COSY and HMBC correlations (Table 3). 
 
17.3
0.89 d (6.8)
42.0
32.5
1.85 m
1.46 m
19.5
0.83 d (6.8)
19.8
0.81 d (6.8)
2.02 m
55.4
5.16 dd
(15.3, 8.2)
20.7
0.97 d (6.8)
39.9
1.21 m
135.2
131.5
5.24 dd
(15.3, 7.0)
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Contrary to EV1, the 1H and 13C NMR spectra revealed the presence of one 
cis double bond (δC 135.6; δH 6.23, d, J = 8.5 Hz and δC 130.2; δH 6.44, d, J = 8.5 
Hz) and two oxygenated quaternary sp3 carbons at δC 81.4 and δC 78.4, instead of 
two conjugated double bonds, in the androstane moiety. The signal of the olefinic 
proton at δH 6.23, d (J = 8.5 Hz; δC 135.6) displayed HMBC cross peaks to the 
carbons at δC 36.9, 81.4 and 78.4, while the signal of the olefinic proton at δH 6.44, 
d (J = 8.5 Hz; δC 130.2) gave HMBC cross peaks to the carbons at δC 81.4 and 
50.8, suggesting that the double bond was located on C-6/C-7, whereas C-5 and 
C-8 were oxygenated.  
 
Table 3. 1H and 13C NMR data (DMSO-d6, 500.13 and 125.77 MHz) of EV2. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1α 
β 
 
34.5, CH2 
 
1.71, dd (13.5, 3.2) 
1.61. m 
 
H-2a, 2b 
H-2a 
 
--- 
C-3, 10 
2a 
b 
29.9, CH2 1.65, m 
1.38, m  
H-1α, 1β, H-2b  
H-1α, 2a, 3 
--- 
--- 
3 64.6, CH 3.57, m H-2b, 4 --- 
4 36.9, CH2 1.83, m H-3 C-2, 3, 5, 6, 10 
5 81.4, C --- --- --- 
6 135.6, CH 6.23, d (8.5) H-7 C-4, 5, 8 
7 130.2, CH 6.44, d (8.5) H-6 C-5, 8, 9 
8 78.4, C --- --- --- 
9 50.8, CH 1.32, m --- C-1, 7, 8 
10 36.5, C --- --- --- 
11a 
b 
22.8, CH2 1.48, m 
1.13, m 
H-11b, 12a, 12b 
H-11a, 12a 
--- 
--- 
12a 
b 
38.7, CH2 1.88, m 
1.18, m 
H-11a, 11b, 12b 
H-11a, 12a 
--- 
--- 
13 44.0, C --- --- --- 
14 51.2, CH 1.44, m --- C-8, 16 
15a 
b 
28.3, CH2 1.66, m 
1.23, m 
H-15b, 16 
H-15a 
--- 
--- 
16 20.2, CH2 1.39, m H-15a --- 
17 55.4, CH 1.21, m H-20, 22 C-13, 15, 18, 20 
18 12.6, CH3 0.77, s --- C-12, 13, 14, 17 
19 17.9, CH3 0.79, s --- C-5, 9, 10 
20 39.9, CH 2.02, m H-17, 21, 22 --- 
21 20.7, CH3 0.97, d (6.8) H-20 C-17, 20, 22 
22 135.2, CH 5.16, dd (15,3, 8.2) H-17, 20, 23 C-20, 24 
23 131.5, CH 5.24, dd (15.3, 7.0) H-22, 24 C-20, 24 
24 42.0, CH 1.85, m H-23, 25, 28 C-25, 26, 27, 28 
25 32.5, CH 1.46, m H-24, 26/27 C-23, 24, 26/27 
26/27 19.8, CH3 
19.5, CH3 
0.83, d (6.8) 
0.81, d (6.8) 
H-25, 26/27 
H-25, 26/27 
C-24, 25, 26/27 
C-24, 25, 26/27 
28 17.3, CH3 0.89, d (6.8) H-24 C-23, 24, 25 
OH-3 --- 4.63, brs --- --- 
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This was corroborated by the HMBC correlation of the methyl singlet at δH 0.79 (δC 
17.9) to the oxygenated quaternary carbon at δC 81.4 (C-5). Taking together the 
NMR data, it was possible to conclude that the structure of EV2 was:  
 
1.46 m
64.6
135.2
32.5131.5
4.63 brs
3.57 m
0.79 s
130.2
6.44 d
(8.5)
6.23 d
(8.5)
78.4
81.4
135.6
50.8
36.9
17.9
 
 
The 1H and 13C NMR chemical shift values of EV2 are compatible with 
those reported for ergosterol peroxide (Figure 48) by Kim et al. (1997). 
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Figure 48. Structure of ergosterol peroxide (EV2). 
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Ergosterol (EV1) and ergosterol peroxide (EV2) belong to the subclass of 
modified triterpenoid steroids, which include several widely known drugs such as 
corticosteroids and cardioactive glycosides, several biological and physiologically 
relevant hormones, as well as phytosterols. Isolation of ergosterol and ergosterol 
peroxide from the extract of E. variecolor KUFC 7092 was not surprising since 
ergosterol is the predominant fungal sterol, representing approximately 70% of the 
sterols present in fungi. As a component of fungal membranes, ergosterol is 
involved in several biological functions such as membrane fluidity regulation, 
activity and distribution of integral proteins and control of the cellular cycle (Bard et 
al., 1993). Analogously, isolation of ergosterol peroxide is not unexpected since it 
has been reported as the H2O2-dependent enzymatic oxidation product of 
ergosterol (Bates et al., 1976).  
Despite their wide distribution, both fungal steroids have been a focus of 
several reports regarding to their therapeutic potential. Apart from being the major 
precursor for the synthesis of vitamin D2 (Holick, 2003), there are a number of 
reports on biologically active properties of ergosterol as well as of ergosterol 
peroxide. 
Both ergosterol and its peroxide were reported as anti-inflammatory agents, 
suppressing LPS-induced inflammation in RAW 246.7 macrophages through the 
inhibition of NF-κB and C/EBPβ, as well as phosphorylation of MAPK’s (Kobori et 
al., 2007). Kuo et al. (2011) have found that the anti-inflammatory action of 
ergosterol was also associated with the inhibition of COX-2 expression. In the 
previous study by Kobori et al. (2007), ergosterol peroxide was found to display 
growth inhibitory activity against colorectal adenocarcinoma HT29 cells, 
presumably as a result of the accumulation of ROS. In spite of the fact that 
antitumor molecular mechanisms of ergosterol and ergosterol peroxide are not 
clarified yet, there are several reports on their cytotoxic activity against a wide 
spectrum of cancer cell lines. While ergosterol displayed growth inhibitory activity 
against MCF-7 (breast adenocarcinoma) cell line (Subbiah and Abplanalp, 2003) 
and an inhibitory effect on rat urinary bladder carcinogenesis (Yazawa et al., 
2000), ergosterol peroxide was shown to be cytotoxic against human 
hepatocellular carcinoma Hep 3B (Chen et al., 2009a) and human multiple 
myeloma U266 cells (Rhee et al., 2012), and against human gastric tumor (SNU-
1), human hepatoma (SNU-354), human colorectal tumor (SNU-C4) and murine 
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sarcoma-180 cell lines (Nam et al., 2001). Additionally, ergosterol peroxide also 
exhibited inhibitory effect against androgen-sensitive (LNCaP) and –insensitive 
(DU-145) human prostate cancer cells at micromolar concentrations (Russo et al., 
2010), as well as against several chemoresistant tumor cells (Wu et al., 2012). 
Interestingly, while ergosterol acts as a modulator of the cholesterol regulatory 
effect in cell cycle progression in human cells (Suárez et al., 2002), its peroxide 
displayed the anti-atherosclerotic activity, through the ihbition of hACAT-1 and Lp-
PLA2 (Kim et al., 2005). The biological properties of ergosterol peroxide include 
also antibacterial (Duarte et al., 2007) and trypanocidal activity (Ramos-Lignorio et 
al., 2012) against Mycobacterium tuberculosis and Trypanosoma cruzi, 
respectively, as well as renal fibrosis preventive effect (Zhu et al., 2013).      
 
3.1.2. Structure Elucidation of Orcinol and 1H-Indole-3-
carboxylic acid 
 
 3.1.2.1. Orcinol (EV3) 
EV3 was isolated as colorless mass. The 13C NMR, DEPT and HSQC 
spectra (Table 4) revealed the presence of three quaternary sp2 (δC 157.8, 156.3, 
141.0), three methine sp2 (δC 112.1, 111.3, 103.4) and one methyl (δC 21.4) 
carbon. The 1H NMR spectrum revealed the presence of three meta-coupled 
aromatic protons at δH 6.19, dd, J = 2.0, 2.0 Hz (δC 103.4), δC 6.30, d, J = 2.0 Hz, 
2H (δC 112.1 and 111.3), and the aromatic methyl protons at δH 2.13, s (δC 21.4) 
(Table 4). 
 
Table 4. 1H and 13C NMR data (CDCl3, 300.13 and 75.47 MHz) of EV3.  
Position δC, type δH, mult. (J in Hz) HMBC 
 
1 
 
157.8, C 
 
--- 
 
--- 
2 103.4, CH 6.19, dd (2.0, 2.0) C-1, 3, 4, 6 
3 156.3, C --- --- 
4 112.1, CH 6.30, d (2.0) C-2, 3, 6, 7 
5 141.0, C --- --- 
6 111.3, CH 6.30, d (2.0) C-1, 2, 4, 7 
7 21.4, CH3 2.13, s C-4, 5, 6 
 
 The low frequencies of the aromatic protons, together with high frequencies 
of the quaternary sp2 carbons (δC 157.8 and 156.3) suggested the 1,3,5-
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trissubstituted methylphenol. The HMBC spectrum (Table 4) showed cross peaks 
of the methyl singlet at δH 2.13 (δC 21.4) to the carbon at δC 141.0, 112.1 and 
111.3; of the doublet at δH 6.30 (J = 2.0 Hz) to the carbons at δC 156.3, 112.1, 
111.3, 103.4 and 21.4; and of the double doublet at δH 6.19 (J = 2.0, 2.0 Hz; δC 
103.4) to the carbon at δC 157.8, 156.3, 112.1 and 111.3, thus suggesting the 
structure of EV3 as 5-methylbenzene 1,3-diol.  
 
157.8
2.13 s21.4
6.19 dd 
(2.0, 2.0)
6.30 d (2.0)
156.3
103.4
112.1
111.3
141.0
 
 
The 1H and 13C NMR data of EV3 were in agreement with those reported for 
orcinol (Figure 49) by Gavin and Tabacchi (1975). Orcinol (EV3) has been also 
reported from the lichens Evernia prunasti (L.) ARCH (Nomura et al., 2012) and 
Parmotrema grayana and was found to have antioxidant activity (Thadhani et al., 
2011). 
1
2
3
4
5
6
7  
 
Figure 49. Structure of orcinol (EV3). 
 
 3.1.2.2. 1H-Indole-3-carboxylic acid (EV4) 
EV4 was isolated as white amorphous solid. The 13C NMR, DEPT and 
HSQC spectra (Table 5) revealed the presence of four quaternary sp2 (δC 165.9, 
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136.4, 126.0, 107.3) and five methine sp2 (δC 132.3, 122.1, 121.0, 120.6, 112.2) 
carbons.  
 
Table 5. 1H and 13C NMR data (DMSO-d6, 500.13 and 125.77 MHz) of EV4. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
2 
 
132.3, CH 
 
8.00, s 
 
--- 
 
C-3, 8, 9 
3 107.3, C --- --- --- 
4 120.6, CH 8.00, d (7.6) H-5 C-3, 6, 8 
5 121.0, CH 7.15, ddd (7.6, 7.6, 1.3) H-4, 6 C-7, 9 
6 122.1, CH 7.19, ddd (7.6, 7.6, 1.3) H-5, 7 C-4, 8 
7 112.2, CH 7.46, d (7.6) H-6 C-5, 9 
8 136.4, C --- --- --- 
9 126.0, C --- --- --- 
10 165.9, CO --- --- --- 
NH --- 11.81, s --- --- 
OH --- 11.95, brs --- --- 
 
 The 1H NMR spectrum (Table 5) displayed two doublets at δH 8.00 (J = 7.6 
Hz) and δH 7.46 (J = 7.6 Hz), two double double doublets at δH 7.19 (J = 7.6, 7.6, 
1.3 Hz) and δH 7.15 (J = 7.6, 7.6, 1.3 Hz), two singlets at δH 8.00 and 11.81, 
besides a broad singlet at δH 11.95. 
 The COSY spectrum (Table 5) exhibited cross peaks of the doublet at δH 
8.0 (J = 7.6 Hz) to the double double doublet at δH 7.15 (J = 7.6, 7.6, 1.3 Hz), and 
of the doublet at δH 7.46 (J = 7.6 Hz) to the double double doublet at δH 7.19 (J = 
7.6, 7.6, 1.3 Hz). In turn, the two double double doublets at δH 7.15 (J = 7.6, 7.6, 
1.3 Hz) and 7.19 (J = 7.6, 7.6, 1.3 Hz) were correlated with each other, as well as 
with the doublets at δH 8.00 (J = 7.6 Hz) and 7.46 (J = 7.6 Hz), respectively, 
suggesting the presence of a 1,2-disubstituted benzene ring (A). This was 
confirmed by the correlations displayed by the HMBC spectrum (Table 5) which 
showed cross peaks of the doublet at δH 7.46 (J = 7.6 Hz; δC 112.2) to the sp
2 
methine carbon at δC 121.0 and the sp
2 quaternary carbon at δC 126.0, and of the 
doublet at δH 8.0 (J = 7.6 Hz; 120.6) to the sp
2 methine carbon at δC 122.1 and the 
sp2 quaternary carbon at δC 136.4.  
Furthermore, the HMBC spectrum also exhibited cross peaks of the doublet 
at δH 8.00 (J = 7.6 Hz; δC 120.6) to the quaternary sp
2 carbon at δC 107.3, and of 
the singlet at δH 8.00 (δC 132.3) to the quaternary sp
2 carbons at δC 107.3 and 
126.0, suggesting that one of the substituents of the 1,2-dissubstituted benzene 
ring was an ethenyl fragment (B). Since the singlet at δH 8.00 (δC 132.3) also 
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showed the HMBC cross peak to quaternary sp2 carbon at δC 136.4, the cyclic 
nature of the substituents on the carbons at δC 126.0 and 136.4 was suggested 
(B). Moreover, the chemical shift value of the substituted aromatic carbon at δC 
136.4 and of the olefinic carbon at δC 132.3 (δH 8.00, s) were characteristics of the 
nitrogen bearing sp2 carbons.  
 
A
132.3
B
7.19 ddd
(7.6, 7.6, 1.3)
7.15 ddd
(7.6, 7.6, 1.3)
8.00 d
(7.6)
8.00 s
8.00 d
(7.6)
11.81 s
136.4
7.46 d
(7.6)
120.6
107.3
120.6
126.0
112.2
122.1
121.0
 
 
Since the 1H NMR spectrum displayed a singlet at δH 11.81, the presence of 
the 2,3-dihydro-1H-indole rings system was proposed. That the substituent on C-3 
(δC 107.3) of the indole moiety was the carboxyl group was supported by the 
presence of the carbon at δC 165.9, characteristic of the conjugated carbonyl, and 
a broad singlet at δH 11.95 in the 
1H NMR spectrum. This hypothesis was also 
supported by a low chemical shift value of C-3 (δC 107.3) which is characteristic of 
the sp2 carbon with the electron withdrawing substituent. Consequently the 
structure of EV4 was proposed as: 
 
1
2
3
4
5
6
7
8
9
10
 
 
Figure 50. Structure of 1H-indole-3-carboxylic acid (EV4). 
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Literature survey revealed that the structure of EV4 corresponded to the 
monoindole alkaloid 1H-indole-3-carboxylic acid (Figure 50) (Wang et al., 2012) 
previously reported not only from fungi (Wu et al., 2013) but also from several 
other sources such as Streptomyces sp. (Kavitha et al., 2010, Shaaban et al., 
2008), plant pathogens (Tan et al., 2004) and marine sponges (Wang et al., 2012). 
1H-Indole-3-carboxylic acid proved to be a promising antimicrobial agent, 
displaying good antibacterial activity not only against the Gram-positive bacteria 
Staphylococcus aureus and Staphylococcus epidermis, but also against the Gram-
negative Escherichia coli and Xanthomonas campestris. Additionally, the 
monoindole alkaloid exhibited also good antifungal activity against dermatophytes 
such as Candida albicans and Epidermophyton flocosum, as well as strong growth 
inhibitory activity against Fusarium oxysporum (Kavitha et al., 2010).   
 
3.1.3. Structure Elucidation of Anthraquinones 
  
3.1.3.1. Erythroglaucin (EC1) 
EC1 was isolated as red needles. The 1H NMR spectrum (Table 6) 
exhibited the signals of three hydrogen-bonded hydroxyl groups at δH 13.75, s, 
12.46, s and 12.38, s, in addition to three doublets of the aromatic protons at δH 
7.41 (J = 2.5 Hz), 7.14 (J = 0.8 Hz) and 6.71 (J = 2.5 Hz), and a methyl doublet at 
2.36 (J = 0.8 Hz). The 13C NMR spectrum (Table 6) displayed sixteen carbon 
signals which, through DEPT (90º and 135º) and HSQC spectra (Table 6), were 
categorized into two conjugated ketone carbonyls (δC 188.9, 186.5), nine 
quaternary sp2 (δC 166.4, 165.2, 157.9, 157.2, 140.7, 135.1, 111.8, 110.6, 110.5), 
three methine sp2 (δC 129.3, 105.4, 106.9), one methoxy (δC 56.2) and one methyl 
(δC 16.5) carbons.  
The COSY spectrum (Table 6) showed correlations between the meta-
coupled aromatic protons at δH 6.71, d (J = 2.5 Hz; δC 106.9) and δH 7.41, d (J = 
2.5 Hz; δC 105.4) on the one hand, and between the aromatic proton at δH 7.14, d 
(J = 0.8 Hz; δC 129.3) and the methyl protons at δH 2.36, d (J = 0.8 Hz; δC 16.5) on 
the other hand, suggesting the presence of one 1,2,3,4,6-pentasubstituted and 
one 1,2,3,5-tetrasubstituted benzene rings in the molecule. 
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129.3 106.9
105.4
7.41 d
(2.5)
2.36 d
(0.8)
16.5
7.14 d
(0.8)
6.71 d
(2.5)
 
 
Table 6. 1H and 13C NMR data (CDCl3, 500.13 and 125.77 MHz) of EC1. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1 
 
157.2, C 
 
--- 
 
--- 
 
--- 
2 129.3, CH 7.14, d (0.8) H-11 C-4, 9a, 11 
3 140.7, C --- --- --- 
4 157.9, C --- --- --- 
4a 111.8, C --- --- --- 
5 105.4, CH 7.41, d (2.5) H-7 C-7, 8a, 10 
6 166.4, C --- --- --- 
7 106.9, CH 6.71, d (2.5) H-5 C-5, 8, 8a 
8 165.2, C --- --- --- 
8a 110.5, C --- --- --- 
9 188.9, CO --- --- --- 
9a 110.6, C --- --- --- 
10 186.5, CO --- --- --- 
10a 135.1, C --- --- --- 
11 16.5, CH3 2.36, d (0.8) H-2 C-2, 3, 4 
OCH3-6 56.2, CH3 3.95, s --- C-6 
OH-1 --- 12.38, s --- C-1, 2, 9a 
OH-4 --- 13.75, s --- C-3, 4, 4a 
OH-8 --- 12.46, s --- C-7, 8, 8a 
 
The HMBC spectrum (Table 6) showed correlations of the hydrogen-
bonded hydroxyl proton at δH 12.38, s to the carbons at δC 157.2, 129.3, and 
110.6, of another hydrogen-bonded hydroxyl proton at δH 13.75, s, to the carbons 
at δC 157.9, 140.7 and 111.8, of the methyl protons at δH 2.36, d (J = 0.8 Hz; δC 
16.5) to the carbons at δC 140.7, 129.3 and 157.9, as well as of the aromatic 
proton at δH 7.14, d (J = 0.8 Hz; δC 129.3) to the carbons at δC 110.6 and 157.9, 
suggesting that the 1,2,3,4,6-pentasubstituted benzene was part of the system 
shown below:  
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157.2
12.38 s
110.6
16.5
13.75 s
140.7
129.3
111.8
157.9
2.36 d
(0.8)
7.14 d
(0.8)
 
 
That three of the substituents of the 1,2,3,5-tetrasubstituted benzene ring 
were hydroxyl, methoxy and the carbonyl groups was substantiated by the HMBC 
correlations of the aromatic proton at δH 6.71, d (J = 2.5 Hz; δC 106.9) to the 
carbons at δC 110.5 and 105.4, of the aromatic proton at δH 7.41, d (J = 2.5 Hz; δC 
105.4) to the carbons at δC 186.5, 110.5 and 106.9, of the hydrogen-bonded 
hydroxyl proton at δH 12.46, s to the carbons at δC 165.2, 106.9 and 110.5, and of 
the methoxy proton at δH 3.95, s (δC 56.2) to the carbon at δC 166.4. 
 
165.2
110.5
12.46 s
3.95 s
56.2
186.5
7.41 d
(2.5)
166.4
105.4
106.9
6.71 d
(2.5)
 
 
Combining these two partial structures led to the structure of EC1 as 1,4,8-
trihydroxy-6-methoxy-3-methylanthracene-9,10-dione. The NMR data of EC1 were 
compatible with those reported for erythroglaucin (Figure 51), the anthraquinone 
isolated from different species of the genus Eurotium (Anke et al., 1980). 
Erythroglaucin has not only been reported as a metabolic product from different 
genus of microfungi, namely Alternaria (Andersen et al., 2008; Suemitsu et al., 
1977), but also from macrofungi (Beattie et al., 2010) and several lichens of 
different genera (Manojlović et al., 2000; Sochting and Frödén, 2002).  
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1
2
3
4
4a
5
6
7
8
8a99a
10 10a
11
 
 
Figure 51. Structure of erythroglaucin (EC1). 
 
 Regarding to its biological properties, this anthraquinone was reported to 
have antibacterial activity against Pseudomonas fluorescens and Pseudomonas 
glicinea, and antifungal activity against human pathogenic fungi including 
Aspergillus niger, Doratomyces stemonitis, Penicillium verucosum and 
Trichoderma viride (Manojlović et al., 2000). Interestingly, erythroglaucin was 
found to cause DNA cleavage through photo-induced production of ROS 
(Rajendran et al., 2004). It displayed also moderate radical-scavenging activity 
against DPPH (Wang et al., 2006). Erythroglaucin was shown to display structure-
uncoupling activity using rat liver mitochondria (Betina and Kuzela, 1987), as well 
as iron-chelating capability (Engstrom et al., 1982). 
 
3.1.3.2. Physcion (EC2) 
EC2 was isolated as orange needles, and the general features of its 1H and 
13C NMR spectra closely resembled those of EC1. However, the 1H NMR 
spectrum (Table 7) revealed the presence of two hydrogen-bonded hydroxyl 
groups at δH 12.13, s and δH 12.33, s, four aromatic protons at δH 6.69, d (J = 2.5 
Hz), 7.09, d (J = 0.8 Hz), 7.38, d (J = 2.5 Hz) and 7.64, d (J = 0.8 Hz), one 
methoxy group (δH 3.94, s) and one aromatic methyl group (δH 2.46, s). The 
13C 
NMR spectrum (Table 7) displayed also sixteen carbon signals which were 
categorized, according to DEPT (90º and 135º) and HSQC (Table 7), as two 
ketone carbonyls (δC 195.9, 182.1), eight quaternary sp
2 (δC 166.5, 165.2, 162.5, 
148.5, 135.2, 133.2, 114.0, 110.3), four methine sp2 (δC 125.5, 121.3, 108.2, 
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106.8), one methoxy (δC 56.1) and one methyl (δC 22.2) carbon, suggesting the 
anthraquinone nucleus. 
 
Table 7. 1H and 13C NMR data (CDCl3, 500.13 and 
125.77 MHz) of EC2. 
Position δC, type δH, mult. (J in Hz) HMBC 
 
1 
 
162.5, C 
 
--- 
 
--- 
2 125.5, CH 7.09, d (0.8) C-4, 9a, 11 
3 148.5, C --- --- 
4 121.3, CH 7.64, d (0.8) C-2, 9a, 10, 11 
4a 133.2, C --- --- 
5 108.2, CH 7.38, d (2.5) C-7, 8a, 10 
6 166.5, C --- --- 
7 106.8, CH 6.69, d (2.5) C-5, 8, 8a 
8 165.2, C --- --- 
8a 110.3, C --- --- 
9 195.9, CO --- --- 
9a 114.0, C --- --- 
10 182.1, CO --- --- 
10a 135.2, C --- --- 
11 22.2, CH3 2.46, s C-2, 3, 4 
OCH3-6 56.1, CH3 3.94, s C-6 
OH-1 --- 12.13, s C-1, 2, 9a 
OH-4 --- --- --- 
OH-8 --- 12.33, s C-7, 8, 8a 
 
That one of the 1,2,3,5-tetrasubstituted benzene rings was a 1-hydroxy-3-
methoxybenzene ring of the anthraquinone was corroborated not only by the 
chemical shift values of the aromatic protons and their corresponding carbons (δH 
6.69, d, J = 2.5 Hz; δC 106.8 / δH 7.38, d, J = 2.5 Hz; δC 108.2) and the hydrogen-
bonded hydroxyl group at δH 12.33, s, but also by the HMBC correlations of the 
hydroxyl proton at δH 12.33, s  to the carbons at δC 165.2, 110.3 and 106.8, of the 
aromatic proton at δH 6.69, d (J = 2.5 Hz; δC 106.8) to the carbon at δC 165.2, 
108.2 and 110.3, and of the aromatic proton at δH 7.38, d (J = 2.5 Hz; δC 108.2) to 
the carbons at δC 110.3 and 106.8 and to the carbonyl carbon at δC 182.1. That 
another part of the anthraquinone was a 1-hydroxy-3-methylbenzene was 
supported by the presence of the hydrogen-bonded hydroxyl proton at δH 12.13, s, 
which gave HMBC correlations to the carbons at δC 162.5, 125.5 and 114.0, and 
the methyl singlet at δH 2.46 (δC 22.2) which, in turn, gave HMBC correlations to 
the carbons at δC 148.5, 125.5, and 121.3, as well as the HMBC correlations of the 
doublet of the aromatic proton at δH 7.64 (J = 0.8 Hz; δC 121.3) to the carbonyl at 
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δC 182.1, the methyl carbon at δC 22.2, and the aromatic carbons at δC 125.5 and 
114.0. 
 
182.1
12.13 s
195.9
133.2
7.64 d
(0.8)
2.46 s
7.09 d
(0.8)
148.5
125.5
162.5
114.0
121.322.2
 
  
Thus the structure of EC2 was proposed as 1,8-dihydroxy-6-methoxy-3-
methylanthracene-9,10-dione. The 1H and 13C NMR data of EC2 was compatible 
with those of physcion (Figure 52), the pigment isolated from several species of 
the genus Eurotium (Anke et al., 1980).  
 
1
2
3
4
4a
5
6
7
8
8a99a
10 10a
11
 
 
Figure 52. Structure of physcion (EC2). 
 
Physcion was reported not only from different fungal species, mainly from 
Aspergillus (Li et al., 2014; Yang et al., 2013a) and Microsporum genera 
(Wijesekara et al., 2014), and from lichens (Bačkorová et al., 2012), but also as a 
pigment from several plant species, especially from the genus Rheum (Agarwal et 
al., 2000; Choi et al., 2013; Feng et al., 2013), Cassia (Jain et al, 2013; Kim et al., 
2004) and Polygonum (Leu et al., 2008; Qiu et al., 2013). 
 87 
 
CHAPTER III. RESULTS AND DISCUSSION 
 
 The biological activities of physcion are vast and cover a wide range of 
potentially useful therapeutic properties. Like erythroglaucin, physcion exhibited 
strong to moderate antifungal activity not only against the human pathogenic fungi 
Candida albicans, Cryptococcus neoformans and Trichophyton mentagrophytes 
(Agarwal et al., 2000), but also against plant pathogenic fungi such as Botrytis 
cinerea, Erysiphe graminis, Phytophthera infestans and Rhizoctomia solani (Kim 
et al., 2004). Recently, the antiproliferative properties of physcion were reported. It 
displayed inhibitory activity against human cervical carcinoma HeLa cells by 
causing apoptosis with formation of intracellular free radicals like ROS, as well as 
through the regulation of Bcl-2 and Bax expression, and activation of caspase-3 
pathway (Wijisekara et al., 2014). Additionally, the compound exhibited also in 
vitro cytotoxic activity against the human cancer cell lines A375 (malignant skin 
melanoma), Hep2 (epidermoid laryngeal carcinoma) and U937 (lymphoma). Anti-
inflammatory properties of physcion were also reported in the same study, 
presumably due to the inhibition of the expression of iNOS protein (Gosh et al., 
2010). In other recent study, physcion was classified as a potentially usefull agent 
for diabetic nephropathy treatment, due to its inhibitory activity on the secretion of 
IL-6 in high-glucose-induced mesangial cells, and by causing significant decrease 
on the production of collagen IV and fibronectin (Yang et al., 2013a). Furthermore, 
the suppression of IL-1β and protein expression of ICAM-1 and caspase-3 were 
associated with physcion protective effects against cerebral injury (Zhang et al., 
2005). However, the most interesting biological property of physcion refers to its 
potent tyrosinase inhibitory activity which together with the great percutaneous 
absorption classified the compound as a potentially useful skin-whitening agent 
(Leu et al., 2008). Physcion also exhibited iron-chelating capability (Engstrom et 
al., 1982).  
 
3.1.3.3. Catenarin (EC3) 
EC3 was isolated as dark orange amorphous solid. The 1H and 13C NMR 
data (Table 8) closely resembled those of EC1, except for the lack of the methoxy 
substituent, suggesting a similar structure to that of EC1. The 13C NMR and HSQC 
spectra (Table 8) revealed the presence of fifteen carbon signals, which were 
categorized as two hydrogen bonded ketone carbonyls (δC 187.5, 186.3), nine 
 88 
 
CHAPTER III. RESULTS AND DISCUSSION 
 
quaternary sp2 (δC 166.4, 164.6, 156.7, 156.0, 139.6, 134.7, 111.6, 110.2, 108.7), 
three methine sp2 (δC 129.2, 108.8, 108.3) and one methyl (δC 15.9) carbon. The 
1H NMR spectrum (Table 8) revealed the presence of three hydrogen-bonded 
hydroxyl protons at δH 13.17, brs and at δH 12.16 brs (2OH), three aromatic 
protons at δH 7.23, s, 7.10, d (J = 2.4 Hz), 6.53, d (J = 2.4 Hz) and one aromatic 
methyl group at δH 2.24, s. 
 
Table 8. 1H and 13C NMR data (DMSO-d6, 300.13 
and 75.47 MHz) of EC3. 
Position δC, type δH, mult. (J in Hz) HMBC 
 
1 
 
156.0, C 
 
--- 
 
--- 
2 129.2, CH 7.23, s  C-4, 9a, 11 
3 139.6, C --- --- 
4 156.7, C --- --- 
4a 111.6, C --- --- 
5 108.8, CH 7.10, d (2.4) C-7, 8a, 10 
6 166.4, C ---  
7 108.3, CH 6.53, d (2.4) C-5, 8, 8a 
8 164.6, C --- --- 
8a 108.7, C --- --- 
9 187.5, CO --- --- 
9a 110.2, C --- --- 
10 186.3, CO --- --- 
10a 134.7, C --- --- 
11 15.9, CH3 2.24, s C-2, 3, 4 
OH-1 --- 12.16, brs --- 
OH-4 --- 13.17, brs --- 
OH-6 --- ND --- 
OH-8 --- 12.16, brs --- 
ND Not detected 
 
The HMBC spectrum (Table 8) displayed correlations of the aromatic proton 
at δH 7.23, s (δC 129.2) to the carbons at δC 156.7, 110.2, 15.9, and of the methyl 
protons at δH 2.24, s (δC 15.9) to the carbons at δC 156.7, 139.6 and 129.2, 
confirming the existence of the 1,4-dihydroxy-5-methyl benzene moiety 
analogously to EC1. In turn, the HMBC cross peaks of the doublet of the proton at 
δH 7.10 (J = 2.4 Hz; δC 108.8) to the carbons at δC 186.3, 108.7, 108.3, as well as 
of the doublet at δH 6.53 (J = 2.4 Hz; δC 108.3) to the carbons at δC 164.6, 108.8 
and 108.7, determined a 1,5-dihydroxybenzene ring structure. 
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164.6
108.7
12.16 s
186.3
7.10 d
(2.4)
166.4
108.8
108.3
6.53 d
(2.4)
 
 
Combination of the two partial structures led to the structure of EC3 as 
1,4,6,8-tetrahydroxy-3-methylanthracene-9,10-dione. The 1H and 13C NMR data of 
EC3 are compatible with those reported for catenarin (Figure 53), the 
anthraquinone isolated from Eurotium cristatum (Anke et al., 1980).  
 
1
2
3
4
4a
5
6
7
8
8a99a
10 10a
11
 
 
Figure 53. Structure of catenarin (EC3). 
 
 Like erythroglaucin and physcion, catenarin was also identified as a 
metabolic product of several fungal species of the genus Eurotium (Anke et al., 
1980; Du et al., 2008). Catenarin was originally isolated from several species of 
the plant pathogenic fungi of the genus Helminthosporium (Raistrick et al., 1933; 
1934) and later from other plant pathogens such as Pyrenophora tritici-repentis 
(Wakuliński et al., 2003) and Talaromyces stipitatus (van Eijk, 1973), as well as 
from the shrub Ventilago leiocarpa Benth. (Lin et al., 2001). 
 Catenarin also exhibited antibacterial activity namely against the Gram-
positive bacteria Aureobacterium liquefaciens, Arthrobacter globiformis, Bacillus 
brevis, Bacillus circulans, Bacillus subtilis and Curtobacterium plantarum, as well 
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as antifungal activity against Epicoccum nigrum (Wakuliński et al., 2003). 
Catenarin was found to prevent type 1 diabetes in non-obese diabetic mice 
through a strong suppressive effect on leukocyte migration, which involved the 
inactivation of the MKK6/p38 and MKK7/JNK signaling cascades and the reduction 
of calcium influx in the CCR5 and CXCR4 pathways in T cells (Shen et al., 2012).  
 
3.1.3.4. Emodin (EC4) 
EC4 was isolated as yellow amorphous solid and its 1H and 13C NMR data 
(Table 9) closely resembled those of EC2. However, the 1H and 13C NMR spectra 
of EC4 did not exhibit the signal of a methoxy group. The 13C NMR spectrum 
displayed fifteen carbon signals which were categorized, according to DEPT (90º 
and 135º) and HSQC (Table 9), as two ketone carbonyls (δC 189.6, 181.4), eight 
quaternary sp2 (δC 165.8, 164.6, 161.4, 148.2, 135.0, 132.8, 113.3, 108.8), four 
methine sp2 (δC 124.1, 120.5, 108.9, 107.9) and one methyl (δC 21.5) carbons. 
The 1H NMR spectrum (Table 9) displayed two pairs of meta-coupled aromatic 
protons at δH 7.45, d (J = 1.2 Hz) / 7.14, d (J = 1.2 Hz), and at 7.08, d (J = 2.4 Hz) 
/ 6.56, d (J = 2.4 Hz), as well as one aromatic methyl group at δH 2.39, s. 
 
Table 9. 1H and 13C NMR data (DMSO-d6, 500.13 
and 125.77 MHz) of EC4. 
Position δC, type δH, mult. (J in Hz) HMBC 
 
1 
 
161.4, C 
 
--- 
 
--- 
2 124.1, CH 7.14, d (1.2)  C-1, 4, 9a, 11 
3 148.2, C --- --- 
4 120.5, CH 7.45, d (1.2) C-2, 9a, 10, 11 
4a 132.8, C --- --- 
5 108.9, CH 7.08, d (2.4) C-6, 7, 8a, 10 
6 165.8, C --- --- 
7 107.9, CH 6.56, d (2.4) C-5, 8, 8a 
8 164.6, C --- --- 
8a 108.8, C --- --- 
9 189.6, CO --- --- 
9a 113.3, C --- --- 
10 181.4, CO --- --- 
10a 135.0, C --- --- 
11 21.5, CH3 2.39, s C-2, 3, 4 
OH-1  12.00, brs --- 
OH-6  ND --- 
OH-8  12.00, brs --- 
ND Not detected 
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  The chemical shift values of the two meta-coupled aromatic protons at δH 
7.08, d (J = 2.4 Hz; δC 108.9) and 6.56, d (J = 2.4 Hz; δC 107.9), and the HMBC 
correlations (Table 9) of the unshielded aromatic proton at δH 7.08, d (J = 2.4 Hz; 
δC 108.9) to the non-hydrogen bonded carbonyl at δC 181.4 and to the carbons at 
δC 165.8, 108.8, 107.9, and of the shielded aromatic proton at δH 6.56, d (J = 2.4 
Hz; δC 107.9) to the carbons at δC 164.6, 108.9, 108.8, revealed the existence of 
the 6,8-dihydroxybenzene ring of the anthraquinone.  
 
164.6
108.8
12.00 brs
181.4
7.08 d
(2.4)
165.8
108.9
107.9
6.56 d
(2.4)
 
 
The existence of the 1-hydroxy-5-methyl benzene moiety of the 
anthraquinone was corroborated by the HMBC cross peaks of the doublet at δH 
7.45 (J = 1.2 Hz; δC 120.5) to the non-hydrogen bonded carbonyl carbon at δC 
181.4 and the carbons at δC 124.1, 113.3, 21.5, of the doublet at δH 7.14 (J = 1.2 
Hz; δC 124.1) to the carbons at δC 161.4, 120.5, 113.3, 21.5, as well as of the 
methyl singlet at δH 2.39 (δC 21.5) to the carbons at δC 148.2, 124.1 and 120.5. 
 
181.4
161.4
113.3
21.5
7.45 d
(1.2)
148.2
124.1
120.5
2.39 s
7.14 d
(1.2)
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Therefore, the structure of EC4 was proposed as 1,6,8-trihydroxy-3-
methylanthracene-9,10-dione, or commonly known as emodin (Figure 54). The 1H 
and 13C NMR data of EC4, as well as its physical constants were compatible with 
those of the anthraquinone emodin, reported earlier from several species of the 
lichens of the genus Xanthoria (Manojlović et al., 2000).  
 
1
2
3
4
4a
5
6
7
8
8a99a
10 10a
11
 
 
Figure 54. Structure of emodin (EC4). 
 
Despite its isolation from the fungi of the genus Eurotium (Anke et al., 
1980), emodin has been widely reported from several plant genera including 
Cassia (Kim et al., 2004; Lee et al., 2010), Frangula (Kremer et al., 2012) and 
Polygonum (Hsiang and Ho, 2008; Kuo et al., 1997; Leu et al, 2008), and as a 
major constituent of rhubarb, Rheum palmatum L. (Chen et al., 2002; 2010a; Choi 
et al., 2013). 
Emodin is the most extensively studied anthraquinone which displayed a 
vast number of pharmacological properties such as antitumor, 
immunosuppressive, antimicrobial, anti-inflammatory and antidiabetic. Literature 
survey reveals several reports on its cytotoxic activity against several human 
cancer cell lines through several different mechanisms (Hsu and Chung, 2012). 
Emodin exhibited antiproliferative effect against Raji, HeLa, Calu-1 Wish, Vero, 
SW620 and K562 cell lines (Choi et al., 2007; Kuo et al., 1997; Lin et al.,2001), 
with a notable antitumor effect in human leukemia K562 cell line, both in vitro and 
in vivo, leading to a significant decrease of tumor volume and weight in nude mice 
inoculated with K562 cells (Chun-Guang et al., 2010). However, the majority of 
reports refer to the anticancer potential of emodin against human pancreatic and 
liver cancer cell lines. Emodin demonstrated antiproliferative and antimetastatic 
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effect on human pancreatic cancer cell line SW 1999 (Liu et al., 2011a) and 
induced Panc-1 cells apoptosis through the decline of the mitochondrial 
membrane potential (Liu et al., 2012). Furthermore, it also potentiated the 
antitumor effects of gemcitabine in human pancreatic cancer cell line SW 1999, 
which was related to the downregulation of NF-κB, leading to an enhancement on 
the effect of gemcitabine and overcoming resistance (Liu et al., 2011b). 
Interestingly, emodin displayed the synergistic property of overcoming 
chemoresistance in several cancer cell lines, significantly enhancing the DNA 
damage caused by oxaliplatin and inducing oxaliplatin resistance reversal in 
hepatocellular carcinoma HepG2 cells, through the inhibition of ERCC1 expression 
by the FGFR2/ERK1/2 signaling pathway (Chen et al., 2013).  Notably, emodin 
was reported to display antiproliferative activity against other human liver cancer 
cells such as SK-HEP-1, Bel-7402 and PLC/PRF/5, through several 
complementary mechanisms including the activation of caspase-8 and -9, p53 and 
p21 upregulation, NF-κB downregulation, and intracellular ROS production (Shieh 
et al., 2004; Yu et al., 2013). Emodin was also proved to be an effective apoptosis 
inducer in human promyeloleukemic HL-60 and in C6 glioma cells through the 
activation of the caspase-3 cascade (Chen et al., 2002; Kuo et al., 2009), and the 
antiproliferative activity against prostate cancer cell lines LNCaP and PC-3, as well 
as against the human lung (A549) and bone (MG-63) cell lines, also seems to be 
partially dependent on the generation of ROS (Masaldan and Iyer, 2014). The 
antimetastatic activity was also observed in prostate DU 145 and lung A549 
cancer cell lines by downregulation of the expression of the chemokine receptor 
CXCR4 (Ok et al., 2012). Zhang et al. (1999) reported that emodin was a potent 
tyrosine kinase inhibitor and repressed cellular transformation and metastasis in 
breast cancer cells (Zhang et al., 1999; Zhang and Hung, 1996). Recently, the 
antiproliferative effect on breast cancer cell lines was reported as being associated 
with the downregulation of the estrogen receptor α (ERα) protein levels, thereby 
suppressing ERα transcriptional activation in MCF-7 and MDA-MB-453 cell lines 
(Huang et al., 2013). These findings led us to hypothesize that the in vitro 
anticancer activity of the crude extract of Eurotium cristatum KUFC 7356 against 
MCF-7 cancer cell line (Almeida et al., 2010) may be in part derived from emodin 
cytotoxic activity. Additionally, emodin was found to inhibit the migration and 
invasion in human tongue cancer SCC-4 cells through the inhibition of gene 
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expression of MMP-9 and MMP-2 (Chen et al., 2010a) and by inducing DNA 
damage and inhibiting DNA repair gene expression (Chen et al., 2010b). Recently, 
emodin was also classified as a potential new therapeutic drug for head and neck 
squamous cell carcinoma cancer due to its in vivo inhibitory activity of TWIST1-
induced invasions, and inhibition of the β-catenin and Akt pathways (Way et al., 
2014). Immunosuppressive properties of emodin have also been reported 
demonstrating a helpful effect for the modulation of immune suppression and 
induction of immune tolerance through the inhibition of the differentiation and 
maturation of dendritic cells and increased production of CD4+CD25+ T cells 
(Zhang et al., 2012). Emodin immunosuppressive properties were confirmed by 
the immunosuppressive effect mediated through the generation of hydrogen 
peroxide from semiquinone and regulation by arachidonic acid metabolites (Huang 
et al., 1992), and the in vivo effect alleviating acute rejection following liver 
transplantation in rats as prolonging liver allograft survival (Tong et al., 2011). 
Administration of emodin against LPS-induced mouse mastitis revealed a 
protective effect against LPS-induced mammary gland injury and inflammatory cell 
infiltration by decreasing the transcriptional production of proinflammatory 
cytokines TNF-α, IL-6 and IL-1β (Li et al., 2013b). The anti-inflammatory properties 
of emodin were also observed in other in vivo models, displaying an effective anti-
inflammatory response in collagen-induced arthritic mice through the inhibition of 
the NF-κB pathway and subsequent MMP production (Hwang et al., 2013) as well 
as a significant reduction of oedema volume in carrageenan-induced rat-paw 
model through iNOS inhibition (Gosh et al., 2010). Recently, the in vitro anti-
inflammatory activity of emodin on LPS-induced RAW264.7 macrophages was 
also reported, supposedly due to the inhibition of P-gp function caused by the 
decreased expression of COX-2 protein through the MAPK/AP1 pathway (Choi et 
al., 2013). Emodin revealed also therapeutic potential in the prevention or 
treatment of glucose-induced structural and functional abnormalities, due to the 
amelioration of glucose-induced TGF-β1 and matrix synthesis in human peritoneal 
mesothelial cells by inhibiting PKCα activation and phosphorylation of CREB 
(Chan et al., 2003). Furthermore, emodin exhibited potent and selective in vitro 
and in vivo inhibitory activity against 11β-hydroxysteroid dehydrogenase type 1, 
and its oral administration in diet-induced obese mice antagonized insulin 
resistance and lowered blood glucose and hepatic PEPCK (Feng et al., 2010; Liu 
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et al., 2009). Recently, it was also reported to cause a significant decrease of 
collagen IV and fibronectin production (Yang et al., 2013a), revealing a potential 
use not only in diabetic nephropathy but also generally in metabolic syndrome or 
type 2 diabetes. Its potential in the treatment of progressive renal diseases was 
also confirmed by the amelioration of renal failure in nephrectomized rats treated 
with emodin, due to the suppression of IL-1β induced mesangial cells proliferation 
(Wang et al., 2007). The potent in vivo anti-angiogenic effect through the inhibitory 
function toward VEGF-A –induced angiogenesis by blocking receptor-2 (KDR/Flk-
1) phosphorylation (Kwak et al., 2006) as well as the in vitro anticoagulation effect 
of emodin-eluting biodegradable polymer coating stents (Pan et al., 2010), turn 
emodin as an interesting candidate for the development of alternative drugs for the 
treatment of cardiovascular diseases. When administered orally in IgE-sensitized 
mice, emodin exhibited anti-allergic activity, suppressing IgE-mediated 
anaphylactic reaction and mast cell activation (Lu et al., 2011). Emodin was also 
demonstrated to be a potential candidate for the development of antipigmentation 
agents due to its inhibition of phosphorylation of Kit and other transmembrane 
tyrosine kinases, and subsequent melanin synthesis (Lee et al., 2010). Emodin 
exhibited antimicrobial activity against several human pathogenic fungi and 
bacteria such as Aspergillus niger, Doratomyces stemonitis, Trichoderma viride 
and Penicillium verucosum, and against the bacteria Pseudomonas fluorescens, 
Pseudomonas glicinea, Pseudomonas phaseolicola (Manojlović et al., 2000), 
Streptococcus iniae (Nakano et al., 2012) and Helicobacter pylori strains SS1 and 
ATCC 43504 (Chen et al., 2009b), respectively. Emodin displayed also antiviral 
activity against herpes simplex virus (HSV) type 1, through the inhibition of HSV-1 
UL12 alkaline nuclease (Hsiang and Ho, 2008). 
 
 3.1.3.5. Questin (EC5) 
EC5 was isolated as orange-yellow amorphous solid and its 1H and 13C 
NMR spectra (Table 10) were very similar to those of EC2. The 1H spectrum 
(Table 10) displayed the signals of one hydrogen-bonded hydroxyl proton at δH 
13.24, s, two pairs of meta-coupled aromatic protons at δH 7.42, d (J = 1.6 Hz) / 
7.12, d (J = 1.6 Hz), and at δH 7.20, d (J = 2.3 Hz) / 6.84, d (J = 2.3 Hz), one 
methoxy group at δH 3.90, s and one methyl group at δH 2.39, s. The 
13C NMR, 
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DEPT and HSQC spectra (Table 10) revealed the presence of one hydrogen-
bonded carbonyl (δC 186.3), one non hydrogen-bonded carbonyl (δC 182.3), eight 
quaternary sp2 (δC 164.4, 163.4, 161.7, 146.6, 136.8, 132.0, 114.4, 112.6), four 
methine sp2 (δC 124.2, 119.1, 106.9, 104.9), one methoxy (δC 56.3) and one 
methyl (δC 21.4) carbon.  
 
Table 10. 1H and 13C NMR data (DMSO-d6, 300.13 
and 75.47 MHz) of EC5. 
Position δC, type δH, mult. (J in Hz) HMBC 
 
1 
 
161.7, C 
 
--- 
 
--- 
2 124.2, CH 7.12, d (1.6)  C-4, 9a, 11 
3 146.6, C --- --- 
4 119.1, CH 7.42, d (1.6) C-2, 9a, 10, 11 
4a 132.0, C --- --- 
5 106.9, CH 7.20, d (2.3) C-7, 8a, 10 
6 164.4, C --- --- 
7 104.9, CH 6.84, d (2.3) C-5, 6, 8a 
8 163.4, C --- --- 
8a 112.6, C --- --- 
9 186.3, CO --- --- 
9a 114.4, C --- --- 
10 182.3, CO --- --- 
10a 136.8, C --- --- 
11 21.4, CH3 2.39, s C-2, 3, 4 
OCH3-8 56.3, CH3  3.90, s C-8 
OH-1 --- 13.24, s --- 
OH-6 --- ND --- 
ND Not detected 
 
The chemical shift values of the meta-coupled protons (and their 
corresponding carbons) at δH 7.42, d (J = 1.6 Hz; δC 119.1) and 7.12, d (J = 1.6 
Hz; δC 124.2), and the aromatic methyl protons at δH 2.39, s (δC 21.4) were similar 
to those of the 1-hydroxy-3-methylphenyl portion of EC2. This was corroborated by 
the HMBC correlations of the aromatic proton at δH 7.42, d (J = 1.6 Hz; δC 119.1) 
to the carbonyl carbon at δC 182.3, and the carbons at δC 124.2, 114.4, 21.4, of 
the aromatic proton at δH 7.12, d (J = 1.6 Hz; δC 124.2) to the carbons at δC 119.1, 
114.4, 21.4, and of the methyl protons at δH 2.39, s (δC 21.4) to the carbons at δC 
146.6, 124.2 and 119.1. 
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13.24 s
182.3
161.7
114.4
21.4
7.42 d
(1.6)
146.6
124.2
119.1
2.39 s
7.12 d
(1.6)
 
 
That another part of the anthraquinone was 6-hydroxy-8-methoxyphenyl 
instead of 8-hydroxy-6-methoxyphenyl as in EC2 was supported by the presence 
of only one hydrogen-bonded hydroxyl group, as well as by the HMBC correlations 
of the aromatic proton at δH 7.20, d (J = 2.3 Hz; δC 106.9) to the carbons at δC 
182.3, 112.6, 104.9, of the aromatic proton at δH 6.84, d (J = 2.3 Hz; δC 104.9) to 
the carbons at δC 164.4, 112.6, 106.9, as well as of the methoxy protons at δH 
3.90, s (δC 56.3) to the carbon at δC 163.4. 
 
56.3
3.90 s
163.4
112.6
182.3
7.20 d
(2.3)
164.4
106.9
104.9
6.84 d
(2.3)
 
 
 Consequently, the structure of EC5 was established as 1,6-dihydroxy-8-
methoxy-3-methyl-9,10-anthracene-9,10-dione, commonly known as questin 
(Figure 55) (Fujimoto et al., 1999). 
Like erythroglaucin, physcion, catenarin and emodin, questin has been also 
previously reported from several species of Eurotium (Anke et al., 1980; Slack et 
al, 2009), as well as from plants belonging to the genera Cassia (Hyun et al., 
2009) and Polygonum (Choi et al., 2007). 
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Figure 55. Structure of questin (EC5). 
 
 Like emodin, questin also displayed high immunosuppressive activity 
against Con A (T cells) and LPS-induced (B cells) proliferation of mouse splenic 
lymphocytes (Fujimoto et al., 1999). Questin was also proved to be cytotoxic 
against human colon cancer cell SW620 and exhibited inhibitory activity against 
Cdc25 B (Choi et al., 2007). 
 
Anthraquinones are aromatic polyketides produced by repetitive Claisen 
condensations of an acyl CoA starting unit with malonyl-CoA elongations units. 
Biosynthesis of erythroglaucin (EC1), physcion (EC2), catenarin (EC3), emodin 
(EC4) and questin (EC5) is shown in Scheme 2 (Dewick, 2009). 
Anthraquinones are commonly isolated from plants of the Polygonaceae 
family, e.g., the genus Rheum and Polygonum (Choi et al., 2007; 2013; Feng et 
al., 2013; Hsiang and Ho, 2008; Kuo et al., 1997; Leu et al., 2008; Qiu et al., 
2013), however they have been also reported from several fungal species of the 
genus Eurotium (Anke et al., 1980; Du et al., 2008; Li et al., 2009a; Slack et al., 
2009). Although erythroglaucin, physcion and catenarin have been previously 
reported from E. cristatum (Almeida et al., 2010; Anke et al., 1980), this study 
reports the presence of emodin and questin for the first time from this species 
(Gomes et al., 2012).  
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7
Hypothetical poly-β-keto ester
Aldol reactions, 
enolizations
Emodin (EC4)
-CO2
-H2O
[O]
Catenarin (EC3) Questin (EC5)
O2
O-Methylation
O-Methylation
Physcion (EC2)
Erythroglaucin (EC1)
O-Methylation
 
 
Scheme 2. Biosynthetic pathway of the anthraquinones EC1-EC5. 
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3.1.4. Structure Elucidation of Diketopiperazine 
Derivatives 
 
 3.1.4.1. cyclo-(L-Tryptophyl-L-phenylalanyl) (EV5) 
EV5 was isolated as white solid. The 13C NMR, DEPT and HSQC spectra 
(Table 11) revealed the presence of six quaternary sp2 (δC 166.9, 166.2, 136.5, 
136.1, 127.6, 108.8), ten methine sp2 (δC 129.7, 129.7, 128.1, 128.1, 126.4, 124.5, 
121.0, 118.8, 118.5, 111.4), two methine sp3 (δC 55.6, 55.3) and two methylene 
sp3 (δC 39.7, 29.7) carbons.  
 
Table 11. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of EV5. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1 
 
--- 
 
10.9, s 
 
--- 
 
C-3, 8, 9 
2 124.5, CH 6.94, s --- C-3, 8, 9 
3 108.8, C --- --- --- 
4 118.8, CH 7.47, d (7.5) H-5 C-3, 6, 8 
5 118.5, CH 6.97, dd (7.5, 7.5) H-4, 6 C-7, 9 
6 121.0, CH 7.06, dd (7.5, 7.5) H-5, 7 C-4, 8 
7 111.4, CH 7.31, d (7.5) H-6 C-5, 9 
8 136.1, C --- --- --- 
9 127.6, C --- --- --- 
10a 
b 
29.7, CH2 2.78, dd (14.4, 4.3) 
2.50, dd (14.4, 5.9) 
H-10b, 11 
H-10a, 11 
C-2, 3, 11, 16 
C-2, 3, 11, 16 
11 55.3, CH 3.96, m H-10, 12 C-16 
12 --- 7.94, d (2.3) H-11 C-14, 16 
13 166.2, CO --- --- --- 
14 55.6, CH 3.83, m H-15, 17 C-13 
15 --- 7.73, d (2.3) H-14 C-11, 13 
16 166.9, CO --- --- --- 
17a 
b 
39.7, CH2  2.43, dd (13.4, 4.6) 
1.80, dd (13.4, 7.1) 
H-14, 17b 
H-14, 17a 
C-13, 14, 18, 19, 23 
C-13, 14, 18, 19, 23 
18 136.5, C --- --- --- 
19 129.7, CH 6.68, d (6.9) H-20 C-17, 21 
20 128.1, CH 7.17, m H-19, 21 C-18, 22 
21 126.4, CH 7.17, m H-20, 22 C-19, 23 
22 128.1, CH 7.17, m H-21, 23 C-18, 20 
23 129.7, CH 6.67, d (6.9) H-22 C-17, 21 
 
 The 1H NMR spectrum in combination with the HSQC spectrum (Table 11), 
displayed the signals of four aromatic protons at δH 7.47, d, J = 7.5 Hz (δC 118.8), 
6.97, dd, J = 7.5, 7.5 Hz (δC 118.5), 7.06, dd, J = 7.5, 7.5 Hz (δC 121.0), and 7.31, 
d, J = 7.5 Hz (δC 111.4). The COSY spectrum (Table 11) showed cross peaks of 
the doublet at δH 7.47 (J = 7.5 Hz) to the double doublet at δH 6.97 (J = 7.5, 7.5 
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Hz), as well as of the doublet at δH 7.31 (J = 7.5 Hz) to the double doublet at δH 
7.06 (J = 7.5, 7.5 Hz), with the coupling constant values indicating an ortho-
coupling between the two pairs of protons. Furthermore, the two double doublets 
at δH 6.97 (J = 7.5, 7.5 Hz) and δH 7.06 (J = 7.5, 7.5 Hz) were correlated with each 
other indicating the presence of a 1,2-disubstituted benzene ring. Analogously to 
EV4, the HMBC cross peaks of the methine singlet at δH 6.94 (δC 124.5) to the 
quaternary sp2 carbon at δC 136.1 and 127.6, of the doublet at δH 7.47 (J = 7.5 Hz; 
δC 118.8) to δC 108.8 and δC 136.1, and of the doublet at δH 7.31 (J = 7.5 Hz; δC 
111.4) to δC 127.6, revealed the presence of a 2,3-dihydro-1H-indole moiety (A). 
 
A
124.5
7.06 dd
(7.5, 7.5)
6.97 dd
(7.5, 7.5)
7.47 d
(7.5)
6.94 s
10.90 s
7.31 d
(7.5)
136.1
118.8
108.8127.6
111.4
121.0
118.5
 
  
The 1H NMR spectrum also displayed the signals of additional five aromatic 
protons at δH 6.68, d, J = 6.9 Hz, δH 7.17, m, δH 7.17, m, δH 7.17, m and δH 6.67,d, 
J = 6.9 Hz, which, in combination with the HSQC spectrum, were assigned to the 
monosubstituted benzene ring (B). This was supported by the COSY cross peaks 
of the two doublets at δH 6.68 (J = 6.9 Hz; δC 129.7) and δH 6.67 (J = 6.9 Hz; δC 
129.7) to a multiplet at δH 7.17, as well as by the HMBC cross peaks of the 
doublets at δH 6.68 (J = 6.9 Hz; δC 129.7) and δH 6.67 (J = 6.9 Hz; δC 129.7) to the 
carbon at δC 126.4, and of the multiplet at δH 7.17 to the carbons at δC 129.7 and 
136.5. 
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136.5
B
7.17 m
7.17 m
7.17 m
6.68 d
(6.9)
126.4
128.1
129.7
128.1
6.67 d
(6.9)
129.7
 
  
 The 1H NMR spectrum, in conjunction with the HSQC spectrum, also 
exhibited two pairs of methylene proton at δH 2.50, dd (J = 14.4, 5.9 Hz; δC 29.7) / 
2.78, dd (J = 14.4, 4.3 Hz; δC 29.7) and δH 1.80, dd (J = 13.4, 7.1 Hz; δC 39.7) / 
2.43, dd (J = 13.4, 4.6 Hz; δC 39.7), two multiplets of methine protons at δH 3.96 
(δC 55.3) and δH 3.83 (δC 55.6), as well as two doublets at δH 7.94 (J = 2.3 Hz) and 
δH 7.73 (J = 2.3 Hz). As the latter doublets did not display HSQC cross peaks, they 
were assumed to be nitrogen-bearing protons. 
 The COSY spectrum revealed the presence of two coupling systems, one of 
which comprising the two double doublets at δH 2.50 (J = 14.4, 5.9 Hz; δC 29.7) 
and 2.78 (J = 14.4, 4.3 Hz; δC 29.7), the multiplet at 3.96 (δC 55.3) and the doublet 
at δH 7.94 (J = 2.3 Hz), and another of the double doublets at δH 1.80 (J = 13.4, 
7.1 Hz; δC 39.7) and 2.43 (J = 13.4, 4.6 Hz; δC 39.7), the multiplet at δH 3.83 (δC 
55.6) and the doublet at δH 7.73 (J = 2.3 Hz). Since the HMBC spectrum exhibited 
cross peaks of the doublet at 7.94 (J = 2.3 Hz) to the methine carbon at δC 55.6 
and the quaternary carbon at δC 166.9, and of the doublet at δH 7.73 (J = 2.3 Hz) 
to the methine carbon at δC 55.3 and the quaternary carbon at δC 166.2, the two 
coupling systems should be in a cyclic form. Furthermore, the methylene proton at 
δH 2.78, dd (J = 14.4, 4.3 Hz; δC 29.7) also showed HMBC correlations to the 
methine carbon at δC 55.3 and the quaternary carbon at δC 166.9, while the 
methylene proton at δH 2.43, dd (J = 13.4, 4.6 Hz; δC 39.7) exhibited HMBC 
correlations to the methine carbon at δC 55.6 and the quaternary carbon at δC 
166.2. The correlation pattern and the 1H and 13C chemical shift values were 
characteristic of the disubstituted 1,4-diketopiperazine ring (C). 
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29.7
C
2.43 dd
(13.4, 4.6)
1.80 dd
(13.4, 7.1)
3.83 m
55.3
7.94 d
(2.3)
7.73 d
(2.3)
3.96 m
166.9
166.2
55.6
2.50 dd
(14.4, 5.9)
2.78 dd
(14.4, 4.3)
39.7
 
 
 That the 1,4-diketopiperazine ring was linked to the 2,3-dihydro-1H-indole 
moiety (A) through the methylene carbon at δC 29.7, and with the phenyl ring (B) 
through the methylene carbon at δC 39.7, was supported by the HMBC 
correlations of the methylene proton at δH 2.78, dd (J = 14.4, 4.3 Hz; δC 29.7) and 
2.50, dd (J = 14.4, 5.9 Hz; δC 29.7) to the olefinic carbons at δC 108.8 and 124.5, 
as well as of the aromatic protons at δH 6.68, d (J = 6.9 Hz; δC 129.7) and δH 6.67, 
d (J = 6.9 Hz; δC 129.7) to the methylene carbon at δC 39.7. 
 
2.78 dd
(14.4, 4.3)
2.50 dd
(14.4, 5.9)
108.8
29.7
124.5 136.5
6.67 d
(6.9)
39.7
1.80 dd
(13.4, 7.1)
2.43 dd
(13.4, 4.6)
129.7
6.68 d
(6.9)
129.7
 
 
Therefore, the structure of EV5 was proposed as 3-benzyl-6-(1H-indol-3 
ylmethyl)piperazine-2,5-dione. The 1H and 13C NMR data of EV5 were in 
agreement with those reported for cyclo-(L-tryptophyl-L-phenylalanyl) (Figure 56) 
by Kimura et al. (1996). This cyclic peptide was reported from both Penicillium 
(Kimura et al., 1996) and Aspergillus spp. (Chu et al., 2011), and recently from the 
Gram-negative bacterium Comamonas testosterone (Kumar et al., 2013). 
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Figure 56. Structure of cyclo-(L-tryptophyl-L-phenylalanyl) (EV5). 
 
Cyclo-(L-tryptophyl-L-phenylalanyl) was shown to exhibit antibacterial 
activity against ten human pathogenic bacteria with a significantly good activity 
against the Gram-negative bacteria Vibrio cholera and Salmonella typhi, proving to 
be more effective than the standard antibiotics ciprofloxacin and ampicillin. 
Additionally, it displayed also good antifungal activity against plant pathogenic 
fungi, with a significantly potent activity against Fusarium oxysporum and 
Rhizoctonia solani (Kumar et al., 2013). Its antiproliferative properties were 
reported by Ding et al. (2008), as moderate growth inhibitor of thirty-seven human 
tumor cell lines, with an average IC50 value of 3.3 µg/mL. 
 
 3.1.4.2. Neoechinulin A (EC8) 
EC8 was isolated as dark red solid and its 1H and 13C NMR data (Table 12) 
were similar to those of EV5. The 13C NMR (Table 12) spectrum revealed the 
presence of two amide carbonyls (δC 166.0, 159.0), six methine sp
2 (δC 144.7, 
120.6, 119.3, 118.5, 111.5, 110.2), five quaternary sp2 (δC 143.8, 134.9, 125.6, 
124.5, 102.8), one methylene sp2 (δC 111.4), one methine sp
3 (δC 50.6), one 
quaternary sp3 (δC ~39.0) and three methyl (δC 27.3, 27.3, 19.8) carbons.  
The 1H NMR and HSQC spectra (Table 12) exhibited the presence of four 
aromatic protons at δH 7.43, dd (J = 7.3, 1.2 Hz; δC 111.5), 7.20, d (J = 7.3 Hz; δC 
118.5), 7.08, ddd (J = 7.3, 7.3, 1.2 Hz; δC 120.6) and 7.02, ddd (J = 7.3, 7.3, 1.2 
Hz; δC 119.3). The COSY spectrum (Table 12) revealed cross peaks between the 
doublet at δH 7.20 (J = 7.3 Hz) and the double double doublet at δH 7.02 (J = 7.3, 
7.3, 1.2 Hz), between the double doublet at δH 7.43 (J = 7.3, 1.2 Hz) and the 
double double doublet at δH 7.08 (J = 7.3, 7.3, 1.2 Hz), and between the double 
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double doublet at δH 7.08 (J = 7.3, 7.3, 1.2 Hz) and the double double doublet at 
δH 7.02 (J = 7.3, 7.3, 1.2 Hz), thus suggesting the presence of a 1,2-disubstituted 
benzene ring. 
 
Table 12. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of EC8. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1 
 
--- 
 
10.95, s 
 
H-5 
 
C-2, 3, 3a, 7a 
2 143.8, C --- --- --- 
3 102.8, C --- --- --- 
3a 125.6, C --- --- --- 
4 118.5, CH 7.20, d (7.3) H-5 C-3, 6, 7a 
5 119.3, CH 7.02, ddd (7.3, 7.3, 1.2) H-4, 6 C-3a, 7 
6 120.6, CH 7.08, ddd (7.3, 7.3, 1.2) H-5, 7 C-4, 7a 
7 111.5, CH 7.43, dd (7.3, 1.2) H-6 C-3a, 5 
7a 134.9, C --- --- --- 
8 110.2, CH 6.96, s --- C-2, 3a, 10, 13 
9 124.5, C --- --- --- 
10 159.0, CO --- --- --- 
11 --- 8.35, d (1.7) H-12 C-9, 13 
12 50.6, CH 4.14, dd (6.9, 1.7) H-11, 20 C-13, 20 
13 166.0, CO --- --- --- 
14 --- 8.27, brs --- C-10, 12, 13 
15 ~39.0, C --- --- --- 
16 144.7, CH 6.08, dd (17.3, 10.4) H-17a, 17b C-2, 15, 18, 19 
17a 
b 
111.4, CH2 5.05, d (17.3) 
5.06, d (10.4) 
H-16, 17b 
H-16, 17a 
C-15, 16 
C-15, 16 
18 27.3, CH3 1.51, s --- C-2, 15, 16, 19 
19 27.3, CH3 1.51, s --- C-2, 15, 16, 18 
20 19.8, CH3 1.45, d (6.9) H-12 C-12, 13 
 
 The HMBC spectrum (Table 12) exhibited correlations of the aromatic 
proton at δH 7.20, d (J = 7.3 Hz; δC 118.5) to the carbons at δC 120.6 and 134.9, of 
the aromatic proton at δH 7.02, ddd (J = 7.3, 7.3, 1.2 Hz; δC 119.3) to the carbons 
at δC 125.6 and 111.5, of the aromatic proton at δH 7.08, ddd (J = 7.3, 7.3, 1.2 Hz; 
δC 120.6) to the carbons at δC 134.9 and 118.5, and of the aromatic proton at δH 
7.43, dd (J = 7.3, 1.2 Hz; δC 111.5) to the carbons at δC 119.3 and 125.6, thus 
confirming the 1,2-disubstituted benzene moiety. Since the HMBC spectrum also 
showed cross peaks of the doublet at δH 7.20, d (J = 7.3 Hz; δC 118.5) to the 
quaternary sp2 carbon at δC 102.8, and of the singlet at δH 10.95 to the quaternary 
sp2 carbons at δC 102.8, 143.8 and the aromatic carbons at δC 134.9 and 125.6, 
the presence of the 2,3-disubstituted 2,3-dihydro-1H-indole moiety was proposed. 
 
 106 
 
CHAPTER III. RESULTS AND DISCUSSION 
 
7.20 d (7.3)
7.08 ddd 
(7.3, 7.3, 1.2)
120.6
119.3
102.8
125.6
143.8
111.5
10.95 s
7.43 dd 
(7.3, 1.2)
118.5
134.9
7.02 ddd 
(7.3, 7.3, 1.2)
 
 
 Furthermore, the COSY spectrum also revealed couplings of the olefinic 
proton at δH 6.08, dd (J = 17.3, 10.4 Hz; δC 144.7) to the methylene sp
2 protons at 
δH 5.05, d (J = 17.3 Hz; δC 111.4) and 5.06, d (J = 10.4 Hz; δC 111.4). Since the 
HMBC spectrum displayed correlations of the olefinic proton at δH 6.08, dd (J = 
17.3, 10.4 Hz; δC 144.7) to the quaternary sp
3 carbon at δC ~39.0 and the methyl 
carbons at δC 27.3, of the methylene protons at  δH 5.05, d (J = 17.3 Hz; δC 111.4) 
and 5.06, d (J = 10.4 Hz; δC 111.4) to the carbons at δC 144.7 and 39.0, and of the 
methyl protons at δH 1.51, s (δC 27.3) to the carbons at δC ~39.0 and 144.7, the 
presence of a 1-methylbuten-3-yl moiety was confirmed. 
 
5.05 d (17.3)
~39.0
111.4
27.3
27.3
144.76.08 dd 
(17.3, 10.4)
5.06 d (10.4)
1.51 s
1.51 s
 
 
 That the 1-methylbuten-3-yl moiety was attached to C-2 (δC 143.8) of the 
indole ring system was supported by the HMBC correlations of the methyl protons 
at δH 1.51, s, and the olefinic proton at δH 6.08, dd (J = 17.3, 10.4 Hz; δC 144.7) to 
the quaternary sp2 carbon at δC 143.8: 
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144.7
27.3
143.8
6.08 dd
(17.3, 10.4)
1.51 s
 
 
The COSY spectrum also revealed the continuous coupling system of the 
doublet at δH 8.35 (J = 1.7 Hz), the double doublet at δH 4.14 (J = 6.9, 1.7 Hz; δC 
50.6) and the methyl doublet at δH 1.45 (J = 6.9 Hz; δC 19.8). On the other hand, 
the doublet at δH 8.35 (J = 1.7 Hz) exhibited the HMBC cross peaks to the 
quaternary sp2 carbon at δC 124.5 and the carbonyl at δC 166.0, while the broad 
singlet at δH 8.27 gave HMBC cross peaks to the carbons at δC 159.0 and 50.6. 
Since the singlet of the olefinic proton at δH 6.96 (δC 110.2) showed also cross 
peaks to the carbonyls at δC 166.0 and 159.0, the presence of 1,4-
diketopiperazine with substituents on C-2 (δC 124.5) and C-5 (δC 50.6), was 
confirmed. 
 
6.69 s
110.2
4.14 dd (6.9, 1.7)
1.45 d (6.9)
124.5
50.6
19.8
166.0
159.0
8.27 brs
8.35 d (1.7)
 
 
 Finally, the HMBC cross peak of the singlet at δH 6.96 (δC 110.2) to the 
carbons of the indole ring system at δC 143.8 and 125.6 confirmed the attachment 
of the substituted 1,4-diketopiperazine moiety to 2,3-dihydro-1H-indole portion 
through the carbon at δC 110.2 of the former and the carbon at δC 102.8 of the 
latter. 
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6.96 s
102.8
110.2
143.8
 
 
 Therefore, the structure of EC8 was proposed as (3Z)-3-[[2-(1,1-
dimethylallyl)-1H-indol-3-yl]methylene]-6-methyl-piperazine-2,5 dione which is 
commonly known as neoechinulin A (Figure 57) (Li et al., 2004). 
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Figure 57. Structure of neoechinulin A (EC8). 
 
 Neoechinulin A has been widely reported from several species of fungi, 
both from marine and terrestrial environments, essentially from species of the 
genus Aspergillus (Dossena et al., 1974; Li et al., 2004; Marchelli et al., 1977; 
Nagasawa et al., 1975; Yagi and Do, 1999) and Eurotium (Du et al., 2012; Kim et 
al., 2013; Li et al., 2008b; Slack et al., 2009). Interestingly, most of the Aspergillus 
spp. reported to produce neoechinulin A, refer to Eurotium anamorphs. 
Additionally, the diketopiperazine alkaloid was also found to be a metabolic 
product of several marine derived species of the genus Chaetomium (Wang et al., 
2006), Microsporum (Dewapriya et al., 2013; Wijesekara et al., 2014) and 
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Penicillium (Zhou et al., 2010), as well as from the higher plants Bridelia ferruginea 
(Pettit et al., 2008) and Cyrtomium fortumei (Yang et al., 2013b). 
Neoechinulin A was reported as a potential candidate for the development 
of new drugs for the treatment of neurodegenerative diseases like Parkinson and 
Alzheimer’s disease. Neoechinulin A can protect neuronal PC12 cells from 
cytotoxicity due to oxidative / nitrosative stress induced by the superoxide / nitric 
oxide co-generator 3-morpholinosydronimine (SIN-1), inducing activation of 
caspase-3-like proteases and by elevating the cellular reserve capacity for 
NAD(P)H generation (Akashi et al., 2012; Kimoto et al., 2007; Kuramochi et al., 
2008; Maruyama et al., 2004). Subsequent studies revealed that neoechinulin A 
can also protect PC12 cells from the Parkinson disease-inducing neurotoxins 
MPP+ and rotenone (Akashi et al., 2011; Kajimura et al., 2008). Interestingly, a 
SAR study performed to examine the cytoprotective activity of neoechinulin A and 
several synthetic derivatives, against cytotoxicity induced by SIN-1 in NGF-
differentiated PC12 cells, revealed that the C-8/C-9 double bond plays a key role 
in the cytoprotective activity (Aoki et al., 2010). Recently, neoechinulin A revealed 
potential to be developed as a modulator of neuro-inflammatory process in 
Alzheimer’s disease due to its anti-inflammatory activity, presumably dependent 
on the regulation of p38 and ASK-1 kinases, and nuclear translocation of the NF-
κB p65 and p50 subunits (Dewapriya et al., 2013). The anti-inflammatory effect 
was also observed in LPS-stimulated RAW 264.7 macrophages through the 
inhibition of the NF-κB and p38 MAPK pathways. Additionally, neoechinulin A also 
markedly suppressed the production of NO and PGE2 and the expression of iNOS 
and COX-2 (Kim et al., 2013). In other recent study, neoechinulin A 
antiproliferative effect against human cervical carcinoma HeLa cells has been 
tested. It was found to exhibit significant cytotoxic activity by inducing cell 
apoptosis in association with the activation of the expression of caspase family 
enzymes and p53, followed by Bax and Bcl-2 regulation (Wijisekara et al., 2014).  
Neoechinulin A also displayed significant radical scavenging activity against 
DPPH, having higher antioxidant activity than α-tocopherol, and its UV-A 
protecting activity being more effective than the sunscreen oxybenzone (Li et al., 
2004; Yagi and Do, 1999). 
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3.1.4.3. Neoechinulin E (EC9) 
EC9 was isolated as an orange-red solid. The 13C NMR (Table 13) 
displayed signals for eighteen carbons, which were categorized as two amide 
carbonyls (δC 160.5, 152.3), six quaternary sp
2 (δC 157.3, 145.6, 135.2, 126.1, 
123.4, 103.8), six methine sp2 (δC 144.9, 121.1, 119.8, 119.7, 116.0, 111.6), one 
methylene sp2 (δC 112.0), one quaternary sp
3 (δC ~39.0) and two methyl (δC 27.7, 
27.7) carbons. The 1H and 13C NMR spectra of EC9 (Table 13) closely resembled 
those of EC8, except for the lack of one methine (δH 4.14, dd, J = 6.9, 1.7 Hz; δC 
50.6) and one methyl (δH 1.45, d, J = 6.9 Hz; δC 19.8), and the presence of the 
additional quaternary sp2 carbon at δC 157.3. 
 
Table 13. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of EC9. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1 
 
--- 
 
11.23, s 
 
--- 
 
C-2, 3, 3a 
2 145.6, C --- --- --- 
3 103.8, C --- --- --- 
3a 126.1, C --- --- --- 
4 119.7, CH 7.43, d (7.6) H-5 C-6, 7a 
5 119.8, CH 7.02, dd (7.6, 7.6) H-4, 6 C-3a, 7 
6 121.1, CH 7.11, dd (7.6, 7.6) H-5, 7 C-4, 7a 
7 111.6, CH 7.43, d (7.6) H-6 C-3a, 5 
7a 135.2, C --- --- --- 
8 116.0, CH 7.19, d (1.0) --- C-2, 3a, 10 
9 123.4, C --- --- --- 
10 160.5, CO --- --- --- 
11 --- 11.97, brs --- --- 
12 157.3, C --- --- --- 
13 152.3, CO --- --- --- 
14 --- 9.85, brs --- C-10, 12 
15 ~39.0, C --- --- --- 
16 144.9, CH 6.07, dd (17.5, 10.6) H-17a, 17b --- 
17a 
b 
112.0, CH2 5.06, d (17.5) 
5.08, d (10.6) 
H-16 
H-16 
C-15, 16 
C-15, 16 
18 27.7, CH3 1.48, s --- C-2, 15, 16, 19 
19 27.7, CH3 1.48, s --- C-2, 15, 16, 18 
 
 The 1H NMR and HSQC spectra (Table 13) exhibited the signals of four 
aromatic protons at δH 7.43, d (J = 7.6 Hz, 2H; δC 119.7 and 111.6), 7.11, dd (J = 
7.6, 7.6 Hz; δC 121.1) and 7.02, dd (J = 7.6, 7.6 Hz; δC 119.8) which, through the 
COSY correlations, revealed the presence of a 1,2-disubstituted benzene ring, 
similar to that of EC8. Furthermore, the singlet at δH 11.23, which gave HMBC 
cross peaks to the carbon of the benzene ring at δC 126.1 and the substituted 
olefinic carbons at δC 103.8 and 145.6, suggested that the 1,2-disubstituted 
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benzene ring is part of the 2,3-dihydro-1H-indole ring system. Similar to EC8, the 
presence of the 1-methylbuten-3-yl fragment was evidenced by the coupling of the 
two doublets at δH 5.06 (J = 17.5 Hz; δC 112.0) and 5.08 (J = 10.6 Hz; δC 112.0) to 
the double doublet at δH 6.07 (J = 17.5, 10.6 Hz; δC 144.9), as well as the 
presence of the two methyl groups at δH 1.48, s (δC 27.7). Like EC8, the 1-
methylbuten-3-yl on C-2 (δC 145.6) of the indole ring was substantiated by the 
HMBC cross peak between the singlet of the methyl protons at δH 1.48 (δC 27.7) 
and the carbon at δC 145.6 of the indole moiety. 
 
135.2
11.23 s
111.6
119.8
121.1
7.11 dd
(7.6, 7.6)
7.43 d (7.6)
7.02 dd 
(7.6, 7.6)
~39
7.43 d (7.6)
119.7
144.9
103.8
126.1
27.7
145.6
6.07 dd
(17.5, 10.6)
1.48 s
112.0
5.06 d (17.5)
5.08 d (10.6)
 
 
 Contrary to EC8, the olefinic proton of a trisubstituted double bond and the 
broad singlets of the amide hydrogens appeared at higher frequencies (δH 7.19, J 
= 1.0 Hz; δC 116.0) / (δH 9.85; δH 11.97, respectively). Interestingly, the broad 
singlet at δH 9.85 showed HMBC cross peaks to the quaternary carbons at δC 
160.5 and 157.3, while the broad singlet at δH 11.97 did not exhibit any cross 
peaks. Similar to EC8, the doublet of the olefinic proton at δH 7.19 (J = 1.0 Hz; δC 
116.0) exhibited HMBC cross peaks to the carbons at δC 126.1 and 145.6 of the 
2,3-dihydro-1H-indole moiety, in addition to the quaternary sp2 carbon at δC 160.5. 
Considering the chemical shift value of the carbons and protons, as well as the 
HMBC correlations, this portion of EC9 must be:  
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7.19 d (1.0)
9.85 brs
157.3
152.3
123.4
116.0
160.5
 
 
Thus, the structure of EC9 was proposed as: 
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Figure 58. Structure of the enol form of neoechinulin E (EC9). 
 
After a literature search, it was found that neoechinulin E, the prenylated 
indolopiperazine derivative, isolated from Aspergillus amstelodami (Marchelli et al., 
1977) presented the same 1H and 13C data as that of EC9. However, the structure 
of neoechinulin E was reported as: 
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  It is important to note that the structure of EC9 and neoechinulin E are 
tautomers, which EC9 represents an enol form (Figure 58). 
Contrary to neoechinulin A, neoechinulin E has not widely been reported. 
Except for its identification from the fungi Aspergillus amstelodami and the plant 
Cyrtomium fortumei, (Marchelli et al., 1977 and Yang et al., 2013b respectively), 
neoechinulin E was reported so far, from the genus Eurotium (Li et al., 2008b; 
Slack et al., 2009). 
To the best of our knowledge, the only reported biological property of 
neoechinulin E refers to its strong radical scavenging activity against DPPH (Li et 
al., 2008b). 
 
3.1.4.4. Neoechinulin (EC7) 
EC7 was isolated as a purple solid. The 13C NMR (Table 14) displayed 
twenty-three carbon signals which were categorized, according to HSQC and 
DEPT (135º and 90º), as ten quaternary sp2 (δC 160.5, 157.3, 152.3, 145.3, 135.5, 
134.4, 131.1, 124.2, 123.0, 103.6), six methine sp2 (δC 145.0, 124.1, 120.8, 119.6, 
116.2, 110.6), one methylene sp2 (δC 111.9), one quaternary sp
3 (δC ~39.0), one 
methylene sp3 (δC 33.8) and four methyl (δC 27.7, 27.7, 25.6, 17.7) carbons.  
The 13C NMR spectrum (Table 14) was very similar to that of EC9 except 
for the presence of additional two methyl carbons at δC 17.7 and 25.6, one 
methylene sp3 at δC 33.8, one methine sp
2 at δC 124.1 and one quaternary sp
2 at 
δC 131.1. The COSY spectrum (Table 14) displayed correlations of the olefinic 
proton at δH 5.35, t (J = 7.4 Hz; δC 124.1) to the methylene protons at δH 3.39, d (J 
= 7.4 Hz, 2H; δC 33.8) and the methyl protons at δH 1.73, s (2CH3, δC 17.7 and 
25.6), suggesting that the additional five carbons was 3-methyl-2-butenyl moiety.  
 
3.39 d (7.4)
3.39 d (7.4)
131.1
124.1 25.6
17.7
1.73 s
1.73 s
33.8
5.35 t (7.4)
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This was confirmed by the HMBC cross peaks of the doublet of the 
methylene protons at δH 3.39 (J = 7.4 Hz, 2H; δC 33.8) to the methine sp
2 carbon 
at δC 124.1 and the quaternary sp
2 carbon at δC 131.1, of the triplet at δH 5.35 (J = 
7.4 Hz; δC 124.1) to the methyl carbons at δC 17.7 and 25.6, and of the singlet at 
δH 1.73 (2CH3, δC 17.7 and 25.6) to the quaternary sp
2 carbon at δC 131.1 and the 
methine sp2 carbon at δC 124.1. 
  
Table 14. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of EC7. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1 
 
--- 
 
11.11, s 
 
--- 
 
C-2, 3, 3a 
2 145.3, C --- --- --- 
3 103.6, C --- --- --- 
3a 124.2, C --- --- --- 
4 119.6, CH 7.34, d (8.1) H-5 C-3, 6, 7a 
5 120.8, CH 6.87, d (8.1) H-4, 20 C-3a, 7, 20 
6 134.4, C --- --- --- 
7 110.6, CH 7.21, s H-20 C-3a, 5, 20 
7a 135.5, C --- --- --- 
8 116.2, CH 7.19, s --- C-2, 3a, 10 
9 123.0, C --- --- --- 
10 160.5, CO --- --- --- 
11 --- 11.98, brs --- C-9, 13 
12 157.3, CO --- --- --- 
13 152.3, CO --- --- --- 
14 --- 9.77, brs --- C-10 
15 ~39.0, C  --- --- --- 
16 145.0, CH 6.07, dd (17.3, 10.5) H-17a, 17b C-15, 18, 19 
17a 
b 
111.9, CH2 5.06, d (17.3) 
5.09, d (10.5) 
H-16, 17b 
H-17, 17a 
C-15, 16 
C-15, 16 
18 27.7, CH3 1.48, s --- C-2, 16, 19 
19 27.7, CH3 1.48, s --- C-2, 16, 18 
20 33.8, CH2 3.39, d (7.4) H-21 C-5, 6, 7, 21, 22 
21 124.1, CH 5.35, t (7.4) H-20, 23, 24 C-23, 24 
22 131.1, C --- --- --- 
23 17.7, CH3 1.73, s H-21 C-21, 22, 24 
24 25.6, CH3 1.73, s H-21 C-21, 22, 23 
 
Unlike the 1H NMR spectrum of EC9, the 1H NMR spectrum (Table 14) of 
EC7 displayed three aromatic protons at δH 7.34, d (J = 8.1 Hz; δC 119.6), δH 7.21, 
s (δC 110.6) and δH 6.87, d (J = 8.1 Hz; δH 120.8), suggesting the presence of a 
substituent on C-5 or C-6 of the benzene ring of the 2,3-dihydro-1H-indole portion. 
Since the doublet at δH 7.34 (J = 8.1 Hz; δC 119.6) gave HMBC cross peaks to the 
carbons at δC 103.6 and 135.5, which were assigned to C-3 and C-7a of the indole 
portion, and also to the quaternary sp2 carbon at δC 134.4, the substituent was on 
C-6 (δC 134.4) of the benzene ring. That the substituent on C-6 (δC 134.4) was the 
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3-methyl-2-butenyl group was supported by the HMBC cross peaks of the doublet 
at δH 6.87 (J = 8.1 Hz; δC 120.8) and the singlet at δH 7.21 (δC 110.6) to the 
methylene carbon signal at δC 33.8, as well as of the doublet at δH 3.39 (J = 7.4 
Hz; δC 33.8) to the aromatic carbons at δC 120.8 and 110.6. 
  
3.39 d (7.4)
33.8
110.6
134.4
120.8
7.21 s
6.87 d (8.1)
 
 
Table 15. Comparison of 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 
MHz) of EC7 and EC9.  
Position EC7  EC9 
 δC, type δH, mult. (J in Hz)  δC, type δH, mult. (J in Hz) 
 
1 
 
--- 
 
11.11, s 
  
--- 
 
11.23, s 
2 145.3, C ---  145.6, C --- 
3 103.6, C ---  103.8, C --- 
3a 124.2, C ---  126.1, C --- 
4 119.6, CH 7.34, d (8.1)  119.7, CH 7.43, d (7.6) 
5 120.8, CH 6.87, d (8.1)  119.8, CH 7.02, dd (7.6, 7.6) 
6 134.4, C ---  121.1, CH 7.11, dd (7.6, 7.6) 
7 110.6, CH 7.21, s  111.6, CH 7.43, d (7.6) 
7a 135.5, C   135.2, C --- 
8 116.2, CH 7.19, s  116.0, CH 7.19, d (1.0) 
9 123.0, C ---  123.4, C --- 
10 160.5, CO ---  160.5, CO --- 
11 --- 11.98, brs  --- 11.97, brs 
12 157.3, CO ---  157.3, C --- 
13 152.3, CO ---  152.3, CO --- 
14 --- 9.77, brs  --- 9.85, brs 
15 ~39.0, C ---  ~39.0, C --- 
16 145.0, CH 6.07, dd (17.3, 10.5)  144.9, CH 6.07, dd (17.5, 10.6) 
17a 
b 
111.9, CH2 5.06, d (17.3) 
5.09, d (10.5) 
 112.0, CH2 5.06, d (17.5) 
5.08, d (10.6) 
18 27.7, CH3 1.48, s  27.7, CH3 1.48, s 
19 27.7, CH3 1.48, s  27.7, CH3 1.48, s 
20 33.8, CH2 3.39, d (7.4)  --- --- 
21 124.1, CH 5.35, t (7.4)  --- --- 
22 131.7, C ---  --- --- 
23 17.7, CH3 1.73, s  --- --- 
24 25.6, CH3 1.73, s  --- --- 
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 The rest of the 13C and 1H signals were very similar to those of EC9 (Table 
15).  
Therefore, EC7 corresponded to EC9 with a prenyl group on C-6 (δC 134.4). 
The structure established for EC7 corresponded to neoechinulin (Figure 59), a 
prenylated indolopiperazine derivative previously reported from the fungi 
Aspergillus amstelodami (Marchelli et al., 1977) and Aspergillus ruber (Nagasawa 
et al., 1975). 
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Figure 59. Structure of neoechinulin (EC7). 
 
3.1.4.5. Echinulin (EC6) 
EC6 was isolated as white amorphous solid. The 13C NMR spectrum (Table 
16) revealed the presence of two amide carbonyls (δC 168.7, 167.9), five methine 
sp2 (δC 145.7, 124.5, 122.8, 122.8, 115.1), eight quaternary sp
2 (δC 141.3, 133.8, 
132.9, 132.2, 131.5, 129.0, 123.4, 104.1), one methylene sp2 (δC 112.3), two 
methine sp3 (δC 54.6, 50.7), one quaternary sp
3 (δC 38.9), three methylene sp
3 (δC 
34.6, 31.3, 29.5) and seven methyl (δC 27.9, 27.8, 25.8, 25.7, 19.8, 17.9, 17.9) 
carbons.  
The 1H NMR spectrum (Table 16) displayed signals of one amine proton at 
δH 8.08, s, two aromatic protons at δH 7.16, s and 6.83, s, two amide protons at δH 
6.80, brs and 5.74, brs, five olefinic protons at δH 6.13, dd (J = 17.5, 10.6 Hz), 
5.43, t (J = 6.1 Hz), 5.39, m, 5.19, d (J = 17.5 Hz) and 5.18, d (J = 10.6), two 
methine protons at δH 4.43, d (J = 10.0 Hz) and 4.12, m, six methylene protons at 
δH 3.67, dd (J = 14.7, 2.9 Hz), 3.56, d (J = 6.1 Hz; 2H), 3.42, d (J = 6.8 Hz; 2H) 
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and 3.21, dd (J = 14.7, 11.7 Hz) and seven methyl groups at δH 1.89, s, 1.83, s, 
1.77, s (6H), 1.57, d (J = 7.3 Hz) and 1.54, s (6H).  
 
Table 16. Comparison of the 1H and 13C NMR data (300.13 and 75.47 MHz) of 
EC6 (CDCl3) and EC8 (DMSO-d6).  
Position EC6  EC8 
 δC, type δH, mult. (J in Hz)  δC, type δH, mult. (J in Hz) 
 
1 
 
--- 
 
8.08, s 
  
--- 
 
10.95, s 
2 141.3, C ---  143.8, C --- 
3 104.1, C ---  102.8, C --- 
3a 129.0, C ---  125.6, C --- 
4 115.1, CH 7.16, s  118.5, CH 7.20, d (7.3) 
5 133.8, C ---  119.3, CH 7.02, ddd (7.3, 7.3, 1.2) 
6 122.8, CH 6.83, s  120.6, CH 7.08, ddd (7.3, 7.3, 1.2) 
7 123.4, C ---  111.5, CH 7.43, dd (7.3, 1.2) 
7a 132.2, C ---  134.9, C --- 
8a 
b 
29.5, CH2 3.21, dd (14.7, 11.7) 
3.67, dd (14.7, 2.9) 
 110.2, CH 6.96, s 
9 54.6, CH 4.43, d (10.0)  124.5, C --- 
10 168.7, CO ---  159.0, CO --- 
11 --- 6.80, brs  --- 8.35, d (1.7) 
12 50.7, CH 4.12, m  50.6, CH 4.14, dd (6.9, 1.7) 
13 167.9, CO ---  166.0, CO --- 
14 --- 5.74, brs  --- 8.27, brs 
15 38.9, C ---  ~39.0, C --- 
16 145.7, CH 6.13, dd (17.5, 10.6)  144.7, CH 6.08, dd (17.3, 10.4) 
17a 
b 
112.3, CH2 5.19, d (17.5) 
5.18, d (10.6) 
 111.4, CH2 5.05, d (17.3) 
5.06, d (10.4) 
18 27.9, CH3 1.54, s  27.7, CH3 1.51, s 
19 27.8, CH3 1.54, s  27.7, CH3 1.51, s 
20 34.6, CH2 3.42, d (6.8)  19.8, CH3 1.45, d (6.9) 
21 124.5, CH 5.39, m  --- --- 
22 131.5, C ---  --- --- 
23 17.9, CH3 1.77, s  --- --- 
24 25.8, CH3 1.77, s  --- --- 
25 31.3, CH2 3.56, d (6.1)  --- --- 
26 122.8, CH 5.43, t (6.1)  --- --- 
27 132.9, C ---  --- --- 
28 17.9, CH3 1.89, s  --- --- 
29 25.7, CH3 1.83, s  --- --- 
30 19.8, CH3 1.57, d (7.3)  --- --- 
 
Analysis of the 1H and 13C NMR spectra of EC6 revealed that, except for 
the substituted benzene ring, another part of the molecule was similar to that of 
EC8 differing only in the single bond on C-8/C-9 in the former, instead of the 
double bond in the latter. 
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4.12 m
1.57 d (7.3)
50.7
19.8
29.5
54.6
3.21 dd 
(14.7, 11.7)
3.67 dd 
(14.7, 2.9)
4.43 d (10.0)
 
 
In contrast to EC8, the 1H NMR spectrum displayed only two singlets of the 
aromatic protons at δH 7.16 and 6.83, suggesting that they were in the meta 
position of the benzene ring of the 2,3-dihydro-1H-indole portion. Furthermore, the 
13C NMR spectrum revealed additional carbons comprising two pairs of methyl (δC 
17.9, 2CH3 / δC 25.7, 25.8), two methine sp
2 (δC 122.8, 124.5), two quaternary sp
2 
(δC 131.5, 132.9) and two methylene sp
3 (δC 31.3, 34.6) carbons which, in 
combination with the presence of the methyl singlets at δH 1.89, 1.83 and 1.77 
(6H), a triplet at δH 5.43 (J = 6.1 Hz), a multiplet at δH 5.39, and two doublets at δH 
3.42 (J = 6.8 Hz) and 3.56 (J = 6.1 Hz), confirmed the existence of another two 
prenyl groups in the molecule. Consequently, the benzene ring of the indole 
portion of EC6 bares two prenyl substituents either on C-5 and C-7, or C-4 and C-
6. 
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or
1 1 22
33
4 4
5 5
66
77
3a
7a
3a
7a
 
  
Since the chemical shift values of the aromatic protons of EC6 (δH 
7.16, s and 6.83, s) were more similar to those of H-4 (δH 7.20) and H-6 (δH 7.08) 
than those of H-5 (δH 7.02) and C-7 (δH 7.43) of EC8, the two prenyl substituents 
were placed on C-5 (δC 133.8) and C-7 (δC 123.4) of the benzene ring of the 2,3-
dihydro-1H-indole moiety. Therefore EC6 was identified as echinulin (Figure 60). 
In fact, echinulin was previously reported from the culture of the same fungus by 
Almeida et al. (2010) and later by Du et al. (2012). 
Echinulin is a common prenylated indolopiperazine derivative, first isolated 
from Aspergillus amstelodami in 1961 by Birch et al., and later from various 
sources such as its teleomorph Eurotium amstelodami (Slack et al., 2009), as well 
as from several other species from the genus Eurotium (Butinar et al., 2005; Gao 
et al., 2011a; Li et al., 2008b; Podojil et al., 1979; Smetanina et al.,2007; Sohn et 
al., 2013). Echinulin was also identified from cultures of different fungal species 
such as Aspergillus variecolor (Wang et al., 2007) and Penicillium griseofulvum 
(Zhou et al., 2010), as well as from different plants of Anacardiaceae, 
Cucurbitaceae and Orchidaceae families (Talapatra et al., 2001; Zhao et al., 
1991). 
 Echinulin displayed in vitro inhibitory activity with an IC50 value of 29.4 µM 
against PTP1B, a potential drug target for the treatment of type 2 diabetes and 
obesity (Sohn et al., 2013). 
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Figure 60. Structure of echinulin (EC6). 
 
 Similarly to the anthraquinones EC1-EC5 isolated and those reported in 
literature, also the polyprenylated indole diketopiperazine alkaloids echinulin, 
neoechinulin, neoechinulin A and E, belong to the characteristic metabolic profile 
from Eurotium genus. Despite the reports on the isolation of the diketopiperazine 
derivatives from some plants (Pettit et al., 2008; Talapatra et al., 2001; Yang et al., 
2013a; Zhao et al., 1991) and other fungi (Dewapriya et al., 2013; Wang et al., 
2006; 2007; Wijesekara et al., 2014; Zhou et al., 2010), most reports refer to 
echinulin, neoechinulin, neoechinulin A and E as metabolic products from 
Eurotium species (Almeida et al., 2010; Birch et al., 1961; Du et al., 2012; Kim et 
al., 2013; Li et al., 2008b; Slack et al., 2009) was well as from their anamorphs, 
specially from Aspergillus amstelodami (Marchelli et al., 1977). 
 With exception to echinulin, previously reported by Almeida et al. (2010), 
and neoechinulin A by Du et al. (2012), this was the first report on the isolation of 
the diprenylated triketopiperazine alkaloid neoechinulin from Eurotium species, 
thus classifying it as a possible new extrolite for this genus, and an additional tool 
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for taxonomic identification (Gomes et al., 2012). Additionally, neoechinulin E was 
also identified for the first time from E. cristatum species (Gomes et al., 2012).   
 
3.1.4.6. Eurocristatine (EC10) 
 A new diketopiperazine dimer (EC10), which we named eurocristatine, was 
also isolated from E. cristatum KUFC 7356, in addition to the known metabolites 
(EC1-EC9).  
EC10 was isolated as white crystals and its IR spectrum showed absorption 
bands for amine (3450 cm-1), aromatic (3190 cm-1) and carbonyls (1662 cm-1) 
groups. The 13C NMR, DEPT and HSQC spectra (Table 17) revealed the presence 
of sixteen carbon signals which can be categorized as two amide carbonyls (δC 
168.4, 167.5), two quaternary sp2 (δC 149.1, 130.4), four methine sp
2 (δC 128.7, 
124.4, 117.9, 108.9), one quaternary sp3 (δC 59.7), four methine sp
3 (δC 78.8, 
62.3, 55.7, 32.0), one methylene sp3 (δC 37.3) and two methyl (δC 19.0, 18.0) 
carbons. However, the (+)-HR-ESIMS exhibited the m/z 569.2905 [M+H]+, which 
corresponded to the molecular formula C32H36N6O4, implying that each carbon 
signal must correspond to two carbon atoms.  
 
Table 17. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of EC10.  
P
a
 δC, type δH, mult. (J in Hz) COSY HMBC NOESY 
 
1 
 
--- 
 
6.74, brs 
 
H-2 
 
C-2, 3, 4, 9 
 
H-2 
2 78.8, CH 4.90, brs H-1 --- H-1, 11 
3 59.7, C --- --- --- --- 
4 130.4, C --- --- --- --- 
5 124.4, CH 7.39, d (7.5) H-2 C-3, 7, 9 H-6, 12β 
6 117.9, CH 6.63, dd (7.5, 7.5) H-5, 7 C-4, 8 --- 
7 128.7, CH 7.02, dd (7.5, 7.5) H-6, 8 C-5, 9 --- 
8 108.9, CH 6.60, d (7.5) H-7 C-4, 6 --- 
9 149.1, C --- --- --- --- 
11 55.7, CH 4.12, t (9.0) H-12α, 12β C-12, 13 H-2, 17, 18, 19 
12α 37.3, CH2 2.39, dd (14.0, 9.5) H-11, 12β C-3, 4, 11, 13 H-12β 
12β  3.14, dd (14.0, 9.5) H-11, 12α C-3, 4, 11, 13 H-5, 12α 
13 168.4, CO --- --- --- --- 
14 --- 8.27, d (4.2) H-15 C-11, 13, 15, 16 H-17, 18, 19 
15 62.3, CH 3.39, t (5.0) H-14, 17 C-13, 16, 17, 18, 19 --- 
16 167.5, CO --- --- --- --- 
17 32.0, CH 1.94, m H-15, 18, 19 C-15, 16, 18, 19 H-11, 18, 19 
18 19.0, CH3 0.80, d (6.7) H-17 C-15, 18, 19 H-17, 19 
19 18.0, CH3 0.69, d (6.7) H-17 C-15, 18, 19 H-17, 18 
P
a
 Position 
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The coupling system of the aromatic protons at δH 7.39, d (J = 7.5 Hz; δC 
124.4), 6.63, dd (J = 7.5, 7.5 Hz; δC 117.9), 7.02, dd (J = 7.5, 7.5 Hz; δC 128.7) 
and 6.60, d (J = 7.5 Hz; δC 108.9) observed in the COSY spectrum (Table 17), 
revealed the presence of one 1,2-disubstituted benzene ring. This was confirmed 
by the HMBC cross peaks of the doublet at δH 7.39 (J = 7.5 Hz; δC 124.4) to the 
carbons at δC 128.7 and 149.1, of the double doublet at 6.63 (J = 7.5, 7.5 Hz; δC 
117.9) to the carbons at δC 108.9 and 130.4, of the double doublet at δH 7.02 (J = 
7.5, 7.5 Hz; δC 128.7) to the carbons at δC 124.4 and 149.1, and of the doublet at 
δH 6.60 (J = 7.5 Hz; δC 108.9) to the carbons at δC 117.9 and 130.4. Moreover, the 
doublet at δH 7.39 (J = 7.5 Hz; δC 124.4) also showed HMBC cross peaks to the 
quaternary sp3 carbon at δC 59.7, while the broad singlet at δH 6.74, which did not 
show cross peaks with any carbon in the HSQC spectrum, displayed HMBC cross 
peaks to the aromatic carbons at δC 130.4 and 149.1 as well as to the quaternary 
sp3 carbon at δC 59.7 and the methine sp
3 carbon at δC 78.8. These correlations 
suggested the presence of the 2,3,3-trisubstituted-2,3-dihydro-1H-indole portion. 
 
130.4
6.63 dd
(7.5, 7.5)
7.39 d (7.5)
59.7
7.02 dd
(7.5, 7.5)
6.74 brs
6.60 d (7.5)
128.7
117.9
124.4
78.8
149.1
108.9
 
  
 The COSY spectrum showed that another part of the molecule consisted of 
three coupling systems, i.e., of the methylene protons at δH 2.39, dd (J = 14.0, 9.5 
Hz; δC 37.3) and 3.14, dd (J = 14.0, 9.5 Hz; δC 37.3) to the methine proton at δH 
4.12, t (J = 9.0 Hz; δC 55.7), of the amide proton at δH 8.27, d (J = 4.2 Hz) to the 
methine proton at δH 3.39, t (J = 5.0 Hz; δC 62.3) and of the methine proton at δH 
3.39, t (J = 5.0 Hz; δC 62.3) to the methine proton at δH 1.94, m (δC 32.0), and of 
the methine proton at δH 1.94, m (δC 32.0) to the methyl protons at δH 0.80, d (J = 
6.7 Hz; δC 19.0) and 0.69, d (J = 6.7 Hz; δC 18.0). The HMBC spectrum showed 
cross peaks of the doublet of the amide proton at δH 8.27 (J = 4.2 Hz) to the 
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methine carbon signals at δC 55.7, 62.3 and the amide carbonyl carbons at δC 
167.5 and 168.4, indicating that another portion of the molecule was a 1,4-
diketopiperazine system. Additionally, the HMBC cross peaks of the doublet of the 
amide proton at δH 8.27 (J = 4.2 Hz) to the methine carbon at δC 62.3, of the triplet 
at δH 3.39 (J = 5.0 Hz; δC 62.3) to the carbon at δC 32.0 and to the methyl carbons 
at δC 19.0 and 18.0, and of the multiplet of the methine proton at δH 1.94 (δC 32.0) 
to the amide carbonyl carbon at δC 167.5, to the methine carbon at δC 62.3 and 
methyl carbons at δC 19.0 and 18.0, indicated that the isopropyl moiety was placed 
on C-15 (δC 62.3) of the diketopiperazine ring. 
 
3.14 dd (14.0, 9.5)
2.39 dd (14.0, 9.5)
37.3
8.27 d (4.2)
19.0
32.0
62.3
4.12 t (9.0)
55.7
18.0
1.94 m
0.80 d (6.7)
3.39 t (5.0)
167.5
168.4
0.69 d (6.7)
 
 
That the 1,4-diketopiperazine ring moiety was linked to the indole ring 
system through C-2 (δC 78.8) of the latter and N-10 of the former, and through the 
methylene group on C-3 (δC 59.7) of the latter and C-11 (δC 55.7) of the former, 
was evidenced by correlations between the methine proton at δH 4.12, t (J = 9.0 
Hz; δC 55.7) and the signals of the methylene protons at δH 3.14, dd and 2.39, dd 
(J = 14.0, 9.5 Hz; δC 37.3), as well as the HMBC correlations of the methylene 
proton at δH 2.39, dd (J = 14.0; 9.5 Hz; δC 37.3) to the carbons at δC 59.7, 130.4 
and 168.4.  
 The cross peaks observed in the NOESY spectrum between the signals at 
δH 4.90, brs / 4.12, t (J = 9.0 Hz) and δH 4.12, t (J = 9.0 Hz) / 1.94, m, δH 4.12, t (J 
= 9.0 Hz) / 0.80, d (J = 6.7 Hz), δH 4.12, t (J = 9.0 Hz) / 0.69, d (J = 6.7 Hz), 
suggested that the isopropyl substituent was α oriented. 
 Taking altogether the NMR data, the partial structure A (C16H18N3O2) was 
proposed. 
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78.8
A
3.14 dd (14.0, 9.5)
2.39 dd (14.0, 9.5)
55.7
130.4
37.3
59.7
4.12 t (9.0)
4.90 brs
 
Since the (+)-HR-ESIMS gave the molecular formula C32H36N6O4, the 
complete structure of eurocristatine (EC10) (Figure 61) must comprise two A units 
connected to each other through the carbon at δC 59.7.  
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Figure 61. Structure of eurocristatine (EC10). 
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Final proof of the structure and stereochemistry assigned to EC10 was 
provided by an X-ray analysis which established the absolute configuration of C-
2/2’, C-3/3’, C-11/11’ and C-15/15’, respectively as 2/2’R, 3/3’S, 11/11’S and 
15/15’R. The result depicted in the ORTEP view shown in Figure 62 also revealed 
the symmetrical nature of eurocristatine (EC10). 
 
 
 
Figure 62. ORTEP view of EC10. 
 
Although several diketopiperazine dimers have been previously reported 
from many fungal sources, and especially from Aspergillus species (Barrow et al., 
1993; Barrow and Sedlock, 1994; Cai et al., 2012; Ding et al., 2008; Li et al., 
2009b; Ovenden et al., 2004; Raju et al., 2009; Son et al., 1999; Takahashi et al., 
1994; 1995a; 1995b; Varoglu et al., 1997; Yamada et al., 2002), eurocristatine 
(EC10) represents the first diketopiperazine dimer isolated from the genus 
Eurotium. 
Recently, two diketopiperazine dimers whose structures closely resemble to 
eurocristatine (EC10), were reported from two distinct marine algal-derived strains 
of Eurotium sp. (Figure 63). Interestingly, the unsymmetrical dimer cristatumin D 
(148) was also isolated from a strain of E. cristatum EN-220 isolated from the 
marine alga Sargassum thunbergii (Du et al., 2012), whereas cristatumin E (149) 
the stereoisomer of eurocristatine (EC10), was isolated from the algicolous 
Eurotium herbariorum HT-2 (Li et al., 2013a).  
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Innumerable natural products bearing the 2,5-diketopiperazine ring with a 
wide spectrum of therapeutically relevant bioactivities have been isolated to date. 
Diketopiperazines, also known as piperazine-2,5-diones, are the simplest 
cyclodipeptides found in Nature, derived from different amino acids and one or 
more isoprene units, being also found as degradation products of polypeptides. 
This class of bioactive secondary metabolites is produced by several organisms 
such as fungi, bacteria, plants and even mammals, being often found alone or 
embedded in larger and more complex architectures. Natural diketopiperazines 
are biosynthetically assembled by nonribosomal peptide synthetases (NRPSs) and 
cyclodipeptide synthases (CDPs), with a structural diversity achieved through 
choice of amino acid precursors and enzyme-catalyzed reactions like 
dimerizations (Cornacchia et al., 2012; Martins and Carvalho, 2007).  
 
EC10 149148  
 
Figure 63. Diketopiperazine dimers related to eurocristatine (EC10). 
 
While cyclo-(L-tryptophyl-L-phenylalanyl) (EV5) derives from a simple 
cyclization of L-tryptophan and L-phenylalanine, echinulin (EC6) and its analogs 
correspond to tri-, di- (EC7) or mono- (EC8-9) prenylated derivatives of a cyclic 
dipeptide consisting of L-tryptophan and L-alanine. Eurocristatine (EC10) is a 
dimerized cyclic dipeptide derived from two molecules of L-tryptophan and two 
molecules of L-valine. Despite the limited number of reports concerning the 
biosynthesis of dimerized cyclodipeptides, recently a plausible and unifying 
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hypothesis was proposed for the biosynthetic pathway of dimeric 
diketopiperazines joined through C3/C3’ bond (Kim et al., 2009). Thus the 
structure of eurocristatine (EC10) suggests that it was derived from a common 
biosynthetic pathway proposed in Scheme 3. 
 
Condensation
L-tryptophan
D-valine
Eurocristatine (EC10)
Radical dimerization
Condensation
 
 
Scheme 3. Proposed biosynthetic pathway for eurocristatine (EC10). 
 
3.1.5. Structure Elucidation of Meroditerpenes 
 
3.1.5.1. Chevalone B (NL1)  
 NL1 was isolated as colorless crystal and its molecular formula C28H40O5 
was established on the basis of the (+)-HR-ESIMS m/z 457.2949 [M+H]+ 
(calculated 457.2954), indicating nine degrees of unsaturation. The IR spectrum 
showed absorption bands for ester (1702 cm-1), conjugated ketone (1585 cm-1) 
and olefinic (1585 cm-1) groups.  
 The 13C NMR, DEPT and HSQC spectra (Table 18) revealed the presence 
of one ester carbonyl (δC 170.9), one conjugated ester carbonyl (δC 165.3), three 
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quaternary sp2 (δC 163.2, 159.7, 97.7), one methine sp
2 (δC 100.6), four methine 
sp3 (δC 80.6, 60.1, 55.4, 51.8), four quaternary sp
3 (δC 80.4, 37.3, 37.1, 36.9), 
seven methylene sp3 (δC 40.8, 40.1, 37.9, 23.4, 18.6, 17.7, 16.7) and seven methyl 
(δC 27.8, 21.2, 20.4, 19.7, 16.4, 16.2, 16.0) carbons. 
 
Table 18. 1H and 13C NMR data (CDCl3, 300.13 and 75.47 MHz) of NL1. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1α 
β 
 
37.9, CH2 
 
1.73, m 
1.07, m 
 
H1β 
H-1α 
 
C-2, 3, 5 
--- 
2 23.4, CH2 1.68, m H-3 C-3 
3 80.6, CH 4.46, dd (11.0, 5.1) H-2 C-1, 2, 22, 23, CO (Ac-3) 
4 37.3, C --- --- --- 
5 55.4, CH 0.88, m H-6α, 6β  --- 
6α 
β 
17.7, CH2 1.57, m 
1.46, m 
H-5 
H-5 
--- 
--- 
7α 
β 
40.8, CH2 1.86 dt (12.8, 4.8) 
1.04, m 
H-7β 
H-7α 
C-5, 8, 9 
--- 
8 36.9, C --- --- --- 
9 60.1, CH 0.93, dd (12.4, 2.0) H-11β --- 
10 37.1, C --- --- --- 
11α 
β 
18.6, CH2 1.70, m  
1.35, dd (12.4, 3.2) 
H-11β, 12α 
H-9, 11α, 12α 
--- 
--- 
12α 
β 
40.1, CH2 2.06, dd (12.0, 4.3) 
1.59, dd (12.0, 3.2) 
H-11α, 11β, 12β 
H-12α 
C-9, 14 
--- 
13 80.4, C --- --- --- 
14 51.8, CH 1.46, dd (12.8, 4.8) H-15α, 15β  C-7, 9, 12, 13,  
15α 
β 
16.7, CH2 2.43, dd (16.9, 4.8) 
2.17, dd (16.9, 12.0) 
H-14, 15β 
H-14, 15α 
C-13, 14, 16, 17, 21 
C-8, 14, 16 
16 97.7, C --- --- --- 
17 163.2, C --- --- --- 
18 100.6, CH 5.69, s H-20 C-16, 17, 19, 20 
19 159.7, C --- --- --- 
20 19.7, CH3 2.18, s H-18 C-18, 19 
21 165.3, CO --- --- --- 
22 27.8, CH3 0.86, s --- C-3, 4, 5, 23 
23 16.0, CH3 0.89, s --- C-3, 4, 5, 22 
24 16.2, CH3 0.88, s --- C-1, 5, 9, 10 
25 16.4, CH3 0.87, s --- C-7, 8, 9, 14 
26 20.4, CH3 1.20, s --- C-12, 13, 14 
Ac-3 170.9, CO 
21.2, CH3 
--- 
2.05, s 
--- 
--- 
--- 
CO (Ac-3) 
 
 The 1H NMR spectrum, in conjunction with the HSQC spectrum (Table 18), 
displayed the signals of one olefinic proton at δH 5.69, s, one oxymethine proton at 
δH 4.46, dd (J = 11.0, 5.1 Hz), three methine protons at 1.46, dd (J = 12.8, 4.8 Hz), 
0.93, dd (J = 12.4, 2.0 Hz) and 0.88, m, and seven methyl groups at δH 2.18, s,  
2.05, s, 1.20, s, 0.89, s, 0.88, s, 0.87, s and 0.86, s. 
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While the COSY spectrum (Table 18) displayed the cross peak of the 
oxymethine proton signal at δH 4.46, dd (J = 11.0, 5.1 Hz) to the signals of the 
methylene protons at δH 1.68, m (2H; δC 23.4), the HMBC spectrum (Table 18) 
displayed correlations of the oxymethine proton at δH 4.46, dd (J = 11.0, 5.1 Hz; δC 
80.6) and of the methyl protons at δH 2.05, s (δC 21.2) to the carbonyl carbon at δC 
170.9, indicating the presence of the acetoxyl group  on the oxymethine carbon 
(δC 80.6). Furthermore, the HMBC cross peaks of the signal of the oxymethine 
proton at δH 4.46, dd (J = 11.0, 5.1 Hz; δC 80.6) to the methyl carbons at δC 27.8 
and 16.0, and to the methylene sp3 carbons at δC 37.9 and 23.4, and of the signals 
of the methyl protons at δH 0.86, s (δC 27.8) and 0.89, s (δC 16.0) to the 
oxymethine carbon at δC 80.6, the quaternary sp
3 carbon at δC 37.3 and the 
methine sp3 carbon at δC 55.4, suggested the existence of the fragment A. 
 
23.4
21.2
2.05 s
A
27.8
16.0
37.9
170.9
0.89 s
0.86 s
4.46 dd 
(11.0, 5.1)
37.3
55.480.6
 
 
Additionally, the HMBC correlations of the methyl protons at δH 0.88, s (δC 
16.2) to the methine sp3 carbons at δC 60.1 and 55.4, the methylene sp
3 carbon at 
δC 37.9, and of the methyl protons at δH 0.87, s (δC 16.4) to the carbons at δC 60.1, 
40.8 and 36.9, suggested the existence of a 2-acetoxy-5,6-disubstituted-1,1,4a,6-
tetramethyldecalin fragment (B). 
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B
37.9
0.87 s
16.2
16.4
0.88 s 0.93 dd (12.4, 2.0)
55.4
60.1
37.1
40.8
36.9
 
 
 Moreover, the methyl singlet at δH 0.87 (δC 16.4) also gave cross peak to 
the methine sp3 carbon at δC 51.8, which, in turn showed HMBC cross peak to the 
methyl singlet at δH 1.20 (δC 20.4). Since the methyl singlet at δH 1.20 (δC 20.4) 
also displayed HMBC cross peaks to the oxyquaternary carbon at δC 80.4 and the 
methylene carbon at δC 40.1, the perhydrophenanthrene skeleton was suggested. 
This was supported by the HMBC correlations of the methylene proton at δH 2.06, 
dd (J = 12.0, 4.3 Hz; δC 40.1) to the methine sp
3 carbons at δC 60.1, 51.8, and of 
the methine proton at δH 1.46, dd (J = 12.8, 4.8 Hz; δC 51.8) to the carbons at δC 
80.4, 60.1 and 40.1. Since the COSY spectrum displayed correlations of the 
methine proton at δH 1.46, dd (J = 12.8, 4.8 Hz; δC 51.8) to the methylene protons 
at δH 2.43, dd (J = 16.9, 4.8 Hz; δC 16.7) and 2.17, dd (J = 16.9, 12.0 Hz; δC 16.7), 
the methylene group (δC 16.7) was connected to the methine carbon at δC 51.8. 
The HMBC cross peaks of the methylene protons at δH 2.43, dd (J = 16.9, 4.8 Hz; 
δC 16.7) and 2.17, dd (J = 16.9, 12.0 Hz; δC 16.7) to the carbons at δC 80.4 and 
51.8 confirmed the presence of fragment C. 
 
16.7
2.43 dd 
(16.9, 4.8)
0.87 s
C
2.17 dd 
(16.9, 12.0)
2.06 dd 
(12.0, 4.3)
1.59 dd 
(12.0, 3.2)
1.20 s
1.70 m
51.8
1.35 dd
(12.4, 3.2)
1.46 dd 
(12.8, 4.8)
20.4
40.1
18.6
16.4
80.4
60.1
37.1 36.9
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Another portion of the molecule consists of the olefinic proton at δH 5.69, s 
(δC 100.6) and the methyl protons at δH 2.18, s (δC 19.7), which showed cross 
peak to each other in the COSY spectrum, suggesting an allylic coupling.  This 
was also confirmed by the HMBC cross peak between the singlet at δH 5.69 (δC 
100.6) to the methyl carbon at δC 19.7. Since the HBMC spectrum displayed cross 
peaks of the singlet of the olefinic proton at δH 5.69 (δC 100.6) to the sp
2 carbons 
at δC 163.2, 159.7, 97.7, this portion must contain two double bonds. The HMBC 
spectrum also displayed cross peaks of the methyl singlet at δH 2.18 (δC 19.7) to 
the quaternary sp2 carbon at δC 159.7 and the methine sp
2 carbon at δC 100.6. 
This correlation pattern, together with the presence of a quaternary sp2 carbon at 
165.3, suggested that this portion of the molecule should correspond to 6-methyl-
2H-pyran-1-one (D). 
 
163.2
D
165.3
5.69 s
19.7
159.7
100.6
97.7
2.18 s
 
  
 That the perhydrophenanthrene portion (fragment C) was connected to the 
6-methyl-2H-pyran-1-one portion (fragment D) through an ethereal bridge, was 
substantiated by the HMBC cross peaks of the signals of the methylene protons at 
δH 2.43, dd (J = 16.9, 4.8 Hz; δC 16.7) and 2.17, dd (J = 16.9, 12.0 Hz; δC 16.7) to 
the carbonyl carbon at δC 165.3 and the quaternary sp
2 carbons at δC 163.2 and 
97.7 of the 6-methyl-2H-pyran-1-one ring. Thus, the structure of NL1 was 
established as:   
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2.43 dd 
(16.9, 4.8)
2.17 dd 
(16.9, 12.0)
163.2
97.7
165.3
80.4
51.8
 
 
Since the oxymethine proton (H-3) appeared as a double doublet at δH 4.46 
(J = 11.0, 5.1 Hz), the position of the acetoxyl group on C-3 (δC 80.6) was β-
oriented (Kojima and Hogura, 1989).  
Literature survey revealed that NL1 corresponded to chevalone B (Figure 
64), a meroditerpene isolated from the culture of fungus Eurotium chevalieri 
(Kanokmedhakul et al., 2011). 
Chevalone B was reported to exhibit strong cytotoxicity against human 
epidermoid carcinoma (KB) and human small cell lung cancer (NCI-H187) cell 
lines with IC50 values of 2.9 and 3.9 µg/mL (Kanokmedhakul et al., 2011). 
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Figure 64. Structure of chevalone B (NL1). 
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3.1.5.2. Aszonapyrone A (NL2)  
NL2 was also isolated as colorless crystal and its (+)-HR-ESIMS m/z 
457.2954 [M+H]+ (calculated for C28H41O5) indicated that it had the same 
molecular formula (C28H40O5) and degree of unsaturation as NL1. The 
1H and 13C 
NMR spectra of NL2 (Table 19) resembled those of NL1, expect for the presence 
of the exocyclic methylene group (δH 4.83, s and 4.60, s; δC 106.4 and δC 148.3) 
instead of the methyl group on the oxyquaternary carbon (δH 1.20, s; δC 20.4) of 
NL1, and a broad singlet of the hydroxyl group at δH 11.18. 
  
Table 19. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of NL2. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1α 
β 
 
37.6, CH2 
 
1.64, brd (11.2) 
1.00, m 
 
H-1β 
H-1α 
 
C-3, 5 
C-24 
2 22.9, CH2 1.62, m H-3 --- 
3 79.9, CH 4.39, dd (10.1, 5.9) H-2 C-1, 22, 23, Ac-3 
4 37.4, C --- --- --- 
5 54.7, CH 0.92, d (9.5) H-6β --- 
6α 
β 
18.4, CH2 1.54, m 
1.40, m 
--- 
H-5 
--- 
--- 
7α 
β 
39.5, CH2 1.85, m 
1.38, m 
H-7β 
H-7α 
C-5, 9 
C-25 
8 37.4, C --- --- --- 
9 59.1, CH 1.06, d (12.2) H-11α --- 
10 36.9, C --- --- --- 
11α 
β 
23.4, CH2 1.24, m  
1.57, m 
H-9 
--- 
--- 
--- 
12α 
β 
37.7, CH2 2.50, brs 
1.80, m 
--- 
--- 
C-14 
C-9, 13 
13 148.3, C --- --- --- 
14 53.0, CH 2.44, d (2.9) H-15α, 15β  C-7,13, 16, 25 
15α 
β 
18.3, CH2 2.46, dd (14.4, 2.9) 
2.30, d (14.4) 
H-14, 15β 
H-14, 15α 
C-13, 14, 16, 17, 21 
C-13, 14, 16, 17, 21 
16 101.0, C --- --- --- 
17 164.7, C --- --- --- 
18 99.9, CH 5.92, s H-20 C-16, 17, 19, 20 
19 159.5, C --- --- --- 
20 19.2, CH3 2.11, s H-18 C-18, 19 
21 164.8, CO --- --- --- 
22 27.7, CH3 0.83, s --- C-3, 4, 5, 23 
23 16.0, CH3 0.81, s --- C-3, 4, 5, 22 
24 16.4, CH3 0.80, s --- C-1, 5, 9 
25 14.9, CH3 0.69, s --- C-7, 9, 14 
26a 
b 
106.4, CH2 4.83, s 
4.60, s 
H-14, H-26b 
H-26a 
C-12, 14 
C-12, 14 
Ac-3 170.1, CO 
21.0, CH3 
--- 
2.00, s 
--- 
--- 
--- 
CO (Ac-3) 
OH-17 --- 11.18, brs --- --- 
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  The existence of the 2-acetoxy-5,6-disubstituted-1,1,4a,6-
tetramethyldecalin fragment was evidenced by the HMBC correlations (Table 19) 
of the oxymethine proton at δH 4.39, dd (J = 10.1, 5.9 Hz; δC 79.9) to the acetoxy 
carbonyl carbon at δC 170.1, the methylene carbon at δC 37.6, and the methyl 
carbons at δC 27.7 and 16.0, of the methyl protons at δH 2.00, s (δC 21.0) to the 
carbonyl carbon at δC 170.1, of the methyl protons at δH 0.83, s (δC 27.7) and 0.81, 
s (δC 16.0) to the methine sp
3 carbons at δC 79.9 and 54.7, and the quaternary sp
3 
carbon at δC 37.4, of the methyl protons at δH 0.80, s (δC 16.4) to the methine sp
3 
carbons at δC 59.1 and 54.7, and the methylene carbon at δC 37.6, and of the 
methyl protons at δH 0.69, s (δC 14.9) to the methine sp
3 carbons at δC 59.1 and 
53.0, and the methylene carbon at δC 39.5. As the HMBC spectrum displayed 
cross peaks of the methylene proton singlets at δH 4.83 (δC 106.4) and 4.60 (δC 
106.4) to the methylene carbon at δC 37.7 and the methine carbon at δC 53.0, the 
exocyclic methylene group was on C-13 (δC 148.3). 
 
37.4
37.6
21.0
2.00 s
79.9
4.83 s
4.60 s
37.7
106.4
0.83 s
0.80 s
4.39 dd
(10.1, 5.9)
0.81 s
16.4
53.0
27.7
54.7
170.1
16.0
39.5
0.69 s 148.3
59.1
14.9
 
 
 Similar to NL1, the nonterpenoid moiety of NL2 was also the 6-methyl-2H-
pyran-1-one as evidenced by the allylic coupling of the olefinic proton at δH 5.92, s 
(δC 99.9) to the methyl protons at δH 2.11, s (δC 19.2) observed in the COSY 
spectrum (Table 19), as well as by the HMBC cross peaks of the singlet of the 
olefinic proton at δH 5.92 (δC 99.9) to the olefinic carbons at δC 164.7, 159.5, 101.0 
and the methyl carbon at δC 19.2, and of the methyl singlet at δH 2.11 (δC 19.2) to 
the olefinic carbons at δC 159.5 and 99.9. Since the 
1H NMR spectrum displayed a 
broad singlet at δH 11.18, it was suggested that the hydroxyl group was on the 
olefinic carbon at δC 164.7. This hypothesis was supported by the chemical shift 
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value of the hydroxyl proton at δH 11.18, brs, characteristic of the enolic hydroxyl 
group, as well as the absence of oxyquaternary carbon at δC 80.4. 
 
11.18 brs
164.7
2.11 s
5.92 s
19.2
159.5
99.9
101.0
 
 
Like NL1, the perhydrophenanthrene and the 6-methyl-2H-pyran-1-one 
portions were connected through the methylene group (δH 2.46, dd, J = 14.4, 2.9 
Hz; δC 18.3) of the former and the quaternary sp
2 carbon at δH 101.0 of the latter, 
as evidenced by the HMBC cross peaks of the double doublet of the methylene 
proton at 2.46 (J = 14.4, 2.9 Hz; δC 18.3) to the carbons at δC 101.0, 164.7 and 
164.8. 
 
18.3
2.46 dd 
(14.4, 2.9)
2.30 d 
(14.4)
164.7
101.0 164.8
148.3
53.0
 
 
 Thus, the structure of NL2 was established as [8- [(4-hydroxy-6-methyl -2-
oxo-pyran-3-yl) methyl] - 1,1,4a,8a – tetramethyl – 7 – methylene - 
2,3,4,4b,5,6,8,9,10,10a-decahydrophenanthren-2-yl] acetate, which corresponds 
to the meroditerpene aszonapyrone A (Figure 65), originally isolated from the 
fungus Aspergillus zonatus by Kimura et al. (1982), and recently from the fungus 
Eurotium chevalieri (Kanokmedhakul et al., 2011). 
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 Aszonapyrone A was found to exhibit antibacterial activity against 
Staphylococcus aureus 209P and S. aureus res. with the MIC value of 6.3 µg/mL 
(Kimura et al., 1982). 
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Figure 65. Structure of aszonapyrone A (NL2).  
 
3.1.5.3. Aszonapyrone B (NL3)  
NL3 was also isolated as colorless crystal. The 1H and 13C NMR spectra of 
NL3 (Table 20) closely resembled those of NL2, except for the lack of the acetoxyl 
group (δH 2.00, s; δC 21.0 / δC 170.1). The 
13C NMR, DEPT and HSQC spectra 
(Table 20) revealed the presence of one conjugated ester carbonyl (δC 164.7), four 
quaternary sp2 (δC 164.5, 158.8, 148.3, 100.9), one methylene sp
2 (δC 105.9), one 
methine sp2 (δC 99.9), four methine sp
3 (δC 80.0, 59.4, 54.8, 52.9), seven 
methylene sp3 (δC 39.9, 38.1, 37.4, 27.0, 22.7, 18.3, 18.3), three quaternary sp
3 
(δC 39.9, 37.4, 36.9) and five methyl (δC 29.9, 18.9, 15.8, 15.4, 14.7) carbons. The 
presence of the hydroxyl group on C-3 (δC 80.0) of the diterpenoid moiety was 
confirmed by a multiplet at δH 3.10 in the 
1H NMR spectrum and the corresponding 
oxymethine carbon at δC 80.0, as well as the higher chemical shift value of  C-2 
(δC 27.0) than that in NL1 and NL2. 
 The rest of the 1H and 13C signals were very similar to those of NL2 (Table 
20). 
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Table 20. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz, T = 45 ºC) 
of NL3. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1α 
β 
 
38.1, CH2 
 
1.65, m 
0.95, m 
 
H-1β 
H-1α 
 
--- 
--- 
2 27.0, CH2 1.50, m H-3 --- 
3 80.0, CH 3.10, m H-2 --- 
4 37.4, C --- --- --- 
5 54.8, CH 0.80, m H-6β --- 
6α 
β 
18.3, CH2 1.60, m 
1.39, m 
--- 
H-5 
--- 
--- 
7 38.7, CH2 1.65, m --- --- 
8 39.9, C --- --- --- 
9 59.4, CH 1.02, m  H-11 --- 
10 36.9, C --- --- --- 
11 22.7, CH2 1.61, m  H-9 --- 
12 39.9, CH2 2.50, m --- --- 
13 148.3, C --- --- --- 
14 52.9, CH 2.47, m --- C-12, 16 
15α 
β 
18.3, CH2 2.50, m 
2.30, m 
H-15β 
H-15α 
C-13, 21 
C-13, 14, 16, 21 
16 100.9, C --- --- --- 
17 164.5, C --- --- --- 
18 99.9, CH 5.90, s H-20 C-16, 19, 20 
19 158.8, C --- --- --- 
20 18.9, CH3 2.10, s H-18 --- 
21 164.7, CO --- --- --- 
22 29.9, CH3 0.92, s --- C-3, 4, 5, 23 
23 15.4, CH3 0.69, s --- C-3, 4, 5, 22 
24 15.8, CH3 0.78, s --- C-1, 5, 9, 10 
25 14.7, CH3 0.71, s --- C-8, 9, 13 
26a 
b 
105.9, CH2 4.82, s 
4.60, s 
H-26b 
H-26a 
C-12, 14 
C-12, 14 
 
Thus, the structure of NL3 was established as the deacetyl analogue of 
NL2, which corresponded to aszonapyrone B (Figure 67), also isolated from 
Eurotium chevalieri (Kanokmedhakul et al., 2011).  
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Table 21. Comparison of the 1H and 13C NMR data (DMSO-d6, 300.13 and 
75.47 MHz) of NL2 and NL3.  
Position NL2  NL3 
 δC, type δH, mult. (J in Hz)  δC, type δH, mult. (J in Hz) 
 
1α 
β 
 
37.6, CH2 
 
1.64, brd (11.2) 
1.00, m 
  
38.1, CH2 
 
1.65, m 
0.95, m 
2 22.9, CH2 1.62, m  27.0, CH2 1.50, m 
3 79.9, CH 4.39, dd (10.1, 5.9)  80.0, CH 3.10, m 
4 37.4, C ---  37.4, C --- 
5 54.7, CH 0.92, d (9.5)  54.8, CH 0.80, m 
6α 
β 
18.4, CH2 1.54, m 
1.40, m 
 18.3, CH2 1.60, m 
1.39, m 
7α 
β 
39.5, CH2 1.85, m 
1.38, m 
 38.7, CH2 1.65, m 
8 37.4, C ---  39.9, C --- 
9 59.1, CH 1.06, d (12.2)  59.4, CH 1.02, m  
10 36.9, C ---  36.9, C --- 
11α 
β 
23.4, CH2 1.24, m  
1.57, m 
 22.7, CH2 1.61, m  
12α 
β 
37.7, CH2 2.50, brs 
1.80, m 
 39.9, CH2 2.50, m 
13 148.3, C ---  148.3, C --- 
14 53.0, CH 2.44, brd (2.9)  52.9, CH 2.47, m 
15α 
β 
18.3, CH2 2.46, dd (14.4, 2.9) 
2.30, d (11.8) 
 18.3, CH2 2.50, m 
2.30, m 
16 101.0, C ---  100.9, C --- 
17 164.7, C ---  164.5, C --- 
18 99.9, CH 5.92, s  99.9, CH 5.90, s 
19 159.5, C ---  158.8, C --- 
20 19.2, CH3 2.11, s  18.9, CH3 2.10, s 
21 164.8, CO ---  164.7, CO --- 
22 27.7, CH3 0.83, s  29.9, CH3 0.92, s 
23 16.0, CH3 0.81, s  15.4, CH3 0.69, s 
24 16.4, CH3 0.80, s  15.8, CH3 0.78, s 
25 14.9, CH3 0.69, s  14.7, CH3 0.71, s 
26a 
b 
106.4, CH2 4.83, s 
4.60, s 
 105.9, CH2 4.82, s 
4.60, s 
Ac-3 170.1, CO 
21.0, CH3 
--- 
2.00, s 
   
OH-17 --- 11.18, brs    
  
Since NL3 was obtained in suitable crystal for the X-ray diffraction, its 
crystal structure was determined. X-ray analysis confirmed the proposed structure 
and the absolute configuration of the stereogenic carbons (C-3S, C-8S and C-
10R) as previously proposed by Kanokmedhakul et al. (2011). The ORTEP view of 
NL3 is shown in Figure 66.     
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Figure 66. ORTEP view of NL3. 
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Figure 67. Structure of aszonapyrone B (NL3). 
 
3.1.5.4. Sartorypyrone C (NP1)  
NP1 was isolated as white solid and its molecular formula C26H38O4 was 
established on the basis of the (+)-HR-ESIMS m/z 415.2836 [M+H]+ (calculated 
415.2848), indicating eight degrees of unsaturation. The IR spectrum showed 
absorption bands for hydroxyl (3445 cm−1), conjugated ester carbonyl (1668 cm−1) 
and olefin (1649, 1636 cm−1) groups. The general features of the 1H and 13C NMR 
spectra of NP1 (Table 22) closely resembled those of NL3. The 13C NMR, DEPT 
and HSQC spectra (Table 22) exhibited the signals of six quaternary sp2 (δC 
164.6, 164.3, 159.3, 136.6, 126.2. 101.4), one methine sp2 (δC 99.9), three 
quaternary sp3 (δC 38.8, 38.4 and 36.8), one oxymethine sp
3 (δC 76.9), two 
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methine sp3 (δC 56.0, 54.8), seven methylene sp
3 (δC 38.0, 37.9, 34.2, 22.1, 21.7, 
18.2, 17.7), and six methyl (δC 28.1, 21.2, 20.3, 19.2, 16.3 and 15.7) carbons. 
However, contrary to the 13C NMR spectrum of NL3, the 13C NMR spectrum of 
NP1 displayed a tetrasubstituted double bond (δC 126.2 and 136.6) and a sp
2 
methyl group (δH 1.55, s; δC 20.3) instead of the exocyclic methylene group. 
The 1H NMR spectrum together with the HSQC spectrum (Table 22), 
displayed the signals of an olefinic proton at δH 5.90, s, methylene protons at δH 
3.02, brs, one oxymethine proton at δH 2.97, m, two methine protons at δH 0.97, 
brd (J = 11.4 Hz) and 0.67, brd (J = 9.6 Hz), and six methyl groups at δH 2.12, s,  
1.55, s, 0.89, s, 0.86, s, 0.77, s, and 0.66, s. 
 
Table 22. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of NP1 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
1 
 
37.9, CH2 
 
1.65, m 
 
H-2 
 
--- 
2 21.7, CH2 1.46, m H-1, 3 --- 
3 76.9, CH 2.97, m H-2 --- 
4 38.4, C --- --- --- 
5 54.8, CH 0.67, brd (9.6) H-6 --- 
6 17.7, CH2 1.35, m H-5, 7 --- 
7 38.0, CH2 1.96, m H-6 --- 
8 38.8, C --- --- --- 
9 56.0, CH 0.97, brd (11.4) H-11 C-24 
10 36.8, C --- --- --- 
11 18.2, CH2 1.46, m H-9, 12 --- 
12 34.2, CH2 1.94, m H-11 --- 
13 126.2, C --- --- --- 
14 136.6, C --- --- --- 
15 22.1, CH2 3.02, brs --- C-8, 13, 14, 16, 17, 21 
16 101.4, C --- --- --- 
17 164.3, C --- --- --- 
18 99.9, CH 5.90, s H-20 C-16, 17, 19, 20 
19 159.3, C --- --- --- 
20 19.2, CH3 2.12, s H-18 C-18, 19 
21 164.6, C --- --- --- 
22 28.1, CH3 0.86, s --- C-3, 4, 5, 23 
23 15.7, CH3 0.66, s --- C-3, 4, 5, 22 
24 16.3, CH3 0.77, s --- C-1, 5, 9, 10 
25 21.2, CH3 0.89, s --- C-8, 9, 14 
26 20.3, CH3 1.55, s --- C-12, 13, 14 
 
The HMBC correlations (Table 22) of the methyl protons at δH 0.86, s (δC 
28.1) and 0.66, s (δC 15.7) to the carbons at δC 76.9, 54.8, 38.4, of the methyl 
protons at δH 0.77, s (δC 16.3) to the carbons at δC 56.0, 54.8, 37.9 and 36.8, and 
of the methyl protons at δH 0.89, s (δC 21.2) to the carbons at δC 136.6, 56.0 and 
38.8, confirmed the presence of the tetramethylperhydrophenanthrene moiety.  
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Moreover, the HMBC cross peaks of the singlet of the methyl protons at δH 1.55 
(δC 20.3) to the tetrasubstituted olefinic carbons at δC 136.6 and 126.2, and the 
methylene carbon at δC 34.2, of the singlet of the methyl protons at δH 0.89 (δC 
21.2) to the olefinic carbon at δC 136.6, of the methylene protons at δH 3.02, brs 
(2H; δC 22.1) to the olefinic carbons at δC 136.6 and 126.2 confirmed the presence 
of the methyl group at C-13 (δC 126.2). 
 
3.02 brs
76.9
34.2
21.2
136.6
126.2
0.89 s
20.3
1.55 s
22.1
3.02 brs
56.0
37.9
16.3
38.4
54.8
0.77 s
15.7
0.66 s
28.1
0.86 s
 
 
 The existence of the same 4-hydroxy-6-methyl-2H-pyran-2-one was 
evidenced by the singlets of the olefinic proton at δH 5.90 and the methyl protons 
at δH 2.12 in the 
1H NMR spectrum as well as by the HMBC cross peaks of the 
singlet at δH 5.90, s (δC 99.9) to the carbons at δC 164.3, 159.3, 101.4, 19.2, and of 
the methyl singlet at δH 2.12 (δC 19.2) to the carbons at δC 159.3 and 99.9. In the 
same manner, the HMBC cross peaks of the broad singlet at δH 3.02 of the 
methylene protons (δC 22.1) to the tetrasubstituted olefinic carbons at δC 136.6 
and 126.2 of the perhydrophenanthrene portion and to the carbons at δC 164.6, 
164.3 and 101.4 of the 4-hydroxy-6-methyl-2H-pyran-2-one portion, confirmed that 
the two portions were connected through this methylene carbon (δC 22.1). 
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3.02 brs3.02 brs
19.2
159.3
99.9
5.90 s
164.6
2.12 s
126.2
136.6
38.8
164.3
101.4
22.1
 
 
 Finally, the stereochemistry of the hydroxyl group on C-3 (δC 76.9) was β as 
supported by the chemical shift value (δC 15.7) of the C-4 axial methyl (CH3-23) 
which suffered a γ-gauche interaction (Mahato and Kundu,1994).  
 Thus the structure of NP1 is established as 3-[[(4aR,4bR,7S,8aR,10aR)-7-
hydroxy-2,4b,8,8,10a-pentamethyl-4,4a,5,6,7,8a,9,10-octahydro-3H-phenanthren-
1-yl]methyl]-4-hydroxy-6-methyl-pyran-2-one. Literature survey revealed that NP1 
is a new analogue of aszonapyrones which we have named sartorypyrone C 
(Figure 68). 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
2223
24 25
26
 
 
Figure 68. Structure of sartorypyrone C (NP1). 
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Terpenoid moieties can be appended to such diverse molecules such as 
ribosomal and non-ribosomal peptides, phenazines, pyrroles, however 
predominantly polyketides, leading to a class of secondary metabolites commonly 
known as meroterpenoids.  
 
2
GPP
b
Acetylation
a
Sartorypyrone A (205)
Aszonapyrone A (NL2)
Sartorypyrone C (NP1)
Chevalone B (NL1)
H2O
Acetylation
a
b
Aszonapyrone B (NL3)
 
Scheme 4. Proposed biosynthetic pathway for sartorypyrone C (NP1), 
aszonapyrones A (NL2) and B (NL3) and chevalone B (NL1). 
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Isolation of the new monocyclic meroditerpene sartorypyrone A (177) from 
the culture of the soil fungus Neosartorya fischeri KUFC 6344, as well as the 
isolation of sartorypyrone B (196) from the marine sponge-associated Neosartorya 
tsunodae KUFC 9213 by our research group (Eamvijarn et al., 2013), allowed the 
establishment of an hypothetical biosynthetic pathway leading to the formation of 
sartorypyrone C (NP1), chevalone B (NL1), and aszonapyrones A (NL2) and B 
(NL3) (Scheme 4). 
Despite the general occurrence of meroterpenenes from higher plants and 
marine organisms, this class of metabolites is most often isolated from fungi (Geris 
and Simpson, 2009). A number of diterpenes containing a α- or β-pyrone ring has 
been reported as a preponderant group of fungal secondary metabolites (Geris 
and Simpson, 2009). The proposed metabolic pathways (Scheme 4) clearly 
evidence the structural similarity of aszonapyrones A (NL2) and B (NL3), 
sartorypyrones A-C (177, 196 and NP1) and chevalones A-C (139-141) (Figure 
69).  
 
NP1
177
196
NL3 R = H
NL2 R = Ac
139 R = H
NL1/140 R = Ac 141  
 
Figure 69. Structures of aszonapyrones A (NL2) and B (NL3), sartorypyrones A-C 
(177, 196 and NP1) and chevalones A-C (139-141). 
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Despite the isolation of aszonapyrone A from a culture of Aspergillus 
zonatus (Kimura et al., 1982) and from Eurotium chevalieri (Kanokmedhakul et al., 
2011), as well as the isolation of chevalones A-C also from E. chevalieri 
(Kanokmedhakul et al., 2011), it is apparent that this subclass of meroditerpenes 
belong to a new extrolite profile from some species of Neosartorya. This finding is 
supported by the isolation of sartorypyrone C from N. paulistensis KUFC 7897 
(Gomes et al., 2014), chevalone B and aszonapyrones A and B from N. laciniosa 
KUFC 7896 (Eamvijarn et al., 2013), as well as by the isolation of sartorypyrone A 
and aszonapyrone A from N. fischeri KUFC 6344, sartorypyrone B from N. 
tsunodae KUFC 9213 (Eamvijarn et al., 2013), and chevalones B and C from N. 
siamensis KUFC 6349 (Gomes et al., 2014). 
 
3.1.6. Structure Elucidation of Quinazolinone Alkaloids 
  
3.1.6.1. 4(3H)-Quinazolinone (NP4)  
NP4 was isolated as colorless crystal. The 13C NMR, DEPT and HSQC 
spectra (Table 23) displayed signals of three quaternary sp2 (δC 160.7, 148.8, 
122.6) and five methine sp2 (δC 145.4, 134.3, 127.2, 126.8, 125.8) carbons.  
The 1H NMR spectrum (Table 23) displayed a broad singlet at δH 12.27, 
apparently belonging to the amine/amide proton, a singlet of an imine proton at δH 
8.10, one double doublet at δH 8.13 (J = 7.7, 1.2 Hz), two double double doublets 
at δH 7.82 (J = 7.7, 7.7, 1.2 Hz) and 7.53 (J = 7.7, 7.7, 1.2 Hz) and one doublet at 
δH 7.67 (J = 7.7 Hz).  
 
Table 23. 1H and 13C NMR data (DMSO-d6, 500.13 and 
125.77 MHz) of NP4. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
2 
 
145.4, CH 
 
8.10, s 
 
--- 
 
--- 
4 160.7, CO --- --- --- 
5 122.6, C --- --- --- 
6 125.8, CH 8.13, dd (7.7, 1.2) H-7 C-4, 8, 10 
7 126.8, CH 7.53, ddd (7.7, 7.7, 1.2) H-6, 8 C-5, 9 
8 134.3, CH 7.82, ddd (7.7, 7.7, 1.2) H-7, 9 C-6, 10 
9 127.2, CH 7.67, d (7.7) H-8 C-5, 7 
10 148.8, C --- --- --- 
NH-3 --- 12.27, brs --- --- 
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 The COSY spectrum (Table 23) displayed correlations between the double 
doublet at δH 8.13 (J = 7.7, 1.2 Hz) and the double double doublet at δH 7.53 (J = 
7.7, 7.7, 1.2 Hz), as well as between the doublet at δH 7.67 (J = 7.7 Hz) and the 
double double doublet at δH 7.82 (J = 7.7, 7.7, 1.2 Hz) indicating an ortho-coupling 
between the two pairs of protons. Furthermore, the two double double doublets at 
δH 7.53 (J = 7.7, 7.7, 1.2 Hz) and 7.82 (J = 7.7, 7.7, 1.2 Hz) were correlated with 
each other, indicating the presence of a 1,2-disubstituted benzene ring. This was 
confirmed by the HMBC cross peaks of the double doublet at δH 8.13 (J = 7.7, 1.2 
Hz; δC 125.8) to the carbons at δC 148.8 and 134.3, of the double double doublet 
at δH 7.53 (J = 7.7, 7.7, 1.2 Hz; δC 126.8) to the carbons at δC 127.2 and 122.6, of 
the double double doublet at δH 7.82 (J = 7.7, 7.7, 1.2 Hz; δC 134.3) to the carbons 
at δC 148.8 and 125.8, and of the doublet at δH 7.67 (J = 7.7 Hz; δC 127.2) to the 
carbons at δC 126.8 and 122.6. 
 
7.82 ddd
(7.7, 7.7, 1.2)
125.8
7.67 d (7.7)
8.13 dd
(7.7, 1.2)
7.53 ddd
(7.7, 7.7, 1.2)
122.6
134.3
126.8
148.8
127.2
 
 
 The HMBC spectrum (Table 23) also revealed the correlation of the 
aromatic proton at δH 8.13, dd (J = 7.7, 1.2 Hz; δC 125.8) to the quaternary sp
2 
carbon at δC 160.7.  
 
145.4
12.27 brs
8.10 s
8.13 dd
(7.7, 1.2)
160.7
125.8
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Taking altogether the 1H and 13C NMR data, the structure of NP4 was 
proposed as 4(3H)-quinazolinone (Figure 70). The structure was confirmed by 
comparison of its 1H and 13C NMR data with those provided by NMR Shift 
Database website (http://nmrshiftdb.nmr.uni-koeln.de/portal/js_pane/P-
Results/nmrshiftdbaction/showDetailsFromHome/molNumber/20050524;jsessionid
=B74F40CF04748F5C14DE27712653152A?&tab=1_0#spectrum20096536 
accessed on 11th March 2013). Literature survey revealed that NP4 is a new 
natural product. However, its derivatives have been widely reported from various 
biological sources (Mhaske and Argade, 2006)  
 
1
2
3
4
5
6
7
8
9
10
 
 
Figure 70. Structure of 4(3H)-quinazolinone (NP4). 
 
3.1.6.2. 3’- (4-Oxoquinazolin-3-yl) spiro [1H-indole-3,5’-
oxolane] - 2,2’-dione (NP5/NL5)  
NP5/NL5 was isolated as white solid  and its molecular formula C19H13N3O4 
was established based on the (+)-HR-ESIMS m/z 348.0968 [M+H]+ peak, 
indicating fifteen degrees of unsaturation. The 13C NMR, DEPT and HSQC spectra 
(Table 24) revealed the presence of seven quaternary sp2 (δC 175.4, 171.9, 159.8, 
147.8, 142.7, 126.4, 121.4), nine methine sp2 (δC 147.8, 135.1, 131.6, 127.7, 
127.4, 126.1, 125.3, 123.1, 110.7), one quaternary sp3 (δC 80.9), one methine sp
3 
(δC 56.5) and one methylene sp
3 (δC 33.4) carbon. 
The 1H NMR spectrum (Table 24) displayed signals for eight aromatic 
protons at δH 8.23, d (J = 7.6 Hz), 7.92, dd (J = 7.6, 7.6 Hz), 7.76, d (J = 7.6 Hz), 
7.66, d (J = 7.6 Hz), 7.63, dd (J = 7.6, 7.6 Hz), 7.41, dd (J = 7.6, 7.6 Hz), 7.18, dd 
(J = 7.6, 7.6 Hz) and 6.96, d (J = 7.6 Hz), suggesting the existence of two aromatic 
rings. The COSY spectrum (Table 24) exhibited cross peaks of the doublet at δH 
7.66 (J = 7.6 Hz) to the double doublet at δH 7.18 (J = 7.6, 7.6 Hz) and of the 
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doublet at δH 6.96 (J = 7.6 Hz) to the double doublet at δH 7.41 (J = 7.6, 7.6 Hz), 
as well as between the double doublets at δH 7.18 (J = 7.6, 7.6 Hz) and 7.41 (J = 
7.6, 7.6 Hz) indicating the presence of a 1,2-disubstituted benzene ring.  
 
Table 24. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of 
NP5/NL5. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
2 
 
175.4, CO 
 
--- 
 
--- 
 
--- 
3 80.9, C --- --- --- 
3a 126.4, C --- --- --- 
4 125.3, CH 7.66, d (7.6) H-5 C-3, 6, 7a 
5 123.1, CH 7.18, dd (7.6, 7.6) H-4, 6 C-3a, 7 
6 131.6, CH 7.41, dd (7.6, 7.6) H-5, 7 C-7a, 4 
7 110.7, CH 6.96, d (7.6) H-6 C-3a, 5 
7a 142.7, C --- --- --- 
2’ 171.9, CO --- --- --- 
3’ 56.5, CH 5.67, t (10.0) H-4’ C-2’, 2’’,4’, 4’’  
4’ 33.4, CH2 3.01, d (10.0) H-3’ C-2, 2’, 3, 3a, 3’   
2’’ 147.8, CH 8.63, s --- C-3’, 4’’, 8’’a  
4’’ 159.8, CO --- --- --- 
4’’a 121.4, C --- --- --- 
5’’ 126.1, CH 8.23, d (7.6) H-6’’ C-4’’, 7’’, 8’’a  
6’’ 127.7, CH 7.63, dd (7.6, 7.6) H-5’’, 7’’ C-4’’a, 8’’ 
7’’ 135.1, CH 7.92, dd (7.6, 7.6) H-6’’, 8’’ C-5’’, 8’’a  
8’’ 127.4, CH 7.76, d (7.6) H-7’’ C-4’’a, 6’’, 8’’a  
8’’a 147.7, C --- --- --- 
NH-1  10.92, s --- C-2, 3, 3a, 7a  
 
This was confirmed by the HMBC cross peaks of the doublet at δH 7.66 (J = 
7.6 Hz; δC 125.3) to the carbon at 142.7, and of the doublet at δH 6.96 (J = 7.6 Hz; 
δC 110.7) to the quaternary sp
2 carbon at δC 126.4. Moreover, the HMBC spectrum 
(Table 24) also showed cross peaks of the singlet at δH 10.92, which showed no 
HSQC correlation, to the quaternary carbons of the aromatic ring at  δC 126.4 and 
142.7, as well as to the oxygen bearing quaternary sp3 carbon at δC 80.9 and the 
carbonyl carbon at δC 175.4, suggesting that the 1,2-disubstituted benzene ring 
was part of a 3-disubstituted 1H-indolin-2-one portion. This was also supported by 
the HMBC correlation between the aromatic proton at δH 7.66 (J = 7.6 Hz; δC 
125.3) to the oxyquaternary carbon at δC 80.9. 
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126.4
7.18 dd
(7.6, 7.6)
7.66 d (7.6)
80.9
10.92 s
6.96 d (7.6)
7.41 dd
(7.6, 7.6)
131.6
123.1
125.3
175.4
142.7
110.7
 
 
The COSY spectrum also showed another coupling system consisting of 
the triplet at δH 5.67 (J = 10.0 Hz, δC 56.5) and the doublet at δH 3.01 (2H, J = 10.0 
Hz, δC 33.4). Further analysis of the HMBC spectrum revealed cross peaks of the 
doublet at δH 3.01 (2H, J = 10.0 Hz; δC 33.4) to the carbonyl carbon at δC 175.4, 
the aromatic carbon at δC 126.4 and the oxyquaternary carbon at δC 80.9 of the 
indolinone fragment, as well as of the triplet of the methine proton δH 5.67 (J = 
10.0 Hz; δC 56.5) to the carbonyl carbon at δC 171.9 and the methylene carbon at 
δC 33.4. These correlations suggested the attachment of a spirolactone ring at C-3 
(δC 80.9) of the indolinone ring.  
 
3.01 d (10.0)
171.9
175.4
3.01 d (10.0)
5.67 t (10.0)
126.4
80.9
56.5
33.4
 
 
Another portion of the molecule also consists of the 1,2-disubstituted 
benzene ring which was evidenced by the cross peaks of the doublet at δH 8.23 (J 
= 7.6 Hz) to the double doublet at δH 7.63 (J = 7.6, 7.6 Hz), of the doublet at δH 
7.76 (J = 7.6 Hz) to the double doublet at δH 7.92 (J = 7.6, 7.6 Hz), as well as 
between the double doublets at δH 7.63 (J = 7.6, 7.6 Hz) and δH 7.92 (J = 7.6, 7.6 
Hz) in the COSY spectrum. Moreover, the HMBC cross peaks of the doublet at δH 
8.23 (J = 7.6 Hz; δC 126.1) to the quaternary sp
2 carbons at δC 159.8 and 147.7, of 
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the doublet at δH 7.76 (J = 7.6 Hz; δC 127.4) to the quaternary sp
2 carbons at δC 
147.7 and 121.4, as well as of the singlet at δH 8.63 (δC 147.8) to the carbons at δC 
159.8 and 147.7, suggested that the 1,2-disubstituted benzene ring was part of a 
N-substituted quinazolin-4-one fragment. 
 
147.8
7.76 d (7.6)
8.63 s
147.7
8.23 d (7.6)
7.63 dd 
(7.6, 7.6)
7.92 dd 
(7.6, 7.6)
126.1
121.4
159.8
127.4
135.1
127.7
 
 
That the spiro[indoline-3,5’-tetrahydrofuran]-2,2’-dione fragment was 
connected to the quinazolin-4-one moiety through the methine carbon at δC 56.5 of 
the former and the amide nitrogen atom of the latter, was substantiated by the 
HMBC cross peaks of the triplet of the methine proton at δH 5.67 (J = 10.0 Hz; δC 
56.5) to the carbons at δC 159.8 and 147.8 from the quinazolinone moiety, as well 
as of the singlet of methine proton at δH 8.63, s (δC 147.8) to the methine carbon at 
δC 56.5.  
 
8.63 s
159.8
5.67 t (10.0)
147.8
56.5
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Thus, the structure of NP5/NL5 was established as 3’-(4-oxoquinazolin-3-
yl)spiro[1H-indole-3,5’-oxolane]-2, 2’-dione (Figure 71). Furthermore, the NOESY 
spectrum displayed a correlation between the signals of the methine proton at δH 
5.67, t (J = 10.0 Hz; δC 56.5) and the imine proton at δH 8.63, s (δC 147.8). 
 
1
2
3
3a
4
5
6
7
7a
1'
2'
3'
4'
3''
4''
4''a 5''
6''
7''8''
8''a
1''
2''
 
 
Figure 71. Structure of 3’-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5’-oxolane]-2, 2’-
dione (NP5/NL5). 
  
The 1H and 13C NMR and other physical data including the optical rotation 
of NP5/NL5 ([α]20D = +19.7) were in agreement with those reported for 3’-(4-
oxoquinazolin-3-yl) spiro [1H-indole-3,5’-oxolane]- 2,2’-dione, the 
indoloquinazolinone alkaloid previously isolated from  the soil fungus Neosartorya 
siamensis KUFC 6349 by Buttachon et al. (2012).  
 
3.1.6.3. Tryptoquivaline L (NP2/NL4) 
NP2/NL4 was isolated as colorless crystal and exhibited the (+)-HR-ESIMS 
[M+H]+ peak at m/z 433.1509 corresponding to C23H21N4O5, indicating sixteen 
degrees of unsaturation.  The 13C NMR, DEPT and HSQC spectra (Table 25) 
revealed the presence of seven quaternary sp2 (δC 171.3, 170.8, 159.8, 147.6, 
138.3, 132.4, 121.4), nine methine sp2 (δC 147.6, 135.1, 131.8, 127.7, 127.4, 
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126.2, 126.1, 125.4, 114.8), four quaternary sp2 (δC 147.6, 138.3, 132.4, 121.4), 
two methine sp3 (δC 86.2, 56.9), two quaternary sp
3 (δC 83.5, 70.4), one methylene 
sp3 (δC 34.5) and two methyl (δC 22.8, 16.4) carbons. 
 
Table 25. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of 
NP2/NL4. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
2 
 
86.2, CH 
 
5.25, s 
 
--- 
 
C-3,13, 14, 15 
3 83.5, C --- --- --- 
4 132.4, C --- --- --- 
5 126.1, CH 7.83, d (7.3) H-6 C-7, 9 
6 125.4, CH 7.36, ddd (7.3, 7.3, 1.1) H-5, 7 C-4, 8 
7 131.8, CH 7.54, dd (7.3, 7.3) H-6, 8 C-5, 9 
8 114.8, CH 7.51, d (7.3) H-7 C-4, 6 
9 138.3, C --- --- --- 
11 170.8, CO --- --- --- 
12 56.9, CH 5.59, t (10.0) H-13α, 13β C-11, 13, 18, 26 
13α 
β 
34.5, CH2 3.07, dd (13.1, 9.3) 
3.45, dd (13.1, 11.9) 
H-12, 13β 
H-12, 13α 
C-2, 11, 12 
C-2, 3, 4, 12 
14 171.3, CO --- --- --- 
15 70.4, C --- --- --- 
18 159.8, CO --- --- --- 
19 121.4, C --- --- --- 
20 126.2, CH 8.25, d (7.7) H-21, 22 C-18, 22, 24 
21 127.7, CH 7.64, dd (7.7, 7.7) H-20, 22 C-19, 23 
22 135.1, CH 7.93, ddd (7.7, 7.7, 1.2) H-20, 21, 23 C-20, 24 
23 127.4, CH 7.77, d (7.7) H-22 C-19, 21 
24 147.6, C --- --- --- 
26 147.6, CH 8.57, s --- C-12, 18, 19, 24  
27 16.4, CH3 1.36, s --- C-14, 15, 28 
28 22.8, CH3 1.26, s --- C-14, 15, 27 
OH --- 8.81, s --- C-2, 15 
 
The 1H NMR spectrum (Table 25) was similar to that of NP5/NL5 exhibiting 
the signals of eight aromatic protons at δH 8.25, d (J = 7.7 Hz), 7.93, ddd (J = 7.7, 
7.7, 1.2 Hz), 7.83, d (J = 7.3 Hz), 7.77, d (J = 7.7 Hz), 7.64, dd (J = 7.7, 7.7 Hz), 
7.36, ddd (J = 7.3, 7.3, 1.1 Hz), 7.54, dd (J = 7.3, 7.3 Hz) and 7.51, d (J = 7.3 Hz), 
a triplet of one methine proton at δH 5.59 (J = 10.0 Hz) and a singlet of one 
methine proton at δH 5.25, two methylene protons at δH 3.45, dd (J = 13.1, 11.9 
Hz) and 3.07, dd (J = 13.1, 9.3 Hz), a singlet of the imine proton at δH 8.57, 
besides a singlet of the hydroxyl/amine proton at δH 8.81, and two methyl singlets 
at δH 1.36 and 1.26. 
Like NP5/NL5, the presence of a 1,2-disubstituted benzene ring was 
evidenced by the COSY cross peaks of the doublet at δH 7.83 (J = 7.3 Hz) to the 
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double double doublet at δH 7.36 (J = 7.3, 7.3, 1.1 Hz), of the doublet at δH 7.51 (J 
= 7.3 Hz) to the double doublet at δH 7.54 (J = 7.3, 7.3 Hz), and also by the double 
double doublet at δH 7.36 (J = 7.3, 7.3, 1.1 Hz) and the double doublet at 7.54 (J = 
7.3, 7.3 Hz) . Additionally, the HMBC cross peaks of the doublet at δH 7.83 (J = 7.3 
Hz; δC 126.1) to the quaternary sp
2 carbon at δC 138.3, the double double doublet 
at δH 7.36 (J = 7.3, 7.3, 1.1 Hz; δC 125.4) to the quaternary sp
2 carbon at δC 132.4, 
the double doublet at δH 7.54 (J = 7.3, 7.3 Hz; δC 131.8) to the quaternary sp
2 
carbon at δC 138.3, the doublet at δH 7.51 (J = 7.3 Hz; δC 114.8) to the quaternary 
sp2 carbon at δC 132.4, confirmed the presence of the 1,2-disubstituted benzene 
ring. Since the singlet at δH 5.25 (δC 86.2) gave cross peak to the oxyquaternary 
sp3 carbon at δC 83.5, the presence of a 2,3-dihydro-1H-indole was suggested. 
 
83.5
7.36 ddd 
(7.3, 7.3, 1.1)
7.83 d (7.3)
86.2
5.25 s
7.51 d (7.3)
7.54 dd
(7.3, 7.3)
131.8
125.4
126.1
132.4
138.3
114.8
 
 
Similar to NP5/NL5, the COSY spectrum showed the coupling of the 
methylene protons at δH 3.07, dd (J = 13.1, 9.3 Hz) and 3.45, dd (J = 13.1, 11.9 
Hz) to the methine proton at δH 5.59, t (J = 10.0 Hz), suggesting the existence of a 
five-membered spirolactone substituent at C-3 (δC 83.5). This was confirmed by 
the HMBC correlations of the methine proton at δH 5.25, s (δC 86.2) to the 
methylene carbon at δC 34.5 and the quaternary sp
2 carbon at δC 171.3, of the 
methylene proton at δH 3.45, dd (J = 13.1, 11.9 Hz; δC 34.5) to the carbons at δC 
83.5, 86.2 and 132.4 of the indole moiety, and the methine sp3 carbon at δC 56.9, 
of the methylene proton at δH 3.07, dd (J = 13.1, 9.3 Hz; δC 34.5) to the methine 
carbon at 86.2 of the indole moiety, the methine sp3 carbon at δC 56.9, and the 
carbonyl carbon at δC 170.8, as well as of the methine proton at δH 5.59, t (J = 
10.0 Hz; δC 56.9) to the methylene carbon at δC 34.5 and the carbonyl carbon at 
δC 170.8. 
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3.45 dd (13.1, 11.9)
5.59 t (10.0)
3.07 dd (13.1, 9.3)
5.25 s
132.4
170.8
83.5
34.5
86.2
56.9
 
 
Further analysis of the HMBC spectrum revealed that the singlet at δH 5.25 
(δC 86.2) of the 2,3-dihydro-1H-indole portion also gave cross peaks to the 
quaternary carbon at δC 70.4 and the carbonyl carbon at δC 171.3, while the two 
methyl singlets at δH 1.26 (δC 22.8) and δH 1.36 (δC 16.4) also gave cross peaks to 
the quaternary carbon at δC 70.4 and the carbonyl carbon at δC 171.3. These 
correlations led to the conclusion that the carbonyl carbon at δC 171.3 was 
connected to the nitrogen of the indole ring and thus suggesting the presence of a 
6-5-5-gem-dimethylimidazoindolone ring. Moreover, since the singlet at δH 8.81 
gave cross peaks to the quaternary carbon at δC 70.4 and the methine carbon at 
δC 86.2, the hydroxyl group was placed on the nitrogen of the imidazolone ring.  
 
8.81 s
1.36 s
171.3
5.25 s
16.4
70.4
86.2
1.26 s
22.8
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That the aromatic protons at δH 8.25, d (J = 7.7 Hz), 7.64, dd (J = 7.7, 7.7 
Hz), 7.93, ddd (J = 7.7, 7.7, 1.2 Hz) and 7.77, d (J = 7.7 Hz) belonged to another 
1,2-disubstituted benzene ring was supported by the cross peaks between the 
doublet at δH 8.25 (J = 7.7 Hz) and the double doublet at δH 7.64 (J = 7.7, 7.7 Hz), 
between the doublet at δH 7.77 (J = 7.7 Hz) and the double double doublet at δH 
7.93 (J = 7.7, 7.7, 1.2 Hz) as well as the cross peaks between the double doublet 
at δH 7.64 (J = 7.7, 7.7 Hz) and the double double doublet at δH 7.93 (J = 7.7, 7.7, 
1.2 Hz) observed in the COSY spectrum. This was confirmed by the HMBC cross 
peaks of the double doublet at δH 7.64 (J = 7.7, 7.7 Hz; δC 127.7) to the quaternary 
sp2 carbon at δC 121.4, and of the double double doublet at δH 7.93 (J = 7.7, 7.7, 
1.2 Hz; δC 135.1) to the quaternary sp
2 carbon at δC 147.6. Since the doublet at δH 
8.25 (J = 7.7 Hz; δC 126.2) and the singlet at δH 8.57 (δC 147.6) showed HMBC 
cross peaks to the quaternary sp2 carbons at δC 159.8 and 147.6, the second 1,2-
disubstituted benzene ring was part of a N-substituted quinazolin-4-one moiety. 
 
8.25 d (7.7)
7.93 ddd
(7.7, 7.7, 1.2)
7.64 dd 
(7.7, 7.7)
126.28.57 s
7.77 d (7.7)
147.6
127.7
159.8
121.4
147.6
127.4
135.1
 
 
That the quinazolinone moiety was connected to the 6-5-5-gem-
dimethylimidazoindolone ring system via the five-membered spirolactone was 
evidenced by the HMBC correlations of the methine proton at δH 5.59, t (J = 10.0 
Hz; δC 56.9) to the carbonyl carbon at δC 159.8 and the methine sp
2 carbon at δC 
147.6 of the quinazolinone ring, as well as of the imine proton at δH 8.57, s (δC 
147.6) to the methine sp3 carbon at δC 56.9 of the spirolactone ring. 
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56.9
8.57 s
5.59 t (10.0)
159.8
147.6
 
 
 In order to determine the stereochemistry of NP2/NL4, the NOESY 
experiment was carried out. The NOESY spectrum exhibited correlations between 
the signals of the singlet at δH 5.25 and the signals of the protons at δH 8.81, s (N-
OH), 3.07, dd (J = 13.1, 9.3 Hz), and 1.36, s, as well as between the signals of the 
imine proton at δH 8.57, s and the proton at δH 5.59, t (J = 10.0 Hz), indicating that 
the methine proton at δH 5.25, s and the methyl protons at δH 1.36, s are on the 
same side, and that the methine proton at δH 5.25, s is β-oriented.  
The 1H and 13C NMR data and the optical rotation of NP2/NL4 ([α]20D = -
30.5) were in agreement with those of tryptoquivaline L (Figure 72) previously 
reported from Neosartorya siamensis KUFC 6349 (Buttachon et al., 2012). 
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Figure 72. Structure of tryptoquivaline L (NP2/NL4). 
 
3.1.6.4. Tryptoquivaline H (NP3) 
NP3 was also isolated as white solid  and its molecular formula C22H18N4O5 
was established on the basis of the (+)-HR-ESIMS m/z 419.13496 [M+H]+, 
indicating sixteen degrees of unsaturation. The general features of the 1H and 13C 
NMR spectra (Table 26) of NP3 were very similar to those of NP2/NL4.  
The 13C NMR, DEPT and HSQC spectra (Table 26) displayed signals of 
seven quaternary sp2 (δC 170.6, 169.9, 159.8, 147.5, 138.2, 132.4, 121.4), nine 
methine sp2 (δC 147.6, 135.1, 131.9, 127.6, 127.4, 126.1, 126.0, 125.5, 114.9), 
three methine sp3 (δC 88.6, 67.3, 56.9), one quaternary sp
3 (δC 83.7), one 
methylene sp3 (δC 33.8) and one methyl (δC 10.6) carbon.  
 The 1H NMR spectrum, in conjunction with the HSQC spectra (Table 26), 
displayed two singlets of one proton each at δH 8.79 and δH 8.55, besides the 
signals of eight aromatic protons at δH 8.24, dd (J = 7.7, 1.3 Hz), 7.93, ddd (J = 
7.7, 7.7, 1.3 Hz), 7.81, d (J = 7.5 Hz), 7.77, d (J = 7.7 Hz), 7.64, dd (J = 7.7, 7.7 
Hz), 7.54, ddd (J = 7.5, 7.5, 1.0 Hz), 7.51, d (J = 7.5 Hz) and 7.37, ddd (J = 7.5, 
7.5, 1.0 Hz), three methine protons at δH 5.58, t (J = 10.0 Hz), 5.43, s and 4.01, q 
(J = 7.0 Hz), two methylene protons at δH 3.46, dd (J = 13.1, 11.0 Hz) and 3.04, dd 
(J = 13.1, 9.3 Hz), and one methyl doublet at δH 1.44 (J = 7.1 Hz).    
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Table 26. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of NP3. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
2 
 
88.6, CH 
 
5.43, s 
 
--- 
 
C-3,13, 14, 15 
3 83.7, C --- --- --- 
4 132.4, C --- --- --- 
5 126.0, CH 7.81, d (7.5) H-6 C-3, 7, 9 
6 125.5, CH 7.37, ddd (7.5, 7.5, 1.0) H-5, 7 C-4, 8 
7 131.9, CH 7.54, ddd (7.5, 7.5, 1.0) H-6, 8 C-5, 9 
8 114.9, CH 7.51, d (7.5) H-7 C-4, 6 
9 138.2, C --- --- --- 
11 170.6, CO --- --- --- 
12 56.9, CH 5.58, t (10.0) H-13α, 13β C-3, 11, 18, 26 
13α 
β 
33.8, CH2 3.04, dd (13.1, 9.3) 
3.46, dd (13.1, 11.0) 
H-12, 13β 
H-12, 13α 
C-2, 4, 11 
C-2, 3, 4, 12 
14 169.9, CO --- --- --- 
15 67.3, CH 4.01, q (7.0) H-27 C-2, 14, 27 
18 159.8, CO --- --- --- 
19 121.4, C --- --- --- 
20 126.1, CH 8.24, dd (7.7, 1.3) H-21 C-18, 22, 24 
21 127.6, CH 7.64, dd (7.7, 7.7) H-20, 22 C-19, 23 
22 135.1, CH 7.93, ddd (7.7, 7.7, 1.3) H-21, 23 C-20, 24 
23 127.4, CH 7.77, d (7.7) H-22 C-19, 21 
24 147.5, C --- --- --- 
26 147.6, CH 8.55, s --- C-12, 18, 19, 24  
27 10.6, CH3 1.44, d (7.1) H-15 C-14, 15 
OH --- 8.79, s --- C-2, 15 
 
 The presence of the 2,3-dihydro-1H-indole ring system connected to the 
spirolactone ring on C-3, as was in NP2/NL4, was confirmed by the cross peaks of 
the double double doublet at δH 7.37 (J = 7.5, 7.5, 1.0 Hz; δC 125.5) to the doublet 
at δH 7.81 (J = 7.5 Hz; δC 126.0) and the double double doublet at δH 7.54 (J = 7.5, 
7.5, 1.0 Hz; δC 131.9), of the doublet at δH 7.51 (J = 7.5 Hz; δC 114.9) to the 
double double doublet at δH 7.54 (J = 7.5, 7.5, 1.0 Hz; δC 131.9), and of the triplet 
at δH 5.58 (J = 10.0 Hz; δC 56.9) to the two double doublets of the methylene 
protons at δH 3.04 (J = 13.1, 9.3 Hz; δC 33.8) and 3.46 (J = 13.1, 11.0 Hz; δC 33.8) 
in the COSY spectrum (Table 26), as well as by the HMBC cross peaks of the 
singlet at δH 5.43 (δC 88.6) to the carbons at δC 83.7 and 33.8, of the triplet at δH 
5.58 (J = 10.0 Hz; δC 56.9) to the carbons at δC 83.7 and 170.6, and of the double 
doublets δH 3.46 (J = 13.1, 11.0 Hz; δC 33.8) and 3.04 (J = 13.1, 9.3 Hz; δC 33.8) 
to the carbons at δC 83.7, 88.6, 56.9 and 170.6. 
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7.37 ddd
(7.5, 7.5, 1.0)
132.4
5.43 s
7.81 d (7.5)
114.9
3.04 dd (13.1, 9.3)
7.54 ddd
(7.5, 7.5, 1.0)
7.51 d (7.5)
5.58 t (10.0)
138.2
3.46 dd (13.1, 11.0)
131.9
88.6
125.5
126.0
83.7
170.6
56.9
33.8
 
 
 The presence of the 6-5-5-methylimidazoindoline ring system was based on 
the cross peaks between the methyl doublet at δH 1.44 (J = 7.1 Hz) and the 
methine quartet at δH 4.01 (J = 7.0 Hz), in the COSY spectrum, as well as by the 
HMBC cross peaks of the methyl doublet at δH 1.44 (J = 7.1 Hz; δC 10.6) to the 
methine carbon at δC 67.3 and the carbonyl carbon at δC 169.9, of the methine 
quartet at δH 4.01 (J = 7.0 Hz; δC 67.3) to the methine carbon at δC 88.6, the 
carbonyl carbon at δC 169.9 and the methyl carbon at δC 10.6, as well as of the 
methine singlet at δH 5.43 (δC 88.6) to the carbonyl carbon at δC 169.9 and the 
methine carbon at δC 67.3. Since the HMBC spectrum showed cross peaks of the 
singlet at δH 8.79 to the methine sp
3 carbons at δC 88.6 and 67.3, the hydroxyl 
group (δH 8.79, s) was on the nitrogen of the imidazolone ring.   
 
1.44 d (7.1)
5.43 s
8.79 s
4.01 q (7.0)169.9
88.6
10.6
67.3
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 The COSY spectrum also displayed cross peaks for the aromatic protons at 
δH 8.24, dd (J = 7.7, 1.3 Hz), 7.93, ddd (J = 7.7, 7.7, 1.3 Hz), 7.77, d (J = 7.7 Hz) 
and 7.64, dd (J = 7.7, 7.7 Hz), evidencing the coupling system of another 1,2-
disubstituted benzene ring. Analogously to NP2/NL4 and NP5/NL5, the HMBC 
cross peaks of the double doublet at δH 8.24 (J = 7.7, 1.3 Hz; δC 126.1) to the 
quaternary sp2 carbons at δC 159.8 and 147.5, of the doublet at δH 7.77 (J = 7.7 
Hz; δC 127.4) to the quaternary sp
2 carbon at δC 121.4, as well as of the singlet of 
the methine proton at δH 8.55 (δC 147.6) to the quaternary sp
2 carbons at δC 
159.8, 147.5 and 121.4, provided an unequivocal evidence of the existence of the 
N-substituted quinazolin-4-one ring system. 
 
. 
147.6
8.24 dd
(7.7, 1.3)
8.55 s
127.4
7.77 d (7.7)
7.93 ddd
(7.7, 7.7, 1.3)
7.64 dd
(7.7, 7.7)
121.4
159.8
147.5
135.1
127.6
126.1
 
 
As in NP2/NL4, the 6-5-5-methylimidazoindoline ring system was 
connected to the quinazolinone moiety through the methine carbon at δC 56.9 of 
the five-membered spirolactone ring and the amide nitrogen of the quinazolinone 
ring, as evidenced by the HMBC cross peaks of the triplet at δH 5.58, t (J = 10.0 
Hz; δC 56.9) to the imine carbon at δC 147.6 and the carbonyl carbon at δC 159.8. 
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8.55 s
147.6
5.58 t (10.0)
159.8
56.9
 
 
 Since the NOESY spectrum exhibited the correlation between the methine 
proton at δH 5.43, s (δC 88.6) and the methyl protons at δH 1.44, d (J = 7.1 Hz; δC 
10.6), the methyl group and this methine proton are on the same side of the 
imidazoindolone moiety. 
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Figure 73. Structure of tryptoquivaline H (NP3). 
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 Thus, the structure corresponds to that of tryptoquivaline H (Figure 73), a 
tryptoquivaline analogue previously reported from Neosartorya siamensis KUFC 
6349 (Buttachon et al., 2012). 
 
3.1.6.5. Tryptoquivaline F (NP6) 
NP6 was also isolated as white solid, and its molecular formula C22H18N4O4, 
established on the basis of the (+)-HR-ESIMS m/z 403.1399 [M+H]+, was 16 amu 
less than that of NP3, implying that its molecular formula is one oxygen atom less 
that of NP3. Analysis of the 1H, 13C NMR, COSY, HSQC, and HMBC spectra 
(Table 27) revealed a close similarity between the structures of NP6 and NP3. The 
13C NMR, DEPT and HSQC spectra (Table 27) displayed signals of seven 
quaternary sp2 (δC 176.9, 170.8, 159.7, 147.6, 140.9, 131.9, 121.4), nine methine 
sp2 (δC 147.6, 135.1, 131.7, 127.7, 127.4, 126.2, 126.0, 125.5, 117.1), one 
quaternary sp3 (δC 86.3), three methine sp
3 (δC 84.6, 59.5, 57.0), one methylene 
sp3 (δC 31.0) and one methyl (δC 17.6) carbon.  
The 1H NMR spectrum (Table 27) displayed the signals of eight aromatic 
protons at δH 8.22, d (J = 7.7 Hz), 7.90, dd (J = 7.7, 7.7 Hz), 7.76, d (J = 7.7 Hz), 
7.69, d (J = 7.5 Hz), 7.63, dd (J = 7.7, 7.7 Hz), 7.57, dd (J = 7.5, 7.5 Hz), 7.47, d (J 
= 7.5 Hz) and 7.39, dd (J = 7.5, 7.5 Hz), and the COSY spectrum (Table 27) 
revealed the coupling systems of two 1,2-disubstituted benzene rings as in 
NP2/NL4 and NP3. Like NP3, the 1H NMR spectrum (Table 27) showed a singlet 
of the olefinic proton at δH 8.55, a triplet and a doublet of the methine protons at δH 
5.66 (J = 9.7 Hz) and 5.50 (J = 8.5 Hz) respectively, a multiplet and a double 
doublet of the methylene protons at δH 3.44 and 2.88 (J = 12.0, 9.4 Hz) 
respectively, the quartet of the methine proton at δH 3.63 (J = 6.6 Hz) and the 
doublet of the methyl protons at δH 1.39 (J = 6.8 Hz). However, the triplet at δH 
3.90 (J = 7.0 Hz), which did not show any HSQC correlation, was present instead 
of the singlet of the N-OH proton (δH 8.79). 
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Table 27. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of NP6. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
2 
 
84.6, CH 
 
5.50, d (8.5) 
 
--- 
 
C-3, 14 
3 86.3, C --- --- --- 
4 131.9, C --- --- --- 
5 125.5, CH 7.69, d (7.5) H-6 C-3, 7, 9 
6 126.0, CH 7.39, dd (7.5, 7.5) H-5, 7 C-4, 8 
7 131.7, CH 7.57, dd (7.5, 7.5) H-6, 8 C-5, 9 
8 117.1, CH 7.47, d (7.5) H-7 C-4, 6 
9 140.9, C --- --- --- 
11 170.8, CO --- --- --- 
12 57.0, CH 5.66, t (9.7) H-13α, 13β C-11, 18 
13α 
β 
31.0, CH2 2.88, dd (12.0, 9.4) 
3.44, m 
H-12, 13β 
H-12, 13α 
C-11 
--- 
14 176.9, CO --- --- --- 
15 59.5, CH 3.63, q (6.6) NH, H-27 --- 
18 159.7, CO --- --- --- 
19 121.4, C --- --- --- 
20 126.2, CH 8.22, d (7.7) H-21 C-18, 22, 24 
21 127.7, CH 7.63, dd (7.7, 7.7) H-20, 22 C-19, 23 
22 135.1, CH 7.90, dd (7.7, 7.7) H-21, 23 C-20, 24 
23 127.4, CH 7.76, d (7.7) H-22 C-19, 21 
24 147.6, C --- --- --- 
26 147.6, CH 8.55, s --- C-12, 18, 24  
27 17.6, CH3 1.39, d (6.8) H-15 C-14, 15 
NH --- 3.90, t (7.0) H-2, 15 --- 
 
 While the HMBC correlations of the aromatic proton at δH 7.69, d (J = 7.5; 
δC 125.5) to the quaternary carbons at δC 140.9 and 86.3, the aromatic proton at 
δH 7.47, d (J = 7.5 Hz; δC 117.1) to the quaternary sp
2 carbon at δC 131.9, and the 
methine proton at δH 5.50, d (J = 8.5 Hz; δC 84.6) to the quaternary sp
3 carbon at 
δC 86.3 indicated that one of the 1,2-disubstituted benzene rings was part of a 2,3-
dihydro-1H-indole moiety (A), the HMBC correlations between the aromatic proton 
at δH 8.22, (J = 7.7 Hz; δC 126.2) and the quaternary sp
2 carbons at δC 159.7 and 
147.6, the aromatic proton at δH 7.76, d (J = 7.7 Hz; δC 127.4) and the quaternary 
sp2 carbon at δC 121.4, and between the methine proton at δH 8.55, s (δC 147.6) 
and the quaternary sp2 carbons at δC 159.7 and 147.6, revealed the existence of 
the N-substituted quinazolin-4-one ring (B), as in NP2/NL4 and NP3. 
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A
86.3
B
8.55 s
147.6
7.69 d (7.5)
8.22 d (7.7)
117.1
127.4
5.50 d (8.5)
7.76 d (7.7)
7.47 d (7.5)
131.9
140.9
84.6
121.4
159.7
147.6
125.5
126.2
 
 
 The HMBC cross peaks (C) of the methine proton at δH 5.50, d (J = 8.5 Hz; 
δC 84.6) to the amide carbonyl at δC 176.9, and of the methyl protons at δH 1.39, d 
(J = 6.8 Hz; δC 17.6) to the carbonyl carbon at δC 176.9 and the methine carbon at 
δC 59.5 confirmed the presence of the 6-5-5-methylimidazoindolone ring. The 
COSY spectrum displayed correlations (D) between the proton at δH 3.90, t (J = 
7.0 Hz) and the methine protons at δH 5.50, d (J = 8.5 Hz) and 3.63, q (J = 6.6 Hz), 
suggesting that the N16-OH group of NP2/NL4 and NP3 was replaced by N16-H 
in NP6. 
 
C D
5.50 d (8.5)
3.90 d (7.0)
3.63 q (6.6)
84.6
1.39 d (6.8)
5.50 d (8.5)
59.53.63 q (6.6)176.9
84.6
17.6
59.5
 
 
 The connection of the imidazoindolone ring to the quinazolinone ring via the 
five-membered spirolactone ring was confirmed by the HMBC correlations of the 
methine proton at δH 5.66, t (J = 9.7 Hz; δC 57.0) to the carbonyl carbons at δC 
170.8 and 159.7, and of the imine proton at δH 8.55, s (δC 147.6) to the methine 
sp3 carbon at δC 57.0. 
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5.66 t (9.7)
170.8
159.7
147.6
8.55 s
57.0
 
 
 Analogously to NP2/NL4 and NP3, the NOESY spectrum exhibited 
correlations between the signals of the proton at δH 5.50, d (J = 8.5 Hz) and the 
methyl protons at δH 1.39, d (J = 6.8 Hz), as well as between the signals of the 
methine proton at δH 5.66, t (J = 9.7 Hz) and the methine proton at δH 8.55, s.  
  
1
2
3
4
5
6
7
8
9
10
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12
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19
20
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2223
2425
27
26
 
 
Figure 74. Structure of tryptoquivaline F (NP6). 
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Consequently, the structure of NP6 was established as tryptoquivaline F 
(Figure 74), the deoxy analog of tryptoquivaline H (NP3). The 1H and 13C NMR 
data, as well as the optical rotation ([α]20D = -120.0) of NP6 were in agreement with 
those reported for tryptoquivaline F, a tryptoquivaline derivative isolated also from 
Neosartorya siamensis KUFC 6349 (Buttachon et al., 2012). 
 
3.1.6.6. Tryptoquivaline T (NL6) 
NL6 was isolated as white solid (mp. 258-260 ºC), and its molecular formula 
C24H20N4O5 was established on the basis of the (+)-HR-ESIMS m/z 445.1512 [M+ 
H]+, indicating seventeen degrees of unsaturation. The IR spectrum showed 
absorption bands for aromatic (3010, 1582, 1450 cm−1) and carbonyls of 
ester/amide groups (1700 cm−1). The general features of the 1H and 13C spectra 
(Table 28) of NL6 closely resembled those of NP2/NL4. The 13C NMR, DEPT and 
HSQC spectra (Table 28) revealed three amide/ester carbonyls (δC 172.5, 171.1 
and 160.0), one N-formyl (δC 162.3), four quaternary sp
2 (δC 147.8, 138.4, 133.5, 
121.4), nine methine sp2 (δC 148.1, 135.1, 131.8, 127.6, 127.4, 126.8, 126.7, 
126.2, 116.4), two quaternary sp3 (δC 84.2 and 64.1), two methine sp
3 (δC 81.0 
and 57.7), one methylene sp3 (δC 33.8) and two methyl (δC 26.6 and 25.5) 
carbons. 
The 1H NMR spectrum (Table 28) displayed the signals of one olefinic 
proton at δH 8.62, s, eight aromatic protons at δH 8.26, dd (J = 8.0, 1.0 Hz), 8.04, 
dd (J = 8.0, 1.0 Hz), 7.93, ddd (J = 8.0, 8.0, 1.0 Hz), 7.76, d (J = 8.0 Hz), 7.63, ddd 
(J = 8.0, 8.0, 1.0 Hz), 7.61, ddd (J = 8.0, 8.0, 1.0 Hz), 7.56, dd (J = 8.0, 1.0 Hz) 
and 7.46, ddd (J = 8.0, 8.0, 1.0 Hz), two methine protons at δH 6.10, s and 5.47, dd 
(J = 10.7, 8.6 Hz), two methylene protons at δH 3.40, dd (J = 14.0, 10.7 Hz) and 
3.30, dd (J = 14.0, 8.6 Hz), and the protons of two methyl groups at δH 1.72, s and 
1.55, s, besides a doublet at δH 8.73 (J = 0.9 Hz). 
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Table 28. 1H and 13C NMR data (DMSO-d6, 300.13 and 75.47 MHz) of NL6. 
Position δC, type δH, mult. (J in Hz) COSY HMBC 
 
2 
 
81.0, CH 
 
6.10, s 
 
H-29 
 
C-3,13, 14 
3 84.2, C --- --- --- 
4 133.5, C --- --- --- 
5 126.8, CH 8.04, dd (8.0, 1.0) H-6 C-3, 7, 9 
6 126.7, CH 7.46, ddd (8.0, 8.0, 1.0) H-5 C-4, 8 
7 131.8, CH 7.61, ddd (8.0, 8.0, 1.0) H-6, 8 C-5, 9 
8 116.4, CH 7.56, dd (8.0, 1.0) H-7 C-4, 6 
9 138.4, C --- --- --- 
11 171.1, CO --- --- --- 
12 57.7, CH 5.47, dd (10.7, 8.6) H-13 C-11, 18 
13α 
β 
33.8, CH2 3.30, dd (14.0, 8.6) 
3.40, dd (14.0, 10.7) 
H-12, 13β 
H-12, 13α 
C-2, 3, 4 
C-2, 3, 4 
14 172.5, CO --- --- --- 
15 64.1, C --- --- --- 
18 160.0, CO --- --- --- 
19 121.4, C --- --- --- 
20 126.2, CH 8.26, dd (8.0, 1.0) H-21 C-18, 22, 24 
21 127.6, CH 7.63, ddd (8.0, 8.0, 1.0) H-20, 22 C-19, 23 
22 135.1, CH 7.93, ddd (8.0, 8.0, 1.0) H-21, 23 C-20, 24 
23 127.4, CH 7.76, d (8.0) H-22 C-19, 21 
24 147.8, C --- --- --- 
26 148.1, CH 8.62, s --- C-12, 18, 24  
27 26.6, CH3 1.72, s --- C-14, 15, 28 
28 25.5, CH3 1.55, s --- C-14, 15, 27 
29 162.3, CO 8.73, d (0.9) H-2 C-2 
 
The coupling system of the aromatic protons at δH 8.04, dd (J = 8.0, 1.0 
Hz), 7.46, ddd (J = 8.0, 8.0, 1.0 Hz), 7.61, ddd (J = 8.0, 8.0, 1.0 Hz) and 7.56, dd 
(J = 8.0, 1.0 Hz), which was evidenced by the COSY spectrum (Table 28), 
together with the HMBC correlations (Table 28) of the aromatic proton at δH 8.04, 
dd (J = 8.0, 1.0 Hz; δC 126.8) to the quaternary carbons at δC 84.2 and 138.4, of 
the aromatic proton at δH 7.56, dd (J = 8.0, 1.0 Hz; δC 116.4) to the quaternary sp
2 
carbon at δC 133.5, of the methine proton at δH 6.10, s (δC 81.0) to the quaternary 
carbons at δC 84.2 and 172.5, and of the methyl protons at δH 1.72, s (δC 26.6) 
and 1.55, s (δC 25.5) to the quaternary carbon at δC 64.1 and the carbonyl carbon 
at δC 172.5, indicated the presence of the 6-5-5-gem-dimethylimidazoindolone ring 
system. The presence of the doublet at δH 8.73 (J = 0.9 Hz), which gave the 
HSQC cross peak to the carbon at δC 162.3, indicated the presence of the 
aldehyde group. Since this doublet displayed HMBC cross peak to the methine 
carbon at δC 81.0, the formyl group was on the nitrogen atom of the imidazolone 
ring. 
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8.73 d (0.9)
162.3
126.8
1.72 s
1.55 s
25.5
26.6
6.10 s
7.56 dd
(8.0, 1.0)
7.61 ddd
(8.0, 8.0, 1.0)
8.04 dd 
(8.0, 1.0)
7.46 ddd
(8.0, 8.0, 1.0)
116.4
138.4
126.7
131.8
133.5
172.5
64.1
84.2
81.0
 
  
 The COSY spectrum also revealed another coupling system of the aromatic 
protons at δH 8.26, dd (J = 8.0, 1.0 Hz), 7.63, ddd (J = 8.0, 8.0, 1.0 Hz), 7.93, ddd 
(J = 8.0, 8.0, 1.0 Hz) and 7.76, d (J = 8.0 Hz), of the 1,2-disubstituted benzene ring 
which, through the HMBC correlations of the aromatic proton at δH 8.26, dd (J = 
8.0, 1.0 Hz; δC 126.2) to the quaternary sp
2 carbons at δC 160.0 and 147.8, of the 
aromatic proton at δH 7.76, d (J = 8.0 Hz; δC 127.4) to the quaternary sp
2 carbon at 
δC 121.4, and of the methine proton at δH 8.62, s (δC 148.1) to the quaternary sp
2 
carbons at δC 160.0 and 147.8, confirmed the presence of the same N-substituted 
quinazolin-4-one moiety as in NP2/NL4. 
 
148.1
7.93 ddd
(8.0, 8.0, 1.0)7.76 d (8.0)
127.4
8.62 s
8.26 dd
(8.0, 1.0)
7.63 ddd
(8.0, 8.0, 1.0)147.8
121.4
160.0
135.1
127.6
126.2
 
  
The HMBC correlations of the methylene protons at δH 3.30, dd (J = 14.0, 
8.6 Hz; δC 33.8) and 3.40, dd (J = 14.0, 10.7 Hz; δC 33.8) to the carbons at δC 
81.0, 84.2 and 133.5 of the indole moiety, of the methine proton at δH 5.47, dd (J = 
10.7, 8.6 Hz; δC 57.7) to the carbonyl carbons at δC 171.1 and 160.0, as well as of 
the methine proton at δH 8.62, s (δC 148.1) to the methine carbon at δC 57.7, 
confirmed that the N-substituted quinazolin-4-one and 6-5-5-gem-
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dimethylimidazoindolone fragments were connected via the five-membered 
spirolactone as in NP2/NL4, NP3 and NP6. 
 
5.47 dd 
(10.7, 8.6)
8.62 s
6.10 s
171.1
3.40 dd (14.0, 10.7)
3.30 dd (14.0, 8.6)
81.0
57.7
160.0
148.1
133.5
84.2
33.8
 
 
The only difference between the structures of NL6 and NP2/NL4 is the 
presence of the formyl group on N-16 of the gem-dimethyl imidazoindole moiety in 
the former and a hydroxyl group in the latter. On the other hand, the structure of 
NL6 differs from that of tryptoquivaline O, which was previously isolated from 
Neosartorya siamensis KUFC 6349 (Buttachon et al., 2012), in that there are two 
methyl groups on C-15 (δC 64.1) of the imidazoindole ring in the former instead of 
one methyl group in the latter. 
Since the chemical shift values of the protons at δH 6.10, s and 5.47, dd (J = 
10.7, 8.6 Hz) of NL6 are similar of those of the corresponding protons of 
tryptoquivaline O, we assume that the stereochemistry of NL6 is the same as that 
of tryptoquivaline O, i.e., C-2S, C-3S and C-12R. This assumption was also 
supported by the negative value of the rotation ([α]D
25 = - 83.3) of NL6. Thus, NL6 
is a new tryptoquivaline analogue which we have named tryptoquivaline T (Figure 
75).  
 
 170 
 
CHAPTER III. RESULTS AND DISCUSSION 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
2223
2425
27
26
28
 
 
Figure 75. Structure of tryptoquivaline T (NL6). 
 
The biosynthetic pathway for the isolated tryptoquivalines, which are 
characterized by quinazolinone ring connected to a 6-5-5-imidazoindolone ring 
system via a five-membered spirolactone, still remains uncharacterized. So, we 
proposed the biosynthetic pathways (Scheme 5) of these compounds, based on 
the previous study by Gao et al. (2011b). The skeleton of tryptoquivalines is 
originated from L-tryptophan which undergoes epimerization to yield D-tryptophan. 
Condensation of D-tryptophan with anthranillic acid and one biological equivalent 
of formaldehyde give the indoline quinazolinone derivative. Epoxidation of the 
indole moiety and subsequent opening of the epoxide ring yields the hydroxy 
iminium intermediate followed by lactonization to form the spirolactone ring. 
Condensation with 2-aminobutiric acid (Pathway a) leads to the formation of the 
gem-dimethyl group in 6-5-5-imidazoindolone ring present in tryptoquivaline L, 
while the methyl group in tryptoquivalines F and H derives from the condensation 
with L-alanine (Pathway b).  
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Pathway b
Pathway a
 3-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5-oxolane]-2, 2-dione
(NP5/NL5)
L-tryptophan
Epimerization Condensation
C-2 Hydroxylation
Anthranillic acid
S ..
R
..
..
D-tryptophan
 
 
Scheme 5. Biosynthetic pathways for 3-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5-
oxolane]-2,2’-dione (NP5/NL5) and tryptoquivalines L (NP2/NL4), H (NP3) and F 
(NP6).  
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Enz-SH
Tryptoquivaline L (NP2/NL4)
2-Aminobutyric acid  
 
Pathway a 
 
 
 
Enz-SH
Tryptoquivaline F (NP6)
[O]
L-Alanine
Tryptoquivaline H (NP3)
Pathway b 
  
Scheme 5 (cont). Biosynthetic pathways for 3-(4-oxoquinazolin-3-yl)spiro[1H-
indole-3,5-oxolane]-2,2’-dione (NP5/NL5) and tryptoquivalines L (NP2/NL4), H 
(NP3) and F (NP6).  
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 So far, tryptoquivaline family of alkaloids was found to be produced 
exclusively by fungi, being identified from Aspergillus species such as A. clavatus 
(Büchi et al., 1977; Clardy et al, 1975), A. fumigatus (Yamazaki et al., 1976; 1977; 
1978; 1979), from a marine unidentified Aspergillus strain (Zhou et al., 2013) as 
well as from Corynascus setosus (Fujimoto et al., 1996).  
 Despite the isolation of tryptoquivalines L, H and F from the cultures of A. 
fumigatus (Yamazaki et al., 1977; 1978) and Neosartorya siamensis KUFC 6349 
(Buttachon et al., 2012), this is the first report on the isolation of tryptoquivalines L, 
H and F from N. paulistensis, as well as the isolation of tryptoquivaline L and the 
new tryptoquivaline T from N. laciniosa (Gomes et al., 2014).  
 Analogously to the meroditerpenes isolated from N. paulistensis KUFC 
7897 and N. laciniosa KUFC 7896, as well as from other Neosartorya species, 
tryptoquivalines are also suggested as specific extrolites from some Neosartorya 
species, which can be used as a supplement to morphological and genetic 
taxonomic studies (Samson et al., 2007). The taxonomic study on the genus 
Neosartorya by Samson et al. (2007) led to the identification of tryptoquivaline-like 
and tryptoquivalone-like extrolites from several species such as N. aureola, N. 
fischeri, N. laciniosa, N. udagawae and N. warcupii. Furthermore, besides the 
isolation of tryptoquivalines O from N. siamensis KUFC 6349 (Buttachon et al., 
2012), the new tryptoquivalines P, Q, R and S were also isolated from the marine-
derived fungus Neosartorya sp. HN-M-3 (Sun et al., 2012; Xu et al., 2013b). 
 Consequently, the isolation of tryptoquivalines L, H, F from the Neosartorya 
species we have investigated, can provide an additional tool for the identification 
of the species N. paulistensis and N. laciniosa, as well as tryptoquivaline T, a new 
extrolite which could be useful for the chemotaxonomic identification of other 
species from Neosartorya genus.     
 
 
 
 
 174 
 
CHAPTER III. RESULTS AND DISCUSSION 
 
3.2. Biological Activity Evaluation of the Isolated 
Fungal Secondary Metabolites 
 
 Some of isolated compounds from the investigated fungal extracts were 
tested in three main biological assays: antifungal, antibacterial and cytotoxic 
activities against human cancer cell lines. 
 
3.2.1. Antifungal and Antibacterial Activities Evaluation 
 
 The anthraquinones, erythroglaucin (EC1), physcion (EC2), catenarin (EC3) 
and emodin (EC4), as well as the diketopiperazine alkaloids, echinulin (EC6), 
neoechinulin (EC7), neoechinulins A (EC8) and E (EC9), and eurocristatine 
(EC10) (Figure 76) isolated from E. cristatum KUFC 7356 EtOAc extract, were 
tested for antifungal and antibacterial activities evaluation. 
 
EC8 EC9
EC10
EC1 R1 = OH, R2 = CH3, R3 = H
EC2 R1 = R3 = H, R2 =CH3
EC3 R1 =OH, R2 = R3=H
EC4 R1 = R2 = R3 = H 
EC5 R1 = R2 = H, R3 = CH3 
EC6
EC7
 
Figure 76. Structures of the compounds tested for antifungal and antibacterial 
activities. 
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Metabolites were tested for their antifungal activity against yeast (Candida 
albicans), filamentous fungus (Aspergillus fumigatus) and dermatophyte 
(Trichophyton rubrum) strains, and antibacterial activity against Staphylococcus 
aureus, Escherichia coli and Pseudomonas aeruginosa, according to the 
procedure described by Wattanadilok et al. (2007), specified in Materials and 
Methods (see 4.6.2. Antifungal Activity Bioassays). However, none of the 
compounds exhibited antifungal activity (Gomes et al., 2012).   
 
3.2.2. Cytotoxic Activity Evaluation 
 
 The diketopiperazine alkaloids, neoechinulin (EC7), neoechinulins A (EC8) 
and E (EC9) and eurocristatine (EC10) isolated from E. cristatum KUFC 7356, and 
the meroditerpenes aszonapyrones A (NL2) and B (NL3), isolated from N. 
laciniosa KUFC 7896 extract (Figure 77) were tested for their in vitro growth 
inhibitory effect against three human tumor cell lines MCF-7 (breast 
adenocarcinoma), NCI-H460 (non-small cell lung cancer) and A375-C5 
(melanoma) by the protein binding dye SRB method (see Chapter IV Materials and 
Methods, 4.6.1. Cytotoxic Activity Bioassays).  
 
EC7
NL2 R = Ac
NL3 R = H
EC8
EC9 EC10
 
 
Figure 77. Structures of the compounds tested for in vitro cytotoxic activity against 
human cancer cell lines. 
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None of the diketopiperazine alkaloids (EC7-10) displayed growth inhibitory 
activity on the three human tumor cell lines (Gomes et al., 2012). However, the 
meroditerpene aszonapyrone A (NL2) showed strong growth inhibitory activity 
against the three cell lines, with GI50 = 13.6 ± 0.9 µM, 11.6 ± 1.5 µM and 10.2 ± 1.2 
µM, for MCF-7, NCI-H460 and A375-C5, respectively, while aszonapyrone B 
(NL3), whose structure corresponds to 3-deacetyl aszonapyrone A, was inactive at 
the highest concentration tested (150 µM) (Table 29) (Eamvijarn et al., 2013).    
 
Table 29. Growth inhibitory effect of diketopiperazine alkaloids 
EC7-EC10 and meroditerpenes NL2 and NL3 
Compounds  GI50 (µM) 
  MCF-7 NCI-H460 A375-C5 
 
EC7 
 
 
 
> 150 
 
> 150 
 
> 150 
EC8  > 150 > 150 > 150 
EC9  > 150 > 150 > 150 
EC10  > 150 > 150 > 150 
NL2  13.6 ± 0.9 11.6 ± 1.5 10.2 ± 1.2 
NL3  > 150 > 150 > 150 
Results are given as the lowest concentration causing 50% of cell growth 
inhibition (GI50) after a continuous exposure to the compounds for 48 h, and 
are expressed as mean ± SEM of three independent experiments performed in 
duplicate. Doxorubicin was used as positive control, GI50: MCF-7=60.3±1.2 
nM; NCI-H460=19.6±1.9 nM; A375-C5=130.0±25 nM.  
 
3.2.3. Antibacterial and Antibiofilm Activity Evaluation 
 
Tryptoquivalines L (NP2/NL4), H (NP3), F (NP6) and T (NL6), 4(3H)-
quinazolinone (NP4) and 3’-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5’-oxolane]-2, 
2’-dione (NP5/NL5), together with meroditerpenes aszonapyrone A (NL2) and B 
(NL3), and the new meroditerpene sartorypyrone C (NP1) (Figure 78), were tested 
for their antibacterial activity against bacterial reference strains and environmental 
multidrug-resistant isolates. None of the quinazolinone alkaloids (NP2/NL4, NP3, 
NP5/NL5, NP6, NL6) exhibited relevant antibacterial activity (Table 30a). 
However, within the meroditerpene group, only aszonapyrone A (NL2) presented 
significant MIC values against Gram-positive bacteria, showing the MIC values of 
8 μg/mL against S. aureus ATCC 25923 and B. subtilis ATCC 6633.  
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NP2/NL4 R1 = OH, R2 = Me
NP3         R1 = OH, R2 = H
NP6         R1 = H, R2 = H
NL6         R1 = CHO, R2 = Me
NL2 R = Ac
NL3 R = H
NP4
NP1
NP5/NL5
 
 
Figure 78. Structures of the compounds tested for antibacterial and antibiofilm 
activities. 
Based on these results, the MIC values of aszonapyrone A (NL2) was 
further determined against Gram-positive multidrug-resistant strains, and it was 
found to be active against both S. aureus MRSA and Enterococcus spp. VRE 
isolates (Table 30b). MBC values were only achieved for aszonapyrone A (NL2) 
against Gram-positive reference strains. 
Table 30. Antibacterial activity, expressed in µg/mL of compounds NP1-NP6 
and NL2-NL6 against reference strains (a) and of NL2 against multidrug-
resistant isolates (b). 
a 
  S. aureus 
ATCC 25923 
P. aeruginosa 
ATCC 27853 
B. subtilis 
ATCC 6633 
E. coli 
ATCC 25922 
Compounds  MIC MIB MIC MIB MIC MIB MIC MIB 
NP1  128 --- 128 256 128 --- 128 --- 
NP2/NL4  128 --- 128 256 128 --- 128 --- 
NP3  128 --- 128 256 128 --- 128 --- 
NP4  128 --- 128 256 128 --- 128 --- 
NP5/NL5  256 --- 128 256 128 --- 128 --- 
NP6  128 --- 128 128 128 --- 128 --- 
NL2  8 64 128 256 8 16 128 --- 
NL3  256 --- 128 256 128 --- 128 --- 
NL6  --- --- 128 --- 128 --- 128 --- 
 178 
 
CHAPTER III. RESULTS AND DISCUSSION 
 
b 
  S. aureus B1 S. aureus B2 E. faecalis W1 E. faecium W5 
Compound  MIC MIB MIC MIB MIC MIB MIC MIB 
 
NL2 
 
 
 
8 
 
--- 
 
8 
 
--- 
 
16 
 
--- 
 
16 
 
--- 
(-) : > 256 µg/mL. 
 
 
The disc diffusion method (Table 31) revealed a small synergistic 
association between all the compounds tested and the antibiotics to which E. coli 
G1 was resistant. Even though only a few compounds showed synergism against 
S. aureus B1 and E. faecium W5, association of aszonapyrone A (NL2) with the 
antibiotics was found to produce the biggest halos. 
 
Table 31. Antibacterial efficacy (halos, mm) of combined effect of antibiotics 
with compounds NP1-NP6 and NL2-NL6 (15 µg/disc) against three multidrug-
resistant isolates, using the disc diffusion method. 
  E. coli G1 S. aureus B1 E. faecium W5 
  Antibiotics 
Compounds  CIP AMP CTX S OX AMP CTX VA AMP E 
 
NP1 
  
7 
 
7 
 
= 
 
7.5 
 
= 
 
= 
 
= 
 
= 
 
= 
 
= 
NP2/NL4  7 7 = 7.5 = = = = = = 
NP3  7 7 = 7.5 = = = = = = 
NP4  7 7 = 7.5 = = = = = = 
NP5/NL5  7 7 = 7.5 = = = = = = 
NP6  7 7 = 7.5 = = = = = = 
NL2  8 8 = 8 12.5 13 13 11 12 13.5 
NL3  7 7 = 7.5 11 10 10.5 11 12 13.5 
NL6  7 7 = 7.5 = = = = = = 
Control  0 0 14 0 0 7 0 8 0 0 
Control: Antibiotic with no compounds; CIP: Ciprofloxacin; AMP: Ampicillin; CTX: 
Cefotaxime; S: Streptomycin; OX: Oxacillin; VA: Vancomycin; E: Erythromycin. 
(=): No influence of the compound / Same result as obtained with no compound. 
 
The results of the Checkerboard method, represented by the FIC 
(Fractional Inhibitory Concentration) index, are shown in Table 32. The 
combination effect of aszonapyrone A (NL2) with oxacillin (OX) and ampicillin 
(AMP) against MRSA and VRE isolates, respectively, was found to be indifferent 
(ΣFIC > 0.5). However, aszonapyrone A (NL2) was found to lower the MIC of each 
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antibiotic tested, thus, it may be considered a partially synergist effect. The 
association of aszonapyrone A (NL2) with vancomycin (VA) showed a clear 
synergistic effect (ΣFIC < 0.5) against the two VRE isolates tested.  
 
Table 32. FIC Index results obtained with aszonapyrone A (NL2) and 
antibiotic combinations by checkerboard method. 
  OX VA AMP 
Bacterial Isolate  ƩFIC Activity
a
 ƩFIC Activity ƩFIC Activity 
 
S. aureus B1 
  
0.562 
 
I 
 
--- 
 
--- 
 
2 
 
I 
S. aureus B2  2 I --- --- 2 I 
E. faecalis W1  --- --- 0.312 S 0.75 I 
E. faecium W5  --- --- 0.312 S 0.75 S 
AMP: Ampicillin; OX: Oxacillin; VA: Vancomycin  
a
 S = Synergism; I = Indifference; (-): Not determined 
 
The effect of aszonapyrone A (NL2) at different concentrations (ranging 
from 2x MIC to 1/4x MIC), on the biofilm formation of S. aureus ATCC 25923, B. 
subtilis ATCC 6633, S. aureus B1 and E. faecalis W1 was also assessed using the 
biomass quantification, and the results are shown in Figure 73. All the strains 
tested showed no biofilm formation in the presence of 2x MIC and MIC of 
aszonapyrone A (NL2). However, S. aureus ATCC 25923 and S. aureus B1 
formed more biofilm in the presence of a sub-inhibitory concentration (1/2x MIC) of 
aszonapyrone A (NL2) (Figure 79). 
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Figure 79. Biomass quantification of biofilms of Gram-positive bacteria formed in 
the presence of concentrations ranging from 2x MIC to 1/4x MIC of aszonapyrone 
A (NL2). 
 
In order to confirm the effect of aszonapyrone A (NL2) on biofilm formation, 
the microscopic visualization of the biofilm produced by S. aureus ATCC 25923 
was carried out using a Live/Dead staining. After 24 h, the majority of the cells 
within the biofilm were viable and large aggregates embedded in a matrix could be 
observed (Figure 80A). In the presence of aszonapyrone A (NL2), at a 
concentration equal to the MIC, no biofilm was formed and also no growth was 
observed (Figure 80B). However, at the concentration of 1/2x MIC, it was possible 
to observe more biofilm in comparison to the control (Figure 80C). These results 
are in agreement with those obtained in the biomass quantification for the same 
experimental conditions. However, this result is not unexpected since there are 
several reports of the increase in biofilm formation in both Gram-positive and 
Gram-negative bacteria in the presence of sub-inhibitory concentrations of 
antibiotics (Bessa et al., 2013; Hoffman et al., 2005; Kaplan et al., 2011).  
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Figure 80. Evaluation of S. aureus ATCC 25953 biofilm formation. Live/dead 
viability staining images after 24 h. Control (A); Biofilm formation in the presence 
of the MIC (B) and in the presence of 1/2 of the MIC (C) of aszonapyrone A (NL2). 
 
Interestingly, the BIC value of aszonapyrone A (NL2) was found to be 
higher than 12× MIC against mature biofilms of both S. aureus B1 (BIC > 96 
μg/mL) and E. faecalis W1 (BIC > 192 μg/mL). However, the exact BIC value 
could not be determined due to the limited quantity of this compound available to 
perform all these biological assays. These very high BIC values may reflect the 
difficulty of NL2 in penetrating the extracellular biofilm matrix, thus hampering the 
eradication of the pre-established biofilm (Gomes et al., 2014). 
 
 Finally, the antibacterial activity evaluation of structurally related 
meroditerpenes isolated from our research group, could lead us to hypothesize 
some of the chemical requirements of this class of compounds for the antibacterial 
activity. Chevalones B (140) and C (141) and sartorypyrones A (177) and B (196) 
(Figure 81) were also tested for their antibacterial activity against the four 
reference strains (S. aureus, B. subtilis, E. coli, and P. aeruginosa, as well as the 
environmental multidrug-resistant isolates), however only sartorypyrone A 
exhibited moderate antibacterial activity as well as synergism with antibiotics 
against the Gram-positive multidrug-resistant strains.  
Examination of the structures of the meroditerpenes tested (Figure 81) 
suggested the existence of some common features necessary for the antibacterial 
activity of this class of compounds.   
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NP1
177 196
NL3 R = H
NL2 R = Ac
140 141
 
 
Figure 81. Structures of the meroditerpenes tested for antibacterial activity. 
 
Although aszonapyrone A (NL2), aszonapyrone B (NL3), sartorypyrone C 
(NP1) and sartorypyrone A (177), all contain the 4-hydroxy-6-methyl-2H-pyran-2-
one ring, only aszonapyrone A (NL2) and sartorypyrone A (177) have the β-
acetoxyl group on C-3. On the other hand, while this 4-hydroxy-6-methyl-2H-
pyran-2-one ring is connected to the perhydrophenanthrene portion by the 
ethereal bridge, forming a more rigid pentacyclic structure in chevalone B (140), 
both chevalone C (141) and sartorypyrone B (196) contain the 6-methyl-4H-pyran-
4-one ring connected to the perhydrophenanthrene portion by an ethereal bridge. 
Therefore, it is apparent that the presence of a free 4-hydroxy-6-methyl-2H-pyran-
2-one ring on C-15 and the β-acetoxyl group on C-3 of the perhydrophenanthrene 
portion are required for the antibacterial activity of this series of meroditerpenes. 
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4.1. General Experimental Procedures 
  
Si gel 60 (0.2-0.5 mm; 70-230 mesh, Merck), LiChroPrep Si 60 (0.04-0.063 
mm, Merck) and Sephadex LH-20 were used for column chromatography. 
Analytical TLC was performed on Si gel 60 (GF254, Merck), 0.25 mm thickness 
(The plates were activated at 110 ºC in the oven Binder for 4 hours) and precoated 
silica gel sheets, GF254 (Macherey-Nagel), ALUGRAM
®, Sil G/UV254, 20 x 20 cm. 
TLC plates were visualized under UV254nm and 365nm or developed with iodine 
vapor. 
 1H and 13C NMR spectra were recorded at ambient temperature in CDCl3 or 
DMSO-d6 on a Bruker AMC instrument operating either at 300.13 and 75.47 MHz 
or 500.13 MHz and 125.77 MHz, respectively.  
High resolution mass spectra were measured with a Waters Xevo QToF 
mass spectrometer coupled to a Waters Aquity UPLC system.  
 Ultraviolet and infrared spectra were recorded on a Shimadzu mini-1240UV-
VIS spectrophotometer using 1.000 cm quartz cells, and on an ATT Mattson 
Genesis Series FTIRTM using WinFIRST Software, respectively.  
 Melting points were determined on a Bock monoscope and are uncorrected.  
Optical rotations were determined on an ADP410 Polarimeter. 
The weight was measured on the analytical balance AND GH-202. 
The solvents used were from Merck and Fischer with analytical reagent 
grade. Solvents were evaporated at reduced pressure, using Büchi Heating Bath 
B-49, Büchi Rotavapor R-210, Büchi Vacuum Module V-801 EasyVac and 
Vacuum Pump V-700. 
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4.2. Isolation and Identification of the Biological 
Material 
 
4.2.1. Emericella variecolor KUFC 7092 
 
Emericella variecolor KUFC 7092 was isolated from the marine sponge 
Clathria reinwardti (Figure 82a), which was collected by scuba diving at 15 meters 
depth, from Koh Tarutao, Amphur Mueang, Satun Province, Southern Thailand. 
After rinsing three times with sterile sea water, the sponge was dried on sterile 
filter papers, cut into small pieces (5 x 5 mm) and placed on the plates containing 
malt extract agar (MEA, 30 g of malt extract, 15 g of bacto agar, distilled water 
1000 mL, and adjusted to the final pH at 5.5) 70% sea water, and incubated at 
28ºC under 12h light / 12h dark cycle for 7 days.  
 
 
 
Figure 82. Clathria reinwardti (a). E. variecolor KUFC 7092. Colony on MEA with 
70 % sea water after 14 days (b). Conidiophores and conidia (c). SEM image of 
ascospores (d, e). 
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The fungus was identified by morphological features, including the 
characteristic of ascospores and colonies (Figure 82b-e). The pure cultures were 
deposited as KUFC 7092 at Kasetsart University Fungal Collection, Department of 
Plant Pathology, Faculty of Agriculture, Kasetsart University, Bangkok, Thailand. 
 
4.2.2. Eurotium cristatum KUFC 7356 
 
Eurotium cristatum KUFC 7356 was isolated from the marine sponge 
Mycale sp. (Figure 83a) which was collected from Wonnapa Beach, Bangsaen, 
Chonburi Province, Thailand. After rinsing with sterile sea water, the sponge was 
dried on sterile filter papers, cut into small pieces (5 x 5 mm) and placed on the 
plates containing MEA with 70% sea water. The plates were incubated at room 
temperature for one week and the fungus was transferred onto the MEA + 70% 
sea water slant.  
 
 
 
Figure 83. Mycale sp. (a). E. cristatum KUFC 7356. Colony on PDA with 70 % sea 
water after 14 days (b). Conidiophores and conidia (c). SEM image of ascospores 
(d, e). 
The fungus was identified based on macro- and microscopic characteristics, 
observed under light and scanning electron microscopes (Figure 83b-e). The pure 
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cultures were deposited as KUFC 7356 at Kasetsart University Fungal Collection, 
Department of Plant Pathology, Faculty of Agriculture, Kasetsart University, 
Bangkok, Thailand. 
 
4.2.3. Neosartorya laciniosa KUFC 7896 
 
The strain KUFC 7896 was isolated from a diseased coral (Porites lutea 
ulcerative white spot) (Figure 84) which was collected by Jamrearn Buaruang at 
Ao Nuan Lan Island (altitude 12º 53’ 56.85’’ N, 100º 46’ 39.66’’ E), The Gulf of 
Thailand, Chonburi Province, in May 2010.  
 
 
 
Figure 84. Diseased coral (Porites lutea). 
 
The diseased coral was washed with 0.06% sodium hypochlorite for 1 min, 
followed by sterilized sea water for three times. The diseased coral was cut into 5 
x.5 mm pieces and placed on MEA with 70% sea water, and incubated at 28 ºC for 
5-7 days. The fungus was identified as N. laciniosa by morphological 
characteristics, such as colony growth rate and growth pattern on standard media 
namely Czapek’s agar (CZA), Czapek yeast autolysate agar (CYA) and MEA 
(Figure 85a-c). Microscopic characteristics including size, shape, ornamentation of 
ascospores and Aspergillus laciniosus anamorph were examined under light and 
scanning electron microscopes (Figure 85d-f). This identification was supported by 
sequence analysis of the β-tubulin gene (Glass and Donaldson, 1995) and the 
pure cultures were deposited as KUFC 7896 at Kasetsart University Fungal 
Collection, Department of Plant Pathology, Faculty of Agriculture, Kasetsart 
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University, Bangkok, Thailand, and as MMERU 01 at Microbes Marine 
Environment Research Unit, Division of Environmental Science, Faculty of 
Science, Ramkhamhaeng University, Bangkok, Thailand. 
 
 
 
Figure 85. N. laciniosa KUFC 7896. Colonies incubated for 14 days at 28ºC on 
CZA (a), CYA (b) and MEA (c) media. Ascomata (d). Conidia (e). SEM image of 
ascospores (f). 
 
4.2.4. Neosartorya paulistensis KUFC 7897 
 
 Neosartorya paulistensis KUFC 7897 was isolated from the marine sponge 
Chondrilla australiensis (Figure 86a) which was collected from Mu Kho Lan Beach, 
The Gulf of Thailand, Chonburi Province, in May 2010. The sponge was identified 
by Jamrearn Buaruang, Division of Environmental Science, Faculty of Science, 
Ramkhamhaeng University, Bangkok, Thailand. After rinsing with sterile sea 
water, the sponge was dried on sterile filter papers, cut into small pieces (5 x 5 
mm) and placed on the plates containing MEA with 70% sea water and incubated 
at 28ºC for days. The fungus was identified by morphological features, including 
the characteristic of ascospores and colonies (Figure 86b-e). The identification 
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was supported by sequence analysis of the β-tubulin gene (Glass and Donaldson, 
1995) and the pure cultures were deposited as KUFC 7897 at Kasetsart University 
Fungal Collection, Department of Plant Pathology, Faculty of Agriculture, 
Kasetsart University, Bangkok, Thailand, and as MMERU 02 at Microbes Marine 
Environment Research Unit, Division of Environmental Science, Faculty of 
Science, Ramkhamhaeng University, Bangkok, Thailand. 
 
 
 
 
Figure 86. Chondrilla australiensis (a). N. paulistensis KUFC 7897. Colony on 
PDA with 70 % sea water after 14 days (b). Ascomata (c). Conidia (d). SEM 
image of ascospores (d, e). 
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4.3. Extraction and Isolation of Metabolites  
 
4.3.1. Emericella variecolor KUFC 7356 
  
The fungus was cultured for two weeks at 28ºC in 10 Petri dishes (i.d. 90 
mm) containing 25 mL of MEA with 70% sea water per dish. Thirty five 1000 mL 
Erlenmeyer flasks, each containing 200 g of rice and 150 mL of water, were 
autoclaved, inoculated with five mycelial plugs of E. variecolor KUFC 7356 and 
incubated at 28ºC for 30 days, after which the mouldy rice was macerated in ethyl 
acetate (12 L total) for 7 days and then filtered. The two layers were separated 
using a separatory funnel, and the EtOAC solution was concentrated at a reduced 
pressure to yield 79.5 g of crude EtOAc extract which was washed with 5% of 
NaHCO3 solution (2 x 500 mL) and H2O (3 x 500 mL). The organic layer was dried 
with anhydrous Na2SO4, filtered and evaporated under reduced pressure to give 
51 g of crude extract which was applied on a column chromatography over Si gel 
(0.2-0.5 mm Merck, 663 g) and eluted with mixtures of CHCl3-petrol and CHCl3-
Me2CO, wherein 250 mL fractions were collected as follows: fractions 1-60 
(CHCl3-petrol, 1:1), 61-122 (CHCl3-petrol, 7:3), 123-167 (CHCl3-petrol, 9:1), 168-
196 (CHCl3-Me2CO, 9:1), 197-209 (CHCl3-Me2CO, 4:1), 210-272 (CHCl3-Me2CO, 
7:3), 273-287 (CHCl3-Me2CO, 1:1).  
Fractions 88-90 were combined (3.37 g) and recrystallized in a mixture of 
MeOH and CHCl3 to give 47.7 mg of EV1.  
Fractions 142-173 were combined (2.29 g) and applied on a column 
chromatography of LiChroPrep Si 60 (0.04–0.063 mm Merck, 45 g) and eluted 
with mixtures of CHCl3-petrol and CHCl3-Me2CO, 100 mL sub-fractions were 
collected as follows: sub-fractions 1-46 (CHCl3-petrol, 1:4), 47-138 (CHCl3-petrol, 
2:3), 139-174 (CHCl3-petrol, 3:2), 175-205 (CHCl3-petrol, 9:1), 206-246 (CHCl3-
Me2CO, 9:1). Sub-fractions 58-98 were combined (218.4 mg) and recrystallized in 
MeOH to give 29 mg of EV2. 
Fractions 175-182 were combined (1.76 g) and applied on a column 
chromatography of LiChroPrep Si 60 (0.04–0.063 mm Merck, 35 g) and eluted 
with mixtures of CHCl3-petrol and CHCl3-Me2CO, 100 mL sub-fractions were 
collected as follows: sub-fractions 1-42 (CHCl3-petrol, 3:2), 43-68 (CHCl3-petrol, 
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4:1), 69-77 (CHCl3), 78-89 (CHCl3-Me2CO, 9:1). Sub-fractions 17-34 were 
combined (159.6 mg) and purified by TLC (Si Gel, CHCl3 : petrol : EtOAc, HCO2H, 
7:1:2:0.1) to give 8 mg of EV3.  
Fractions 203-217 were combined (1.35 g) and applied on a column 
chromatography of LiChroPrep Si 60 (0.04–0.063 mm Merck, 44 g) and eluted 
with mixtures of CHCl3-petrol and CHCl3-Me2CO, 100 mL sub-fractions were 
collected as follows: sub-fractions 1-33 (CHCl3-petrol, 1:1), 34-156 (CHCl3-petrol, 
7:3), 157-188 (CHCl3-petrol, 9:1), 189-264 (CHCl3), 265-287 (CHCl3-Me2CO, 9:1). 
Sub-fractions 81-110 were combined (81.9 mg) and recrystallized in MeOH to give 
5 mg of EV4. 
Fractions 238-247 were combined (338.1 mg) and recrystallized in a 
mixture of petrol and CHCl3 to give 24.1 mg of EV5. 
 
Acetylation of EV1: EV1 (27.2 mg) was dissolved in Ac2O (1 mL) / Py (3 
drops) and left to stand overnight in the dark. Elimination of acetic anhydride and 
pyridine yielded 11.8 mg of white solid of EV1Ac. 
 
4.3.2. Eurotium cristatum KUFC 7356 
  
E. cristatum KUFC 7356 was cultured for two weeks at 28ºC in 10 Petri 
dishes (i.d. 90 mm) containing 25 mL of MEA + 70% sea water per dish. Twenty 
five 1000 mL Erlenmeyer flasks, each containing rice (200 g), water (30 mL), and 
sea water (70 mL), were autoclaved, inoculated with five mycelia plugs of E. 
cristatum KUFC 7356, and incubated at 28ºC for 60 days, after which the mouldy 
rice was macerated in EtOAc (11 L total) for 10 days and filtered. The two layers 
were separated using separatory funnel and the EtOAc solution was concentrated 
at reduced pressure to give 25.3 g of crude EtOAc extract which was subject to 
column chromatography over a 0.2-0.5 mm Merck Si gel column (145 g) and 
eluted with mixtures of CHCl3-petrol, CHCl3-Me2CO, CHCl3-MeOH, 250 mL 
fractions being collected as follows: fractions 1-119 (CHCl3-petrol, 1:4), 120-130 
(CHCl3-petrol, 3:7), 131-163 (CHCl3-petrol, 2:3), 164-195 (CHCl3-petrol, 1:1), 196-
234 (CHCl3-petrol, 3:2), 235-260 (CHCl3-petrol, 7:3), 261-273 (CHCl3-petrol, 4:1), 
274-291 (CHCl3-petrol, 9:1), 292-300 (CHCl3), 301-348 (CHCl3-Me2CO, 9:1), 349-
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376 (CHCl3-Me2CO, 4:1), 377-394 (CHCl3-Me2CO, 1:1), 395-402 (CHCl3-MeOH, 
1:1).  
Fractions 13-20 were combined (154 mg) and recrystallized in a mixture of 
CHCl3 and MeOH to give 14 mg of EC1. Fractions 21-29 were combined (259 mg) 
and recrystallized in a mixture of CHCl3 and MeOH to give 6 mg of EC2. Fractions 
91-119 were combined (493 mg) and purified by TLC (Si Gel, CH2Cl2 : Me2CO : 
HCO2H, 98:2:1) to give 5 mg of EC3 and 5 mg of EC4. Fractions 178-201 were 
combined (162 mg) and purified by TLC (Si Gel, CHCl3 : Me2CO : HCO2H) to yield 
9 mg of EC5. Fractions 202-208 were combined (306 mg) and recrystallized in 
Me2CO to yield 53 mg of EC6 and the mother liquor (247 mg) was combined with 
fractions 191-201 (201 mg) to give 5 mg of EC7.  Fractions 209-216 were 
combined (216 mg) and recrystallized in Me2CO to give 51 mg of EC6 and the 
mother liquor (159 mg) was purified by TLC (Si Gel, CHCl3 : Me2CO, HCO2H, 
95:5:1) to yield 13 mg of EC8. Fractions 217-234 were combined (228 mg) and 
recrystallized in Me2CO to give 79 mg of EC6. Fractions 235-247 were combined 
(302 mg) and recrystallized in Me2CO to give 26 mg of EC6 and the mother liquor 
(272 mg) was recrystallized in a mixture of CH2Cl2 and petrol to give 17 mg of 
EC9. Fractions 303-321 were combined (338 mg) and recrystallized in MeOH to 
give 22 mg of EC10. The mother liquor of fractions 303-321 was then combined 
with fractions 277–301 (1.18 g), and applied on a column chromatography of 
LiChroPrep Si 60 (0.04–0.063 mm Merck, 45 g) and eluted with mixtures of CHCl3-
petrol, CHCl3-Me2CO, CHCl3–MeOH, 100 mL sub-fractions were collected as 
follows: sub-fractions. 1-20 (CHCl3-petrol, 1:4), 21-96 (CHCl3-petrol, 3:7), 97-118 
(CHCl3-petrol, 2:3), 119-157 (CHCl3-petrol, 1:1), 158-179 (CHCl3-petrol, 3:2), 180-
290 (CHCl3-petrol, 7:3), 291-325 (CHCl3-petrol, 4:1), 326-349 (CHCl3-petrol, 9:1), 
350-368 (CHCl3), 369-379 (CHCl3-Me2CO, 9:1), 380-403 (CHCl3-Me2CO, 7:3), 
404-413 (CHCl3-Me2CO, 1:1), 414-416 (CHCl3–MeOH, 1:1). Sub-fractions 230-
326 were combined (263 mg) and recrystallized in CHCl3 to give additional 11 mg 
of EC10. 
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4.3.3. Neosartorya laciniosa KUFC 7896 
 
N. laciniosa KUFC 7896 was cultured for one week in five 90 mm Petri 
dishes containing 25 ml of malt extract agar (MEA) with 70% sea water per dish. 
Thirty 1000 ml Erlenmeyer flasks, each containing 200 g rice and 200 ml water, 
were autoclaved, inoculated with ten mycelia plugs of the fungus and incubated at 
28 ºC for 30 days. The moldy rice was macerated in EtOAc (12 L total) for five 
days and then filtered. The two layers were separated using a separatory funnel, 
and the EtOAc solution was concentrated at a reduced pressure to yield 72 g of 
crude EtOAc extract, which was applied on a column chromatography of Silica gel 
(800 g), and eluted with mixtures of CHCl3-petrol and CHCl3-Me2CO, 250 ml 
fractions were collected as follows: fractions 1-19 (CHCl3-petrol, 3:7), 20-114 
(CHCl3-petrol, 1:1), 115-188 (CHCl3-petrol, 7:3), 189-340 (CHCl3-petrol, 9:1), 341-
484 (CHCl3-Me2CO, 9:1), 485-547 (CHCl3-Me2CO, 7:3), 548-603 (CHCl3-Me2CO, 
1:1).  
Fractions 348-364 were combined (7.73 g) and chromatographed over a 
column of LiChroPrep Si 60 (0.04–0.063 mm Merck, 114.01 g) and eluted with 
mixtures of CHCl3-petrol and CHCl3-Me2CO, wherein 100 mL sub-fractions were 
collected as follows: sub-fractions 1-95 (CHCl3-petrol, 7:3), 96-129 (CHCl3-petrol, 
9:1), 130-143 (CHCl3-Me2CO, 9:1), 144-165 (CHCl3-Me2CO, 4:1). Sub-fractions 
39-51 were combined (825.3 mg) and chromatographed over a column of 
LiChroPrep Si 60 (0.04–0.063 mm Merck, 22.6 g) and eluted with mixtures of 
CHCl3-petrol and CHCl3-Me2CO, wherein 100 mL sub-sub-fractions were collected 
as follows: sub-sub-fractions 1-52 (CHCl3-petrol, 3:2), 53-66 (CHCl3-petrol, 4:1), 
67-80 (CHCl3), 81-105 (CHCl3-Me2CO, 4:1). Sub-sub-fractions 15-49 were 
combined (271.1 mg) and purified by TLC (Si Gel, CHCl3 : Me2CO : HCO2H, 
97:3:1) to give 37.9 mg of NL1. 
Fractions 365-396 were combined (3.35 g) and recrystallized in Me2CO to 
give 24.1 mg of NL2. The mother liquor of fractions 365-396 (3.32 g) and fractions 
397-408 (465.7 mg) were combined and chromatographed over a column of 
LiChroPrep Si 60 (0.04–0.063 mm Merck, 43.4 g), and eluted with mixtures of 
CHCl3-petrol and CHCl3-Me2CO, wherein 100 mL sub-fractions were collected as 
follows: sub-fractions 1-43 (CHCl3-petrol, 7:3), 44-56 (CHCl3-petrol, 9:1), 57-81 
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(CHCl3-Me2CO, 9:1), 82-108 (CHCl3-Me2CO, 4:1). Sub-fractions 18-22 were 
combined (706.2 mg) and recrystallized in Me2CO to give an additional 51.1 mg of 
NL2. Fractions 435-437 were combined (625.2 mg) and recrystallized in Me2CO to 
give 12.8 mg of NL3. The mother liquor of fractions 435-437, fractions 409-434 
and fractions 438-448 were combined (2.45 g) and chromatographed over a 
column of LiChroPrep Si 60 (0.04–0.063 mm Merck, 32.5 g) and eluted with 
mixtures of CHCl3-petrol and CHCl3-Me2CO, wherein 100 ml sub-fractions were 
collected as follows: sub-fractions 1-45 (CHCl3-petrol, 7:3), 46-62 (CHCl3-petrol, 
9:1). Sub-fractions 30-32 were combined (209.1 mg) and recrystallized in Me2CO 
to give an additional 8.3 mg of NL3.  
Fractions 449-465 were combined (826.0 mg) and recrystallized in Me2CO 
to give 24.4 mg of NL4. Fractions 508-546 were combined (1.57 g) and 
recrystallized in Me2CO to give 26.6 mg of NL5. The mother liquor of fractions 
508-546 (1.57 g) was combined with fractions 498-507 (793 mg) and 
chromatographed over a LiChroPrep Si 60 column (0.04–0.063 mm Merck, 36 g) 
and eluted with mixtures of CHCl3-petrol and CHCl3-Me2CO wherein 100 ml sub-
fractions were collected as follows: sub-fractions 1-84 (CHCl3-petrol, 9:1), 85-137 
(CHCl3-Me2CO, 9:1), 138-162 (CHCl3-Me2CO, 4:1). Sub-fractions 43-50 were 
combined (214 mg) and recrystallized in Me2CO to give 13 mg of NL6. 
 
4.3.4. Neosartorya paulistensis KUFC 7897 
 
The fungus was cultured for two weeks at 28ºC in 10 Petri dishes (i.d. 90 
mm) containing 25 mL of MEA with 70% sea water per dish. Fifty 1000 mL 
Erlenmeyer flasks, each containing rice (200 g), water (30 mL), and sea water (70 
mL), were autoclaved, inoculated with five mycelia plugs of N. paulistensis KUFC 
7897 and incubated at 28ºC for 30 days, after which the mouldy rice was 
macerated in ethyl acetate (15 L total) for 10 days and then filtered. The two layers 
were separated using a separatory funnel and the ethyl acetate solution was 
concentrated at a reduced pressure to yield crude ethyl acetate extract, which was 
washed with 5% of NaHCO3 solution (2 x 500 mL) and H2O (3 x 500 mL). The 
organic layer was dried with anhydrous Na2SO4, filtered and evaporated under 
reduced pressure to give 51 g of crude extract which was applied on a column 
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chromatography over Si gel (0.2-0.5 mm Merck, 610 g) and eluted with mixtures of 
CHCl3-petrol and CHCl3-Me2CO, wherein 250 mL fractions were collected as 
follows: fractions 1-25 (CHCl3-petrol, 1:4), 26-149 (CHCl3-petrol, 3:7), 150-177 
(CHCl3-petrol, 2:3), 178-278 (CHCl3-petrol, 1:1), 279-399 (CHCl3-petrol, 3:2), 400-
534 (CHCl3-petrol, 4:1), 535-549 (CHCl3-petrol, 9:1), 550-592 (CHCl3), 593- 837 
(CHCl3-Me2CO, 9:1), 838-976 (CHCl3-Me2CO, 4:1), 977-1047 (CHCl3-Me2CO, 
7:3), 1048-1090 (CHCl3-Me2CO, 1:1) and 1091-1112 (CHCl3-Me2CO, 1:4).  
Fractions 299-307 (526 mg) were combined and recrystallized in petrol to 
give 12 mg of NP1. Fractions 627- 696 were combined (1.50 g) and crystallized in 
a mixture of CHCl3 and Me2CO to give 70 mg of NP2. Fractions 739-774 were 
combined (400 mg) and crystalized in Me2CO to give 95 mg of NP3.  
The mother liquor of fractions 739-774 and fractions 697-738 were 
combined (850 mg), applied on a column chromatography of LiChroPrep Si 60 
(0.04–0.063 mm Merck, 46 g) and eluted with mixtures of CHCl3-petrol and CHCl3-
Me2CO, wherein 100 mL sub-fractions were collected as follows: sub-fractions 1-
24 (CHCl3-petrol, 4:1), 25-49 (CHCl3-petrol, 9:1), 50-63 (CHCl3), 64-142 (CHCl3-
Me2CO, 9:1) and 143-163 (CHCl3-Me2CO, 4:1). Sub-fractions 82-86 were 
combined (31 mg) and purified by TLC (Si gel, CHCl3 : Me2CO : EtOAc : HCO2H, 
7:2:1:0.1) to give 8.3 mg of NP2 and 9.6 mg of NP4. Sub-fractions 87-102 were 
combined (250 mg) and purified by TLC (Si gel, CHCl3 : Me2CO : EtOAc : HCO2H, 
7:2:1:0.1) to give additional 38 mg of NP2 and 18 mg of NP3. Sub-fractions 103-
130 were combined (157 mg) and crystallized in Me2CO to give additional 27 mg 
of NP3.  
Fractions 775 -832 were combined (690 mg) and crystalized in Me2CO to 
give 95 mg of NP5, and the mother liquor was combined with fractions 833-860 
were combined (902 mg), applied over a LiChroprep Si 60 column (0.04–0.063 
mm Merck, 41 g) and eluted with mixtures of CHCl3-petrol and CHCl3-Me2CO 
wherein 100 ml sub-fractions were collected as follows: sub-fractions 1-26 (CHCl3-
petrol, 4:1), 27-41 (CHCl3), 42-108 (CHCl3-Me2CO, 9:1). Sub-fractions 61-68 were 
combined and purified by TLC (Si gel, CHCl3 : Me2CO : EtOAc : HCO2H, 7:2:1:0.1) 
to give 4.2 mg of NP2 and 18 mg of NP3. Sub-fractions 69-86 were combined (176 
mg) and recrystallized in Me2CO to give 15 mg of NP5. Fractions 905-947 were 
combined (670 mg) and crystalized in Me2CO to give 16.4 mg of NP6. 
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4.4. Physical Characteristics and Spectroscopic 
Data 
 
Ergosterol (EV1): White amorphous solid (mp 157-159 ºC); 1H and 13C NMR (See 
Table 2). 
 
Ergostel peroxide (EV2): Colorless needles; 1H and 13C NMR (See Table 3). 
 
Orcinol (EV3): Colorless mass; 1H and 13C NMR (See Table 4). 
 
1H-Indole-3-carboxylic acid (EV4): White amorphous solid; 1H and 13C NMR 
(See Table 5). 
 
Cyclo-(L-Tryptophyl-L-phenylalanyl) (EV5): White solid; 1H and 13C NMR (See 
Table 11).       
 
Erythroglaucin (EC1): Red needles (mp 204-206 ºC); 1H and 13C NMR (See 
Table 6). 
 
Physcion (EC2): Orange needles (mp 202-203 ºC); 1H and 13C NMR (See Table 
7). 
 
Catenarin (EC3): Dark orange amorphous solid; 1H and 13C NMR (See Table 8). 
 
Emodin (EC4): Light orange/yellow amorphous solid; 1H and 13C NMR (See Table 
9). 
 
Questin (EC5): Orange/yellow amorphous solid (mp 290-291 ºC); 1H and 13C 
NMR (See Table 10). 
 
Echinulin (EC6): White amorphous solid; 1H and 13C NMR (See Table 16). 
 
Neoechinulin (EC7): Purple solid; 1H and 13C NMR (See Table 14). 
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Neoechinulin A (EC8): Dark red amorphous solid (mp 262-264 ºC); 1H and 13C 
NMR (See Table 12). 
 
Neoechinulin E (EC9): Orange-red amorphous solid; 1H and 13C NMR (See Table 
13). 
 
Eurocristatine (EC10): White crystals (mp 244-245 ºC); [α]20D = +300 (c 0.02, 
MeOH); UV (MeOH) λmax (log ε) 212 (4.5), 241 (4.2), 302 (3.9) nm; IR (KBr) ʋmax 
3450, 3190, 2961, 1662, 1453, 1326 cm-1; 1H and 13C NMR (See Table 17); (+)-
HR-ESIMS m/z 569.2905 [M+H]+ (calculated for C32H37N6O4, 569.2876). 
 
Chevalone B (NL1): Colorless crystals (mp 161-163 ºC); [α]20D = +11 (c 0.12, 
CHCl3); IR (KBr) ʋmax 2937, 1702, 1585, 1378, 1240 cm
-1; 1H and 13C NMR (See 
Table 18); (+)-HR-ESIMS m/z 457.2949 [M+H]+ (calculated for C28H41O5, 
457.2954). 
 
Aszonapyrone A (NL2): Colorless crystal (mp 242-244 ºC); [α]25D = -100 (c 0.02, 
CHCl3); 
1H and 13C NMR (See Table 19); (+)-HR-ESIMS m/z 457.2954 [M+H]+ 
(calculated for C28H41O5, 457.2954). 
 
Aszonapyrone B (NL3): Colorless crystals (mp 171-173 ºC); 1H and 13C NMR 
(See Table 20).                           
 
Tryptoquivaline T (NL6): White solid (mp 258-260 ºC); [α]25D = -83.3 (c 0.04, 
MeOH); IR (KBr) ʋmax 3010, 2930, 2852, 1701, 1582, 1450, 1402, 1269 cm
-1; 1H 
and 13C NMR (See Table 28); (+)-HR-ESIMS m/z 445.1512 [M+H]+ (calculated for 
C28H41O5, 445.1512).       
 
Sartorypyrone C (NP1): White solid (mp 200-202 ºC); [α]25D = -73.5 (c 0.07, 
CHCl3); IR (KBr) ʋmax 3445, 2923, 2942, 2853, 1699, 1668, 1649, 1636, 1507, 
1124 cm-1; 1H and 13C NMR (See Table 22); (+)-HR-ESIMS m/z 415.2836 [M+H]+ 
(calculated for C26H38O4, 415.2848).     
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Tryptoquivaline L (NP2/NL4): Colorless crystal (mp 262-265 ºC); [α]20D = -30.5 (c 
0.02, MeOH); UV (CHCl3) λmax (log ε) 212 (4.69), 226 (4.53), 253 (sh 4.27), 275 
(sh 3.72), 312 (3.17), 301 (3.26) nm; 1H and 13C NMR (See Table 25); (+)-HR-
ESIMS m/z 433.1509 [M+H]+ (calculated for C23H21N4O5, 433.1512).      
 
Tryptoquivaline H (NP3): White solid (mp 246-248 ºC); [α]20D = -20.1 (c 0.03, 
MeOH); UV (CHCl3) λmax (log ε) 210 (4.23), 226 (4.18), 253 (sh), 275 (sh), 312 
(3.30), 301 (3.32) nm; 1H and 13C NMR (See Table 26); (+)-HR-ESIMS m/z 
419.13496 [M+H]+ (calculated for C22H19N4O5, 419.13500). 
 
4(3H)-Quinazolinone (NP4): Colorless crystals (mp 216-218 ºC); 1H and 13C NMR 
(See Table 23). 
 
3’- (4-Oxoquinazolin-3-yl) spiro [1H-indole-3,5’-oxolane] - 2,2’ - dione 
(NP5/NL5): White solid (mp 267-269 ºC); [α]20D = +19.7 (c 0.02, MeOH); UV 
(CHCl3) λmax (log ε) 212 (4.56), 263 (3.72), 301 (3.26), 312 (3.18) nm; 
1H and 13C 
NMR (See Table 24); (+)-HR-ESIMS m/z 348.0968 [M+H]+ (calculated for 
C19H14N3O4, 348.0984). 
 
Tryptoquivaline F (NP6): White solid; [α]20D = -120.0 (c 0.05, MeOH); 
1H and 13C 
NMR (See Table 27); (+)-HR-ESIMS m/z 403.1399 [M+H]+ (calculated for 
C22H19N4O4, 403.1406).          
   
4.5. X-Ray Crystallographic Analysis of EC10 and 
NL3  
 
Crystals suitable for X-ray diffraction were obtained by slow evaporation of 
a solution in methanol (for EC10) and acetone (for NL3). Diffraction data were 
collected at 293 K with a Gemini PX Ultra equipped with CuKa radiation (λ = 
1.54184 Å). The structures were solved by direct methods using SHELXS-97 
(Sheldrick, 1997a) and refined with SHELXL-97 (Sheldrick, 1997b). Carbon, 
oxygen, and nitrogen atoms were refined anisotropically. Hydrogen atoms were 
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either refined freely with isotropic displacement parameters or were positioned 
with an idealized geometry and refined riding on their parent C atoms. For EC10, 
tables containing the final fractional coordinates, temperature parameters, bond 
distances, and bond angles were deposited with the Cambridge Crystallographic 
Data Centre: CCDC reference number 879091. 
 
4.6. Biological Activity Assays  
 
4.6.1. Cytotoxic Activity Bioassays 
 
4.6.1.1. Samples: Stock solutions of the compounds were prepared in DMSO and 
kept at -20ºC. Appropriate dilutions of the compounds were freshly prepared just 
before the assays. 
 
4.6.1.2. Cell cultures: Three human tumour cell lines were used in this study: 
MCF-7 (breast adenocarcinoma, a kind gift from NCI, Bethesda, USA), NCI-H460 
(non-small cell lung cancer, NSCLC, a kind gift from NCI, Bethesda, USA) and 
A375-C5 (melanoma, ECACC, UK). Cells were routinely cultured in RPMI-1640 
with Ultraglutamine (Lonza) supplemented with 10% FBS (PAA) and maintained in 
a humidified incubator at 37 ºC with 5% CO2. Cell number and viability were 
determined with Trypan Blue exclusion assay. All experiments were performed 
with cells in exponential growth with viabilities over 90% and repeated at least 
three times. 
 
4.6.1.3. Cell growth inhibitory assay: The screening of fungal metabolites was 
performed with the Sulforhodamine B (SRB) assay adopted from the National 
Cancer Institute, USA (Vichai and Kirtikara, 2006). Briefly, cells were plated in 96 
well plates (5x103 cells/well for MCF-7 and NCI-H460 cells, and 7.5x103 cells/well 
for the A375-C5 cell line) and incubated at 37 ºC for 24 h. Exponentially growing 
cells were then treated with five dilutions of each compound. After 48 h of 
treatment, cells were fixed with 10% ice-cold trichloroacetic acid, washed and 
stained with SRB. After washing with 1% acetic acid, the bound SRB was 
solubilized with 10 mM Tris Base, and the absorbance was measured at 515 nm in 
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a microplate reader (Biotek Instruments). Then, a dose-response curve was 
obtained for each compound and the corresponding GI50 (the concentration of 
compound that inhibited 50% of net cell growth) was determined. The effect of the 
vehicle solvent (DMSO) on the growth of these cell lines was evaluated by treating 
cells with the maximum concentration of DMSO used in each assay (0.25%).   
 
4.6.2. Antifungal Activity Bioassays 
 
Antifungal activity of fungal metabolites was evaluated against yeast 
(Candida albicans), filamentous fungus (Aspergillus fumigatus) and dermatophyte 
(Trichophyton rubrum) strains: one American Type Culture Collection (ATCC) type 
strain (C. albicans ATTC 10231), one Aspergillus ATCC type strain (A. fumigatus 
ATCC 46645), and one dermatophyte clinical strain (T. rubrum FF5).  
The fungal isolates were identified by standard microbiology methods and 
stored on Sabouraud Dextrose broth with glycerol at -70ºC and subcultured in 
Sabouraud-Chloramphenicol agar. Minimal Inhibitory Concentration (MIC) was 
determined by a microdilution method according to the CLSI reference method 
M27-A2 for yeast (Wayne, 2002a), and M38-A for filamentous fungus (Wayne, 
2002b). The test was performed in sterile 96 flat-bottom well microtitration plates 
and the medium used was MOPS buffered RPMI 1640. Briefly, MICs were 
determined for yeast strain with the adjusted final inoculum of 1-4x104 CFU/mL, 
prepared from a 24-48 hours culture. With A. fumigatus ATCC 46645 the final 
inoculum used was 4-8x104 CFU/mL, prepared from a sporulated culture. Two fold 
serial dilutions of compounds in DMSO, ranging from 250 to 0.25 μg/mL, were 
tested. Fungal growth controls, with and without DMSO, were included. The final 
DMSO concentration was 2%, and did not affect the fungal growth. In addition, 
reference antifungal compounds, fluconazole (Pfizer, United Kingdom) for C. 
albicans ATTC 10231 and T. rubrum FF5 or amphotericin B (Sigma) for A. 
fumigatus ATCC 46645, were used as the standard antifungal drugs. Two fold 
serial dilutions ranging from 128 to 0.25 μg/mL for fluconazole and 16 to 0.063 
μg/mL for amphotericin B were used. Plates were incubated at 30ºC for 4-5 days 
for A. fumigatus ATCC 46645 and 8 days for T. rubrum FF5. All determinations 
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were performed in duplicate and three independent experiments lead to 
concordant results. 
 
4.6.3. Antibacterial Activity Bioassays 
 
4.6.3.1. Bacterial Strains: For the antibacterial bioassays, fungal metabolites 
were tested against reference strains, two Gram-positive (Staphylococcus aureus 
ATCC 25923 and Bacillus subtilis ATCC 6633) and two Gram-negative 
(Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) 
bacteria, and against multidrug-resistant isolates from the environment, S. aureus 
B1 and S. aureus B2 (isolated from public buses),  Enterococcus faecalis W1 and 
E. faecium W5 (isolated from river water) and E. coli G1 (isolated from seagull 
feces). These bacteria were grown in Mueller-Hinton agar (MH – BioKar 
diagnostics, France) from stock cultures. MH plates were incubated at 37°C prior 
to obtain fresh cultures for each in vitro bioassay. 
 
4.6.3.2. Determination of Minimum Inhibitory and Bactericidal 
Concentrations: The minimum inhibitory concentration (MIC) values of the 
compounds were determined by a broth microdilution technique, following the 
recommendations of the Clinical and Laboratory Standards Institute (Wayne, 
2011). Stock solutions of 10 mg/mL (prepared by dissolving each metabolite in 
DMSO (Applichem GmbH, Germany) were serial diluted in Mueller-Hinton broth 
(MHB - BioKar diagnostics, France) to achieve in-test concentrations ranging from 
2 to 256 µg/mL. Ciprofloxacin in the concentration range from 0.03125 to 16 
μg/mL was used as control drug in the experiment. A bacterial inoculum was 
prepared in MHB and standardized in order obtain a concentration of 5 x 105 
CFU/mL in each inoculated well of the microtiter plate. The concentration of 
DMSO in the highest in-test concentration did not affect the microbial growth. The 
MIC was defined as the lowest concentration of the compound that inhibited the 
visible growth. The minimum bactericidal concentration (MBC) was determined by 
spreading 10 µL on MH plates from the sample showing no visible growth and it 
was further incubated for 24 h at 37ºC; the lowest concentration at which no 
bacterial growth occurred on MB plates was defined as the MBC.  
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4.6.3.3. Synergistic Studies: A screening susceptibility test to assess combined 
effect between the compounds and antibiotics was conducted using the disc 
diffusion method on MH. Multidrug-resistant isolates were picked from overnight 
cultures in MH, and suspensions were prepared in buffered peptone water (Oxoid, 
England) by adjusting the turbidity to equal a 0.5 McFarland standard. A set of 
antibiotic discs (Oxoid, England) was selected based on the resistance of the 
isolates towards those antibiotics. Antibiotic discs alone (controls) and 
impregnated with 15 µL of a 1 mg/mL solution (in DMSO) of each metabolite were 
placed on the agar plate seeded with the respective bacteria. 15 µL of DMSO 
impregnated in a sterile filter paper disc (6 mm in diameter) (Oxoid, England) was 
used as the negative control. Inoculated MH plates were incubated overnight at 
37°C. Each compound was tested in duplicate. Potential synergism was recorded 
when the halo of antibiotic discs impregnated with metabolites was greater than 
the halo of antibiotic discs or compound-impregnated blank discs alone.  
Based on the results of the previous assay, potential synergism between 
the most promising compound NL2 and antibiotics (oxacillin, vancomycin and 
ampicillin - Sigma-Aldrich, USA) was checked using a broth microdilution 
checkerboard method and tested against S. aureus MRSA and Enterococcus spp. 
VRE isolates. Briefly, the stock solutions and serial twofold dilutions of the 
compound and antibiotic to at least double the MIC were prepared according to 
the recommendations of CLSI (Wayne, 2011). The metabolite to be tested was 
serially diluted along the ordinate, while the antibiotic was diluted along the 
abscissa. A bacterial inoculum equal to a 0.5 McFarland turbidity standard was 
prepared in MHB. Each microtiter plate well was inoculated with 100 µL of a 
bacterial inoculum of 5 x 105 CFU/mL, and the plates were incubated overnight at 
37ºC. The fractional inhibitory concentration (FIC) was calculated as follows: FIC 
of drug A (FIC A) = MIC of drug A in combination/MIC of drug A alone, and FIC of 
drug B (FIC B) = MIC of drug B in combination/MIC of drug B alone. The FIC index 
(ΣFIC), calculated as the sum of each FIC, was interpreted as follows: ΣFIC  ≤ 0.5, 
synergy; 0.5 <  ΣFIC  ≤ 4, no interaction; 4 <  ΣFIC, antagonism (Odds, 2003). 
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4.6.3.4. Antibiofilm Activity Assay: Giving the promising antibacterial activity of 
NL2 against Gram-positive bacteria, the efficacy of the compound in interrupting 
the biofilm formation was assessed. The metabolite at concentrations of 2x MIC, 
MIC, 1/2x MIC and 1/4x MIC was added to bacterial suspensions of 1 x 106 
CFU/ml in Tryptic Soy broth (TSB - BioKar diagnostics, France). Bacterial 
suspension without metabolite was used as the control. Each broth culture 
obtained was dispensed into a 96-well microtiter plate (200 µL/well) and incubated 
at 37ºC for 24 h. After that time, biofilm was stained with 0.5% crystal violet for 5 
min, rinsed with water, air dried and eluted with acetic acid 33% (v/v).  The optical 
density was measured at 595 nm (OD595) using a microplate reader (iMark™ 
microplate absorbance reader, Bio-Rad Laboratories, USA). Two independent 
experiments were performed in triplicate for each experimental condition. The 
statistical significance of difference between biofilms of controls and biofilms in the 
presence of different concentrations of compound was evaluated using Student’s t 
test. In both cases, probability levels < 0.05 were considered statistically 
significant. The efficacy of NL2 on established biofilm of S. aureus B1 and E. 
faecalis W1 was also evaluated by determining the biofilm inhibitory concentration 
(BIC) according to the method described by Johnson et al., (2002). Briefly, 
bacterial suspensions in TSB at 1 x 106 CFU/mL, were used to grow the biofilms in 
96-well microtiter plate. After 24 h of incubation at 37ºC, the planktonic cells were 
gently removed and the wells were rinsed once and filled with different dilutions 
ranging from the MIC values to 12 x MIC. The OD595 was measured at time 0 and 
after incubation for 24 h at 37ºC. The BIC was determined as the lowest 
concentration of the compound inhibiting growth in the supernatant fluid, confirmed 
by no increase in optical density compared with the initial reading. 
Additionally, microscopic visualization of biofilms of S. aureus ATCC 25923 
was performed using the Live/Dead BacLight viability kit (Molecular Probes, USA). 
Biofilms were formed in 35-mm diameter polystyrene plates using TSB (control) 
and TSB supplemented with MIC and 1/2 x MIC of NL2. After 24 h at 37ºC, the 
planktonic phase was removed from each plate, washed with PBS, stained with 
the appropriate mixture of SYTO 9 and propidium iodide stains and incubated for 
20 minutes at room temperature in the dark; then, were rinsed and examined 
under a fluorescence microscope (BX41 Microscope, Olympus America Inc., 
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USA). Images were recorded at an emission wavelength of 500 nm for SYTO 9 
(green fluorescence) and of 635 nm for propidium iodide (red fluorescence). 
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This study aimed, mainly, to investigate the secondary metabolites 
produced by selected marine-derived fungi (Emericella variecolor KUFC 7092, 
Eurotium cristatum KUFC 7356, Neosartorya laciniosa KUFC 7896 and 
Neosartorya paulistensis KUFC 7897), collected from the Gulf of Thailand, as well 
as to evaluate their relevant biological activity.  
 A total of twenty-five compounds, including three new derivatives, were 
isolated comprising diverse structural groups of compounds including terpenes, 
alkaloids and polyketides. This chemical diversity clearly highlighted marine-
derived fungi biosynthetic capabilities for the production of novel and diverse 
chemical structures. 
 However, despite the corresponding structural diversity, most of the isolated 
compounds have a terrestrial counterpart, or are structurally related to that of 
terrestrial fungi, which can be justified by two major reasons. In one hand, so far 
there is no evidence that marine fungi actively grow in the host macroorganims. 
Most reported species appear to be terrestrial species, washed into to the sea, or 
facultative marine fungi (Proksch et al., 2010). On the other hand, culture 
conditions mimicking the natural environment of this marine-derived fungal species 
is critical, not only to overcome the low culturability of some species, but also to 
activate the metabolic pathways that remain silent under standard culturing 
conditions (Kjer et al., 2010; Zengler et al., 2002). 
This study, together with the latest research results from our research 
group, as well as literature reports dealing with the isolation of secondary 
metabolites from marine fungi, clearly support that the standard procedure of mere 
addition of sea water to the culture media is a limited approach for mimicking the 
marine natural environment, and subsequent production of metabolites with higher 
chemical diversity. To overcome this limitation, several studies point to different 
culturing approaches such as the OSMAC (One Strain, Many Compounds) 
concept (Bills et al., 2008; Bode et al., 2002) and co-culturing (Bertrand et al., 
2013; Rateb et al., 2013; Røssland et al., 2006). 
 
Despite the referred limitations, marine-derived fungal secondary 
metabolites already proved to be a promising source for the development of new 
therapeutic agents (Bugni and Ireland, 2004; Rateb and Ebel, 2011; Saleem et al., 
2007). For the assessment of their biological properties, some of the isolated 
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compounds were screened for antibacterial, antibiofilm, antifungal and anticancer 
activities.  
The burden of cancer is increasing largely being the leading cause of death 
in economically developed countries, and the second leading cause of death in 
developing countries (Jernal et al., 2011). The limited therapeutic arsenal of 
chemotherapeutic agents led to the urgency for more research in this area, with 
marine natural products playing a preponderant role as referred in Chapter I. 
Several compounds resulting from this study were tested against the three human 
cancer cell lines MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung 
cancer) and A375-C5 (melanoma). Among them, aszonapyrone A, the 
meroterpenoid isolated from the fungus Neosartorya laciniosa KUFC 7896, 
displayed strong in vitro growth inhibitory activity against the tested human cancer 
cell lines. Thus, aszonapyrone A represents a novel chemical scaffold with 
potential for the development of new anticancer derivatives.  
Also infectious diseases are leading health problems with high morbidity 
and mortality in the developing countries. Since the mid-1970s, resistance to 
antimicrobial agents has become an escalating problem (Johnson et al., 2001). In 
the last thirty years, treatment of infections caused by Gram-positive bacteria has 
been more problematic than ever, with infections being caused by multidrug-
resistant organisms, particularly methicillin-resistant staphylococci, penicillin- and 
erythromycin-resistant pneumococci, and vancomycin-resistant enterococci 
(Aksoy and Unal, 2008). Although there is a continuing effort in the pharmaceutical 
industry to develop new antimicrobial agents for the treatment of resistant 
infections, pursuing new antibiotic drugs is still a fair and necessary strategy to 
combat the multidrug-resistant bacteria that are spreading both in the community 
and clinical setting (Bassetti et al., 2013). Additionally, biofilm-related infections 
are extremely common nocosomial infectious (Donlan and Costerton, 2002) and 
account for significant morbidity and mortality. Biofilm formation at the surface of 
implants and prostheses are responsible for the failure of several antibiotics, with a 
limited number showing to be effective against biofilms (Gualtieri et al., 2006).  
In light of the results presented in this study, we can conclude that the 
meroditerpene aszonapyrone A is a promising antibacterial agent, especially 
against Gram-positive bacteria, and its effect are comparable to those of standard 
antibiotics currently in use in therapeutics, with the advantage of being also active 
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against bacteria that already exhibit resistance towards these antibiotics. 
Additionally, aszonapyrone A was also found to inhibit the biofilm formation in both 
reference strains and multi-drug resistant isolates. To the best of our knowledge, 
none of the available antibiotics belongs to this class of compounds, which thereby 
may represent a novel and potential topic of investigation in the field of new 
antibacterial agents from the marine-derived fungi. 
Despite the lack of activity of the new compounds, eurocristatine, 
sartorypyrone C and tryptoquivalines T, on the selected biological activity assays, 
they should be considered the starting point for other biological activity assays, 
against different diseases.  
 
The isolation of twenty-one metabolites for the first time from the selected 
species contributed to a new insight, not only identifying new sources of fungal 
metabolites with relevant biological properties reported, but also due to their 
chemotaxonomic value. A single metabolite or metabolite pattern, frequently can 
point to a specific fungal taxon or series of taxa (Frisvad et al., 2008). 
Consequently, the isolation of some of the compounds during this study can be 
useful and classified as an additional tool for the purpose of taxonomic 
identification, in addition to the morphological and genomic classification.  
 
The marine environment is a potential and tremendous source of 
biologically active metabolites, extremely valuable for the development of new 
drugs. This study confirms once more that marine-derived fungi are a prolific 
source for the discovery of new and interesting natural products, with potential for 
the development of new drugs, specifically antibiotic and anticancer agents. 
 
Relevant cytotoxic and antibacterial properties of aszonapyrone A can be 
considered potential to provide a new alternative for the development of new 
anticancer and antibacterial agents in the future, and eurocristatine, sartorypyrone 
C and tryptoquivaline T chemical scaffolds can inspire the development of new 
derivatives that could be useful against other diseases.   
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I.1. Ergosterol (EV1) 
I.1.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
I.1.2. 13C NMR spectrum (75.47 MHz) 
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I.2. Ergosterol peroxide (EV2) 
I.2.1. 1H NMR spectrum (500.13 MHz) 
 
 
 
I.1.2. 13C NMR spectrum (125.77 MHz) 
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I.3. Orcinol (EV3) 
I.3.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
I.3.2. 13C NMR spectrum (75.47 MHz) 
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I.4. 1H-Indole-3-carboxylic acid (EV4) 
I.4.1. 1H NMR spectrum (500.13 MHz) 
 
 
 
 
I.4.2. 13C NMR spectrum (125.77 MHz) 
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I.5. cyclo-(L-Tryptophyl-L-phenylalanyl) (EV5) 
I.5.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
I.5.2. 13C NMR spectrum (75.47 MHz) 
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I.6. Erythroglaucin (EC1) 
I.6.1. 1H NMR spectrum (500.13 MHz) 
 
 
 
 
 
I.6.2. 13C NMR spectrum (125.77 MHz) 
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I.7. Physcion (EC2) 
I.7.1. 1H NMR spectrum (500.13 MHz) 
 
 
 
 
 
I.7.2. 13C NMR spectrum (125.77 MHz) 
 
 
 
 
 
 276 
 
APPENDIX I. NMR SPECTRA OF THE ISOLATED COMPOUNDS 
 
I.8. Catenarin (EC3) 
I.8.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.8.2. 13C NMR spectrum (75.47 MHz) 
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I.9. Emodin (EC4) 
I.9.1. 1H NMR spectrum (500.13 MHz) 
 
 
 
 
 
I.9.2. 13C NMR spectrum (125.77 MHz) 
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I.10. Questin (EC5) 
I.10.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.10.2. 13C NMR spectrum (75.47 MHz) 
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I.11. Echinulin (EC6) 
I.11.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.11.2. 13C NMR spectrum (75.47 MHz) 
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I.12. Neoechinulin (EC7) 
I.12.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.12.2. 13C NMR spectrum (75.47 MHz) 
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I.13. Neoechinulin A (EC8) 
I.13.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.13.2. 13C NMR spectrum (75.47 MHz) 
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I.14. Neoechinulin E (EC9) 
I.14.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.14.2. 13C NMR spectrum (75.47 MHz) 
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I.15. Eurocristatine (EC10) 
I.15.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.15.2. 13C NMR spectrum (75.47 MHz) 
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I.16. Chevalone B (NL1) 
I.16.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.16.2. 13C NMR spectrum (75.47 MHz) 
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I.17. Aszonapyrone A (NL2) 
I.17.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.17.2. 13C NMR spectrum (75.47 MHz) 
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I.18. Aszonapyrone B (NL3) 
I.18.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.18.2. 13C NMR spectrum (75.47 MHz) 
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I.19. Tryptoquivaline L (NP2/NL4) 
I.19.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.19.2. 13C NMR spectrum (75.47 MHz) 
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I.20. 3’-(4-Oxoquinazolin-3-yl)spiro[1H-indole-3,5’-oxolane]-2,2’-
dione (NP5/NL5) 
I.20.1. 1H NMR spectrum (300.13 MHz) 
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I.21. Tryptoquivaline T (NL6) 
I.21.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.21.2. 13C NMR spectrum (75.47 MHz) 
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I.22. Sartorypyrone C (NP1) 
I.22.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.22.2. 13C NMR spectrum (75.47 MHz) 
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I.23. Tryptoquivaline H (NP3) 
I.23.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.23.2. 13C NMR spectrum (75.47 MHz) 
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I.24. 4(3H)-Quinazolinone (NP4) 
I.24.1. 1H NMR spectrum (500.13 MHz) 
 
 
 
 
 
I.24.2. 13C NMR spectrum (125.77 MHz) 
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I.25. Tryptoquivaline F (NP6) 
I.25.1. 1H NMR spectrum (300.13 MHz) 
 
 
 
 
 
I.25.2. 13C NMR spectrum (75.47 MHz) 
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1. Introduction
Eurotium species are the sexual states of Aspergillus species,
notably the Aspergillus glaucus group among others (Geiser, 2009).
Contrary to Aspergillus, only few species of Eurotium have been
investigated for their secondary metabolites. Smetanina et al. (2007)
have reported isolation of the anthraquinone physcion, asperﬂavin,
the prenyl benzaldehyde tetrahydroauroglaucin and the dioxopi-
perazine alkaloid echinulin from the ethyl acetate extract of the
culture of E. repens, isolated from the marine sponge Suberites
domuncula. Li et al. (2008a,b) reported isolation of a series of
dioxopiperazine alkaloids and prenyl benzaldehyde derivatives
from the culture of E. rubrum, an endophytic fungus isolated from the
inner tissue of stems of the mangrove plant Hibiscus tiliaceus. In the
process of investigation of the secondary metabolites from Eurotium
and Aspergillus species, common in Canadian homes, Slack et al.
(2009) have found that the dioxopiperazine derivatives neoechi-
nulin A, neoechinulin B, and epiheveadride were present in the
ﬁltrate extracts of E. rubrum and E. amstelodami, while the ﬁltrate
extract of E. herbariorum contained cladosporin in addition to these
three compounds; however, only the prenyl benzaldehydes
ﬂavoglaucin, auroglaucin and isotetrahydroauroglaucin were found
in the mycelial extracts of the three species. Recently, Kanokmed-
hakul et al. (2011) have reported isolation of the meroterpenoids
chevalones A–D, aszonapyrone A, aszonapyrone B, the sesquiter-
pene alkaloid eurochevalierine, and terpenoid pyrrolobenzoxazine
CJ-12662 from the culture of E. chevalieri. In the course of our
investigation on bioactive metabolites from the marine-derived
fungi, we have recently found that the ethyl acetate extract of the
culture of the marine sponge-associated Eurotium cristatum KUFC
7356 and some of its constituents exhibited the in vitro growth
inhibitory activity on three cancer cell lines (Almeida et al., 2010). In
order to discover more new bioactive metabolites, we have
recultured this fungus to obtain more extract from which a new
diketopiperazine dimer, eurocristatine (1) (Fig. 1) was isolated, in
addition to eight known metabolites including the anthraquinones
erythroglaucin (Anke et al., 1980), physcion (Anke et al., 1980),
catenarin (Anke et al., 1980), emodin (Manojlovic´ et al., 2000) and
the dioxopiperazine alkaloids echinulin (Smetanina et al., 2007),
neoechinulin A (Li et al., 2008a), neoechinulin E (Li et al., 2008a),
variecolorin J (Wang et al., 2007).
2. Results and discussion
Eurocristatine (1) was isolated as white crystals and its IR
spectrum showed absorption bands for amine (3450 cm1),
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aromatic (3190 cm1) and carbonyls (1662 cm1) groups. The 13C
NMR, DEPT and HSQC spectra (Table 1) revealed the presence of 16
carbon signals which can be categorized as 2 amide carbonyls (dC
168.4 and 167.5), 2 quaternary sp2 (dC 149.1 and 130.4), 4 methine
sp2 (dC 128.7, 124.4, 117.9, 108.9), 1 quaternary sp
3 (dC 59.7), 4
methine sp3 (dC 78.8, 62.3, 55.7, 32.0), 1 methylene sp
3 (dC 37.3)
and 2 methyl (dC 19.0 and 18.0) carbons. However, the (+)-
HRESIMS exhibited the m/z 569.2905 [M+H]+, which corre-
sponded to the molecular formula C32H36N6O4, implying that
each carbon signal must correspond to two carbon atoms. The
coupling system of the aromatic protons observed in the COSY
spectrum (Table 1) revealed the presence of one 1,2-disubstituted
benzene ring. The HMBC spectrum (Table 1 and Fig. 2) exhibited
correlations of the proton signal at dH 6.74 brs (NH-1) to the
carbon signals at dC 59.7 (C-3), 78.8 (C-2), 130.4 (C-4) and 149.1
(C-9), conﬁrming that the 1,2-disubstituted benzene ring was part
of the indole moiety of the molecule. The HMBC spectrum (Table 1
and Fig. 2) also showed cross peaks between the signal of NH-14
(dH 8.27d, J = 4.2 Hz) and the methine carbon signals at dC 55.7 (C-
11), dC 62.3 (C-15); the carbonyl carbons at dC 167.5 (C-16), 168.4
(C-13), indicating that another portion of the molecule was a 1,4-
diketopiperazine system. That the 1,4-diketopiperazine moiety
was linked to the indole ring system through C-2 of the latter and
N-10 of the former, and through the methylene group between C-
3 of the latter and C-11 of the former, was evidenced by
correlations between H-11 signal (dH 4.12, t, J = 9.0 Hz) and the
signals of H-12 (dH 3.14, dd, J = 14.0, 9.5; 2.39, dd, J = 14.0, 9.5) in
the COSY spectrum as well as the correlations of the signal of H-
12a (dH 2.39, dd, J = 14.0, 9.5) to the signals of C-3 (dC 59.7), C-4 (dC
130.4), C-13 (168.4) (Table 1 and Fig. 2). Analysis of the COSY
spectrum (Table 1) also revealed the presence of the isopropyl
substituent [dH 1.94, m (1H), 0.80, d (3H, J = 6.7 Hz), 0.69, d (3H,
J = 6.7 Hz); dC 32.0, 19.0, 18.0, respectively], which, through the
correlations observed in the HMBC spectrum of the methyl proton
signals at dH 0.80, d (3H, J = 6.7 Hz) and 0.69, d (3H, J = 6.7 Hz) to
the methine carbon signal at dC 62.3 (C-15) and the correlation
Table 1
1H and 13C NMR data of eurocristatine (1) in DMSO-d6 (
1H 300.13 MHz, 13C 75.47 MHz).
Position dC, type dH (J in Hz) COSY HMBC
a NOESY
1 – 6.74, brs H-2 C-2, 3, 4, 9 H-2
2 78.8, CH 4.90, brs H-1 H-1, 11
3 59.7, C –
4 130.4, C –
5 124.4, CH 7.39, d (7.5) H-2 C-3, 7, 9 H-6, 12b
6 117.9, CH 6.63, dd (7.5, 7.5) H-5, 7 C-4, 8
7 128.7, CH 7.02, dd, (7.5, 7.5) H-6, 8 C-5, 9
8 108.9, CH 6.60, d (7.5) H-7
9 149.1, C
11 55.7, CH 4.12, t (9.0) H-12a, 12b C-12, 13 H-2, 17, 18, 19
12a 37.3, CH2 2.39,dd (14.0, 9.5) H-11, 12b C-3, 4, 11, 13 12b
12b 3.14,dd (14.0, 9.5) H-11, 12a C-3, 4, 11, 13 H-5, 12a
13 168.4, CO
14 – 8.27, d (4.2) H-15 C-11, 13, 15, 16 H-17, 18, 19
15 62.3, CH 3.39, t (5.0) H-14, 17 C-13, 16, 17, 18, 19
16 167.5, CO –
17 32.0, CH 1.94, m H-15, 18, 19 C-15, 16, 18, 19 H-11, 18, 19
18 19.0, CH3 0.80, d (6.7) H-17 C-15, 18, 19 H-17, 19
19 18.0, CH3 0.69, d (6.7) H-17 C-15, 18, 19 H-17, 18
a HMBC correlations are from proton(s) stated to the indicated carbon.
NN
N H
H
CH
3
CH
3
O
O
H
H
N N
NH
O
O
CH
3
CH
3
H
H
H
5
6
7
8
4
9
19
1
2
3 12
13
14
10
15
17
18
16
11
5'
6'
8'
9'
1'
4'
2'
3'
10'
11'
12'
13'
14'
15'
16'
17'
18' 19'
1
7'
Fig. 1. Structure of eurocristatine (1).
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between the signals of NH-14 (dH 8.27, d, J = 4.2 Hz) and H-15 (dH
3.39, t, J = 5.0 Hz) in the COSY spectrum, was placed on C-15 of the
1,4-diketopiperazine ring. The cross peaks observed in the NOESY
spectrum between the signals of H-2/H-11 and H-11/H-17, H-11/
H3-18, H-11/H3-19, suggested that the isopropyl substituent was
a oriented. Taking altogether the NMR data, the partial structure A
(C16H18N3O2) was proposed (Fig. 2). Since the (+)-HRESIMS gave
the molecular formula C32H36N6O4, the complete structure of
eurocristatine (1) must comprise two A units connected to each
other through C-3 (Fig. 1). Final proof of the structure and
stereochemistry assigned to eurocristatine (1) was provided by an
X-ray analysis which established the absolute conﬁguration of C-
2/20, C-3/30, C-11/110and C-15/150, respectively as 2/20R, 3/30S, 11/
110S and 15/150R. The result depicted in the ORTEP view shown in
Fig. 3 also revealed the symmetrical nature of eurocristatine (1).
Although several diketopiperazine dimers have been previously
reported from many fungal sources, and especially from
Aspergillus species (Barrow et al., 1993; Barrow and Sedlock,
1994; Cai et al., 2012; Ding et al., 2008; Li et al., 2009; Ovenden
et al., 2004; Ruju et al., 2009; Son et al., 1999; Takahashi et al.,
1994, 1995a,b; Varoglu et al., 1997; Yamada et al., 2002),
eurocristatine (1) represents the ﬁrst diketopiperazine dimer
isolated from the genus Eurotium. The structure of eurocristatine
(1) closely resembles that of the diketopiperazine dimer isolated
from a marine-derived Aspergillus niger by Ovenden et al.
(2004) although eurocristatine is a symmetrical dimer whereas
asperdimin is not.
Eurocristatine (1) was evaluated for its in vitro growth
inhibitory activity against MCF-7 (breast adenocarcinoma),
NCI-H-460 (non-small lung cancer) and A375-C5 (melanoma)
cell lines using the protein binding dye SRB method (Kijjoa et al.,
2011) and results showed that it was inactive against all the three
cell lines at the highest concentration tested (150 mM). Euro-
cristatine (1) was also evaluated for its antifungal activity against
yeast (Candida albicans), ﬁlamentous fungus (Aspergillus fumiga-
tus) and dermatophyte (Trichophyton rubrum) as well as for its
antibacterial activity against Staphylococcus aureus, Escherichia
coli and Pseudomonas aeruginosa, according to the procedure
described by Wattanadilok et al. (2007) and no antimicrobial
activity was registered.
3. Experimental
3.1. General experimental procedures
Melting points were determined on a Bock monoscope and are
uncorrected. Optical rotations were determined on an ADP410
Polarimeter. Ultraviolet and infrared spectra were recorded on a
Shimadzu mini-1240UV-VIS spectrophotometer and on an ATT
Mattson Genesis Series FTIRTM using WinFIRST Software, respec-
tively. 1H and 13C NMR spectra were recorded at ambient
temperature on a Bruker AMC instrument operating at 300.13
and 75.4 MHz, respectively. High resolution mass spectra were
measured with a Waters Xevo QToF mass spectrometer coupled to
a Waters Aquity UPLC system. A Merck silica gel GF 254 was used
for preparative TLC, and a Merck Si gel 60 (0.2–0.5 mm) was used
for analytical chromatography.
3.2. Extraction of the metabolites
The fungus was isolated, identiﬁed, cultured and extracted
for its secondary metabolites according to the procedure
described in our previous report (Almeida et al., 2010). The
crude ethyl acetate extract was chromatographed over a 0.2–
0.5 mm Merck Si gel column (145 g) and eluted with mixtures of
CHCl3–petrol, CHCl3–Me2CO, CHCl3–MeOH, 250 mL fractions
were collected as follows: frs. 1–119 (CHCl3–petrol, 1:4), 120–
130 (CHCl3–petrol, 3:7), 131–163 (CHCl3–petrol, 2:3), 164–195
(CHCl3–petrol, 1:1), 196–234 (CHCl3–petrol, 3:2), 235–260
(CHCl3–petrol, 7:3), 261–273 (CHCl3–petrol, 4:1), 274–291
(CHCl3–petrol, 9:1), 292–300 (CHCl3), 301–348 (CHCl3–Me2CO,
9:1), 349–376 (CHCl3–Me2CO, 4:1), 377–394 (CHCl3–Me2CO,
1:1), 395–402 (CHCl3–MeOH, 1:1). Frs. 13–20 were combined
(154 mg) and recrystallized in a mixture of MeOH and CHCl3
to give 14 mg of erythroglaucin (Anke et al., 1980). Frs. 21–29
were combined (259 mg) and recrystallized in a mixture of
MeOH and CHCl3 to give 6 mg of physcion (Anke et al., 1980). Frs.
91–119 were combined (493 mg) and puriﬁed by TLC (Si Gel,
CH2Cl2:Me2CO:HCO2H, 98:2:1) to give 5 mg of catenarin (Anke
et al., 1980) and 5 mg of emodin (Manojlovic´ et al., 2000). Frs.
202–208 were combined (306 mg) and recrystallized in Me2CO
Fig. 3. ORTEP view of eurocristatine (1).
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to yield 53 mg of echinulin (Smetanina et al., 2007) and the
mother liquor (247 mg) was combined with frs. 191–201
(201 mg) and puriﬁed by TLC (Si Gel, CHCl3:Me2CO:HCO2H,
95:5:1) to give 5 mg of variecolorin J (Wang et al., 2007). Frs.
209–216 were combined (216 mg) and recrystallized in Me2CO
to give 51 mg of echinulin and the mother liquor (159 mg) was
puriﬁed by TLC (Si Gel, CHCl3:Me2CO:HCO2H, 95:5:1) to yield
13 mg of neoechinulin A (Li et al., 2008a). Frs. 217–234 were
combined (228 mg) and recrystallized in Me2CO to give 79 mg of
echinulin. Frs. 235–247 were combined (302 mg) and recrys-
tallized in Me2CO to give 26 mg of echinulin and the mother
liquor (272 mg) was recrystallized in a mixture of CH2Cl2
and petrol to give 17 mg of neoechinulin E (Li et al., 2008a). Frs.
303–321 were combined (338 mg) and recrystallized in MeOH to
give 22 mg of eurocristatine (1). The mother liquor of frs 303–
321 was then combined with frs. 277–301 (1.18 g) and applied
on a column chromatography of LiChroprep Si60 (0.04–
0.063 mm Merck, 45 g) and eluted with mixtures of CHCl3–
petrol, CHCl3–Me2CO, CHCl3–MeOH, 100 mL subfrs. were col-
lected as follows: subfrs. 1–20 (CHCl3–petrol, 1:4), 21–96
(CHCl3–petrol, 3:7), 97–118 (CHCl3–petrol, 2:3), 119–157
(CHCl3–petrol, 1:1), 158–179 (CHCl3–petrol, 3:2), 180–290
(CHCl3–petrol, 7:3), 291–325 (CHCl3–petrol, 4:1), 326–349
(CHCl3–petrol, 9:1), 350–368 (CHCl3), 369–379 (CHCl3–Me2CO,
9:1), 380–403 (CHCl3–Me2CO, 7:3), 404–413 (CHCl3–Me2CO,
1:1), 414–416 (CHCl3–MeOH, 1:1). Subfrs. 230–326 were
combined (263 mg) and recrystallized in CHCl3 to give more
11 mg of eurocristatine (1).
3.3. Eurocristatine (1)
White crystals; mp 244–245 8C (CHCl3/MeOH); [a]
20
D = +300 (c
0.02, MeOH); UV (MeOH) lmax (log e) 212 (4.5), 241 (4.2), 302
(3.9) nm; IR (KBr) ymax 3450, 3190, 2961, 1662, 1453, 1326 cm
1;
1H and 13C NMR see Table 1; HRESIMS m/z 569.2905 [M+H]+
(calculated for C32H37N6O4, 569.2876).
3.4. X-ray crystal structure of eurocristatine (1)
Crystals suitable for X-ray diffraction were obtained by slow
evaporation of a solution in CHCl3/MeOH for eurocristatine (1).
Diffraction data were collected at 100 K with a Gemini PX Ultra
equipped with Cu Ka radiation (l = 1.54184 A˚). The structure
was solved by direct methods using SHELXS-97 and reﬁned with
SHELXL-97. Crystals were monoclinic, space group P21, cell
volume 2308.37(5) A˚3 and unit cell dimensions a = 10.3549(2) A˚,
b = 9.9862(2) A˚ and c = 22.7778(3) A˚ and b = 101.464(2)8 (uncer-
tainties in parenthesis). Carbon, oxygen and nitrogen atoms
were reﬁned anisotropically. Hydrogen atoms were reﬁned
freely with isotropic displacement parameters. The ﬂack x
parameter was reﬁned with SHELXL-97 by means of TWIN and
BASF to yield 0.031(18). Tables containing the ﬁnal fractional
coordinates, temperature parameters, bond distances, and bond
angles were deposited with the Cambridge Crystallographic Data
Centre: CCDC reference number 879091.
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a b s t r a c t
Two new metabolites including a new aszonalenin analogue (1c) and a new meroditerpene (3) were
isolated, together with aszonalenin (1a), acetylaszonalenin (1b), 13-oxofumitremorgin B (2), aszona-
pyrone A (4b) and helvolic acid, from the culture of the soil fungus Neosartorya ﬁscheri (KUFC 6344).
While the ethyl acetate extract of the culture of the diseased coral-derived fungus Neosartorya laciniosa
(KUFC 7896) furnished aszonapyrone B (4a), aszonapyrone A (4b), tryptoquivaline L and 30-(4-
oxoquinazolin-3-yl) spiro[1H-indole-3,50-oxolane]-2,20-dione, the ethyl acetate extract of the culture of
the marine sponge-associated fungus Neosartorya tsunodae (KUFC 9213) yielded a new analogue of
chevalone C (5) and helvolic acid. The structures of the new compounds were established based on 1D
and 2D NMR spectral analysis as well as HR-ESIMS. Compounds 1aec, 2, 3, 4a, 4b and 5 were evaluated
for their in vitro growth inhibitory activity on the MCF-7 (breast adenocarcinoma), NCI-H460 (non-small
cell lung cancer) and A375-C5 (melanoma) cell lines by the protein binding dye SRB method.
 2013 Elsevier Ltd. All rights reserved.
1. Introduction
Neosartorya species (Trichocomaceae) are sexual forms of the
Aspergillus species, notably the section Fumigati. While the Asper-
gillus species only produce conidospores, Neosartorya species pro-
duce both a sexual state with ascospores and an asexual state with
conidiospores.1 Unlike Aspergillus, Neosartorya species have not
been extensively investigated for their secondary metabolites.
Consequently, we started to investigate the secondary metabolites
of the fungi of this genus. We have previously reported isolation
and structure elucidation of three new reverse prenylated indole
derivatives sartoryglabrins AeC from the culture of a Thai collection
of Neosartorya glabra.2 We later reported isolation of cadenene
sesquiterpene, the indole derivative eurochevalierine, brasilia-
minde B, pyripyropene A and three new metabolites including 1,4-
diacetyl-2,5-dibenzylpiperazine 3,700-oxide, a quinazolinone-
containing indole derivative and a phenyl ester of 2,4-dihydroxy-
6-methylbenzoic acid from the culture of the soil fungus Neo-
sartorya pseudoﬁsheri, as well as the in vitro cytostatic activity of the
cadenene sesquiterpene and eurochevalierine in human cancer
cancer cells.3 Recently, we reported isolation of a new indole al-
kaloid sartorymensin, and new analogues of tryptoquivaline and
ﬁscalins, produced by a Thai collection of the soil fungus Neo-
sartorya siamensis (KUFC 6349), as well as their in vitro growth
* Corresponding author. Tel.: þ351 220428331; fax: þ351 222062232; e-mail
addresses: ankijjoa@icbas.up.pt, anakekijjoa@yahoo.com (A. Kijjoa).
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inhibitory activity on the human U373 and Hs683 glioblastoma, the
A549 non-small cell lung cancer, the MCF-7 breast cancer and the
SKMEL-28 melanoma cell lines by MTT colorimetric assay.4
In our ongoing search for bioactive compounds produced by soil
and marine-derived fungi of the genus Neosartorya, we have in-
vestigated the cultures of the soil fungus Neosartorya ﬁscheri and
the marine-derived fungi Neosartorya tsunodae and Neosartorya
laciniosa. Although N. ﬁscheri has been extensively investigated for
its secondary metabolites,5e9 to the best of our knowledge, there is
no report on the secondary metabolites produced by N. tsunodae
and N. laciniosa. Examination of a collection of N. ﬁscheri (KUFC
6344), isolated from the coastal forest soil in Thailand, resulted in
isolation of a new aszonalenin analogue (1c) and a new mer-
oditerpene sartorypyrone A (3), in addition to ﬁve known metab-
olites including aszonalenin (1a),10 acetylaszonalenin (1b),10 13-
oxofumitremorgin B (2),11 aszonapyrone A (4b)12 (Fig. 1) and hel-
volic acid,13 from the ethyl acetate extract of its culture. In order to
investigate the secondarymetabolites proﬁle of themarine-derived
fungi of this genus, we also examined Thai collections of N. laciniosa
(KUFC 7896), isolated from a diseased coral (Porites lutea) from the
Gulf of Thailand, and N. tsunodae (KUFC 9213), isolated from the
marine sponge Aka coralliphaga, collected from the coral reef of the
Similan islands, Phagna province, southern Thailand. The ethyl
acetate extract of the culture of N. laciniosa (KUFC 7896) furnished
aszonapyrone B (4a),14 aszonapyrone A (4b)12 (Fig. 1), tryptoqui-
valine L4 and 30-(4-oxoquinazolin-3-yl) spiro[1H-indole-3,50-oxo-
lane]-2,20-dione,4 while the ethyl acetate extract of the culture of N.
tsunodae (KUFC 9213) yielded, besides helvolic acid,13 sartorypyr-
one B (5), a new analogue of chevalone C (Fig. 1). Additionally, we
also evaluated the in vitro growth inhibitory activity of compounds
1aec, 2, 3, 4a, b and 5 (Fig. 1) on MCF-7 (breast adenocarcinoma),
NCI-H460 (non-small cell lung cancer) and A375-C5 (melanoma)
cell lines by the protein binding dye SRB method.
2. Results and discussion
Compound 1c was isolated as pale yellow semisolid, and its
molecular formula C24H23N3O4 was established on the basis of the
(þ)-HR-ESIMS m/z 418.1767 [MþH]þ, indicating ﬁfteen degrees of
unsaturation. The general features of the 1H and 13C NMR spectra of
1c closely resembled those of aszonalenin (1a) and acetylaszona-
lenin (1b). The IR spectrum showed absorption bands for hydroxyl
(3377 cm1), amine (3242 cm1), aromatic (3089, 1485 cm1),
amide carbonyl (1680, 1657 cm1) and oleﬁn (1605 cm1 g) groups.
The 13C NMR, DEPT and HSQC spectra (Table 1) revealed two amide
carbonyls (dC 169.1 and 166.9), one N-formyl (dC 162.4), ﬁve qua-
ternary sp2 (dC 153.1, 136.1. 133.6, 133.1, 127.0), eight methine sp2 (dC
142.6, 132.7, 131.3, 125.7, 120.5, 118.4, 115.5, 112.1), one methylene
sp2 (dC 115.0), two quaternary sp3 (dC 59.4, 41.2), two methine sp3
(dC 80.9, 57.1), one methylene sp3 (dC 32.7) and two methyl (dC 22.8,
22.4) carbons. The coupling system of the aromatic protons ob-
served in the COSY spectrum (Table 1) revealed the presence of one
1,2-disubstituted and one 1,2,4-trisubstituted benzene rings.
Analysis of the HMBC spectrum (Table 1) indicated that the 1,2,4-
1
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Fig. 1. Secondary metabolites of Neosartorya ﬁscheri (KUFC 6344), N. laciniosa (KUFC 7896) and N. tsunodae (KUFC 9213).
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trisubstituted benzene ring was part of a 2,3-dihydro-1H-indole
moiety while the 1,2-disubstituted benzene ring was part of a 3,4-
dihydro-1H-1,4-benzodiazepine-2,5-dione portion. That the 2,3-
dihydro-1H-indole and the 3,4-dihydro-1H-1,4-benzodiazepine-
2,5-dione portions were linked together through a pyrrolidine ring
was corroborated by the HMBC cross peaks of H-2 (dH 5.99, s) to C-
11 (dC 57.1); H-10a (dH 3.38, dd, J¼13.9, 8.6 Hz) to C-3 (dC 59.4), C-9
(dC 136.1), C-17 (dC 169.1), as well as of N16-H (dH 8.27, s) to C-11 and
C-14 (dC 127.0) (Fig. 2a). Additionally, the coupling system observed
in the COSY spectrum (Table 1) also revealed the presence of a 2-
methylbut-3-en-2-yl substituent, which was corroborated by the
HMBC cross peaks (Table 1) of H3-50 (dH 1.15, s) to C-20 (dC 142.6), C-
30 (dC 41.2), CH3-40(dC 22.8); H-40 (dH 1.02, s) to C-20, C-30, CH3-50 (dC
22.4); H-20 (dH 5.90, dd, J¼17.3, 10.8 Hz) to CH3-50; H-10a and H-10b
(dH 5.11, d, J¼17.3 Hz and 5.15, d, J¼10.8 Hz) to C-20 and C-30. That
the 2-methylbut-3-en-2-yl substituent was on C-3 was sub-
stantiated by the HMBC cross peaks of H-2 to C-30; H-10a to C-30 as
well as of H3-40 and H3-50 to C-3 (Fig. 2a). These 1H and 13C NMR
datawere very similar to those reported for aszonalenin,5 and since
the HMBC spectrum (Fig. 2a) also displayed cross peak between the
proton signal at dH 8.95, s, to the signal of C-8 (dC 133.6), the formyl
group was placed on N-1.
In order to verify the relative conﬁguration of C-2, C-3 and C-11,
the NOESY experiment was carried out. The NOESY spectrum
(Fig. 2b) displayed correlations of H-2 to H3-40, H3-50, H-10a; and of
H-11 (dH 4.04, t, J¼8.4 Hz) to H-10b (dH 2.43, dd, J¼13.9, 8.2 Hz);
however no correlation between H-2 and H-11 was observed.
Consequently, the relationship between H-2 and H-11 was trans
whereas the relationship between H-2 and the 2-methylbut-3-en-
2-yl substituent on C-3 was cis. Thus, the relative conﬁguration of
C-2, C-3 and C-11 of 1c was the same as that of the corresponding
carbons of aszonalenin.5 Taking together the 1H and 13C NMR data,
the HMBC and NOESY correlations and the molecular formula, the
structure of 1c was established as 1-formyl-5-hydroxyaszonalenin.
Although several analogues of aszonalenin have been previously
isolated,15 to our knowledge, this is the ﬁrst report of isolation of
the 5-hydroxyl analogue of aszonalenin.
Compound 3 was isolated as brown viscous mass and its molec-
ular formula C28H40O5 was established on the basis of the (þ)-HR-
ESIMS m/z 457.2954 [MþH]þ, indicating nine degrees of unsatura-
tion. The IR spectrum showed absorption bands for hydroxyl
(3434 cm1), oleﬁnic (3080, 1585 cm1) and carbonyl (1730,
1684 cm1) groups. The 13C NMR, DEPT and HSQC spectra (Table 2)
revealed thepresenceof oneester carbonyl (dC 171.1), oneconjugated
ester carbonyl (dC 166.8), six quaternary sp2 (dC 166.1, 159.9, 146.6,
138.2, 135.4, 101.7), three methine sp2 (dC 124.1, 120.5, 101.1), one
methylene sp2 (dC 109.2), one quaternary sp3 (dC 39.1), two methine
sp3 (dC 78.9, 51.0), sevenmethylene sp3 (dC 39.7, 38.2, 31.7, 28.6, 26.3,
23.6, 22.4) and sixmethyl (dC 26.0, 21.3,19.6,17.5,16.3,15.9) carbons.
The existence of a 4-hydroxy-6-methyl-2H-pyran-2-onemoietywas
supported not only by the cross peak between H-19 (dH 6.00, d,
J¼0.7 Hz) and H3-21 (dH 2.19, s) in the COSY spectrum but also by
HMBC cross peaks of H-19 to C-17 (dC 101.7), C-18 (dC 166.1), C-20 (dC
159.9), C-21 (dC 19.6) and H3-21 to C-19 (dC 101.1) and C-20 (Fig. 3a).
That another portion of the molecule 1-acetoxy-2,2-dimethyl-4-
methylidenecyclohexyl derivative was evidenced by the correla-
tions of H-1 (dH 4.66, dd, J¼8.9, 4.1) to H-6b (dH 1.55, m) andH-6a (dH
1.85,m) in the COSY spectrum, aswell as byHMBC cross peaks of H-1
to C-2 (dC 39.1), C-3 (dC 51.0), CH3-26 (dC 17.5) and CO (dC 170.1); H-7a
(dH 4.88, br s) and H-7b (dH 4.62, br s) to C-3 and C-5 (dC 31.7); H-5b
(dH 2.31, dt, J¼13.5, 5.6Hz) to C-1 (dC 78.9), C-3, C-4 (dC 146.6) andC-7
(dC 109.2); H3-25 (dH 0.94, s), and H3-26 (dH 0.79, s) to C-1, C-2, C-3
(Fig. 3a). Since H-1 appeared as a double doublet with the coupling
constants of 8.9 and 4.1 Hz, the position of the acetoxyl group on C-1
wasb.Moreover, theCOSY spectrumalso exhibited correlations ofH-
11 (dH 5.05, dd, J¼5.6, 6.5 Hz) to H3-23 (dH 1.58, s) and H-12 (dH 2.08,
m), aswell as ofH-15 (dH5.29, ddd, J¼7.2, 7.2,1.0Hz) toH3-24 (dH1.77,
Table 1
1H and 13C NMR (CDCl3, 300.13 and 75.47 MHz) and HMBC assignments for 1c
Position dC, type dH (J in Hz) COSY HMBC
2 80.9, CH 5.99, s C-30 , 8, 9, 11, NCHO
3 59.4, C d
4 112.1, CH 6.79, d (2.5) H-6 C-5, 6, 8
5 153.1, C d
6 115.5, CH 6.74, dd (8.5, 2.5) H-4, 7 C-4, 8
7 118.4, CH 7.76, d, (8.5) H-6 C-5, 9
8 133.6, C d
9 136.1, C d
10a 32.7, CH2 3.38, dd (13.9, 8.6) H-10b, 11 C-3, 30 , 9, 17
b 2.43, dd (13.9, 8.2) H-10a, 11 C-2, 30 , 9
11 57.1, CH 4.04, t (8.4) H-10a, 10b C-10
13 166.9, CO d
14 127.0, C d
15 133.1, C d
16 d 8.27, s C-11, 14
17 169.1, CO d
18 120.5, CH 6.92, d (7.7) H-19 C-14, 20
19 132.7, CH 7.43, ddd
(7.7, 7.7, 1.5)
H-18, 20 C-15, 21
20 125.7, CH 7.21, dd (7.7, 7.7) H-19, 21 C-14, 18
21 131.3, CH 7.75, d (7.7) H-20 C-13, 19
10a 115.0, CH2 5.11, d (17.3) H-20 C-20 , 30
b 5.15, d (10.8) H-20
20 142.6, CH 5.90, dd
(17.3, 10.8)
H-10a, 10b C-50
30 41.2, C d
40 22.8, CH3 1.02, s C-20 , 3, 30 , 50
50 22.4, CH3 1.15, s C-20 , 3, 30 , 40
NCHO 162.4, CO 8.95, s C-8
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Fig. 2. Key HMBC (a) and NOESY (b) correlations of compound 1c.
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s) and H-16 (dH 3.20, d, J¼7.2 Hz), suggesting the presence of two
trisubstituted double bonds in themolecule. These coupling systems
were corroborated by HMBC cross peaks of H-11 signal to the signals
of C-9 (dC 38.2) and C-23 (dC 15.9); and H3-23 to C-9, C-10 (dC 135.4)
andC-11 (dC 124.1), aswell as cross peaks ofH-15 signal to the signals
of C-13 (dC 39.7) andC-24 (dC 16.3). Additionally, theHMBC spectrum
also exhibited a cross peak between the signals of H-12 and C-14 (dC
138.2), suggesting that the two trisubstituted double bonds were
connected throughC-12 andC-13, thus another partial structurewas
a 3,7-dimethylnona-2,6-diene. That the 3,7-dimethylnona-2,6-
diene portion and the 1-acetoxy-2,2-dimethyl-4-methylidene-
cyclohexyl derivative were connected through C-8 of the former
and C-3 of the latter was substantiated by cross peaks observed be-
tween the signals of H-3 (dH 1.72, dd, J¼9.1, 3.1) and H-8 (dH 1.59, m)
in the COSY spectrum. Moreover, the HMBC cross peaks of H-16
signal to the signals of C-17, C-18 and C-22 (dC 166.8) provided evi-
dence that another substituent of the 3,7-dimethylnona-2,6-diene
portion was the 4-hydroxy-6-methyl-2H-pyran-2-one moiety, con-
nected through C-16 of the former and C-17 of the latter. In order to
determine the relative conﬁguration of the stereogenic carbons and
the conﬁguration of the double bonds at C-10 and C-14, the NOESY
experiment was carried out. As the NOESY spectrum (Fig. 3b)
exhibited cross peaks of H-3 signal to the signals of H-1 and H3-25,
the relationship between H-1 and H-3 was cis. Consequently, the
relative conﬁguration of C-1 andC-3was 1S*, 3S*. Furthermore, since
the NOESY spectrum also exhibited cross peaks of H-11 to H-12 and
H-9 (dH 1.80, m), as well as of H-15 to H-13 (dH 2.04, m) and H-16
(Fig. 3b), the conﬁguration of the double bonds at C-10 and C-14was
10E, 14E. Thus, compound 3 was a new monocyclic meroditerpene,
which we have named sartorypyrone A.
Compound 5was isolated as yellow viscous mass and its molec-
ular formula C30H42O7 was established on the basis of the (þ)-HR-
ESIMS m/z 515.3038 [MþH]þ(calculated 515.3009), indicating ten
degrees of unsaturation. The IR spectrum showed absorption bands
for ester (1734 cm1), conjugated ketone (1670 cm1) and oleﬁnic
(1631, 1596 cm1) groups. The 13C NMR, DEPT and HSQC spectra
(Table 3) revealed the presence of one carbonyl of a conjugated ke-
tone (dC 180.8), two ester carbonyls (dC 170.7 and 170.2), three qua-
ternary sp2 (dC 162.7, 160.7, 98.5), one methine sp2 (dC 111.8), four
quaternary sp3 (dC 84.2, 37.4, 37.3, 36.9), ﬁve methine sp3 (dC 77.7,
Table 2
1H and 13C NMR (CDCl3, 300.13 and 75.47 MHz) and HMBC assignments for 3
Position dC, type dH (J in Hz) COSY HBMC
1 78.9, CH 4.66, dd (8.9, 4.1) H-6a, 6b C-2, 3, 5,
26, CO (Ac)
2 39.1, C d
3 51.0, CH 1.72, dd (9.1, 3.1) H-8 C-2, 4, 8
4 146.6, C d
5a 31.7, CH2 2.03, m H-5b, 6a, 6b
b 2.31, dt, (13.5, 5.6) H-5a, 6a, 6b C-1, 3, 4, 7
6a 28.6, CH2 1.85, m H-5a, 5b, 6b
b 1.55, m H-5a, 5b, 6a
7a 109.2, CH2 4.88, br s H-7b C-3, 5
b 4.62, br s H-7a C-3, 5
8 23.6, CH2 1.59, m H-3, 9
9 38.2, CH2 1.80, m H-8
10 135.4, C d
11 124.1, CH 5.05, dd (5.6, 6.5) H-12, 23 C-9, 23
12 26.3, CH2 2.08, m H-11, 13
13 39.7, CH2 2.04, m H-12
14 138.2, C d
15 120.5, CH 5.29, ddd
(7.2, 7.2, 1.0)
H-16, 24 C-13, 24
16 22.4, CH2 3.20, d (7.2) H-15 C-14, 15,
17, 18, 22
17 101.7, C d
18 166.1, C d
19 101.1, CH 6.00, d (0.7) H-21 C-17, 18, 20, 21
20 159.9, C d
21 19.6, CH3 2.19, s H-19 C-19, 20
22 166.8, CO d
23 15.9, CH3 1.58, s C-9, 10, 11
24 16.3, CH3 1.77, s C-13, 14, 15
25 26.0, CH3 0.94, s C-1, 2, 3, 26
26 17.5, CH3 0.79, s C-1, 2, 3, 25
OAc 171.1, CO d
21.3, CH3 2.07, s CO (OAc)
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Fig. 3. Key HMBC (a) and NOESY (b) correlations of compound 3.
Table 3
1H and 13C NMR (CDCl3, 300.13 and 75.47 MHz) and HMBC assignments for 5
Position dC, type dH (J in Hz) COSY HMBC
1a 41.8, CH2 1.36, dd (14.8, 3.8) H-2
b 2.08, dd (14.8, 3.8) H-2
2 69.4, CH 5.36, ddd
(4.0, 3.8, 3.8)
H-1, 3 C-3, 4, CO (Ac-2)
3 77.7, CH 4.61, d (4.0) H-2 C-2, 4, 22, 23, CO
(Ac-3)
4 37.4, C d
5 55.3, CH 1.04, m H-6
6 17.6, CH2 1.59, m H-5, 7a, b
7a 40.8, CH2 1.92, ddd
(12.8, 3.0, 3.0)
H-6, 7b
b 1.12, m H-6, 7a
8 37.3, C d
9 60.8, CH 0.95, m H-11
10 36.9, C d
11 18.9, CH2 1.39, m H-9, 12
1.42, m
12 40.0, CH2 1.68, m H-11
2.03, m
13 84.2, C d
14 52.4, CH 1.51, dd (12.7, 4.9) H-15a, b C-8, 13
15a 15.3, CH2 2.55, dd (16.4, 4.9) H-14, 15b C-13, 14, 16, 17, 21
b 2.15, dd (16.4, 12.7) H-14, 15a
16 98.5, C d
17 180.8, CO d
18 111.8, CH 6.05, br s H-20 C-16, 19, 20
19 160.7, C d
20 19.3, CH3 2.22, s H-18 C-18, 19
21 162.7, C d
22 29.0, CH3 0.90, s C-3, 4, 5, 23
23 17.4, CH3 1.05, s C-3, 4, 5, 22
24 17.0, CH3 1.12, s C-1, 5, 9, 10
25 16.3, CH3 0.92, s C-7, 8, 9, 14
26 20.5, CH3 1.29, s C-12, 13, 14, Ac-2
Ac-2 170.2, CO d
21.3, CH3 2.06, s CO (Ac-2)
Ac-3 170.7, CO d
20.9, CH3 2.03, s CO (Ac-3)
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69.4, 60.8, 55.3, 52.4), sixmethylene sp3 (dC 41.8, 40.8, 40.0,18.9,17.6,
15.3) and eight methyl (dC 29.0, 21.3, 20.9, 20.5, 19.3, 17.4, 17.0, 16.3)
groups. Except for the presence of an additional acetoxyl group, the
1H and 13C NMR data (Table 3), revealed the existence of a perhy-
drophenanthrene moiety connected to the 2-methyl-4H-pyran-4-
one portion through the methylene group and the ethereal bridge,
similar to those of chevalone C, a meroditerpenoid isolated from
Eurotium chevalieri.14 The COSY spectrum (Table 3) revealed the
coupling of the oxymethine proton (dH 5.36, ddd, J¼4.0, 3.8, 3.8, H-2)
to another oxymethine proton (dH 4.61, d, J¼4.0, H-3) and to the
methylene protons at dH 1.36, dd, J¼14.8, 3.8 and dH 2.08, dd, J¼14.8,
3.8 (dC 41.8). That the acetoxyl groups were on C-2 (dC 69.4) and C-3
(dC 77.7) were corroborated by the HMBC cross peaks of H-2 signal
and the methyl protons signal at dH 2.06, s (dC 21.3) to the carbonyl
signal at dC 170.2, aswell as of theHMBCcrosspeaksofH-3 signal and
the signal of themethyl protons at dH 2.03, s (dC 20.9) to the carbonyl
signal at dC 170.7, respectively (Fig. 4a). The HMBC spectrum also
exhibited cross peaks of H-3 signal to the signals of CH3-23 (dC 17.4)
and CH3-22 (dC 29.0), C-4 (dC 37.4) and C-2, as well as cross peaks of
H-2 to the signals of C-3 and C-4 (Fig. 4a). Since H-3 and H-2, re-
spectively, appeared as a doublet at dH4.61 (J¼4.0Hz) andadouble of
double doublet at dH 5 0.36 (J¼4.0, 3.8, 3.8), the positions of the
acetoxyl groups on C-2 and C-3 were both b oriented.16
The positions of the methyl groups on C-8, C-10 and C-13 were
determined by a NOESY experiment. The NOESY spectrum (Fig. 4b)
exhibited cross peaks of the methyl protons signal of the b-acetoxyl
group on C-2 (dH 2.06, s) to the signals of CH3-23 (dH 1.05, s) and
CH3-24 (dH 1.12, s), implying that CH3-24 was b oriented. That CH3-
25 and CH3-26 were both b oriented was evidenced by the cross
peaks between the signals of CH3-24 and CH3-25 (dH 0.92, s), as well
as between the signals of CH3-25 and CH3-26 (dH 1.29, s). The NOESY
spectrum also displayed cross peaks of the signal of H-15a (dH 2.55,
dd, J¼16.4, 4.9) to the signals of H-14 (dH 1.51, dd, J¼12.7, 4.9) and H-
7a (dH 1.92, ddd, J¼12.8, 3.0, 3.0), suggesting that the latters were
a oriented. In turn, the signal of H-7a also exhibited cross peaks to
H-5 signal (dH 1.04, m), implying that it was also a oriented. Since H-
3 signal was found to exhibit cross peak with the proton signal at dH
1.36, dd, J¼14.8, 3.8, the latter was assigned for H-1a. Thus, com-
pound 5 is a 2b-acetoxyl analogue of chevalone C, and since it is
a new compound, we have named it sartorypyrone B.
To our knowledge, this is the ﬁrst report of isolation of mer-
oditerpenes from N. ﬁscheri, even though xanthone derivatives in-
cluding ergochrome and indole alkaloids, such as aszonalenin
derivatives, tryptoquivalines, ﬁscalins and fumitremorgins, have
been previously reported from this fungus.5e9
The biosynthetic pathways leading to the formation of sartor-
ypyrone A (3), aszonapyrone B (4a), aszonapyrone A (4b) and sar-
torypyrone B (5) can be hypothesized to originate from the reaction
of the triketide derivative (I) with GPP to form the meroditerpene
intermediate (II). Enolization of II leads to the formation of the in-
termediate III, which can undergo different modes of cyclization.
Cyclization via pathway awould yield the monocyclic diterpene in-
termediate (IV), which upon acetylation, produces sartorypyrone A
(3), while cyclization via pathway b would lead to the formation of
aszonapyrone B (4a); and after acetylation of the b-hydroxyl group
on C-3, yields aszonapyrone A (4b). On the other hand, formation of
the pyran ring (pathway c) would lead to the hexacyclic derivative
(VI), which gives chevalone C upon acetylation of the b-hydroxyl
group on C-3. Hydroxylation of C-2 of chevalone C, followed by
acetylation of this b-hydroxyl group would ﬁnally form sartorypyr-
one B (5). Isolation of sartorypyrone A (3), together with aszona-
pyrone B (4a), aszonapyrone A (4b) and sartorypyrone B (5) provides
evidence that extension of the diterpene unit by the triketidemoiety
occurs prior to cyclization of GPP, and that different modes of cycli-
zation ofGPP can operate to produce thesemeroditerpenoids (Fig. 5).
Aszonalenin derivatives (1aec), 13-oxofumitremorgin B (2), sar-
torypyrone A (3), aszonapyrone B (4a), aszonapyrone A (4b) and
sartorypyrone B (5) were evaluated for their capacity to inhibit the
in vitro growth of MCF-7 (breast adenocarcinoma), NCI-H460 (non-
small cell lung cancer) and A375-C5 (melanoma) cell lines, using the
protein binding dye SRB method. Results (Table 4) showed that,
among themeroditerpenes tested, aszonapyroneA (4b)was themost
active, showingstronggrowth inhibitoryactivityagainst the threecell
lines,withGI50¼13.60.9 mM,11.61.5mMand10.21.2mM, forMCF-
7, NCI-H460 and A375-C5, respectively, while aszonapyrone B (4a),
whose structure corresponds to 3-deacetyl aszonapyrone A (4b), was
inactiveat thehighest concentration tested(150mM). SartorypyroneB
(5) also exhibited strong growth inhibitory activity, although less
active than aszonapyrone A (4b), having GI50¼17.87.4 mM,
20.52.4 mM and 25.04.4, respectively, for MCF-7, NCI-H460 A375-
C5. Interestingly, sartorypyrone A (3), which possesses a monocyclic
diterpene core, was more selective, exhibiting similar inhibitory ac-
tivity to sartorypyroneB (5) against A375-C5 (GI50¼21.51.9 mM), but
less active against MCF-7 (GI50¼46.37.6 mM) and NCI-H460
(GI50¼37.34.0 mM) cell lines. On the contrary, all the three aszona-
leninderivatives (1aec)were found tobe inactive against all the three
cell lines at the highest concentration tested (150 mM), whereas 13-
oxofumitremorgin B (2) exhibited only weak inhibitory activity
against all the three cell lines (GI50¼115.020.0 mM, 123.311.5 mM
and 68.612.9 mM, respectively, for MCF-7, NCI-H460 and A375-C5).
3. Experimental section
3.1. General experimental procedures
Melting points were determined on a Bock monoscope and are
uncorrected. Optical rotations were determined on an ADP410
Polarimeter. Infrared spectra were recorded on an ATT Mattson
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Fig. 4. Key HMBC (a) and NOESY (b) correlations of compound 5.
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Genesis Series FTIR using WinFIRST Software. 1H and 13C NMR
spectra were recorded at ambient temperature on a Bruker AMC
instrument operating at 300.13 and 75.4 MHz, respectively. High
resolution mass spectra were measured with a Waters Xevo QToF
mass spectrometer coupled to a Waters Aquity UPLC system. A
Merck silica gel GF254 was used for preparative TLC, and a Merck Si
gel 60 (0.2e0.5 mm) was used for analytical chromatography.
3.2. Fungal material
The strain KUFC 6344 was isolated from coastal forest soil at
Samaersarn island (altitude 12 340 2300 N,100 570 2300 E), Chonburi
Province, Thailand, in November 2008. Brieﬂy, 1 g of the soil (col-
lected from the surface) was placed in 65% ethanol for 10e20 min,
after which the liquid was drained off. The soil particles were
placed into sterile Petri dishes, mixed with GAN and streptomycin
sulfate and incubated at 28 C. The fungus was identiﬁed as N.
ﬁscheri by the morphological features, including characteristic of
ascospores, conidiogenesis and colonies. The identiﬁcation was
supported by sequence analysis of the b-tubulin, calmodulin and
actin genes and homologies of those gene sequences between the
strain and N. ﬁscheri NRRL 181T were 100%, 100% and 99.7% (Gen-
eBank accession No.; EF669796, EF669865 and DQ094863), re-
spectively. The pure cultures were deposited as KUFC 6344 at the
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Fig. 5. Proposed biogenesis of meroditerpenes sartorypyrone A (3), aszonapyrone B (4a), aszonapyrone A (4b) and sartorypyrone B (5).
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Mycology Laboratory, Department of Plant Pathology, Faculty of
Agriculture, Kasetsart University, Bangkok, Thailand, and as IFM
59696 at the Medical Mycology Research Center, Chiba University,
Japan.
The strain KUFC 7896 was isolated from a diseased coral (P. lutea
ulcerativewhite spot) at AoNuan Lan island (altitude 12 530 56.8500
N, 100 460 39.6600 E), Chonburi Province, in the Gulf of Thailand, in
May 2010. The diseased coral was washed with 0.06% sodium hy-
pochlorite for 1 min, followed by sterilized sea water for three
times. The diseased coral was cut into 0.50.5 cm pieces and placed
on malt extract agar (MEA) with 70% sea water and incubated at
28 C for 5e7 days. The fungus was identiﬁed as N. laciniosa by
morphological characteristics, such as colony growth rate and
growth pattern on standard media namely Czapek’s agar (CZA),
Czapek yeast autolysate agar (CYA) and malt extract agar (MEA).
Microscopic characteristics including size, shape, ornamentation of
ascospores and Aspergillus laciniosus anamorph were examined
under light and scanning electron microscopes. This identiﬁcation
was supported by sequence analysis of the b-tubulin gene as de-
scribed in the previous report17 and the pure cultures were de-
posited as KUFC 7896 at Kasetsart University Fungal Collection,
Department of Plant Pathology, Faculty of Agriculture, Kasetsart
University, Bangkok, Thailand, and as MMERU 01 at Microbes Ma-
rine Environment Research Unit, Division of Environmental Sci-
ence, Faculty of Science, Ramkhamhaeng University, Bangkok,
Thailand.
N. tsunodae Yaguchi, Abliz & Y. Horie was isolated from the
marine sponge A. coralliphaga, which was collected from the coral
reef of the Similan islands, Phagna province, Thailand, by scuba
diving at 10m depth, in April 2010 and the spongewas identiﬁed by
J. Buaruang. Brieﬂy, the sponge tissue was cut into a piece of
0.50.5 cm, placed on the malt extract agar (MEA) with 70% sea
water and incubated for 28 C for 7 days. The fungus was identiﬁed
by one of us (T.D.), by morphological features, including the char-
acteristic of ascospores and colonies. The identiﬁcation was sup-
ported by sequence analysis of the b-tubulin gene described in the
previous report18 and the pure cultures were deposited as KUFC
9213 at Kasetsart University Fungal Collection, Department of Plant
Pathology, Faculty of Agriculture, Kasetsart University, Bangkok,
Thailand.
3.3. Extraction of the metabolites
N. ﬁscheri (KUFC 6344) was cultured for one week in ﬁve 90 mm
Petri dishes with 25 ml of potato dextrose agar per dish. Twenty
ﬁve 1000ml Erlenmeyer ﬂasks each containing cooked rice (300 g),
were autoclaved, incubated with two mycelia plugs of N. ﬁscheri
(KUFC 6344) and incubated at 28 C for 30 days. Themoldy rice was
macerated in ethyl acetate (20 L total) for three days and then ﬁl-
tered. The two layers were separated using a separatory funnel and
the ethyl acetate solution was concentrated at a reduced pressure
to yield 62.5 g of crude ethyl acetate extract, which was dissolved in
500 ml of a 4:1 mixture of CHCl3 and EtOAc and then washed with
H2O (3500 ml). The organic layer was dried with anhydrous
Na2SO4, ﬁltered and evaporated under reduced pressure to give
50 g of the crude extract, which was applied on a column chro-
matography of Silica gel (350 g) and eluted with mixtures of pet-
roleCHCl3 and CHCl3eMe2CO, 250 ml fractions were collected as
follows: Frs 1e89 (petroleCHCl3, 1:1), 90e179 (petroleCHCl3, 3:7),
180e288 (petroleCHCl3, 1:9), 289e358 (CHCl3), 359e430
(CHCl3eMe2CO, 9:1), 431e451 (CHCl3eMe2CO, 7:3). Frs 107e131
were combined (2.8 g) and applied on a Silica gel column (30 g) and
eluted with mixtures of CHCl3epetrol, 100 ml fractions were col-
lected as follows: sfrs 1e38 (petroleCHCl3, 7:3), 39e64 (pet-
roleCHCl3, 1:1). Sfr 41 (286 mg) was crystallized in a mixture of
petrol and CHCl3 to give 39.4 mg of aszonalenin (1a). Sfrs 46e64
were combined (50.9 mg) and puriﬁed by TLC (Si Gel, CHCl3/petrol,
9:1) to give 24 mg of sartorypyrone A (3). Frs 132e159 were com-
bined (1.86 g) and applied on a Silica gel column (30 g) and eluted
with mixtures of CHCl3epetrol, 100 ml fractions were collected as
follows: sfrs 1e66 (petroleCHCl3, 7:3), 67e112 (petroleCHCl3, 1:1).
Sfrs 49e64 were combined (188 mg) and puriﬁed by TLC (Si Gel,
CHCl3/Me2CO/HCO2H, 9:1:0.1) to give an additional 18 mg of sar-
torypyrone A (3). Sfrs 65e80 were combined (530 mg) and puriﬁed
by TLC (Si Gel, CHCl3/EtOAc/petrol/HCO2H, 8:1:1:0.1) to give 40 mg
of 13-oxofumitremorgin B (2). Frs 175e189 were combined
(890.9 mg) and crystallized in a mixture of petrol and CHCl3 to give
320 mg of aszonapyrone A (4b). Frs 190e225 were combined
(975 mg) and crystallized in a mixture of petrol and CHCl3 to give
140 mg of aszonapyrone A (4b) and the mother liquor was applied
on a Silica gel column (28 g) and eluted with mixtures of
CHCl3epetrol, 100 ml fractions were collected as follows: sfrs 1e8
(petroleCHCl3, 1:1), 9e43 (petroleCHCl3, 3:7), 44e53 (pet-
roleCHCl3, 1:9). Sfrs 9e16 were combined and crystallized in
a mixture of petrol and CHCl3 to give an additional 53 mg aszo-
napyrone A (4b). Frs 226e236 were combined (1.75 g) and crys-
tallized in a mixture of petrol and CHCl3 to give 214.4 mg of
acetylaszonalenin (1b). Frs 237e293 were combined and crystal-
lized in a mixture of petrol and CHCl3 to give helvolic acid (153mg).
Frs 294e332 were combined (1.15 g) and applied on a Silica gel
column (30 g) and eluted with mixtures of petroleCHCl3, 100 ml
fractions were collected as follows: sfrs 1e7 (petroleCHCl3, 1:1),
8e66 (petroleCHCl3, 3:7), 67e81 (petroleCHCl3, 1:9). Sfrs 35e40
were combined (70.9 mg) and puriﬁed by TLC (Si Gel, CHCl3/EtOAc/
Me2CO/HCO2H, 15:6:1:0.1) to give 34 mg of 1-formyl-5-hydr-
oxyaszonalenin (1c).
N. laciniosa (KUFC 7896) was cultured for one week in ﬁve
90 mm Petri dishes with 25 ml of malt extract agar (MEA) with 70%
sea water per dish. Thirty 1000 ml Erlenmeyer ﬂasks, each con-
taining 200 g rice and 200 ml water, were autoclaved, inoculated
with ten mycelia plugs of the fungus and incubated at 28 C for 30
days. The moldy rice was macerated in ethyl acetate (12 L) for ﬁve
days and then ﬁltered. The two layers were separated using a sep-
aratory funnel, and the ethyl acetate solution was concentrated at
a reduced pressure to yield 72 g of crude ethyl acetate extract, which
was applied on a column chromatography of Silica gel (800 g) and
eluted with mixtures of petroleCHCl3 and CHCl3eMe2CO, 250 ml
fractions were collected as follows: frs 1e19 (CHCl3epetrol, 3:7),
20e114 (CHCl3epetrol, 1:1), 115e188 (CHCl3epetrol, 7:3), 189e340
(CHCl3epetrol, 9:1), 341e484 (CHCl3eMe2CO, 9:1), 485e547
(CHCl3eMe2CO, 7:3), 548e603 (CHCl3eMe2CO, 1:1). Frs 365e396
were combined (3.35 g) and recrystallized in Me2CO to give 24.1 mg
Table 4
Growth inhibitory effect of aszonalenin derivatives (1aec), 13-oxofumitremorgin B
(2), sartorypyrone A (3), aszonapyrone B (4a), aszonapyrone A (4b) and sartor-
ypyrone B (5) in three human tumour cell lines
Compounds GI50 (mM)
MCF-7 NCI-H460 A375-C5
1a >150 >150 >150
1b >150 >150 >150
1c >150 >150 >150
2 115.220.0 123.311.5 68.612.9
3 46.37.6 37.34.0 21.51.9
4a >150 >150 >150
4b 13.60.9 11.61.5 10.21.2
5 17.87.4 20.52.4 25.04.4
Results are given as the lowest concentration causing 50% of cell growth inhibition
(GI50) after a continuous exposure to the compounds for 48 h, and are expressed as
meanSEM of three independent experiments performed in duplicate. Doxorubicin
was used as positive control, GI50: MCF-7¼60.31.2 nM; NCI-H460¼19.61.9 nM;
A375-C5¼130.025.2 nM.
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of aszonapyrone A (4b). The mother liquor of frs 365e396 (3.32 g)
and frs 397e408 (465.7 mg) were combined and chromatographed
over a column of LiChroprep Si 60 (40e63 mm, 43.4 g) and eluted
with mixtures of CHCl3epetrol and CHCl3eMe2CO, wherein 100 ml
sub-fractions were collected as follows: sfrs 1e43 (CHCl3epetrol,
7:3), 44e56 (CHCl3epetrol, 9:1), 57e81 (CHCl3eMe2CO, 9:1),
82e108 (CHCl3eMe2CO, 4:1). Sfrs 18e22were combined (706.2mg)
and recrystallized in Me2CO to give an additional 51.1 mg of aszo-
napyrone A (4b). Frs 435e437 were combined (625.2 mg) and
recrystallized in Me2CO to give 12.8 mg of aszonapyrone B (4a). The
mother liquor of frs 435e437, frs 409e434 and frs 438e448 were
combined (2.45 g) and chromatographed over a column of LiChro-
prep Si 60 (40e63 mm, 32.5 g) and eluted with mixtures of
CHCl3epetrol and CHCl3eMe2CO, wherein 100 ml sub-fractions
were collected as follows: sfrs 1e45 (CHCl3epetrol, 7:3), 46e62
(CHCl3epetrol, 9:1). Sfr 30e32 were combined (209.1 mg) and
recrystallized in Me2CO to give an additional 8.3 mg of aszonapyr-
one B (4a). Frs 449e465 were combined (826.0 mg) and recrystal-
lized in Me2CO to give 24.4 mg of tryptoquivaline L. Frs 508e546
were combined (1.57 g) and recrystallized in Me2CO to give 26.6 mg
of 30-(4-oxoquinazolin-3-yl) spiro[1H-indole-3,50-oxolane]-2,20-
dione.
N. tsunodae (KUFC9213),was cultured foroneweek inﬁve 90mm
Petri disheswith25mlofmalt extract agar (MEA)with70% seawater
per dish. Fifty 1000ml Erlenmeyer ﬂasks, each containing 200 g rice
and 150 ml water, were autoclaved, inoculated with ten mycelia
plugs of the fungus and incubated at 28 C for30days. Themoldy rice
was macerated in ethyl acetate (10 L total) for seven days and then
ﬁltered. The two layers were separated using a separatory funnel,
and the ethyl acetate solution was concentrated at a reduced pres-
sure to yield 40 g of crude ethyl acetate extract, which was chro-
matographedover a 0.2e0.5mmMerck Silica gel column (400 g) and
eluted with mixtures of CHCl3epetrol and CHCl3eMe2CO, wherein
250 ml fractions were collected as follows: frs 1e14 (CHCl3epetrol,
1:9),15e43 (CHCl3epetrol, 3:7), 44e78 (CHCl3epetrol,1:1), 79e140
(CHCl3epetrol, 7:3), 141e181 (CHCl3epetrol, 9:1), 182e253
(CHCl3eMe2CO, 9:1), 254e314 (CHCl3eMe2CO, 7:3). Frs 193e208
were combined (980 g) and puriﬁed by TLC (Si Gel, CHCl3/Me2CO/
HCO2H, 9.5:0.5:0.1) to yield 92 mg of sartorypryrone B (5). Frs
220e243 were combined (920 mg) and chromatographed over
a LiChroprep Si 60 column (40e63 mm, 25 g) and eluted with
CHCl3eMe2CO, 9:1; 50 ml fractions were being collected. Sfrs 5e8
were combined and puriﬁed by TLC (Si Gel, CHCl3/Me2CO/HCO2H,
9:1:0.1) to yield 130 mg of sartorypryrone B (5). Frs 283e298 were
combined (507 mg) and applied over a Silica gel column (10 g) and
eluted with mixtures of CHCl3eMe2CO; 50 ml fractions were col-
lected as follows: sfrs 1e10 (CHCl3eMe2CO, 9:1), 11e25
(CHCl3eMe2CO, 7:3). Sfrs 5e10 were combined and recrystallized in
a mixture of petroleCHCl3 to give 31.4 mg of helvolic acid. Frs
299e315 were combined (140.8 mg) and puriﬁed by TLC (Si Gel,
CHCl3/Me2CO/HCO2H, 9.5:0.5:0.1) to give an additional 10 mg of
sartorypryrone B (5).
3.3.1. 1-Formyl-5-hydroxyaszonalenin (1c). Pale yellow semisolid.
½a25D 18 (c 0.056, CHCl3); IR (KBr) nmax 3377, 3242, 3089, 2966,
2923, 2852, 1680, 1657, 1605, 1496, 1485, 1465, 1384 cm1. 1H and
13C see Table 1. HR-ESIMS m/z 418.1777 [MþH]þ (calculated for
C24H24N3O4, 418.1767).
3.3.2. Sartorypyrone A (3). Brown viscous mass. ½a25D þ74.8 (c 0.02,
CHCl3); IR (KBr) nmax 3434, 3080, 2964, 2942, 2872, 1730, 1684,
1667, 1585, 1448, 1245 cm1. 1H and 13C see Table 2. HR-ESIMS m/z
457.2967 (MþH)þ (calculated for C28H41O5, 457.2954).
3.3.3. Sartorypyrone B (5). Yellow viscous mass; ½a20D 59.0 (c 0.07,
CHCl3); IR (KBR) nmax 2939,1734,1670,1631,1596,1426,1238 cm1;
1H and 13C see Table 3. HR-ESIMSm/z 515.3038 [MþH]þ (calculated
for C30H43O7, 515.3009).
3.4. Bioassay
3.4.1. Cell cultures. Three human tumour cell lines were used in
this study: MCF-7 (breast adenocarcinoma, a kind gift from NCI,
Bethesda, USA), NCI-H460 (non-small cell lung cancer, NSCLC,
a kind gift from NCI, Bethesda, USA) and A375-C5 (melanoma,
ECACC, UK). Cells were routinely cultured in RPMI-1640 with
Ultraglutamine (Lonza) supplemented with 10% FBS (Fetal Bovine
Serum, PAA) and maintained in a humidiﬁed incubator at 37 C
with 5% CO2. Cell number and viability were determined with
Trypan Blue exclusion assay. All experiments were performed with
cells in exponential growth with viabilities over 90% and repeated
at least three times.
3.4.2. Cell growth inhibitory assay. The screening of compounds
was performed with the Sulforhodamine B (SRB) assay adopted
from the National Cancer Institute, USA.19 Brieﬂy, cells were plated
in 96 well plates (5103 cells/well for MCF-7 and NCI-H460 cells,
and 7.5103 cells/well for the A375-C5 cell line) and incubated at
37 C for 24 h. Exponentially growing cells were then treated with
ﬁve dilutions of each compound. After 48 h of treatment, cells were
ﬁxed with 10% ice-cold trichloroacetic acid, washed and stained
with SRB. After washing with 1% acetic acid, the bound SRB was
solubilized with 10 mM Tris Base, and the absorbance was mea-
sured at 515 nm in a microplate reader (Biotek Instruments). Then,
a doseeresponse curve was obtained for each compound and the
corresponding GI50 (the concentration of compound that inhibited
50% of net cell growth) was determined. The effect of the vehicle
solvent (DMSO) on the growth of these cell lines was evaluated by
treating cells with the maximum concentration of DMSO used in
each assay (0.25%).
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Abstract: A new meroditerpene, sartorypyrone C (5), was isolated, together with the 
known tryptoquivalines L (1a), H (1b), F (1c), 3′-(4-oxoquinazolin-3-yl) spiro 
[1H-indole-3,5′]-2,2′-dione (2) and 4(3H)-quinazolinone (3), from the culture of the marine 
sponge-associated fungus Neosartorya paulistensis (KUFC 7897), while reexamination of 
the fractions remaining from a previous study of the culture of the diseased coral-derived 
fungus N. laciniosa (KUFC 7896) led to isolation of a new tryptoquivaline derivative 
tryptoquivaline T (1d). Compounds 1a–d, 2, 3, and 5, together with aszonapyrones A (4a) 
and B (4b), chevalones B (6) and C (7a), sartorypyrones B (7b) and A (8), were tested for 
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their antibacterial activity against four reference strains (Staphylococcus aureus, Bacillus 
subtilis, Escherichia coli, and Pseudomonas aeruginosa), as well as the environmental 
multidrug-resistant isolates. Only aszonapyrone A (4a) and sartorypyrone A (8) exhibited 
significant antibacterial activity as well as synergism with antibiotics against the  
Gram-positive multidrug-resistant strains. Antibiofilm assays of aszonapyrone A (4a) and 
sartorypyrone A (8) showed that practically no biofilm was formed in the presence of their 
2× MIC and MIC. However, the presence of a sub-inhibitory concentration of ½ MIC of 4a 
and 8 was found to increase the biofilm production in both reference strain and the 
multidrug-resistant isolates of S. aureus. 
Keywords: antibacterial; antibiofilm; multidrug-resistant; tryptoquivalines; meroditerpenes; 
Neosartorya; marine-derived fungi 
 
1. Introduction 
Infectious diseases are leading health problems with high morbidity and mortality in the developing 
countries. Although the introduction of penicillin and other antibiotics ushered in an era of effective 
treatment of microbial infection, their overuse has caused acquired resistance of pathogens to 
antimicrobial agents. Since the mid-1970s, resistance to antimicrobial agents has become an escalating 
problem [1]. In the last 30 years, treatment of infections caused by Gram-positive bacteria has been 
more problematic than ever, with infections being caused by multidrug-resistant organisms, 
particularly methicillin-resistant staphylococci, penicillin- and erythromycin-resistant pneumococci, 
and vancomycin-resistant enterococci [2]. The development of resistance to multiple drugs is therefore 
a worldwide problem in the treatment of these infectious diseases caused by clinically relevant 
pathogenic microorganisms and must be approached in a large variety of strategies [3]. Although there 
is a continuing effort in the pharmaceutical industry to develop new antimicrobial agents for the 
treatment of resistant infections, pursuing new antibiotic drugs is still a fair and necessary strategy to 
combat the multidrug-resistant bacteria that are spreading both in the community and clinical setting [4]. 
Since the marine environment is a prolific source of bioactive compounds with extraordinary chemical 
and biological diversity [5–7], it has become a potential target in the search for new antibiotics. 
Specifically, the marine-derived fungi which have been reported as producers of bioactive metabolites 
with antiviral [8,9], antitumor [10,11] and antibacterial [12–14] activities. In the pursuit for bioactive 
secondary metabolites produced by marine and soil fungi of the genus Neosartorya, we have recently 
reported isolation and structure elucidation of sartorypyrone A (8), aszonapyrone A (4a), aszonalenin, 
acetylaszonalenin, 1-formyl-5-hydroxyaszonalenin and 13-oxofumitremorgin B, from the culture of 
the soil fungus Neosartorya fischeri (KUFC 6344), sartorypyrone B (7b) from the marine  
sponge-associated fungus N. tsunodae, as well as aszonapyrone A (4a), aszonapyrone B (4b), 
tryptoquivaline L (1a) and 3′-(4-oxoquinazolin-3-yl) spiro[1H-indole-3,5′-oxolane]-2,2′-dione (2) from 
N. laciniosa isolated from a diseased coral [15]. 
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Figure 1. Secondary metabolites from Neosartorya paulistensis, N. laciniosa, N. siamensis, 
N. tsunodae and N. fischeri. 
 
Examination of a collection of N. paulistensis (KUFC 7897), isolated from the marine sponge 
Chondrilla australiensis, collected from the Gulf of Thailand, resulted in isolation of a new 
aszonapyrone analogue which we have named sartorypyrone C (5), in addition to five known 
metabolites including tryptoquivalines L (1a), H (1b), F (1c), 3′-(4-oxoquinazolin-3-yl) spiro 
[1H-indole-3,5′-oxolane]-2, 2′-dione (2) and 4(3H)-quinazolinone (3) (Figure 1). Reexamination of the 
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column fractions left over from our previous work of N. laciniosa (KUFC 7896) [15] led to isolation 
of a new tryptoquivaline analogue, tryptoquivaline T (1d), whereas reexamination of the nonpolar 
fractions from the column chromatography of N. siamensis (KUFC 6349) [16] furnished chevalone B 
(6) and chevalone C (7a) (Figure 1). The isolated compounds were evaluated, together with 
sartorypyrone B (7b) previously isolated from N. tsunodae and sartorypyrone A (8) (Figure 1) 
previously isolated from N. fischeri, for antibacterial activity against the Gram-positive 
(Staphylococcus aureus ATCC 25923 and Bacillus subtilis ATCC 6633) and Gram-negative 
(Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) bacteria, as well as 
multidrug-resistant isolates from the environment. The potential synergism between these fungal 
metabolites and antibiotics was evaluated against multidrug-resistant bacteria, methicillin-resistant  
S. aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Since aszonapyrone A (4a) and 
sartorypyrone A (8) exhibited interesting antibacterial activity against both Gram-negative reference 
strains and the environmental multidrug-resistant isolates, their capacity to inhibit biofilm formation 
was also studied. 
Table 1. 
1
H and 
13
C NMR (DMSO, 300.13 and 75.47 MHz) and HMBC assignment for 
tryptoquivaline T (1d). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1 --- ---   
2 81.0, CH 6.10, s H-29 C-3, 13, 14 
3 84.2, C ---   
4 133.5,C ---   
5 126.8, CH 8.04, dd (8.0, 1.0) H-6 C-3, 7, 9 
6 126.7, CH 7.46, ddd (8.0, 8.0, 1.0) H-5 C-4, 8 
7 131.8, CH 7.61, ddd (8.0, 8.0, 1.0) H-6, 8 C-5, 9 
8 116.4, CH 7.56, ddd (8.0, 1.0) H-7 C-4, 6 
9 138.4, C ---   
11 171.1, CO ---   
12 57.7, CH 5.47, dd (10.7, 8.6) H-13 C-11, 18 
13a 33.8, CH2 3.30, dd (14.0, 8.6) H-12, 13b C-2, 3, 4 
b  3.40, dd (14.0, 10.7) H-12, 13a C-2, 3, 4 
14 172.5, CO ---   
15 64.1, C ---   
18 160.0, CO ---   
19 121.4, C ---   
20 126.2, CH 8.26, d (8.0, 1.0) H-21 C-18, 22, 24 
21 127.6, CH 7.63, ddd (8.0, 8.0, 1.0) H-20, 22 C-19, 23 
22 135.1, CH 7.93, ddd (8.0, 8.0, 1.0) H-21, 23 C-20, 24 
23 127.4, CH 7.76, d (8.0) H-22 C-19, 21 
24 147.8, C ---   
26 148.1, CH 8.62, s  C-12, 18, 24 
27 26.6, CH3 1.72, s  C-14, 15, 28 
28 25.5, CH3 1.55, s  C-14, 15, 27 
29 162.3, CHO 8.73, d (0.9) H-2 C-2 
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2. Results and Discussion 
Compound 1d was isolated as white solid, and its molecular formula C24H20N4O5 was established 
on the basis of the (+)-HRESIMS m/z 445.1512 [M + H]
+
, indicating 17 degrees of unsaturation. The 
IR spectrum showed absorption bands for aromatic (3010, 1582, 1450 cm
−1
) and carbonyls of 
ester/amide groups (1700 cm
−1
). The general features of the 
1
H and 
13
C spectra of 1d (Supplementary 
Information, Figures S1 and S2) closely resembled those of tryptoquivaline L (1a). The 
13
C NMR, 
DEPT and HSQC spectra (Table 1) revealed three amide/ester carbonyls (δC 172.5, 171.1 and 160.0), 
one N-formyl (δC 162.3), four quaternary sp
2
 (δC 147.8, 138.4, 133.5, 121.4), nine methine sp
2
 (δC 148.1, 
135.1, 131.8, 127.6, 127.4, 126.8, 126.7, 126.2, 116.4), two quaternary sp
3
 (δC 84.2 and 64.1), two 
methine sp
3
 (δC 81.0 and 57.7), one methylene sp
3
 (δC 33.8) and two methyl (δC 26.6 and 25.5) carbons. 
Analysis of the 
1
H, 
13
C NMR, HSQC, COSY and HMBC (Table 1) revealed the presence of the  
N-substituted quinazolin-4-one and the 6-5-5 gem-dimethyl imidazoindole ring systems which were 
connected via a five membered spirolactone as in tryptoquivaline L [16]. However, the only difference 
between 1d and tryptoquivaline L (1a) is the presence of the formyl group on N-16 of the  
gem-dimethyl imidazoindole moiety in the former and a hydroxyl group in the latter. On the other 
hand, the structure of 1d differs from that of tryptoquivaline O, previously reported from N. siamensis 
by Buttachon et al. [16], in that there are two methyl groups on C-15 of the imidazoindole ring in the 
former instead of one methyl group in the latter. The assignments of the proton and carbon chemical 
shifts for CH3-27 and CH3-28 were based on the NOESY correlation between the signals of H-2  
(δH 6.10, s) and CH3-27(δH 1.72, s). Thus, 1d is a new tryptoquivaline analogue which we have named 
tryptoquivaline T. Since the chemical shift values of H-2 and H-12 of tryptoquivaline T (1d) are 
similar of those of the corresponding protons of tryptoquivaline O, we assume that the stereochemistry 
of tryptoquivaline T (1d) is the same as that of tryptoquivaline O, i.e., C-2S, C-3S and C-12R. This 
assumption was also supported by the negative value of the rotation tryptoquivaline T (1d). 
Compound 5 was also isolated as white solid (mp, 200–202 °C) and its molecular formula C26H38O4 
was established on the basis of the (+)-HRESIMS m/z 415.2836 [M + H]
+
 (calculated 415.2848), indicating 
eight degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl (3445 cm
−1
), 
conjugated ester carbonyl (1668 cm
−1
) and olefin (1649, 1636 cm
−1
) groups. The 
13
C NMR, DEPT and 
HSQC spectra (Table 2) exhibited the signals of one conjugated ester carbonyl (δC 164.6), five 
quaternary sp
2
 (δC 164.3, 159.3, 136.6, 126.2. 101.4), one methine sp
2 (δC 99.9), three quaternary sp
3
 
(δC 38.8, 38.4 and 36.8), one oxymethine sp
3
 (δC 76.9), two methine sp
3
 (δC 56.0, 54.8), seven 
methylene sp
3
 (δC 38.0, 37.9, 34.2, 27.1, 22.1, 18.2, 17.7), and six methyl (δC 28.1, 21.2, 20.3, 19.2, 
16.3 and 15.7) carbons. Except for the presence of one more methyl group instead of an exocyclic 
methylene group, and a tetra-substituted double bond (δC 126.2 and 136.6), the 
1
H and 
13
C data (Table 2, 
Supplementary Information, Figures S3 and S4) revealed the existence of the perhydrophenanthrene 
moiety connected to the 4-hydroxy-6-methyl-2H-pyran-2-one portion through the methylene group, 
similar to those of aszonapyrone B (4b) [15]. That the double bond in the perhydrophenanthrene 
moiety was on C-13 and C-14 was supported by the HMBC correlations of H3-26 (δH 1.55) to C-12 (δC 
34.2), C-13 (δC 126.2), C-14 (δC 136.6); H-15 (δH 3.02, brs) to C-8 (δC 38.8), C-13, C-14, C-16 (δC 
101.4), C-17 (δC 164.3) and C-21 (δC 164.6). That the hydroxyl group on C-3 was β is supported by the 
chemical shift value (δC 15.7) of the C-4 axial methyl (CH3-23) which suffered a γ-gauche interaction [17]. 
Thus, compound 5 is a new analogue of aszonapyrones which we have named sartorypyrone C. 
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Table 2. 
1
H and 
13
C NMR (DMSO, 300.13 and 75.47 MHz) and HMBC assignment for 
sartorypyrone C (5). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1 37.9, CH2 1.65, m H-2  
2 27.1, CH2 1.46, m H-1, 3  
3 76.9, CH 2.97, m H-2  
4 38.4, C --- ---  
5 54.8, CH 0.67, brd (9.6) H-6  
6 17.7, CH2 1.35, m H-5, 7  
7 38.0, CH2 1.96, m H-6  
8 38.8, C --   
9 56.0, CH 0.97, brd (11.4) H-11 CH3-24 
10 36.8, C ---   
11 18.2, CH2 1.46, m H-9, 12  
12 34.2, CH2 1.94, m H-11  
13 126.2, C --- ---  
14 136.6, C --- ---  
15 22.1, CH2 3.02, brs --- C-8, 13, 14, 16, 17, 21 
16 101.4, C --- ---  
17 164.3, C --- ---  
18 99.9, CH 5.90, s  CH3-20, C-1617, 19, 20 
19 159.3, C --- ---  
20 19.2, CH3 2.12, s H-18 C-18, 19 
21 164.6, C --- --- C-3, 4, 5, 23 
22 28.1, CH3 0.86, s --- C-3, 4, 5, 22 
23 15.7, CH3 0.66, s ---  
24 16.3, CH3 0.77, s --- C-1, 5, 9, 10 
25 21.2, CH3 0.89, s --- C-8, 9, 14 
26 20.3, CH3 1.55, s --- C-12, 13, 14 
Compounds 1–8 (Figure 1) were tested for their antibacterial activity against bacterial reference 
strains and environmental multidrug-resistant isolates, and their MIC and MBC (when determined) 
values are shown in Table 3A. It is interesting to note that neither of the indole alkaloids (1a–d, 2) 
exhibited relevant antibacterial activity. However, within the meroditerpene group, only aszonapyrone 
A (4a) and sartorypyrone A (8) presented significant MIC values against Gram-positive bacteria. 
Aszonapyrone A (4a) showed the MIC values of 8 µg/mL against S. aureus ATCC 25923 and  
B. subtilis ATCC 6633, while sartorypyrone A (8) showed the MIC values of 32 and 64 µg/mL, 
respectively, against the same reference strains. Based on these results, the MIC values of these two 
compounds were further determined against Gram-positive multidrug-resistant strains. While 
aszonapyrone A (4a) was found to be active against both S. aureus MRSA and Enterococcus spp. 
VRE isolates, sartorypyrone A (8) did not show any inhibition on the growth of Enterococcus spp. 
VRE isolates in the range of concentrations tested (Table 3B). MBC values were only achieved for 
aszonapyrone A (4a) against Gram-positive reference strains, and since sartorypyrone A (8) did not 
exhibit any bactericidal effect against any strain, its MBC values could not be determined. 
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Table 3. Antimicrobial activity, expressed in µg/mL of 1–8 against references strains (A) and of 4a and 8 against multidrug-resistant  
isolates (B). 
(A) 
Compounds S. aureus ATCC 25923 P. aeruginosa ATCC 27853 B. subtilis ATCC 6633 E. coli ATCC 25922 
 MIC MBC MIC MBC MIC MBC MIC MBC 
1a 128 − 128 256 128 − 128 − 
1b 128 − 128 256 128 − 128 − 
1c 128 − 128 128 128 − 128 − 
1d − − 128 − 128 − 128 − 
2 256 − 128 256 128 − 128 − 
3 128 − 128 256 128 − 128 − 
4a 8 64 128 256 8 16 128 − 
4b 256 − 128 256 128 − 128 − 
5 128 − 128 256 128 − 128 − 
6 − − − − − − − − 
7a − − − − − − − − 
7b − − − − − − − − 
8 32 − − − 64 − − − 
(B) 
Compounds S. aureus B1 S. aureus B1 E. faecalis W1 E. faecium W5 
 MIC MBC MIC MBC MIC MBC MIC MBC 
4a 8 − 8 − 16 − 16 − 
8 32 − 32 − − − − − 
(−): >256 µg/mL. 
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Table 4. Antibacterial efficacy (halos, mm) of combined effect of antibiotics with compounds 1–8 (15 µg/disc) against three  
multidrug-resistant isolates, using the disc diffusion method. 
 E. coli G1 S. aureus B1 E. faecium W5 
 Antibiotics 
Compounds CIP AMP CTX S OX AMP CTX VA AMP E 
1a 7 7 = 7.5 = = = = = = 
1b 7 7 = 7.5 = = = = = = 
1c 7 7 = 7.5 = = = = = = 
1d 7 7 = 7.5 = = = = = = 
2 7 7 = 7.5 = = = = = = 
3 7 7 = 7.5 = = = = = = 
4a 8 8 = 8 12.5 13 13 11 12 13.5 
4b 7 7 = 7.5 11 10 10.5 11 12 13.5 
5 7 7 = 7.5 = = = = = = 
6 7 7 = 7.5 = 9 = = = = 
7a 8 8 = 8 9.5 10 9.5 8.5 9 8 
7b 7 7.5 = 7.5 8.5 9.5 8.5 = = = 
8 7.5 7.5 = 7.5 10 10 10 8.5 7 7 
Control 0 0 14 0 0 7 0 8 0 0 
Control: Antibiotic with no compounds; CIP: Ciprofloxacin; AMP: Ampicillin; CTX: Cefotaxime; S: Streptomycin; OX: Oxacillin; VA: Vancomycin; E: Erythromycin. 
(=): Indicates no influence of the compound; same result as obtained with no compound. 
Table 5. Fractional inhibitory concentration (FIC) index results obtained with 4a/8 and antibiotic combinations by checkerboard method. 
Bacterial Isolate 4a-OX 8-OX 4a-VA 8-Va 4a-AMP 8-AMP 
ΣFIC Activity a ΣFIC Activity ΣFIC Activity ΣFIC Activity ΣFIC Activity ΣFIC Activity 
S. aureus B1 0.562 I 0.516 I − − − − 2 I 0.516 I 
S. aureus B2 2 I 0.625 I − − − − 2 I 0.625 I 
E. faecalis W1 − − − − 0.312 S − − 0.75 I − − 
E. faecium W5 − − − − 0.312 S − − 0.75 S − − 
AMP: Ampicillin; OX: Oxacillin; VA: Vancomycin; a S = synergism; I = indifference; (−): Not determined. 
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The disc diffusion method (Table 4) revealed a small synergistic association between all the 
compounds tested and the antibiotics to which E. coli G1 was resistant. Even though only a few 
compounds showed synergism against S. aureus B1 and E. faecium W5, association of aszonapyrone 
A (4a) with the antibiotics was found to produce the biggest halos, whereas sartorypyrone A (8) 
increased the antibiotic inhibition halos against S. aureus B1 and, to a lesser extent, against E. faecium 
W5. Interestingly, although chevalone C (7a) alone did not show antibacterial activity at the highest 
concentration tested (MIC > 256 mg/mL), it demonstrated a synergistic effect with antibiotics against 
all three multidrug-resistant isolates. The results of the Checkerboard method, represented by the FIC 
index, are shown in Table 5. The combination effect of aszonapyrone A (4a) with oxacillin (OX) and 
ampicillin (AMP) against MRSA and VRE isolates, respectively, was found to be indifferent  
(ΣFIC > 0.5); however, aszonapyrone A (4a) was found to lower the MIC of each antibiotic tested, 
thus, it may be considered a partially synergist effect. The association of aszonapyrone A (4a) with 
vancomycin (VA) showed a clear synergistic effect (ΣFIC < 0.5) against the two VRE isolates tested. 
The combination of sartorypyrone A (8) with OX and AMP against MRSA isolates was found to be 
also indifferent. Since the MIC of sartorypyrone A (8) against VRE was higher than 256 µg/mL, no 
checkerboard method was performed for this compound against VRE isolates. 
The effect of aszonapyrone A (4a) and sartorypyrone A (8), at different concentrations (ranging 
from 2× MIC to 1/4× MIC), on the biofilm formation of S. aureus ATCC 25923, B. subtilis ATCC 
6633 and S. aureus B1, and also E. faecalis W1 (in the case of 4a) was also assessed using the biomass 
quantification, and the results are shown in Figure 2. All the strains tested showed no biofilm 
formation in the presence of 2xMIC and MIC of aszonapyrone A (4a) and sartorypyrone A (8). 
However, S. aureus ATCC 25923 and S. aureus B1 formed more biofilm in the presence of a  
sub-inhibitory concentration (1/2× MIC) of aszonapyrone A (4a) (Figure 2A). Moreover, S. aureus 
ATCC 25923 was found to produce a significantly (P < 0.05) higher amount of biomass in the 
presence of 1/2× MIC of sartorypyrone A (8), when compared to the control (Figure 2B). In order to 
confirm the effect of these compounds on biofilm formation, the microscopic visualization of the 
biofilm produced by S. aureus ATCC 25923 was carried out using a Live/Dead staining. After 24 h, 
the majority of the cells within the biofilm were viable and large aggregates embedded in a matrix 
could be observed (Figure 3A). In the presence of aszonapyrone A (4a), at a concentration equal to the 
MIC, no biofilm was formed and also no growth was observed (Figure 3B). However, at the 
concentration of 1/2× MIC, it was possible to observe more biofilm in comparison to the control 
(Figure 3C). These results are in agreement with those obtained in the biomass quantification for the 
same experimental conditions. However, this result is not unexpected since there are several reports of 
the increase in biofilm formation in both Gram-positive and Gram-negative bacteria in the presence of 
sub-inhibitory concentrations of antibiotics [18–20]. Interestingly, the BIC value of aszonapyrone A 
(4a) was found to be higher than 12× MIC against mature biofilms of both S. aureus B1  
(BIC > 96 µg/mL) and E. faecalis W1 (BIC > 192 µg/mL). However, the exact BIC value could not be 
determined due to the limited quantity of this compound available to perform all these biological 
assays. These very high BIC values may reflect the difficulty of 4a in penetrating the extracellular 
biofilm matrix, thus hampering the eradication of the pre-established biofilm. 
Examination of the structures of the meroditerpenes tested (Figure 1) suggested the existence of 
some common features necessary for the antibacterial activity of this class of compounds. Although 
Mar. Drugs 2014, 12 831 
 
 
aszonapyrone A (4a), aszonapyrone B (4b), sartorypyrone C (5) and sartorypyrone A (8), all contain 
the 4-hydroxy-6-methyl-2H-pyran-2-one ring, only aszonapyrone A (4a) and sartorypyrone A (8) have 
the β-acetoxyl group on C-3. On the other hand, this 4-hydroxy-6-methyl-2H-pyran-2-one ring is 
connected to the perhydrophenanthrene portion by the ethereal bridge, forming a more rigid pentacyclic 
structure in chevalone B (6). On the other contrary, both chevalone C (7a) and sartorypyrone B (7b) 
contain the 6-methyl-4H-pyran-4-one ring connected to the perhydrophenanthrene portion by an 
ethereal bridge. Therefore, it is apparent that the presence of a free 4-hydroxy-6-methyl-2H-pyran-2-one 
ring on C-15 and the β-acetoxyl group on C-4 of the perhydrophenanthrene portion are required for the 
antibacterial activity of this series of meroditerpenes. 
Figure 2. Biomass quantification of biofilms of Gram-positive bacteria formed in the 
presence of different concentrations (ranging from 2× MIC to 1/4× MIC) of 4a (A)  
and 8 (B). 
 
Figure 3. Evaluation of S. aureus ATCC 25953 biofilm formation. Live/dead viability 
staining images after 24 h. Control (A); Biofilm formation in the presence of the MIC (B) 
and in the presence of ½ of the MIC (C) of 4a.  
 
3. Experimental Section 
3.1. General Experimentation Procedures 
Melting points were determined on a Bock monoscope and are uncorrected. Optical rotations were 
determined on an ADP410 Polarimeter (Bellingham+Stanley Ltd., Tunbridge Wells, Kent, UK) 
Infrared spectra were recorded on an ATT Mattson Genesis Series FTIR™ using WinFIRST Software. 
1
H and 
13
C NMR spectra were recorded at ambient temperature on a Bruker AMC instrument (Bruker 
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Biosciences Corporation, Billerica, MA, USA) operating at 300.13 and 75.4 MHz, respectively. High 
resolution mass spectra were measured with a Xevo QToF mass spectrometer (Waters Corporations, 
Milford, MA, USA) coupled to the Aquity UPLC system (Waters Corporations, Milford, MA, USA). 
A Merck silica gel GF254 was used for preparative TLC, and a Merck Si gel 60 (0.2–0.5 mm) was used 
for analytical chromatography. 
3.2. Extraction and Isolation 
Extraction and Isolation of Secondary Metabolites from the Culture of Neosartorya paulistensis 
(KUFC 7897) 
Neosartorya paulistensis (KUFC 7897) was isolated from the marine sponge Chondrilla 
australiensis which was collected from Mu Kho Lan Beach, Chonburi Province, Thailand in May 
2010. After rinsing with sterile sea water, the sponge was dried on sterile filter papers and cut into 
small pieces (5 × 5 mm) and placed on the plates containing malt extract agar (MEA, 30 g of malt 
extract, 15 g of bacto agar, distilled water 1000 mL and adjusted to the final pH at 5.5) with 70% sea 
water and incubated at 28 °C under 12 h light/12 h dark cycle for 7 days. The fungus was identified by 
Prof. Dr. Leka Manoch (Department of Plant Pathology, Kasetsart University, Bangkok, Thailand), by 
morphological features, including the characteristic of ascospores and colonies. The identification was 
supported by sequence analysis of the β-tubulin gene described in the previous report [21] and the pure 
cultures were deposited as KUFC 7897 at Kasetsart University Fungal Collection, Department of Plant 
Pathology, Faculty of Agriculture, Kasetsart University, Bangkok, Thailand, and as MMERU 02 at 
Microbes Marine Environment Research Unit, Division of Environmental Science, Faculty of Science, 
Ramkhamhaeng University, Bangkok, Thailand. The fungus was cultured for two weeks at 28 °C in  
10 Petri dishes (i.d. 90 mm) containing 25 mL of MEA with 70% sea water per dish. Fifty 1000 mL 
Erlenmeyer flasks each containing rice (200 g), water (30 mL), and sea water (70 mL), were 
autoclaved, inoculated with five mycelia plugs of N. paulistensis and incubated at 28 °C for 30 days, 
after which the mouldy rice was macerated in ethyl acetate (15 L total) for 10 days and then filtered. 
The two layers were separated using a separatory funnel and the ethyl acetate solution was 
concentrated at a reduced pressure to yield crude ethyl acetate extract, which was washed with 5% of 
NaHCO3 solution (2 × 500 mL) and H2O (3 × 500 mL). The organic layer was dried with anhydrous 
Na2SO4, filtered and evaporated under reduced pressure to give 51 g of crude extract which was 
applied on a column chromatography over 610 g of Si gel (0.2–0.5 mm, Merck KGaA, Darmstadt, 
Germany) and eluted with mixtures of CHCl3–petrol and CHCl3–Me2CO, wherein 250 mL fractions 
were collected as follows: fractions 1–25 (CHCl3–petrol, 1:4), 26–149 (CHCl3–petrol, 3:7),  
150–177 (CHCl3–petrol, 2:3), 178–278 (CHCl3–petrol, 1:1), 279-399 (CHCl3–petrol, 3:2), 400–534 
(CHCl3–petrol, 4:1), 535–549 (CHCl3–petrol, 9:1), 550–592 (CHCl3), 593–837 (CHCl3–Me2CO, 9:1), 
838–976 (CHCl3–Me2CO, 8:2), 977–1047 (CHCl3–Me2CO, 7:3), 1048–1090 (CHCl3–Me2CO, 1:1) 
and 1091–1112 (CHCl3–Me2CO, 1:4). Frs 299–307 (526 mg) were combined and recrystallized in 
petrol to give 12 mg of sartorypyrone C (5). Frs 627–696 were combined (1.50 g) and crystallized in a 
mixture of CHCl3 and acetone to give 70 mg of tryptoquivaline L (1a). Frs 739–774 were combined 
(400 mg) and crystalized in Me2CO to give 95 mg of tryptoquivaline H (1b). The mother liquor of  
Mar. Drugs 2014, 12 833 
 
 
frs 739–774 and frs 697–774 were combined (850 mg), applied on a column chromatography of 
LiChroprep Si 60 (40–63 mm, 46 g) and eluted with mixtures of CHCl3–petrol and CHCl3–Me2CO 
wherein 100 mL sub-fractions were collected as follows: subfrs 1–24 (CHCl3–petrol, 4:1), 25–49 
(CHCl3–petrol, 9:1), 50–63 (CHCl3), 64–142 (CHCl3–Me2CO, 9:1) and 143–163 (CHCl3–Me2CO, 4:1). 
Subfrs 82–86 were combined (31 mg) and purified by TLC (Si gel, CHCl3–Me2CO–EtOAc–HCO2H, 
7:2:1:0.1) to give 8.3 mg of tryptoquivaline L (1a) and 9.6 mg of 4(3H)-quinazolinone (3) [22]. Subfrs 
87–102 were combined (250 mg) and purified by TLC (Si gel, CHCl3–Me2CO–EtOAc–HCO2H, 
7:2:1:0.1) to give 38 mg of tryptoquivaline L (1a) and 18 mg of tryptoquivaline H (1b).  
Subfrs 103–130 were combined (157 mg) and crystallized in Me2CO to give 27 mg of tryptoquivaline 
H (1b). Frs 775–832 were combined (690 mg) and crystalized in Me2CO to give 95 mg of  
3′-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5′]-2,2′-dione (2). The mother liquor of frs 775–832 and 
frs 833-860 were combined (902 mg) and applied over a LiChroprep Si 60 column (40–63 µm, 41 g, 
Merck KGaA, Darmstadt, Germany) and eluted with mixtures of CHCl3–petrol and CHCl3–Me2CO 
wherein 100 ml sub-fractions were collected as follows: subfrs 1–26 (CHCl3–petrol, 4:1), 27–41 
(CHCl3), 42–108 (CHCl3–Me2CO, 9:1). Subfrs 61–68 were combined and purified by TLC (Si gel, 
CHCl3–Me2CO–EtOAc–HCO2H, 7:2:1:0.1) to give 4.2 mg of tryptoquivaline L (1a) and 18 mg of 
tryptoquivaline H (1b). Subfrs 69-86 were combined (176 mg) and recrystallized in Me2CO to give  
15 mg of 3′-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5′]-2,2′-dione (2). Frs 905–947 were combined 
(670 mg) and crystalized in Me2CO to give 16.4 mg of tryptoquivaline F (1c). The structures of the 
compounds were established by comparison their NMR spectral data with those in the literature [16] as 
well as with authentic samples.  
3.2.1. Sartorypyrone C (5) 
White solid, Mp = 200–202 °C. [α]D
25
 = −73.5° (c 0.07, CHCl3); IR (KBr) νmax 3445, 2923, 2942, 
2853, 1699, 1668, 1649, 1636, 1507, 1124 cm
−1
. 
1
H and 
13
C see Table 1. HR-ESIMS m/z 415.2836  
(M + H)
+
 (calculated for C28H41O5, 415.2848). 
3.2.2. Isolation of Tryptoquivaline T (1d) from the Culture of Neosartorya laciniosa (KUFC 7896) 
Extraction and isolation of tryptoquivaline L (1a) 3′-(4-oxoquinazolin-3-yl) spiro[1H-indole-3, 
5′]-2,2′-dione (2), aszonapyrone A (4a) and aszonapyrone B (4b) from the culture of the diseased coral 
derived fungus Neosartorya laciniosa (KUFC 7896) have been previously described by us [15]. The 
column fractions 498–507 (793 mg) and mother liquor of the combined frs 508–546 (1.57 g) were 
combined and chromatographed over a LiChroprep Si 60 column (40–63 µm, 36 g, Merck KGaA, 
Darmstadt, Germany) and eluted with mixtures of CHCl3–petrol and CHCl3–Me2CO wherein 100 mL 
sub-fractions were collected as follows: Subfrs 1–84 (CHCl3–petrol, 9:1), 85–137 (CHCl3–Me2CO, 
9:1), 138–162 (CHCl3–Me2CO, 4:1). Subfrs 43–50 were combined (214 mg) and recrystallized in 
Me2CO to give 13 mg of tryptoquivaline T (1d). 
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Tryptoquivaline T (1d) 
White solid, Mp = 258–260 °C. [α]D
25
 = −83.3 (c 0.04, MeOH); IR (KBr) νmax 3010, 2930, 2852, 
1701, 1582, 1450, 1402, 1269 cm
−1
. 
1
H and 
13
C see Table 2. HR-ESIMS m/z 445.1512 (M + H)
+
 
(calculated for C28H41O5, 445.1512). 
3.2.3. Isolation of Chevalone B (6) and Chevalone C (7a) from the Culture of Neosartorya siamensis 
(KUFC 6349) 
Isolation and identification of the fungus as well as fractionation of the crude extract and isolation 
of other constituents from the culture of Neosartorya siamensis (KUFC 6349) have been previously 
described by us [16]. Fr 34 (1.02 g) was applied on a column chromatography of Si gel (35 g) and 
eluted with mixtures of petrol–CHCl3 and CHCl3–Me2CO, 100 mL fractions were collected as follows: 
Subfrs 1–32 (CHCl3–petrol 3:7), 33–54 (CHCl3–petrol, 1:1), 55–58 (CHCl3–petrol, 7:3). Subfrs 15–17 
were combined (0.28 g) and crystallized in mixture of petrol and CHCl3 to give 137.5 mg of chevalone 
B (6). Frs 35 (630 g) was applied on a column chromatography of Si gel (35 g) and eluted with 
mixtures of petrol–CHCl3, 100 mL fractions were collected as follows: Frs 1–52 (CHCl3–petrol, 3:7), 
53–64 (CHCl3–petrol, 1:1). Subfrs 33–52 were combined (63.6 mg) and purified by TLC (Si Gel, 
CHCl3–Me2CO–HCO2H, 95:0.5:0.1) to give 12 mg of chevalone C (7a). Subfrs 53–56 were combined 
(300 mg) and crystallized in petrol to give 40.3 mg of chevalone C (7a). Frs 36–53 were combined 
(1.80 g) and crystallized in a mixture of petrol and CHCl3 to give 375 mg of chevalone C (7a).  
Frs 83–100 were combined (300 mg) and crystallized in a mixture petrol and CHCl3 to give 112.5 mg 
of chevalone C (7a). 
3.3. Antibacterial Activity Bioassays 
3.3.1. Bacterial Strains 
For the antibacterial bioassays, fungal metabolites were tested against reference strains, two  
Gram-positive (Staphylococcus aureus ATCC 25923 and Bacillus subtilis ATCC 6633) and two 
Gram-negative (Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) bacteria, 
and against multidrug-resistant isolates from the environment, S. aureus B1 and S. aureus B2 (isolated 
from public buses), Enterococcus faecalis W1 and E. faecium W5 (isolated from river water) and  
E. coli G1 (isolated from seagull feces). These bacteria were grown in Mueller-Hinton agar  
(MH—BioKar diagnostics, Allonne, France) from stock cultures. MH plates were incubated at 37 °C 
prior to obtain fresh cultures for each in vitro bioassay. 
3.3.2. Determination of Minimum Inhibitory and Bactericidal Concentrations 
The minimum inhibitory concentration (MIC) values of the 13 compounds were determined by a 
broth microdilution technique, following the recommendations of the Clinical and Laboratory 
Standards Institute [23]. Stock solutions of 10 mg/mL prepared by dissolving each metabolite in 
dimethylsulfoxide (DMSO—Applichem GmbH, Darmstadt, Germany) were serial diluted in  
Mueller-Hinton broth (MHB—BioKar diagnostics, Allonne, France) to achieve in-test concentrations 
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ranging from 2 to 256 µg/mL. Ciprofloxacin in the concentration range from 0.03125 to 16 μg/mL was 
used as control drug in the experiment. A bacterial inoculum was prepared in MHB and standardized 
in order obtain a concentration of 5 × 10
5
 CFU/mL in each inoculated well of the microtiter plate. The 
concentration of DMSO in the highest in-test concentration did not affect the microbial growth. The 
MIC was defined as the lowest concentration of the compound that inhibited the visible growth. The 
minimum bactericidal concentration (MBC) was determined by spreading 10 µL on MH plates from 
the sample showing no visible growth and it was further incubated for 24 h at 37 °C; the lowest 
concentration at which no bacterial growth occurred on MB plates was defined as the MBC. 
3.3.3. Synergistic Studies 
A screening susceptibility test to assess combined effect between compounds 1–8 and antibiotics 
was conducted using the disc diffusion method on MH. Multidrug-resistant isolates were picked from 
overnight cultures in MH, and suspensions were prepared in buffered peptone water (Oxoid, 
Basingstoke, England) by adjusting the turbidity to equal a 0.5 McFarland standard. A set of antibiotic 
discs (Oxoid, Basingstoke, England) was selected based on the resistance of the isolates towards those 
antibiotics. Antibiotic discs alone (controls) and impregnated with 15 µL of a 1 mg/mL solution  
(in DMSO) of each metabolite were placed on the agar plate seeded with the respective bacteria. 
Fifteen µL of DMSO impregnated in a sterile filter paper disc (6 mm in diameter) (Oxoid, 
Basingstoke, England) was used as the negative control. Inoculated MH plates were incubated 
overnight at 37 °C. Each compound was tested in duplicate. Potential synergism was recorded when 
the halo of antibiotic discs impregnated with metabolites was greater than the halo of antibiotic discs 
or compound-impregnated blank discs alone.  
Based on the results of the previous assay, potential synergism between the most promising 
compounds (4a and 8) and antibiotics (oxacillin, vancomycin and ampicillin—Sigma-Aldrich, St. 
Louis, MO, USA) was checked using a broth microdilution checkerboard method and tested against S. 
aureus MRSA and Enterococcus spp. VRE isolates. Briefly, the stock solutions and serial twofold 
dilutions of each compound and antibiotic to at least double the MIC were prepared according to the 
recommendations of CLSI [23]. The metabolite to be tested was serially diluted along the ordinate, 
while the antibiotic was diluted along the abscissa. A bacterial inoculum equal to a 0.5 McFarland 
turbidity standard was prepared in MHB. Each microtiter plate well was inoculated with 100 µL of a 
bacterial inoculum of 5 × 10
5
 CFU/mL, and the plates were incubated overnight at 37 °C. The 
fractional inhibitory concentration (FIC) was calculated as follows: FIC of drug A (FIC A) = MIC of 
drug A in combination/MIC of drug A alone, and FIC of drug B (FIC B) = MIC of drug B in 
combination/MIC of drug B alone. The FIC index (ΣFIC), calculated as the sum of each FIC, was 
interpreted as follows: ΣFIC ≤ 0.5, synergy; 0.5 < ΣFIC ≤ 4, no interaction; 4 < ΣFIC, antagonism [24]. 
3.3.4. Antibiofilm Activity Assay 
Given the promising antibacterial activity of 4a and 8 against Gram-positive bacteria, the efficacy 
of those two compounds in interrupting the biofilm formation was assessed. The metabolites at 
concentrations of 2× MIC, MIC, 1/2× MIC and 1/4× MIC were added to bacterial suspensions of  
1 × 10
6
 CFU/ml in Tryptic Soy broth (TSB—BioKar diagnostics, Allonne, France). Bacterial 
Mar. Drugs 2014, 12 836 
 
 
suspension without metabolites was used as the control. Each broth culture obtained was dispensed 
into a 96-well microtiter plate (200 µL/well) and incubated at 37 °C for 24 h. After that time, biofilm 
was stained with 0.5% crystal violet for 5 min, rinsed with water, air dried and eluted with acetic acid 
33% (v/v). The optical density was measured at 595 nm (OD595) using a microplate reader  
(iMark™ microplate absorbance reader, Bio-Rad Laboratories, Hercules, CA, USA). Two independent 
experiments were performed in triplicate for each experimental condition. The statistical significance 
of difference between biofilms of controls and biofilms in the presence of different concentrations of 
compounds was evaluated using Student’s t test. In both cases, probability levels <0.05 were 
considered statistically significant. The efficacy of 4a on established biofilm of S. aureus B1 and  
E. faecalis W1 was also evaluated by determining the biofilm inhibitory concentration (BIC) according 
to the method described by Johnson et al. [25]. Briefly, bacterial suspensions in TSB at 1 × 10
6
 
CFU/mL were used to grow the biofilms in 96-well microtiter plate. After 24 h of incubation at 37 °C, 
the planktonic cells were gently removed and the wells were rinsed once and filled with different 
dilutions ranging from the MIC values to 12× MIC. The OD595 was measured at time 0 and after 
incubation for 24 h at 37 °C. The BIC was determined as the lowest concentration of the compound 
inhibiting growth in the supernatant fluid, confirmed by no increase in optical density compared with 
the initial reading. 
Additionally, microscopic visualization of biofilms of S. aureus ATCC 25923 was performed using 
the Live/Dead BacLight viability kit (Life Technologies—Molecular Probes, Carlsbad, CA, USA). 
Biofilms were formed in 35-mm diameter polystyrene plates using TSB (control) and TSB 
supplemented with MIC and 1/2× MIC of 4a. After 24 h at 37 °C. The planktonic phase was removed 
from each plate, washed with PBS, stained with the appropriate mixture of SYTO 9 and propidium 
iodide stains and incubated for 20 minutes at room temperature in the dark; then, were rinsed and 
examined under a fluorescence microscope (BX41 Microscope, Olympus America Inc., Center Valley, 
PA, USA). Images were recorded at an emission wavelength of 500 nm for SYTO 9 (green 
fluorescence) and of 635 nm for propidium iodide (red fluorescence). 
4. Conclusions 
We reported the isolation and structure elucidation of a new meroditerpene, sartorypyrone C (5), 
together with the previously described tryptoquivalines L (1a), H (1b), F (1c), 3′-(4-oxoquinazolin-3-yl) 
spiro[1H-indole-3,5′]-2,2′-dione (2) and 4(3H)-quinazolinone (3), from the culture of the marine 
sponge-associated fungus N. paulistensis (KUFC 7897), as well as a new tryptoquivaline derivative 
which we have named tryptoquivaline T (1d), from the culture of the diseased coral-derived fungus  
N. laciniosa (KUFC 7896). Antibacterial activity evaluation of the isolated compounds, together with 
the previously described meroditerpenes aszonapyrones A (4a) and B (4b), chevalones B (6) and  
C (7a), sartorypyrones B (7b) and A (8), against four reference strains (S. aureus, B. subtilis, E. coli, 
and P. aeruginosa), as well as the environmental multidrug-resistant isolates, showed that only the 
meroditerpenes aszonapyrone A (4a) and sartorypyrone A (8) were active against both Gram-negative 
reference strains and the environmental multidrug-resistant isolates. Aszonapyrone A (4a) also 
exhibited a clear synergistic effect with vancomycin against the two VRE isolates, while it showed 
only partially synergist effect with oxacillin and ampicillin against MRSA and VRE isolates. Both 
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aszonapyrone A (4a) and sartorypyrone A (8) were found to inhibit the biofilm formation in both 
reference strains (S. aureus ATCC 25923 and B. subtilis ATCC 6633) and the multi-drug resistant 
isolates (S. aureus B1 and E. faecalis W1), at the 2× MIC and MIC. 
In light of the results presented in this work, we can conclude that the meroditerpenes aszonapyrone 
A (4a) and sartorypyrone A (8) are two promising antibacterial agents, especially against  
Gram-positive bacteria, and their effects are comparable to those of standard antibiotics currently in 
use in therapeutics, with the advantage of being also active against bacteria that already exhibit 
resistance towards these antibiotics. To the best of our knowledge, none of the available antibiotics 
belongs to this class of compounds, which thereby may represent a novel and potential topic of 
investigation in the field of new antibacterial agents from the marine-derived fungi.  
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